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Abstract
Cancer is nowadays the second leading cause of death in the world. Cancer starts
with a single cell that has accumulated several mutations usually over a long
period of time. One of the main characteristics of this cell is its ability to replicate
unbounded producing, in most occasions, a mass of densely packed daughter cells
that form a solid tumor. Cancerous cells depend on nutrients and oxygen supplied
by pre-existent blood vessels to proliferate. This supply is not enough to maintain
the growth and most tumors remain small and benign due to this constraint.
Occasionally, however, some cells develop the ability to promote the growth of new
capillaries towards them. This process is called tumor-induced angiogenesis and
through it tumors acquire a constant supply of nutrients and oxygen and access to
the whole body through the circulatory system. Tumors that are able to trigger
angiogenesis become malignant as they can grow unbounded and metastasize.
Malignant tumors can grow large enough to damage the functionality of the host
organ and, eventually, lead to death.
A few decades ago, scientists have proposed that blocking angiogenesis could be an
effective treatment against cancer. This therapy, known as antiangiogenic therapy,
has shown promising results in pre-clinical trials, but has not translated into the
expected results in the clinic. A new emerging paradigm in Medicine, namely,
Predictive Medicine, is expected to change the Oncology field and may be the tool
to understand the problems with this therapy. Predictive Medicine is based on
mathematical modeling and computation and has been so far successfully applied
to several areas of Medicine. In the Oncology field it has only been started, but has
already produced sound advances. In particular, in tumor-induced angiogenesis
numerous researchers have proposed mathematical models to address the problem
of antiangiogenic therapies, although there is still a need for improvement to attain
this goal. Angiogenesis is a complex multiscale process that involves several key
mechanisms, many of them not yet accounted for in the models. In addition, most
III
models are simulated in two-dimensional simple geometries, while angiogenesis is
a three-dimensional process and occurs in tissues with non-trivial geometries.
In this thesis we develop mathematical models of tumor-induced angiogenesis that
include key biological mechanisms and we simulate these models in relevant exper-
imental setups and in three-dimensional, subject-specific geometries. To achieve
our modeling and simulation goals, we develop adequate numerical algorithms.
Every model in this thesis is hybrid and involves coupling averaged continuous
theories and cellular-scale discrete agents. In addition, the models are grounded
on the phase-field method which requires solving higher-order partial differential
equations. To overcome these problems we developed a seamless coupling between
the continuous variables and the discrete elements to permit an efficient numerical
treatment of the coupled problem. For the resolution of the high-order partial
differential equations involved in the formulation we used isogeometric analysis,
which in addition provides accuracy, robustness, and the geometric flexibility that
we require to perform simulations in real geometries.
This manuscript presents three new mathematical models for tumor-induced an-
giogenesis. In the first one we started with a previous model to which we added a
conceptual model for haptotaxis, one of the main mechanisms that governs cap-
illary growth. The extended model permitted us to assess the role of haptotaxis
in tumor angiogenesis. Furthermore, we developed for the first time a simulation
of one of the most widely used in vivo assays, the mouse corneal micropocket an-
giogenesis assay, using a three-dimensional, subject-specific geometry. The results
are in agreement with the experiments and predict well-known vascular structures
in three dimensions. In addition, they suggest that, for mathematical models to
achieve the topological complexity observed in in vivo angiogenesis experiments,
two-dimensional simulations may not be enough.
The second model focuses on the long-term dynamics of tumor-induced angio-
genesis, that is, on the regression and regrowth events occurring after the first
growth of blood vessels. The model was simulated both in a two-dimensional
replication of the mouse corneal micropocket assay and in a reproduction of an
in vivo experimental setup. Our simulations predict plasticity and dynamic evo-
lution of angiogenesis at long time spans and are in quantitative agreement with
experiments.
Finally, we developed a fully continuum theory for fluid flow at the tissue scale,
which we coupled with our model for tumor angiogenesis. The model shows how
fluid flow alters tumor-induced vascular patterns through convection, which has
been overlooked in mathematical modeling. Our model predicts a substantial
impact of convection in angiogenesis and an increased malignancy of small solid
tumors.
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Introduction
1.1 Motivation and research objective
Motivation
Cancer facts Cancer is the second cause of death in the world, just behind
cardiovascular diseases (see figure 1.1). According to the last estimation from the
World Health Organization performed in 2012 (Ferlay et al., 2012), approximately
8.2 million of people died from cancer, that is, 15% of all deaths worldwide.
Furthermore, there have been 14.1 million estimated new cases that year. And,
although 32.5 million people diagnosed with cancer from 2008 were alive at the
end of 2012, an estimated 169,3 million years of healthy life were lost globally
because of cancer in 2008. Despite the amount of funding and research in the field,
these figures increase year after year, probably boosted by the growth and aging
of the population.
The global fight against cancer is hindered by the different cancer burden and
cancer types among regions, as highlighted by figures 1.1 and 1.2. Figure 1.1 shows
how the number of people that die from cancer varies greatly between different
income countries (using the World Bank income classification World Bank, 2014).
Population aging and lifestyle —including smoking, diet, and physical activity—
are among the main reasons of cancer deaths in the high and upper-middle income
countries, while insufficient access to treatments and late diagnosis are the causes
for high cancer mortality in lower-middle income countries. The high burden of
1
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Figure 1.1. Leading cases of deaths by cause worldwide and by World Bank income
group. After heart diseases, cancer is the leading death cause globally and in the upper-middle
and high income countries. (Data source: Latest estimates by the World Health Organization
Ferlay et al., 2012)
infections and parasitic diseases in low income countries explain their lower cancer
mortality. Figure 1.2 shows both the age-standardized cancer death rate per one
thousand people and the top three cancer killers per region, separated by gender.
This figure also highlights the non uniform distribution of cancer around the
world, not only in its incidence by country, but also in the regional mortality of
different cancer types. Among all cancer types, lung cancer, which is the most
common cancer in men, causes most cancer deaths worldwide; almost a fifth. It
is one of the top cancer killers in every region shown in figure 1.2, except in the
Sub-Saharan Africa. Breast, colorectal, and prostate cancer are also among the
most deadly ones.
All these facts highlight the importance of a community of interdisciplinary re-
searchers coming from all the branches of Science equipped with all kind of tools
to fight cancer. And among these tools, Knowledge has proven to be the more
powerful. History has shown that the more we know about cancer, the better we
are able to fight it.
Cancer through History Cancer is not a recent illness, but a disease affecting
human beings since thousands of years ago. The first known description of cancer,
which was in particular about breast cancer, comes from an Egyptian papyrus
2
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which is a copy of an older book dating back to 3000 BC. This document explains
how tumors were treated by cauterization with a tool called fire drill, although it
is also written they knew there was no treatment for this disease. The Egyptian
culture attributed the disease to gods will. The Greek civilization also knew about
cancer. In fact the word we use now, cancer, is the Latin translation of the Greek
karkinos, which means crab —because it resembled the shape of a crab—, and it
is ascribed to Hippocrates. This physician, called the Father of Medicine, believed
that the body was composed of four fluids: blood, phlegm, yellow bile, and black
bile. He thought that an excess of black bile anywhere in the body caused cancer.
And for more than 1400 years this was the general belief. It is not until the
paradigm shift that came with the development of the Scientific Method in the
Renaissance period that this theory was questioned again. Autopsies started to be
performed and with them the study of cancer, Oncology, began. Now that bodies
were analyzed looking for the causes of death, new theories began to replace
the previous ones. In the Eighteenth century, John Hunter suggested surgery
as a treatment for certain sorts of cancer: Those that had not yet invaded the
neighboring tissues. Afterwards, the development of anesthesia involved advances
in surgery that allowed improvements in the resection of certain tumors. The use
of the modern microscope in the 19th century meant a big step in the study of
cancer. For more detailed information about cancer History see (Olszewski, 2010;
Sudhakar, 2009).
How cancer is understood nowadays At present, we understand cancer as
a group of diseases —more than a hundred— that share common characteristics:
The uncontrolled proliferation of cells and their ability to invade other tissues and
continue there with their abnormal proliferation. Each cancer is different from
the others in many aspects and they are usually named after the host tissue in
which they develop at first, as in breast cancer, prostate cancer, or lung cancer.
Cancer is originated by a single abnormal cell (Weinberg, 1998) that acquires
through mutations, that is changes in their DNA, malignant characteristics. This
process, called carcinogenesis, is complex and may take years or decades to com-
plete. In fact, there is not full knowledge of the reason for all mutations and that
is why we usually refer to risk factors rather than mutations themselves when
speaking about cancer causes. These factors may be divided into exogenous and
endogenous. 75-80% of cancers develop due to the former and they can be either
physical, chemical, or biological. As shown in figure 1.3, the exogenous factors
with higher impact are tobacco use, obesity and overweight, and pathogen infec-
tions. Many authors estimate that 30% of cancer deaths could be prevented by
reducing these factors through healthy life styles. On the other hand, the endoge-
nous factors represent only 5-7% of the whole and are produced by hereditary
4
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Figure 1.3. Exogenous cancer risk factors. The two risk factors that most contribute to
cancer incidence, tobacco and overweight, could be reduced to a minimum just with healthy
habits. (Adapted from American Asociation for Cancer Research, 2015)
alterations in the DNA sequence. The mechanisms by which cancer occurs in the
remaining cases are not accurately known (Ames et al., 1995). In addition, one
of the most important factors is aging (Torre et al., 2015), as explained latter in
this document.
The consequence of carcinogenesis is usually the creation of solid masses or tumors,
formed by cancerous cells that multiply rapidly, even ignoring the anti-growth
signals sent by the own body. Tumors grow and develop going through a set of
increasingly-malignant stages. Remarkably, tumors can gain the ability to invade
nearby tissues or to colonize and create secondary tumors in distant organs using
the vasculature as a means of transport. It is at this point, when the tumors are
more malignant, that cancer is more lethal. However, there is not a single reason
why cancer kills, but it depends on the type of cancer. One reason is the loss of
function of a vital organ (or organs) due to the uncontrolled and abnormal growth
of the tumor (or tumors). For instance, in lung cancer, eventually, there may be
not enough healthy tissue to absorb oxygen or in colorectal cancer, the lumen
of the digestive system may get blocked. Also, the fine tuned regulation of some
chemical in the body may be unbalanced by a tumor located in the organ that
produces them, for example, the liver. Or the amount of calcium in the blood may
be risen by bone cancer causing unconsciousness and eventually death.
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In most types of cancer, luckily, from carcinogenesis until cancer becomes a real
thread to life, cancerous cells have to overcome several natural barriers that
prevent tumor growth. Continuous research has deepened the knowledge in such
barriers and, nowadays, they are understood as opportunities to treatments that
delay or halt tumor growth. For example, tumors can not grow beyond a certain
size until cancerous cells gain the ability to promote angiogenesis, that is, the
creation of new blood vessels from the pre-existent ones.
The role of angiogenesis in cancer Certain types of cancer form solid tu-
mors of aberrant, mutated cells. These cells, that proliferate in a high-rate manner,
aggregate in solid masses that grow at the expense of the resources of the sur-
roundings. At this stage of tumor growth (called the avascular stage), cancerous
cells depend on diffusion mechanisms to obtain nutrients. However, when the
tumor has grown up to a certain size, not larger than 2mm radius in experiments
(Folkman, 1971), its global growth stops. This occurs due to the scarceness of
nourishment and oxygen that does not even cover the demands for maintaining
the basic cell processes in the core of the mass. Tumors may stay dormant in
this stage for years and only grow further if cancerous cells acquire the ability
to induce angiogenesis. In order to promote vessel growth, tumor cells, and even
malign-induced, non-cancerous cells from the tumor micro-environment, release
chemical signals, called tumor angiogenic factors (TAFs), that alter the phenotype
of the endothelial cells that line nearby capillaries. As a result, new capillaries
grow towards the tumor and provide nourishment to cancerous cells. Thus, an-
giogenesis enables a boost in tumor development, the so-called angiogenic switch
(see figure 1.4), moving the tumor to the vascular phase and endowing cancerous
cells with nutrients and oxygen to grow without limits and with new ways of
migration to other tissues or organs of the body.
The realization of the key role of angiogenesis has leaded to the development of
antiangiogenic therapies. Although this will be explained later in the document,
we advance here that these therapies have not achieved the expected results
yet. Arguably, an emerging paradigm in Medicine called predictive medicine will
change radically cancer investigation and may be the tool to unravel the problems
with antiangiogenic therapy.
Predictive medicine Cancer is a disease with a high morbidity and mortality
rate, thus it is hardly surprising that many people devote their efforts and work
to deepen the knowledge we currently have on cancer, comprehending better the
mechanisms involved and thereby being able to better diagnose and create new
treatments. This research, as well as the clinical practice, is usually developed
6
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Figure 1.4. The angiogenesis switch. Tumors are able promote angiogenesis, the growth
of new vessels from pre-existing ones, through signaling. The nutrient from the new capillar-
ies triggers a virtually unbounded tumor growth and the possibility to metastasize using the
circulatory system.(Adapted from Bergers and Benjamin, 2003)
by groups composed by physicians and biologists. They follow the diagnostic
paradigm, which is heavily based on the experience of the physicians with previ-
ous patients and on statistical data of the effect of the treatments on large groups
of individuals. In the last decades, however, a new paradigm has been proposed:
predictive medicine. Its aim is to predict the emergence, development, and conse-
quences of a disease, as well as to enhance current treatments and propose new
ones. Predictive medicine is based on mathematical modeling and computation.
This new approach has been successfully applied to cardiovascular diseases (Taylor
and Figueroa, 2009) and orthopedics (Taylor and Prendergast, 2015), and it has
recently started to be applied to Oncology (Chauviere et al., 2010; Gatenby and
Maini, 2003; Sanga et al., 2007).
Objectives
This thesis continues the research developed by the Group of Numerical Methods in
Engineering (GMNI) of the Universidade da Coruña in the field of computational
mechanics, in particular, it is the first to explore the sub-field of computational
biomechanics. It is also the first developed under the projectModeling and Simula-
tion of Cancer Growth (MuSIC), whose objective is to introduce predictive models
for cancer growth with the aim of shifting the traditional diagnostic paradigm of
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cancer treatment towards a predictive, patient-specific one. In parallel with the
MuSIC project, the objective of this thesis is to develop mathematical models of
tumor-induced angiogenesis that include key biological mechanisms and to per-
form isogeometric-based numerical simulations in relevant experimental setups
and three-dimensional, subject-specific geometries.
The objectives of this thesis may be divided into three categories:
• Modeling: The goal is to develop novel mathematical models of tumor-
induced angiogenesis that include key biological mechanisms, namely, the
migration of tip endothelial cells following different cues, the ability of cap-
illaries to regress and regrow depending on exterior stimuli, and the role
of interstitial fluid convection in pattern formation. These models involve
continuous fields governed by high-order partial differential equations and
discrete elements.
• Simulation: Most of the mathematical models found in the literature are
simulated in simple, two-dimensional geometries. In fact, we also plan to
perform in silico simulations of the above models in two dimensions that
replicate relevant in vivo angiogenic configurations to facilitate the study of
the model. However, angiogenesis is a three-dimensional process and occurs
in tissues or organs with non-trivial geometries. Hence, the second objec-
tive of this thesis is to go one step beyond and perform three-dimensional
simulations in real geometries that will permit the comparison with exper-
iments. In particular, our goal is to develop a tumor-induced angiogenesis
simulation of one of the most widely used in vivo assays, the mouse corneal
micropocket angiogenesis assay, using a three-dimensional, subject-specific
geometry. To the best knowledge of the author, this simulation will allow
for the first time the comparison between a simulation and an experiment
in a three-dimensional real geometry.
• Computational: The third objective is to develop numerical algorithms
capable of performing the above simulations efficiently. First, we need to
develop a mathematical framework that seamlessly integrates the discrete
agents as part of one of the continuous fields. We also need to use a recently
introduced technology, isogeometric analysis, able to handle the higher order
terms of the partial differential equations in two- and three-dimensional
complex geometries. Furthermore, the algorithms need to be robust, to
overcome the stiffness in space and time that derives from the use of two
scales, and to run efficiently in parallel.
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1.2 Context
1.2.1 Biology background
The objectives of this thesis are deeply grounded on the biology of angiogenesis,
the mathematical modeling of tumor angiogenesis, and the numerical methods to
simulate the models. Therefore, this section is devoted to give a general context
in these three aspects. It starts with a biology background to explain how cancer
grows and spreads and how tumors promote angiogenesis; continues with the state
of the art of mathematical modeling of tumor-induced angiogenesis; and finalizes
with an explanation of the numerical method used to solve the models, namely,
isogeometric analysis.
Cancer growth and spread
Carcinogenesis As said above, carcinogenesis, also called tumorigenesis, is
the process whereby normal cells acquire the capabilities to become cancerous
cells. These capabilities are usually gained through mutations, but also by non-
mutational changes in mechanisms regulating gene expression —those exerting
the transcriptional control; for example whether a gene should be transcribed or
not or the transcription velocity needed under certain circumstances. However,
in the rest of the document, we will refer to both of them just as mutations for
the sake of clarity. There are many genes known to be involved in carcinogenesis
and, surely, many more still unknown. These genes can be classified in oncogenes
and tumor suppressor genes. The former ones refer to those whose upregulated
expression trigger processes which lead to cancer development. On the other hand,
tumor suppressor genes are those that must be removed from the genotype or
downregulated to switch normal cells into malignant.
The first step towards cancer development starts when a cell undergoes a mutation
in one of these genes and for any reason the machinery which was supposed to
eliminate this cell through the apoptotic program fails in its function. This occurs
because the mentioned machinery is not hundred percent efficient. Notwithstand-
ing, this fact does not mean all cells that evade this natural barrier to defective
cells lead to cancer formation. Most of the cells that elude the machinery either
have minor or neuter changes in chromosomes —mutations in genes that do not
jeopardize cell integrity1— or the alterations are so severe that the cell is not
1The mutated genes may be the target of future mutations. For example, one of these changes
might be a replication of a gene. It would be a neuter mutation, but in the future, if mutated
another time, it would not imply inviability for function loss, because its previous role would
be maintained by the other gene (the copy).
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Figure 1.5. Cancer incidence as a function of age. The incidence increases drastically
with age, both in women and men, illustrating that many mutations accumulated along the years
are necessary to develop cancer. (Data source: Cancer Research UK, 2015)
viable and it is doomed to die. However, in the rare cases a mutation results in a
viable cell with altered functions or characteristics it may suppose a step towards
evolution or a step towards a disease like cancer.
The order of magnitude of the number of mutations that an individual may suffer
through its lifespan is 1010 (Alberts et al., 2007). The probability that one of these
mutations affects the machinery that controls cell cycle is so high that, if only
one mutation were required to develop cancer, we would be non-viable organisms.
However, carcinogenesis is a multi-step process that usually takes a long time
—years or decades— to be fully completed because normal cells only acquire a
malignant phenotype through the accumulation of several mutations (Loeb et al.,
2003). For example, an individual who has been exposed to exogenous risk factors
may develop clinically detectable cancer 20 years after2. In fact, many cancers
never develop, because carcinogenesis starts late in the life of an individual, who
may die first due to other reasons. It is remarkable that as life expectancy has
elongated in the last centuries, cancer incidence has increased, demonstrating thus
that aging is a cancer risk factor. Figure 1.5 evidences this fact.
For these reasons, Hanahan and Weinberg in the superb series of papers Hanahan
and Weinberg (2000, 2011) highlighted that one of the main enabling character-
istics to develop cancer is genome instability and mutation of cells. They also
added to these characteristics the ability of tumors to promote inflammation and
the aid from the recruited cells of the tumor micro-environment. The aim of these
papers was to collect all the capabilities that cells must (at least) acquire through
2Cancers originated form endogenous factors usually take less time to develop.
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Figure 1.6. Section of an avascular tumor. A non-invasive avascular tumor reaches a
stable configuration with three main distinguished regions: The proliferative rim, the hypoxic
zone, and the necrotic core. (Adapted from Yu et al., 2004)
mutations to become malignant. They called them The Hallmarks of Cancer and
are the following: Sustaining proliferative signaling, evading growth suppressors,
resisting cell death, enabling replicative immortality, inducing angiogenesis, acti-
vating invasion and metastasis, reprogramming of energy metabolism, and evading
immune destruction. A brief description of them may be found in appendix B.
The stages of tumor growth As a result of carcinogenesis, there is a viable
mutated cell, often called the renegade cell (Weinberg, 1998), which has acquired
partially or totally one or more hallmarks. The cell and its daughters proliferate
generating clonal expansions that inherit the hallmarks. The same process may
be repeated triggered by carcinogenic agents leading to increased malignant sub-
groups of cells, each of them with different gathered traits. Thus, a heterogeneous
mass of aberrant cells originates a tumor.
Tumor growth may be understood as a multistage process. For many tumors, the
first of these stages is avascular growth. At this stage, the tumor relies on diffusion
mechanisms to get nutrients and to remove the waste products of the cell activity
through nearby blood and lymph vessels. However, as the tumor grows, diffusion
mechanisms become insufficient to maintain the high proliferation rate of tumor
cells. At this point, the tumor usually resembles a spheroid where those cells
located far from the vessels, that is towards the center of the spheroid, enter non-
proliferative hypoxic states or die from anoxia, starvation, or metabolic poisoning.
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As a consequence, solid avascular tumors present a characteristic cell-layered
configuration, as shown in figure 1.6. The outermost cells form a thin layer (2
to 3 cells wide), called the proliferative rim, where tumor cells have access to
nutrient delivered by pre-existent, extratumoral capillaries. This layer envelops
the so-called hypoxic zone, where the amount of nourishment is above a deadly
threshold, but it is not enough for cell proliferation. Those cells in the hypoxic
zone enter a quiescent state, only altered when the levels of nutrients vary. Finally,
if the tumor is big enough, there is no means for the cells at its core to obtain
nutrients. These cells necrose3 and form a necrotic core. Contrary to apoptosis,
necrosis generates toxic wastes and, because there is no means to remove the
wastes, the toxicity promotes malignancy or necrosis in the surrounding cells.
Hence, diffusion-limited growth imposes a threshold in the maximum diameter of
an avascular tumor (usually between 1 and 2 mm), for which the cell subdivision
rate at the proliferative rim is balanced with cell death rate at the necrotic core
(Folkman, 1971). The tumor may be years or decades immersed in the avascular
stage (Folkman and Kalluri, 1984) without causing any harm to the host tissue.
Eventually, a tumor cell may find a way to access nutrients and to eliminate wastes.
One of these ways (first hypothesized by Folkman, 1971) is to create its own blood
supply through a process called angiogenesis: the creation of new capillaries from
pre-existing ones. The genomic instability of tumor cells may lead to daughter
cells that have gained the ability to control the balance of angiogenic factors (one
of the above-mentioned hallmarks), for example under hypoxic conditions. As
a consequence, the tumor may overcome the size-limited avascular growth and
enter the so-called vascular stage. This step, usually called the angiogenesis switch
(Bergers and Benjamin, 2003; Folkman and Kalluri, 1984), is often related to a
malignant state of the tumor, as cell proliferation is no longer limited and cells may
enter the bloodstream and migrate to any part of the body, attaining the tumor
invasive-metastatic stage. Due to this key role played by angiogenesis in tumor
growth, we anticipate here that controlling angiogenesis is the aim of some cancer
treatments: the antiangiogenic therapies. Another way through which tumors get
access to nutrients is by co-opting the pre-existing vessels, that is, cancerous cells
migrate towards vessels and proliferate around them. Usually, the high pressure
that the cells exert produces the collapse of the vessel, returning thus the tumor
to an avascular stage.
Invasion and metastasis is usually the last step of tumor growth and typically the
cause of death. It is also the most complex one, as cancer cells must survive in
alien environments from where they were originated and for long times in many
cases. To achieve this stage, as shown in figure 1.7, cells undergo the so called
3Necrosis: It is the premature death of cells caused by external factors. In contrast to apoptosis,
which is a naturally occurring cause of cellular death, necrosis is almost always detrimental.
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Figure 1.7. Invasion and metastasis. Tumor cells may achieve the ability to break through
the basal lamina that envelopes all the tissues and colonize the adjacent ones. They may also
enter the blood flow and spread to distant tissues, generating secondary tumors or metastases.
(Reproduced from Alberts et al., 2007)
invasion-metastasis cascade (Fidler, 2003; Talmadge and Fidler, 2010), which
consists of the following steps:
• Intravasation: Cancer cells enter the blood and lymphatic vessels.
• Dissemination: The circulatory system transports cancer cells passively
throughout the organism. Cancer cells may stay dormant in the blood
stream for long times without producing any harm.
• Extravasation: Cancer cells escape from the vessels into the other distant
tissues.
• Micro-metastasis: Once outside the vessels, cancer cells form small nodules.
• Colonization: Micro-metastasis can only grow further to form macroscopic
tumors if they are able to survive and proliferate in their new emplacement.
To do so they sequester or enslave the cells that form their new tumor
13
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micro-environment.
Tumor stroma One of the changes in the way cancer is understood nowadays
is to consider tumors composed, not just by the cancerous cells, but also by their
micro-environments. If a tumor spreads beyond the vascular steady phase it is due
to the recruitment of the neighboring cells which are present in the extracellular
matrix (ECM). These cells are not malignant per se, but tumors use them for
their own purposes, commonly attracting and controlling them through signaling.
Generally, the tumor-recruited cells are referred to as tumor stroma, because they
are part of the supporting normal tissues.
As shown in figure 1.8, the tumor stroma is composed, at least, by the following
elements:
• Cancer cells: They do not form a homogeneous group, since every lineage is
doted with different traits (the aforementioned hallmarks and characteris-
tics). For example, figure 1.8 not only shows cancer cells, but also invasive
and stem cancer cells.
• Cells associated to newly formed blood and lymph vessels: These are essen-
tially the endothelial cells that line the vessels acting as the blood or lymph
physical barrier and the coverage cells that enwrap the endothelial cells and
provide structural support to the vessels. Both types of cells are recruited
by tumors to satisfy their nutrient needs.
• Activated fibroblasts or cancer-associated fibroblasts: In this category, two
types of fibroblasts are included, namely, reprogrammed variants of normal
fibroblastic cells and myofibroblasts. It has been demonstrated that tumors
use them to enhance proliferation, angiogenesis, invasion, and metastasis.
• Inflammatory infiltrates: They develop several roles in cancer, being the
most prominent their labor in cleaning death cells and debris.
The realization of the key role played by the tumor stroma in cancer development
has implied a big step in understanding this disease. What is more, the core of
some new cancer therapies derived from the regulation of the cancer stroma. For
example, as explained below, antiangiogenic therapy aims to control the devel-
opment of vessels that form part of the malignant stroma. Also, some treatment
fails may be attributed to the reductionist view of targeting only cancer cells or
only a sub-type of them.
The main treatments Currently, there are several treatments, which can be
grouped as follows:
14
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Figure 1.8. Tumor stroma. Cancer cells recruit other cells from their micro-environment
to form the tumor stroma. This stroma includes cancer cells, cells associated to newly formed
vessels, activated fibroblasts, and inflammatory infiltrates. (Reproduced from Hanahan and
Weinberg, 2011)
• Surgery: It is the removal of the tumor (and some surrounding tissue) using
surgical procedures. This treatment is used for small tumors and, despite its
invasiveness, it has the advantage of being highly localized, minimizing side
effects. However, as the contours of the tumor are not well defined, there can
always remain cancerous cells in the tissue which are very likely to regrow.
• Radiation therapy: This treatment is based on the fact that many of
the cancer cells have reduced their ability to repair DNA. Therefore, when
exposed to radiation, the DNA is altered, cells cannot repair it, and they
die. This treatment is relatively localized, but affects a significant number
of healthy cells.
• Chemotherapy: It uses one of the features that distinguish cancer cells
from normal cells: Their high proliferation rate. Chemotherapy usually in-
terrupts one or more of the phases of the cell cycle or alters its external
conditions, so that proliferating cells fail to reproduce and die. It is a non-
localized treatment, thus it can affect any cell in the body, specially those
that multiply rapidly as the cells of nails and hair.
• Immunotherapy: It consists of stimulating the immune system to recog-
nize cancer cells, hence, letting the body itself be the one that removes them.
The most common side effects are skin reactions caused by the injections,
flu-like symptoms, or allergic reactions.
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• Targeted therapies: Those therapies that focus on specific proteins by
binding to the surface cell receptors, disrupting pathways, or interrupting
somehow specific processes that occur especially or to a greater extent in
cancer cells. The drugs for some targets are hard to develop and many of
them can cause side effects. In addition, cancer cells can become resistant
to such drugs.
• Hormone therapy: Slows or stops the growth of cancer that uses hormones
to grow in some type of cancer, as prostate or breast cancer. The side effects
of these therapies are related to the particular hormone that is blocked or
interfered.
• Antiangiogenic therapy: They prevent the formation of new vessels re-
quired for tumor growth. The importance of angiogenesis in processes like
wound healing, heart and kidney functions, fetal development, and repro-
duction lead to side effects that include problems when bleeding, clots in
vessels, hypertension, and protein in the urine.
• Other treatments: Biological response modifiers, vaccines, stem cell trans-
plant, and complementary and alternative medicines.
Usually these treatments are not used exclusively, but combined. For example,
radiation as adjuvant therapy4 to surgery to eliminate those cells that other-
wise could be left by the surgeon; neo-adjuvant5 chemotherapy before radiation
to make cancer cells more sensitive to radiation; or concomitant radiation and
chemotherapy, to ensure the elimination of all cancer cells. Further information
about cancer treatments can be found in (Camidge and Jodrell, 2005; Fentiman,
2005; Jackson and Porte, 2005; Kiltie, 2005).
Despite all the effort made in research, all of these treatments are far from being
definitive, but palliative in many cases, and some of them entail many side effects.
Besides, the therapy chosen for an individual is based on the physicians experience
with previous patients and on the mean treatment response in the clinical phases
of the treatment, that is, the diagnostic paradigm. However, an individual may
be highly responsive to a therapy rejected a priori according to those criteria, or
vice versa. That is why a shift towards the new medical model patient-specific,
predictive medicine is gaining momentum in the last decade. Its aim is to provide
the physicians with another tool to help them assign a treatment to a patient,
based on predictive mathematical models which are fed with data from the spe-
cific patient that will be treated. This model has been successfully applied to
4An adjuvant therapy is a therapy given in addition to the primary, main, or initial one to
maximize its effectiveness.
5A neo-adjuvant therapy is the one given as a first step to shrink the tumor before the main
treatment.
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other medical disorders, as in cardiovascular disease, and it is only starting to be
developed for cancer. As shown later in this chapter, the mathematical oncology
community is doing a lot of effort to develop mathematical models for cancer
growth and spread and, in particular, in blood vessel growth and angiogenesis to
model the angiogenic switch and its consequences.
Blood vessel growth. Angiogenesis
The circulatory system One of the most important systems in the body
is the circulatory system, since its main function is to deliver and collect the
vast majority of molecules that sustain cell life. It serves as a means of oxygen
and nutrient delivery, waste products’ disposal from the cell cycle, long distance
signaling transport, such as hormones and immune surveillance. In addition, it
plays a central role in organogenesis. The circulatory system is often seen as
composed by the cardiovascular system and the lymphatic system. The major
components of the former are the blood, a fluid chiefly consisting of platelets,
blood cells, and plasma; the heart, a muscle responsible for pumping blood; and
the blood vessels, the ducts that span the body and through which blood flows.
The lymphatic system is also formed by a fluid, the lymph, and by vessels, the
lymphatic vessels. Its role is more related to the immune system.
All cells in our body, apart from rare exceptions such as corneal cells, rely on the cir-
culatory system for survival. Thus, it is necessary for the system to span the whole
body. This is only achieved through a strict double tree-like hierarchy (figure 1.9).
Heart-pumped blood is transported through large-caliber, high-pressurized arter-
ies to the main parts of the body. The blood is then distributed by progressively
smaller vessels, namely, medium arteries and arterioles, until it reaches the cap-
illary beds. There, the tree-like hierarchy is replaced by a lattice-like structure
of capillaries, prioritizing thus delivery over transport. It is in the capillaries,
the thinner tubes of the circulatory system, where most of the molecular and
cellular exchange is performed. The molecules leak out (extravasate) and enter
(intravasate) through the permeable walls of these vessels. Once a molecule is
outside them, it reaches the cells mainly by diffusion (Alberts et al., 2007). This
process limits the molecules scope to 100 to 200 micrometers away from the ex-
travasation point. Therefore, every cell should be at that maximum distance from
a capillary; otherwise it would enter in a hypoxia state. Put in other words, the
vessel network has to be dense enough to allow access to every single cell. The
waste and other byproducts of these cells are collected by venules that start the
second tree-like hierarchy (with the opposite direction to the former). Venules
discharge into medium-caliber veins, that in turn flow into large veins. Note that
a great proportion of the waste products as well as immune cells return through
17
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Figure 1.9. The circulatory system. (Reproduced from Marieb, 2003)
the lymphatic system.
The vessels of the circulatory system are formed by different layers, whose number
and purpose varies with the caliber and function of the vessel (see figure 1.9). The
innermost layer, the endothelium, is formed by the main component of the vascular
system, as well as of the lymphatic system: the endothelial cells. These cells line the
blood vessels forming a tube, the lumen, and are usually at a quiescent state. Blood
vessels are enveloped by pericytes whose main function is to stabilize endothelial
cells, but also collaborate in other activities such as regulating the permeability
in certain organs (eg. blood-brain barrier). Pericytes and endothelial cells share
a common basement membrane and the three of them (and occasionally smooth
muscle cells) are the main components of capillaries. Greater vessels are formed
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by increasing number of layers that provide them with support to accommodate
the dynamic loads of the flowing blood.
Mechanisms of vessel growth Functions carried out by the circulatory sys-
tem are essential to sustain life, therefore the generation and maintenance of such
an intricate and complex system is vital. It is during embryogenesis when the
blood and the blood vessel network develops. First, through a process known as
vasculogenesis, endothelial cell precursors6 migrate from the bone marrow towards
the corresponding emplacement and differentiate into endothelial or blood cells,
forming a plexus. Afterwards, the vascular bed is extended and remodeled via
several mechanisms such as angiogenesis (Carmeliet, 2005) and intussusception or
splitting angiogenesis (Kurz et al., 2003). Then, in adult life, physiological vasculo-
genesis, angiogenesis, or intussusception appear at very specific, tightly regulated
events and only for a short time span, usually days or weeks. Examples of such
events are the female reproductive cycle or tissue repair, as in the wound healing
process shown in figure 1.10. Due to the importance of the vascular system, it is
not surprising that defective maintenance of blood vessels or deregulation of its
growth are associated with a number of diseases. When there is an inadequate
vessel maintenance or a downregulated growth, the absence of blood vessels may
affect the tissue repairing program, as in ischemic chronic wounds in diseases such
as stroke, obesity-associated disorders, or myocardial infarction. On the other
hand, an abnormal remodeling or upregulated growth, may promote inflamma-
tory diseases, age-related macular degeneration, or cancer, to name but a few. For
a longer list of diseases related to blood vessel maintenance and formation, the
reader is referred to Carmeliet and Jain (2000). In particular, in cancer, tumors
gain access to the vasculature using several mechanisms (see figure 1.11):
• Using existing blood vessels:
– Vessel co-option: Cancer cells engulf existing blood vessels (Leenders
et al., 2002).
– Vessel translocation: Vessels are attracted towards the tumor loca-
tion (Kilarski et al., 2009).
• Creating new blood vessels:
– Angiogenesis: It is the formation of new blood vessels from the pre-
existing ones.
– Postnatal vasculogenesis: It is the formation of new blood vessels
6Endothelial precursor cells: They are one of the three types of stem cells to be found in
bone marrow.
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Control 60 hours after wounding
100 m 100 m
Figure 1.10. New capillary formation in response to wounding. In the left panel an
image of the control situation is shown. The right one illustrates the blood vessel configuration
sixty hours after wounding.(Reproduced from Alberts et al., 2007)
through the migration from bone-marrow and differentiation of en-
dothelial precursor cells.
– Intussuception or splitting angiogenesis: It is the splitting of one
vessel into two through the formation of a transluminal pillar and its
extension (Burri et al., 2004; Kurz et al., 2003).
– Mosaic vessel formation: It is the incorporation of cancer cells
among the endothelial cells of the vessel walls.
– Vasculogenic mimicry: It is the transdifferentiation of cancer cells
into endothelial cells.
As it might be expected, tumors may exploit several of these mechanisms along
their growth, even at the same time. However, among all of them, angiogenesis
is assumed to account for a substantial fraction of vessel growth and it will be
the objective of study here. It is worth noting that there is not full agreement
between these terms and some authors use angiogenesis as a general term which
includes all these mechanisms of vessel creation and growth. Here, however, we
will use it as the specific term defined above.
The process of tumor angiogenesis Endothelial cell quiescence is maintained
by a tightly controlled balance between chemicals that promote angiogenesis (pro-
angiogenic factors) and those that inhibit angiogenesis (anti-angiogenic factors).
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Tumor cells line
tumor vessels
Figure 1.11. Mechanisms of tumor neovascularization. Tumor cells may gain access to
blood vessels using different mechanisms and usually through a combination of them. (Adapted
from Carmeliet and Jain, 2011)
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Despite this tight control, tumors are able to trigger angiogenesis. Tumor angio-
genesis is a complex phenomenon governed by intertwined molecular mechanisms
whose main components are the so-called tumor angiogenic factors (TAFs). The
latter are chiefly soluble molecules, released by hypoxic cancer cells and their
malignant micro-environment, and membrane receptors in tumor stroma cells.
There are more than twelve known of such molecules and many others still under
research. In addition, there are complex interplays among them that are still being
disentangled and started to be comprehended. More information on TAFs may
be found by the interested reader on appendix C, where we detail the sources,
receptors, and main functions of the best well-known TAFs.
Angiogenesis, as shown in figure 1.12, may be described as a multistage process
composed of the following steps: activation, initiation of the sprout, growth of
the capillary, and finalization of the process (Carmeliet and Jain, 2011; Figg and
Folkman, 2011a; Potente et al., 2011; Weis and Cheresh, 2011). As said above, the
activation starts when the equilibrium of the pro- and anti-angiogenic factors is
disturbed near the endothelial cells that line the blood vessels. The disequilibrium
may be caused by the arrival of tumor pro-angiogenic factor molecules that diffuse
from the hypoxic tumor cells and bind to the receptors of the endothelial cells. Well-
known examples of these factors are vascular endothelial growth factor (VEGF),
fibroblast growth factor (FGF), angiopoietin 2 (Ang-2), or chemokines. Those cells
affected by these tumor angiogenic factors are activated to become the leading
cells of the incipient sprout: the tip endothelial cells (TECs). However, there
is a mechanism, called lateral inhibition, that prevents the formation of several
sprouts in the same region (Hellström et al., 2007): even though several neighboring
endothelial cells may sense the disequilibrium of angiogenic factors, only one of
them changes its phenotype from quiescent to a migratory one and becomes
a TEC. The remaining cells, instead, change their phenotype to a proliferative
one. The latter, referred to as stalk endothelial cells (SECs), will play a role in
the elongation of the sprout, as explained below. The key molecular players of
lateral inhibition are the Delta-like ligand 4 (Dll-4) and its receptor Notch-1. In
brief, TAFs activate the expression of Dll-4 which binds to the membrane Notch-1
receptors of the adjacent cells. Those cells whose Notch-1 receptors get activated
become SECs and only one, the first to express Dll-4, becomes a TEC. By the
end of the activation phase, the endothelial cells have changed their phenotype
and are prepared to create a new sprout. They are, however, still confined by the
mural cells and the basement membrane.
The initiation of the sprouts starts with the liberation of endothelial cells. First,
the pericytes that enwrap the vessels, by means of Ang-2, detach from the region of
the incipient sprout. Then, tumor stromal cells release matrix metalloproteinases
(MMPs) that produce a proteolytic breakdown of the basement membrane that
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Figure 1.12. The angiogenic process. Angiogenesis starts with the activation of tip endothe-
lial cells by tumor angiogenic factors. The incipient sprout, once liberated from the capillary
coverage, grows towards the source of tumor angiogenic factors. The capillary elongates by the
proliferation of stalk endothelial cells. The growth continues until two capillaries anastomose.
The new vessel maturates and blood flows though it irrigating the tissue.
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envelopes the endothelial cells. MMPs also liberate cleaved TAFs from the extra-
cellular matrix. Once the basement membrane is degraded, the endothelial cells
loosen their junctions (VE-Cadherin), the nascent vessel dilates, and a provisional
ECM is laid out to facilitate migration. TECs develop slender cytoplasmic protru-
sions, called filopodia, rich in receptors that enhance the detection of the stimuli
that guide the migration (Gerhardt et al., 2003). The adjoining SECs follow the
first movements of the TEC out of the capillary.
The growth of the capillary includes the guidance of the TECs and the elongation
of the capillary. TECs are guided at least by three different mechanisms, namely,
chemotaxis, haptotaxis, and mechanotaxis. The first refers to the movement to-
wards a gradient of soluble molecules, in this case, TAFs such as VEGF or FGF.
Haptotaxis and mechanotaxis also contribute to establish the growth direction
through focal adhesion sites and the mechanical forces, respectively. Lately, it has
been hypothesized that endothelial cells compete for the TEC position as the
capillary grows (Jakobsson et al., 2010). Behind the TEC, SECs are continuously
dividing stimulated by angiogenic factors, promoting thus the elongation of the
capillary. Meanwhile, the endothelial cells form a lumen, allowing the blood to flow
through them. Furthermore, they attract smooth muscle cells and pericytes, that
provide support to the capillary. This last process, called maturation, is usually
defective in tumor-induced capillaries.
The growth continues until the lumina of two capillaries fuse forming a loop
that allows blood to flow. This phenomenon is called anastomosis. When this
happens, the endothelial cells revert their phenotype to a quiescent one (also
called phalanx phenotype) and recruit more pericytes that help to maintain this
phenotype through signaling. Also, both types of cells create a shared basement
membrane and the endothelial cells reestablish their junctions. The growth may
also be stopped if the driving stimuli end. In tumor angiogenesis, this point is
reached when the hypoxic cancerous cells are supplied with enough nutrients and
oxygen as to become normoxic. The capillaries promoted by tumors are usually
slightly different from those created under normal circumstances, as explained
below. Specifically, they become dependent on TAF presence, thus, when the
stimuli are no longer present, the capillaries regress. In addition, the high pressure
inside the tumor combined with the weakness of the vessels may make them
collapse. Finally, the regrowth of the capillaries is common in tumor development
and it is done at a faster speed aided by the scaffold of basal lamina left behind
by the regression of the vessels (Mancuso et al., 2006).
Characteristics of tumor vessels As a result of the angiogenesis switch, the
once growth-stable avascular tumor has turned into an unstable, vascular, and
malignant tumor pervaded with capillaries. However, as shown in figure 1.13, the
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new capillaries are defective in several senses (Baluk et al., 2005). Overexpression
of pro-angiogenic factors and/or underexpression of anti-angiogenic factors lead to
the formation of a new vasculature that is structurally abnormal. At the anatom-
ical level, the precocious and disorganized capillary sprouting and endothelial cell
proliferation, combined with localized events of regression and regrowth, plus the
increased vascular shunting and collapse result in a marked loose of the strict hi-
erarchy that characterizes the normal vasculature. In addition, capillaries present
saccular regions with haphazard patterns of interconnections. At the cellular level,
endothelial cells show an irregular and disorganized morphology, that even present
long cytoplasmatic projections that transverse the capillary lumen. The associa-
tion between endothelial cells is weak, leading to loose connections between cells.
The perivascular cells that ensheathe normal vessels is loosely attached or even
absent in tumor-induced vessels. The vascular membrane is unusually thick in
some tumors or very thin or absent on others.
Figure 1.13. Physiological versus tumor vessels. Unlike vessels created under physiological
conditions (left panel), tumor vessels (right panel) show a clear loss of the vessel hierarchy and
structure, a marked aberrant morphology, and disorganized and abundant sprouting. (Reproduced
from McDonald and Choyke, 2003)
These anatomical and cellular abnormalities have drastic influences at the func-
tional levels of the new vasculature:
• Heterogeneity in blood flow. Structural defects promote spatial and
temporal heterogeneity blood flow. Furthermore, the flow is often redundant
in closed and blind loops.
• High interstitial pressure.Defects at the cellular levels confer leakiness to
the vasculature. Thus, the intravascular fluids and plasma easily extravasate,
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increasing the interstitial pressure. In addition, the absence of functional
intratumoral lymphatic vessels results in impaired clearance of the fluid. The
high interstitial pressure hinders the delivery of systemically administered
therapies.
• Regional hypoxia. Tumors present local regions of hypoxia due to several
factors such as vascular collapse, regression and regrowth events, regional
poor perfusion, and high interstitial pressure. As cancer cells are more re-
sistant to hypoxia than normal cells, hypoxia promotes their malignant
phenotype, facilitating, for instance, their ability to form metastasis.
• Acidosis. It is caused by the byproducts of necrosis that cannot leave
the tumor because of the faulty transport functionality of the vasculature.
Acidosis compromises the cytotoxic functions of immune cells that infiltrate
the tumor, enhancing the malignant phenotype.
Antiangiogenic treatments Since Folkman hypothesized the angiogenic switch,
antiangiogenic therapy has been a promising treatment against cancer. In the last
decades, different kinds of inhibitors of angiogenesis have been developed, being
most of them VEGF blockers or multi-targeted tirosine-kinase receptor inhibitors
(see appendix C). Some of them, as bevacizumav or sorafeniv, have even been ap-
proved for clinical use against specific types of cancer and usually in combination
with chemotherapy.
However, despite their success in pre-clinical trials, the translation of most an-
giogenic inhibitors to antiangiogenic treatments in humans, that is, to clinical
practice, has not resulted as expected: although in some cases the disease-free
progression has increased, the overall survival did not. There are many hypothe-
ses that try to explain this general failure. Most of these hypotheses are based
on the differences between the pre-clinical and the clinical settings in terms of
simplicity of the former compared to the latter, the unknowns in dose amount,
or the dose timing. Also, some patients are refractory to the treatment and many
others develop resistance to them. For example, Dvorak and colleagues (Nagy and
Dvorak, 2012) have detected that anti-VEGF therapy is effective only at certain
stage of vessel growth (see figure 1.14a), and is refractory otherwise. Recently,
Jain and co-workers have hypothesized that the little efficacy of antiangiogenic
therapies may be due to an excessive pruning of the vasculature (Goel et al., 2011;
Jain, 2001, 2005). High doses or treatments over long time spans prune the vascu-
lature too much and promote hypoxia in the tumor, which in turn increases the
malignancy of tumor cells and their resistance to radiotherapy and chemotherapy.
Thus, excessively pruning leads to more aggressive forms of cancer. They propose
that the aim of antiangiongenic therapy should be instead the normalization of
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(a) Antiangiogenic therapy may be only effective at certain stages of capillary growth.
(Adapted from Nagy and Dvorak, 2012)
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(b) Normalizing the vasculature through antiangiogenic inhibitors, instead of excessive pruning,
may lead to better vascularized tumors, which, in turn, may lead to better distribution of systemic
therapies and to remove hypoxic regions that promote malignancy. (Adapted from Jain, 2005)
A B
(c) Targeting the metabolic differences of dif-
ferentiated endothelial cells. (Reproduced from
Bock et al., 2013)
(d) Targeting microRNAs as an alternative to
VEGF inhibitors. (Reproduced from Boon and
Dimmeler, 2015)
Figure 1.14. New approaches to antiangiogenic therapies.
27
1 · Introduction
the vasculature, as shown in figure 1.14b, such that the adjuvant therapies that
are administered systemically are not impaired by a defective vasculature. Finally,
most antiangiogenic therapies focus on the inhibition of VEGF and, although
the inhibition may be successful, cancer cells may get vascularized through other
molecular pathways or even through other vascularization mechanisms, such as
vasculogenesis. Several researchers are working on new molecular targets and
principles to overcome this problem. For example, figure 1.14c shows how the
different metabolisms of endothelial cells with respect the remaining cells of the
body may be a new target to stop angiogenesis. Other examples include work
with microRNAs (figure 1.14d) or immunotherapy combined with antiangiogenic
treatments.
1.2.2 Mathematical models of tumor-induced angiogenesis
This section reviews the mathematical models that are setting the basis for pre-
dictive medicine in cancer. As there is a wide literature regarding tumor induced-
angiogenesis modeling, only the most prominent models are shown here. Extensive
reviews can be found in Araujo and McElwain (2004); Chaplain (1996); Chaplain
and Anderson (2006); Logsdon et al. (2014); Lowengrub et al. (2010); Mantzaris
et al. (2004); Moreira and Deutsch (2002); Oden et al. (2015); Qutub et al. (2009);
Roose et al. (2007); Sanga et al. (2006); Scianna et al. (2013); Travasso et al.
(2011a).
Classification of the Models
Prior to the review of the state of the art, we define some concepts that may
help to classify the mathematical models. Cancer is a multiscale process, as it
starts with a gene mutation and, in the last phases, may spread to other tissues.
Handling every scale is a non-trivial problem for mathematical models and, in
many cases, they are limited to one of the following:
• Subcellular scale: The characteristic order of magnitude for this scale is
nanometers and it includes phenomena such as oncogene transcription, pro-
tein creation, signaling cascades, or mutational events.
• Cellular scale: The basic unit of this scale is the cell, that is, 10-20 µm.
Examples of characteristic phenomena occurring in cancer at this scale
are proliferation, apoptosis, cellular communication, and tip endothelial cell
migration.
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Table 1.1. Characteristics of discrete, continuous, and hybrid models.
Continuous models Discrete models Hybrid models
Scale Tissue Cellular andsubcellular
Cellular,
subcellular, and
tissue
Advantages
Allow to model
tumor growth
without spatial and
temporal limits
Track cells
Discrete event
description
Combine the
advantages of both
methods
Disadvantages
Can not track
individual cells
Can not describe
discrete events
Spatially and
temporally limited
Greater complexity
in the coupling
• Tissue scale: The order of magnitude of this scale is centimeters and it
includes phenomena such as vascular tumor growth, angiogenesis, or adjacent
tissue invasion.
In the subsequent review of the literature the models are classified, according
to their mathematical abstraction of the biology, into continuous, discrete, and
hybrid models. As shown in table 1.1, each type of model spans different scales.
Continuous models are those that use averaged continuous fields (cell densities or
volume fractions, for instance) governed by equations; generally, partial differential
equations. These models are based on continuum mechanics. They are able to
describe cancer from a tissue scale, but, in general, cannot track individual cells.
Discrete models, on the contrary, are those which track individual cells. These
models usually include cellular and subcellular scales, but are not capable of
handling the tissue scale, since they are limited by computational power. There
are several sub-types of discrete models. The simpler ones are agent-based models:
Those composed by single units that represent cells which interact among them
in a lattice-free space, subject to certain rules. When the space is subdivided
with a lattice and each site can be only occupied by a single cell, the model
sub-type is called Cellular Automaton. In this case the cellular shape is not taken
into account and it allows the representation of a slightly larger scale. The last
discrete sub-type model is the Cellular Potts Model, which can be thought as a
generalization of the Cellular Automaton. In the Cellular Potts model each cell
may be composed by several lattice locations or pixels whose states change to
minimize a global energy. Finally, hybrid models benefit from the discrete and
continuous models advantages, by using both of them. In particular, when there
is a single description for each phase they are usually referred to as composite
discrete-continuous models.
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Review of the literature
Avascular tumor growth The first mathematical models for cancer, developed
during the first half of the last century, focused in the avascular tumor stage and
used a continuum description. These models were posed from a single macro-
scale point of view and modeled tumors as multicellular spheroids. They were
cell population models whose objective was to study tumor growth dynamics.
One of those models was posed by Mayneord (1932). There, using a continuous
mathematical model, he showed that the linear growth dynamics of rat sarcomas
observed in experiments (instead the theoretical exponential growth) could be
explained assuming that not all cells of the tumor proliferated, but only those
cells located in the exterior border of the tumor (the proliferative rim). These
population models evolved to include diffusion processes. For example, Burton
(1966) developed a model for solid tumor in which the growth dynamics were
controlled by oxygen diffusion. As a result he derived a Gompertzian tumor
growth law. Laird (1964) showed that this Gompertzian law fitted with a variety
of transplanted tumors.
In the 1970’s, the angiogenesis switch hypothesis by Folkman (1971) led to the
development of avascular models that tried to explain why some tumors stay
dormant. It also led to the study of angiogenesis alone and coupled with vascular
tumors, as explained in next sections. Many authors proposed models based on
growth inhibitors to explain the referred avascular dormant tumors. One of the
most notable was posed by Greenspan in 1972 and 1974 (Greenspan, 1972, 1974).
He proposed two alternative explanations for the origin of the agent that acted
as growth inhibitor: Either it was produced by necrotic debris or by metabolic
processes associated with the cellular growth. The most prominent models from
the 1980’s were from Adam and Maggelakis (Adam, 1986, 1987a,b; Adam and
Maggelakis, 1989, 1990), in which they used a non-uniform growth inhibitor and
obtained as a result a stable tumor with a necrotic core and a proliferating
rim. In the 1990’s there was an exponential growth of mathematical models for
avascular tumors focused in explaining the observed features of multicellular tumor
spheroids, in particular the differentiation between the necrotic core, the hypoxic
zone, and the proliferative rim. Chaplain and Britton presented a predictive model
to examine the steady-state profile of the growth inhibitory factor in spheroids
(Chaplain and Britton, 1993), and Byrne and Chaplain studied the stability of
steady, radially-symmetric solutions with respect to perturbations (Byrne, 1999;
Byrne and Chaplain, 1997) by assuming the existence of the three distinct layers.
However, detailed experimental investigations showed that the transitions between
the three layers could be gradual, rather than sharp (Hystad and Rofstad, 1994).
This led to mathematical models in which the layers were defined by continuum
densities of proliferative, quiescent, and dead cells (Hinow et al., 2009; Sherratt
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and Chaplain, 2001). Some other models of avascular growth focus on reproducing
different features, such as, for example growth saturation or cell movement (Pérez-
García et al., 2011; Thompson and Byrne, 1999; Ward and King, 1997, 1999). From
a methodological point of view, the mixture theory has been a useful framework
within the continuum modeling of avascular growth (Byrne et al., 2003; Byrne
and Preziosi, 2003; Preziosi and Tosin, 2009). More recently, a new approach
based on the multiphase porous media mechanics theory, has also been proposed
(Sciumè et al., 2013a, 2014, 2013b). Another framework which has produced very
relevant results is that provided by the phase-field method (Cristini et al., 2009;
Hawkins-Daarud et al., 2013, 2012; Lima et al., 2015; Oden et al., 2010, 2013;
Wise et al., 2008). As explained later, the phase-field method is the key method
of the mathematical theories developed in this thesis.
Although all the models presented until now were continuous, the literature is also
rich on discrete models belonging to the class of cellular automata or agent-based
methods that have tried to model avascular growth by considering cell-cell interac-
tions, cell-matrix interactions, and the effect of the micro-environment (Boondirek
et al., 2010; Gerlee and Anderson, 2007; Moreira and Deutsch, 2002). Hybrid
models have also been posed to study specific phenomena, such as cell adhesion
(Anderson, 2005) or interactions between tumors and the immune system.
Tumor induced-angiogenesis Since the discovery of the critical role of angio-
genesis in tumor progression, many researchers have tried to model angiogenesis
under different assumptions. One of the most common is to consider the tumor
just as a fixed source of TAF, that is, to model only the growth of capillaries
without modeling the tumor. Here we review the most notable of these models,
many of which were used afterwards with tumor growth models (as shown in next
section).
One of the first models of angiogenesis as developed by Deakin in 1976 (Deakin,
1976). It was a continuous model consisting of two variables: The endothelial cell
density and one chemical species that represented the TAF. Both variables were
governed by convection-diffusion equations. Most continuous models coming later,
although involving more variables and representing more phenomena, followed
a similar structure. For example, in 1985, Balding and McElwain (Balding and
McElwain, 1985) posed a similar continuum model which also considered one
chemical species, but distinguished between tip endothelial cell concentration that
migrated chemotactically following the gradient of TAF and stalk endothelial
cell concentration that proliferated in the presence of TAF. Furthermore, the
model included branching and anastomosis events. A decade later, Byrne and
Chaplain (1995; 1996) extended Balding and McElwain’s model by adding TAF
consumption and secondary tip proliferation. In the same years, Chaplain and
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Stuart (1993) developed a model that included many essential mechanisms of
angiogenesis, which was subsequently simplified in Chaplain et al. (1995) to permit
a deeper mathematical analysis. This analysis showed that both endothelial cell
proliferation and migration were essential to angiogenesis. Figure 1.15a shows
an example of a simulation of one of these first models, which were usually one
dimensional.
The next step in continuum models of angiogenesis was the incorporation of hapto-
taxis. It came from Orme and Chaplain (1998; 1997) where, besides chemotactic
migration, endothelial cells also migrate following a concentration gradient of
fibronectin through the ECM (see figure 1.15b). This work studies the impor-
tance of haptotaxis versus chemotaxis and the role of fibronectin in haptotaxis.
Furthermore, by altering the parameters of the model, they analyze different
anti-angiogenic strategies. Anderson and Chaplain (1998b) developed a model to
prove an experimental observation: If endothelial cells do not proliferate, angio-
genesis does not reach the tumor and it fails to deliver the nourishment. It was
a one-dimensional model including chemotaxis and haptotaxis, which was subse-
quently widespread to two dimensions in the first part of Anderson and Chaplain
(1998a) and in Chaplain and Anderson (1999), and to more complex geometries
in Valenciano and Chaplain (2004) and in Peterson et al. (2007), as shown in
figure 1.15c. By 2000, several angiogenesis inhibitors were already discovered and
quite well known. Anderson et al. (2000) modeled how secondary tumors remained
in dormant states because already vascularized primary tumor released angiogenic
inhibitors that prevented the vascularization of secondary tumors.
Continuous models keep evolving to include many other key mechanisms of an-
giogenesis. For example, Levine and collaborators (2001a; 2000; 2001b; 2002)
developed models that included endothelial cell migration by chemotaxis (TAF)
and haptotaxis (fibronectin), ECM degradation (protease enzyme), and angiogen-
esis inhibition (angiostatin). It required over sixty parameters to be calibrated.
Plank et al. (2004), extended the previous models to include random walks into
TEC migration. Some continuum models include mechanochemical interactions
between endothelial cells and the extracellular matrix, due to the traction exerted
by endothelial cells on ECM fibers when migrating, for instance Holmes and Slee-
man (2000). Others even consider other mechanisms of tumor vascularization,
as in Stamper et al. (2007), where they model vasculogenesis besides angiogene-
sis. One of the latest continuous models was developed by Santos-Oliveira et al.
(2015), which is based in the phase-field method. In this work they model the
traction forces exerted by tip endothelial cells and the cell-cell adhesion forces.
They study how different responses of other endothelial cells to these forces alter
the morphology of incipient sprouts.
Another question which appears when modeling angiogenesis with continuous
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(a) From left to right: Concentration of tip endothelial cells, endothelial cells, and tumor angiogenic
factor. (Reproduced from Byrne and Chaplain, 1995)
(b) Concentration of endothelial cells forming four sprouts, before (left) and after (right) anas-
tomoses takes place. Tip endothelial cells are guided by chemotaxis and haptotaxis. (Reproduced
from Orme and Chaplain, 1997)
(c) Definition of the geometry (left) and time evolution of the concentration of tip endothelial cells
(middle and right) in a two dimensional model. (Reproduced from Peterson et al., 2007)
Figure 1.15. Continuous models of tumor-induced angiogenesis.
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models is the emplacement of the first endothelial cells, that is, where the activation
of angiogenesis starts. In most models, this selection is imposed a priori by means
of initial conditions. However, some authors endowed their models with different
criteria to select those locations. Orme and Chaplain (1996a) solved this problem
taking into account the local accumulation of endothelial cells as the origin of
new sprouts. Levine et al. (2000) addressed the problem by selecting the tip
endothelial cell through the interaction of endothelial cells, TAF’s, proteases,
fibronectin, angiostatin, pericytes, and macrophages. Addison-Smith et al. (2008)
even developed a model to predict the origin and spacing between sprouts.
Discrete modeling has also produced quality models to study angiogenesis. Con-
trary to continuous ones, these models are able to predict the structure of the
new vasculature, allowing comparison with in vitro or even in vivo experiments.
Agent-based models, in general, track TECs which migrate under the influence
of a continuum field, while SECs follow their path. One example is the model
posed by Stokes and Lauffenburger (1991). It is a lattice-free, two-dimensional
model in which every sprout is characterized by its TEC, whose velocity and
position is governed by a differential equation (chemotaxis) altered by random-
ness and viscosity. Furthermore, they include branching ruled by a probability
function and anastomosis whenever a tip is away from another endothelial cell
a distance equivalent to a cell size. It is noteworthy that the model includes the
influence of the redistribution of endothelial cells between the sprout and the
parent vessel. Contrary to this detailed description of TEC, the TAF is assumed
to be in a steady state. Sleeman and coworkers (Plank and Sleeman, 2003, 2004;
Sleeman and Wallis, 2002) also developed an agent-based model by getting rid
of the lattice of a cellular automata model. In their approach, they model TEC
migration as a random walk, in particular, in Plank and Sleeman (2004), they used
a biased circular random walk (Codling et al., 2008), based on the work of Hill
and Häder (1997) for the trajectories of micro-organisms. Sun et al. (Sun et al.,
2005) introduced the influence of the extracellular matrix in their agent-based
model through an anisotropic directional field that affected tip endothelial cell
migration. Milde and coworkers (Milde et al., 2008) used a similar approach to
model the interactions between the TEC and the ECM, as shown in figure 1.16a.
Capasso et al. (Capasso and Morale, 2009) also included random walks in their
model. Yet another example is the three-dimensional model developed by Das
et al. (Das et al., 2010) that includes cell-cell communication and migration as
a stochastic process. The work by Bentley and coworkers (Bentley et al., 2009)
supposed a breakthrough in angiogenesis modeling. There, they studied lateral
inhibition by means of a hierarchical agent-based model and showed how the feed-
back loop between VEGF-A and Dll-4 determined tip or stalk cell differentiation
(see figure 1.16b).
34
1.2 · Context
(a) Three-dimensional discrete agent-based model that includes the iterations between the TECs
and the ECM. (Reproduced from Milde et al., 2008)
(b) Discrete model of several endothelial cells that differentiate into TECs governed by lateral
inhibition. (Reproduced from Bentley et al., 2009)
(c) Discrete model obtained through the dis-
cretization of a continuous one. (Reproduced
from Anderson and Chaplain, 1998a)
(d) First simulation of the corneal micropocket
assay in a squared domain. (Reproduced from
Tong and Yuan, 2001)
(e) Mouse corneal micropocket assay including
an angiogenesis inhibitor. (Reproduced from
Harrington et al., 2007)
(f) Influence of branching in angiogenesis in
the corneal micropocket assay. (Reproduced
from Jackson and Zheng, 2010)
Figure 1.16. Discrete models of tumor-induced angiogenesis.
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One of the most celebrated discrete model, shown in figure 1.16c, was developed
by Anderson and Chaplain (Anderson and Chaplain, 1998a; Chaplain and An-
derson, 1996). They discretized the equations of a continuous model to create a
Cellular Automata model that governed the TECs. The probabilities for TEC
movement in the Cellular Automata included diffusion, chemotaxis, and hapto-
taxis mechanisms, as in the continuous model. Notably, the results were compared
with in vivo assays performed in the eye of a rabbit (Gimbrone Jr et al., 1974)
and in the cornea of a mouse (Muthukkaruppan et al., 1982) giving successful
similarities. This idea supposed a breakthrough to represent vascular structures
and was further expanded to three-dimensions, to include different branching
and anastomosis criteria, and to model blood flow (Chaplain, 2000; McDougall
et al., 2006, 2002, 2012; Stéphanou et al., 2005, 2006). And, as shown in next
section, many authors use modified versions of this model to simulate vascular
tumor growth. In 2005, Kevrekidis and Whitaker (2005), using a similar idea,
also presented a one-dimensional hybrid model (extended to two dimensions in
Kevrekidis et al., 2006) that included TAFs, ECM, proteases, and angiogenesis
inhibitors. The Cellular Potts models introduced by Glazier and Graner (Graner
and Glazier, 1992) were also used to model angiogenesis. Bauer et al. (2007) used
such a model, where endothelial cells were able to migrate guided by chemotaxis
and haptotaxis, the sprouts were able to branch and anastomose, and the extra-
cellular matrix was modeled in detail. The authors extended further the model to
study the influence of the ECM in TEC migration (Bauer et al., 2009). Some other
examples of Cellular Potts models include the work by Mahoney et al. (2008),
where they added haptotaxis to TEC migration, and by Szabó and Czirók (2010);
Szabó et al. (2008), where they studied the role of cell-cell adhesion.
Finally, discrete models were also used to replicate the corneal micropocket angio-
genesis assay. The first one was developed by Tong and Yuan in 2001 (Tong and
Yuan, 2001). It is a two-dimensional model with an initial circular capillary and
a pellet that release TAF, both embedded in a square domain (see figure 1.16d).
New TECs originate at the capillaries stochastically and migrate and anastomose
according to discrete rules. This model was extended in Harrington et al. (2007)
to include an angiogenesis inhibitor (see figure 1.16e). Furthermore, in Tong and
Yuan (2008b) the authors improved the continuous equation that governs the
dynamics of TAF. In 2011, Jackson and Zheng (Jackson and Zheng, 2010) pro-
posed a different model for corneal angiogenesis (see figure 1.16f) that included
a mechanical model for the elongation of the sprouts and angiopoietin-regulated
phenotypes.
Although discrete models can capture the structure of the vascular network, in
general, they only describe the migration of TECs and assume that SECs follow
their path. In addition, discrete models become computationally unaffordable as
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the number of cells increases. Some authors have developed hybrid models to cir-
cumvent these problems. The common approach in hybrid models for angiogenesis
is to model TECs using a discrete description, while every other component of
the model, such as SECs or TAFs, are modeled as continuum fields. Hence, these
models are able to represent the vascular networks, while benefiting from the
computational effectiveness of continuum modeling. The hybrid model proposed
by Travasso et al. (2011b) and Dias Soares Quinas Guerra and Travasso (2012)
fits into the latter type of theories. It couples cellular-scale discrete agents with
an averaged continuous theory based on the phase field method. The model has
shown significant potential predicting in vivo patterns of tumor-induced capil-
lary growth (see figure 1.17). In opposition to the classical description of sharp
interfaces, the phase-field model describes the interface between phases as diffuse.
This permits avoiding the resolution of moving boundary problems, but requires
solving a higher-order partial differential equation with diffuse interfaces evolving
dynamically over the computational domain. In subsection 1.2.3, we present our
methodology to treat these computational challenges.
Figure 1.17. A hybrid model of tumor-induced angiogenesis. Tumor angiogenic factor
(light blue) promotes angiogenesis from an initial vessel (left). The model captures the formation
of a new vascular network (right). (Reproduced from Travasso et al., 2011b)
Relevant angiogenesis models have also been developed for wound healing, as in
Olsen et al. (1997); Valero et al. (2013, 2015a); Vermolen and Javierre (2012)
(see Valero et al., 2015b for a review), and for skeletal muscle, as in Carlier et al.
(2012); Liu et al. (2011); Reina-Romo et al. (2013).
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Vascular tumor growth Vascular growth modeling has attracted significant
interest in the last few years. Prime examples include the work of Frieboes et
al. (Frieboes et al., 2010, 2007), which couples phase fields to describe tumor
growth with discrete random walks to model angiogenesis. We also mention the
ten-species model of Lima et al. (Lima et al., 2014), which was recently proposed.
Multiscale techniques have also proven important on the development of vascular
growth theories, as shown in Alarcón et al. (2003). Significant examples within the
Cellular Automata framework were given in Gevertz and Torquato (2006); Perfahl
et al. (2011). Other important work includes Breward et al. (2004); Cristini et al.
(2003); Hogea et al. (2006); Orme and Chaplain (1996b); Shirinifard et al. (2009);
Zheng et al. (2005).
Fluid transport in the vicinity a tumor, and in particular blood flow through the
newly created vessels, has received special attention in mathematical modeling
for its important role in tumor growth. Baxter and Jain were among the first
to model fluid flow. In the series of papers Baxter and Jain 1989, 1990, 1991a,b
they studied transport of fluid and molecules in one- and two-dimensional settings
and addressed the role of fluid pressure in tumor growth. Pries, Secomb, and
collaborators worked on the role of blood flow in vascular network, including
the adaptation of vessels to this flow (Pries et al., 2001, 1996, 1998, 1990, 1994;
Secomb and Pries, 2011). Most of the subsequent models that included blood flow
used their theory. As an example, they recently developed a mathematical model
(Secomb et al., 2013) that coupled the discrete angiogenic model of Tong and Yuan
(Tong and Yuan, 2001) with their models of blood flow and vascular adaptation.
Rieger and coworkers developed a two-dimensional Cellular Automata model
(Bartha and Rieger, 2006) (which was extended to three-dimensions in Lee et al.,
2006) that considered both tumor growth and angiogenesis and included vessel
co-option, vessel collapse, and cell death. Notably, vessels collapse and regress
due to absence of intravascular blood flow. In Welter et al. (2008) the authors
incorporated details from the Cellular Automata model in Alarcón et al. (2003)
and analyzed the distribution of a drug injected into the vasculature. Posterior
developments of this model (Welter et al., 2009; Welter and Rieger, 2010, 2013)
included more realistic arterio-venous initial vascular networks and interstitial
fluid pressure to study the influence in tumor growth. Phipps and Kohandel
also studied interstitial fluid pressure within a continuous angiogenesis model
(Phipps and Kohandel, 2011). In Wu et al. (2009, 2008), Wu and coworkers built
intravascular and extravascular fluid pressure into an augmented version of the
angiogenesis model developed in Anderson and Chaplain (1998a). They used the
model in Pries et al. (1994) for the intravascular flow and the work in Baxter and
Jain (1989) for the extravascular flow. Later, in Cai et al. (2011) they coupled this
model with a tumor growth model based on the work in Anderson (2005). Wu
et al. followed a similar approach in Wu et al. (2013), but they also incorporated
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the effect of the lymphatic system.
1.2.3 Isogeometric analysis
The numerical approximation of the higher-order partial differential equation de-
scribing the vascular networks entails several difficulties, such as, for example,
stiffness in space and time, resolution of diffuse interfaces that evolve dynami-
cally, and discretization of higher-order differential operators. In the literature,
we find that on simple geometries it is common to use the finite difference method
(Frieboes et al., 2007; Travasso et al., 2011b; Wise et al., 2008) or spectral meth-
ods (Ye and Cheng, 2005) to approximate higher-order derivatives. However, our
goal is to undertake the discrete/continuous coupling using a global functional
description adequate for finite element methods, which are geometrically flexible.
Variational formulations of higher-order equations require the use of functions
which are globally highly continuous. In particular, the fourth-order equation
that we solve in this thesis requires globally C1-continuous functions. Although
significant progress has been made, see for example (Stogner and Carey, 2007),
the derivation of three-dimensional and geometrically flexible C1-continuous fi-
nite elements is to the best of our knowledge an open problem. Most existing
approaches require the introduction of additional degrees of freedom or stabi-
lization parameters. This has made that the vast majority of the finite element
community continues to utilize mixed methods (Hawkins-Daarud et al., 2012) that
permit the use of C0-continuous elements at the cost of doubling the number of
degrees of freedom. Alternative approaches outside the classical continuous finite
element methods include, among others, the discontinuous Galerkin method (Xia
et al., 2007), the continuous/discontinuous Galerkin method (Engel et al., 2002)
or maximum entropy approximations (Arroyo and Ortiz, 2006; Cyron et al., 2009;
Rosolen et al., 2013).
Recently, Hughes et al. (Hughes et al., 2005) developed a new technology, isogeo-
metric analysis (IGA), that naturally deals with high-order equations being at the
same time geometrically flexible. IGA is a generalization of finite element analysis
(FEA, Hughes, 1987) whose initial goal was to unify computer-aided design (CAD)
and FEA. The main idea of this method is to replace the FEA traditional basis
functions with those utilized in CAD, such as B-splines, non-uniform rational B-
splines (NURBS) (Piegl and Tiller, 1997; Rogers, 2001), T-splines (Bazilevs et al.,
2010; Casquero et al., 2015b), hierarchical B-splines (Schillinger et al., 2012; Scott
et al., 2014), trimmed NURBS (Schmidt et al., 2012), polynomial splines over
hierarchical T-meshes (PHT-splines) (Nguyen-Thanh et al., 2011), Powell-Sabin
B-splines Speleers et al. (2012), or rational Triangular Bézier Splines Xia et al.
(2015). IGA invokes the isoparametric concept, that is, the unknown variables
39
1 · Introduction
are represented in terms of the same basis functions which define the geometry.
The coefficients of the basis functions are the degrees of freedom or control vari-
ables. IGA is a nascent technology compared with the long tradition behind FEA,
and, consequently, it still presents some topics that are being addressed, such as
optimized quadrature rules Auricchio et al. (2012); Hughes et al. (2010) or the
creation of solid volumes from surfaces. The growing community behind IGA is
currently dealing with these topics, which, in any case, are not directly related
with this thesis.
Contrary to FEA, IGA uses basis functions capable of representing the exact
geometry and imposes them on the solution mesh. As a result, this new technology
has potential to overcome the long times dedicated to meshing and bridged the
gap between CAD and FEA. In addition, because IGA uses the CAD description
of the geometry it benefits from the naturally built-in geometric flexibility and the
high-order continuity of the basis functions, which makes it an excellent numerical
method to solve our model. Moreover, IGA also excels in its high-order accuracy,
robustness, and compact support. For these reasons, IGA has been successfully
used in several fields such as fluid mechanics (Akkerman et al., 2011; Bazilevs
et al., 2007; Evans and Hughes, 2013), phase-field models (Bueno et al., 2015, 2016;
Dhote et al., 2014, 2015; Gomez et al., 2008; Liu et al., 2013, 2015), structural
vibrations (Cottrell et al., 2006; Hughes et al., 2008), shell modeling (Benson et al.,
2010; Kiendl et al., 2010), contact problems (De Lorenzis et al., 2011; Dimitri
et al., 2014a,b), fluid-structure interaction problems (Bazilevs et al., 2008, 2006;
Casquero et al., 2015a), shape optimization (Wall et al., 2008), electromagnetics
(Buffa et al., 2010), and biology applications (Auricchio et al., 2015; Bazilevs et al.,
2006; Morganti et al., 2015). Also, several groups have developed software for IGA,
such as, PetIGA (Collier et al., 2013), igatools (Pauletti et al., 2015), or GeoPDEs
(de Falco et al., 2011).
NURBS-based isogeometric analysis and the Galerkin method
Here, we briefly describe the concept of B-splines and NURBS and we show a
NURBS-based IGA example based on the Galerkin discretization. We show this
method because it is the one we use in this thesis, but note, however, that IGA
is not restricted to it and has been used with other discretizations such as the
collocation method (Auricchio et al., 2010; Casquero et al., 2016; Reali and Gomez,
2015; Reali and Hughes, 2015) or the least-squares finite element method (Kadapa
et al., 2015), or in combination with the meshfree method (Rosolen and Arroyo,
2013; Valizadeh et al., 2015).
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B-splines and NURBS For the construction of a B-spline, we need to define
a basis of B-splines and a knot vector, that is, a non-decreasing set of coordinates
in the parameter space7. Let Ξ = {ξ1, ξ2, . . . , ξn+p+1} be the knot vector, where
ξi ∈ R is the ith knot, i is the knot index, i = 1, 2, . . . , n + p + 1, n ∈ N is the
number of basis functions, and p the polynomial order or degree. A univariate
B-spline basis, Ni,p, is defined recursively given some degree p ∈ N and a knot
vector Ξ8. Starting with piece-wise constants (p = 0):
Ni,0 (ξ)
{
1 if ξi ≤ ξ < ξi+1,
0 otherwise.
(1.1)
For higher degrees p = 1, 2, . . . the basis is defined using the Cox-de Bor recursion
formula:
Ni,p (ξ) =
ξ − ξi
ξi+p − ξiNi,p−1 (ξ) +
ξi+p+1 − ξ
ξi+p+1 − ξi+1Ni+1,p−1 (ξ) . (1.2)
Figure 1.18a shows an example for p = 2. Note that the support of each basis
function consists of a few number of elements.
B-spline curves C (ξ) in Rd, where d is the number of spatial dimensions, are
constructed by taking a linear combination of n B-spline basis as follows:
C (ξ) =
n∑
i=1
BiNi,p (ξ) , (1.3)
where Bi ∈ Rd is a vector of coefficients referred to as control points. p-degree
B-splines are Cp−1−m-continuous across knot spans, where m is the multiplicity
of the knot, and C∞-continuous elsewhere. As an example, figure 1.18b shows a
two-dimensional B-spline where p = 2 and Ξ = [0, 0, 0, 1, 1, 3, 4, 5, 5, 5]. Note that
the fourth knot value is repeated twice, so the continuity there is C0.
Using the notion of tensor products, these concepts can be easily generalized to
B-splines of multiple dimensions. Let dp be the number of parametric directions;
for each parametric direction ` = 1, . . . , dp we define a knot vector Ξ`, such that,
Ξ` =
{
ξ`1, ξ
`
2, . . . , ξ
`
n`+p`+1
}
, (1.4)
where p` and n` are the polynomial order and the number of basis functions for
each parametric direction, respectively. We also define a multi-index i ∈ Z, the
set
I =
{
i =
{
i1, . . . , idp
} | i` ∈ {1, . . . , n`} , ` = 1, . . . , dp} , (1.5)
7Knots partition the parameter space into elements.
8The standard in CAD are open knot vectors, defined as those whose first and last knot
values appear p+ 1 times.
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and a multi-index of polynomial orders p = {p1, p2, . . . , pdp}. Given a control net
{Bi} a multivariate B-spline is defined by
V (ξ) =
∑
i∈I
BiNi,p (ξ) , (1.6)
where, using a tensor product structure, the multivariate basis function Ni,p (ξ)
is defined as
Ni,p (ξ) =
dp∏
`=1
N `i`,p`
(
ξ`
)
. (1.7)
Non-uniform rational B-splines or NURBS are a generalization of B-splines. Rd
NURBS are obtained from the projection of Rd+1 B-splines and they allow the
exact representation of several useful geometries, such as conics. Given i and p, the
basis of a B-spline can be projected to create a basis of NURBS in the following
way:
Ri,p (ξ) =
wiNi,p (ξ)∑
j∈I wjNj,p (ξ)
, (1.8)
where wi are positive constants referred to as weights. Similarly to B-spline,
NURBS curves, surfaces, and volumes are created by the linear combination of a
control mesh and their piece-wise basis functions as
V (ξ) =
∑
i∈I
BiRi,p (ξ) . (1.9)
Figure 1.18c shows the exact parametrization of a conic section, in particular a
disk, and figure 1.18d shows a cone built with NURBS. More complex geome-
tries are constructed using two or more NURBS patches, that is, the union of
NURBS, as shown in figure 1.18e. We advance here that we exploit the concept of
NURBS patches to build our parallel code (see subsection 2.3.3). NURBS and B-
splines can also be refined using three different strategies: knot insertion (classical
h-refinement), order elevation (classical p-refinement), and k -refinement, which
increases smoothness in addition to order.
Galerkin discretization in isogeometric analysis Here we show a boundary
value problem solved using isogeometric analysis and the Galerkin method. In
particular, the model problem involves a fourth order partial differential equation,
as that is the maximum order of the equations of the present thesis. However,
as shown along the derivation of the method, isogeometric analysis provides a
framework in which dealing with other orders is straightforward and just a matter
of changing the smoothness of the basis functions. For more details about the
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(a) Basis functions.
(b) B-spline curve. (c) NURBS surface.
(d) NURBS volume. (e) NURBS patch.
Figure 1.18. Basis functions, B-splines, and NURBS. Control points are drawn as red
dots, knots as green squares, control nets as blue lines, and knot spans as green lines.
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resolution of higher-order partial differential equations using isogeometric analysis,
the reader is referred to (Auricchio et al., 2007; Fischer et al., 2011; Gomez et al.,
2008, 2010; Gomez and Nogueira, 2012; Gomez and París, 2011).
Let Ω ⊆ Rd be an open, connected d-dimensional domain and let ∂Ω = Γ be the
Lipschitz boundary of this domain. We consider a linear fourth-order operator A
and appropriate operators BE and BN so that they define essential and natural
boundary conditions on Γ, respectively. The strong form of our model problem is
as follows: Given the smooth functions f : Ω 7→ R, gE : Γ 7→ R, and gN : Γ 7→ R,
find u : Ω 7→ Rd such that
A (u) = f in Ω (1.10)
BE (u) = gE on Γ (1.11)
BN (u) = gN on Γ. (1.12)
Similarly to classical FEA, we derive now the weak form or variational formulation
of the strong problem, by multiplying equation (1.10) with smooth test functions
v, integrating over the domain, and integrating by parts twice. The strong form of
the problem is equivalent under certain assumptions to the following variational
formulation: Given the smooth functions f : Ω 7→ R, gE : Γ 7→ R, and gN : Γ 7→ R,
find u ∈ U such that ∀v ∈ V:
a (u, v) = (f, v) + b 〈gN , v〉 , (1.13)
where a(·, ·) and b 〈·, ·〉 are bilinear forms defined over Ω and Γ respectively and
(·, ·) denotes the L2 (Ω) inner product. b 〈·, ·〉 collects the boundary terms that
enforce the natural boundary conditions. U denotes the trial solution space whose
members satisfy the essential boundary conditions of the strong problem and V
denotes the weighting function space whose members are identical to those of
U , but satisfy the homogeneous counterpart of the essential boundary conditions.
The assumption here is that all the functions are sufficiently smooth, so that the
solution of this weak formulation is a solution of the strong form and vice versa.
In our model problem in particular, because the fourth-order terms of the strong
form are reduced to second-order in the variational formulation, we need our trial
and weighting functions to be at least C1-continuous. Thus, the spaces U and V
are defined as subsets of H2, the Sobolev space of square integrable functions
with square integrable first and second derivatives. If our strong problem only
involved second order terms, for example, we could work with the less restrictive
functional spaces U ,V ⊂ H1.
Now, we need to derive a numerical approximation of the variational formulation.
We perform it using the Galerkin method, which consists on defining discrete
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spaces Uh ⊂ U and Vh ⊂ V in which the approximate solution uh and weighting
function vh of our problem live. Thus, we approximate equation (1.13) by the
following variational problem over the finite-dimensional space: find uh ∈ Uh ⊂ U
such that ∀vh ∈ Vh ⊂ V:
a
(
uh, vh
)
=
(
f, vh
)
+ b
〈
ghN , v
h
〉
. (1.14)
We need to make a choice on the particular finite-dimensional spaces or, equiva-
lently, of their basis functions {Ni}nbi=1, where nb is the dimension of the discrete
space. Here, making use of isogeometric analysis, uh is defined as
uh (x, t) =
nb∑
i=1
uˆi (t)Ni (x) , (1.15)
where Ni are B-spline or NURBS basis functions and the coefficients uˆi are the
control points. The weighting function vh is defined equivalently to equation (1.15).
Furthermore, we assume that there exists a function ghN ∈ Vh such that ghN
∣∣
Γ
= gN .
Note that in IGA the basis functions are defined by the geometry, as in equa-
tion (1.3), but they still need to fulfill some analysis requirements. In our model
problem in particular, as we use a conforming discretization, Ni must be a subset
of H2 so that the relation Vh ⊂ V holds. As explained before, this requirement
is guaranteed by a B-spline or NURBS of order p ≥ 2 (provided that there are
no repeated knot values) because its global continuity is C1. Occasionally, the
simplest basis that represents the geometry may not be smooth enough. However,
these problems can be easily solved using the powerful, yet simple, refinement
techniques of IGA. For example, given our fourth order model problem and a
square geometry parametrized by B-splines of order p = 1, the parametrization
can be k -refined to obtain p = 2, so to increment the global continuity to C1.
Finally, making use of the choice of uh and vh, we can rewrite the problem as the
following linear system:
Auˆ = F, (1.16)
where
uˆ = (uˆi)
nb
i=1 , (1.17)
A = (ai,j)
nb
i,j=1 , with ai,j = a (Nj , Ni) , and (1.18)
F = (Fi)
nb
i=1 , with Fi = (f,Ni) + b
〈
ghN , Ni
〉
. (1.19)
Due to the compact support of the basis functions, the non-zero elements of
the stiffness matrix A are concentrated on a reduced-bandwidth diagonal, which
reduces computational costs.
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1.3 Thesis overview
Following this introduction, in chapter 2 we present a hybrid model for tumor-
induced angiogenesis with chemotactically-guided tip endothelial cells. There, we
put the model into a coherent mathematical and algorithmic framework and in-
troduce a numerical method for the theory. In chapter 3 we propose a new model
that accounts for chemotactic and haptotactic tip endothelial cell migration, cou-
pling the previous theory with a discrete random walk. Using the same numerical
method, we investigate the role of haptotaxis and chemotaxis in the mobility of
tip endothelial cells and its influence in the final vascular patterns. In chapter 4
we show how the effectiveness of our method permitted us to perform large-scale
three-dimensional simulations and to reproduce, also in three dimensions, one of
the most widely used angiogenesis assays: the mouse corneal micropocket angio-
genesis assay. In chapter 5, following a non-conserved phase-field methodology,
we propose a model of tumor angiogenesis that incorporates not only growth of
new capillaries, but their natural regression and regrowth. We also quantitatively
compare the predictions of this model with an in vivo experiment. In chapter 6
we derive a theory that includes the influence of intravascular, transvascular, and
interstiticial flow in angiogenesis. There, we study the different vascular patterns
altered by tumor angiogenic factor convection under different configurations and
the effect of high intratumoral pressure in angiogenesis. Finally, in chapter 7 we
present a summary and the conclusions of this thesis, as well as some recommen-
dations for further developments.
At the end of this document, the reader may find a list of publications that resulted
from the work in this thesis, the appendices, and the bibliography.
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A mathematical model of
tumor-induced angiogenesis
In this chapter we present a hybrid mathematical model for tumor-induced an-
giogenesis and introduce a numerical method based on isogeometric analysis that
naturally couples the discrete cellular-scale kinetics with the continuous descrip-
tion of the macroscale. We develop a mathematical framework that seamlessly
integrates mobile, discrete agents, that represent tip endothelial cells, into the
dynamics of the continuous variables. The latter combined with the high-order
accuracy and the C1 continuity of isogeometric analysis leads to highly efficient
algorithms for solving the mathematical model. The accuracy and versatility of
the method allowed us to perform several simulations that provide insight into
the dynamics of the governing equations and the underlying biological process.
2.1 Introduction
Our modeling strategy is based on the theory proposed by Travasso et al. in
Travasso et al. (2011b), which is a multiscale, hybrid model that describes the vas-
cular development caused by tumor angiogenesis factors released by hypoxic cells.
In their work, both the TECs that lead the capillary growth and the hypoxic cells
are modeled using discrete agents, while the TAF and the capillaries are modeled
as continuous variables. The model accounts for multiple biological phenomena,
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such as for example, the release of TAF by hypoxic cells; the activation of quiescent
endothelial cells and their differentiation into SECs and TECs; and the capillary
growth by chemotaxis. These biological processes are summarized in figure 2.1,
where we also show in light gray fonts some other phenomena not accounted for
in the theory. In Travasso et al. (2011b), the authors focus on the predictive
capabilities of the model, showing that it reproduces in vivo patterns of newly
formed vascular networks (see figure 1.17). Here, we emphasize the mathematical
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Figure 2.1. Conceptual scheme of the tumor angiogenesis process. The process starts
on the top-left corner of the plot, when the quiescent endothelial cells get activated by tumor
angiogenic factors. Thereafter, a series of events lead to the formation of new capillaries:
the differentiation of the endothelial cells by means of tumor angiogenic factors and lateral
inhibition; the initiation of the sprout that breaks into the extracellular matrix; the capillary
growth following different mechanisms; and the end of the growth. The mathematical model
utilized in this chapter accounts for all the phenomena in this figure, except for those plotted
with light gray fonts.
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and algorithmic aspects of the numerical approximation of the theory. Besides
its predictive capabilities, we feel this model is appealing for several reasons: (1)
the model can easily accommodate cellular-scale kinetics into the discrete part;
(2) in spite of the complexity of the vasculature patterns, the continuous part is
simply defined by a system of two partial differential equations on a fixed domain.
This is due to the use of the phase field method to describe the capillary patterns.
The phase-field method is a mathematical theory introduced to solve interfacial
problems. Originally developed for microstructure evolution (Chen, 2002; Em-
merich, 2003) and phase transition (Gomez et al., 2008; Gomez and Hughes, 2011;
Kobayashi, 1994), it has been successfully applied to a number of physical phe-
nomena such as infiltration (Cueto-Felgueroso and Juanes, 2009), multicellular
systems (Nonomura, 2012), or fluid vesicles (Campelo and Hernández-Machado,
2006). Even more relevant to this thesis is the recent application of the phase-field
method to modeling cancer growth (Cristini et al., 2009; Oden et al., 2010).
The rest of the chapter is organized as follows: we describe the tumor angiogenesis
model and develop a mathematical framework for it in section 2.2. Then, we
propose a numerical method to solve the model in section 2.3. In section 2.4 we
show the time evolution of a numerical example, a parametric study of the model,
and several simulations under different initial conditions. We finalize with the
conclusions in section 2.5.
2.2 The tumor angiogenesis model
In this section, we put the model into a coherent mathematical and algorithmic
framework. We understand the model as a staggering scheme that alternatively
uses the continuous and discrete descriptions. Therefore, before introducing the
fundamental equations of the model, we need to discretize the time interval of
interest, namely, (0, T ), into N sub-intervals In = (tn, tn+1), n = 0, 1, . . . , N − 1,
where 0 = t0 < t1 < · · · < tN = T . We will use the notation ∆tn = tn+1 − tn. To
advance the variables of interest, namely, the phase field describing the endothelial
cells’ location (c) and the TAF concentration (f), we need to solve first a discrete,
agent-based model and subsequently a continuous boundary value problem. The
discrete and continuous problems are defined on different spatial domains that
we introduce in what follows. For a pictorial description of the spatial domains
involved in the model, the reader is referred to figure 2.2.
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2.2.1 The spatial domain of the continuous problem
Let Ω ⊂ Rd be an open set, where d = 2 or 3, and let Γ be the boundary
of the domain Ω. The boundary Γ is assumed to be sufficiently smooth (e.g.,
Lipschitz) and to have a well-defined unit outward normal denoted by n. The set
Ω represents a portion of tissue that remains fixed over the time interval (0, T )
and is associated to the continuous part of the model. In Ω, we will define the
fields c : Ω × (0, T ) 7→ [−1, 1] and f : Ω × (0, T ) 7→ [0, fhyc ], which represent,
respectively, the phase field describing the endothelial cells’ location and the TAF
concentration, where fhyc is a positive constant.
2.2.2 The spatial domain of the discrete model
The discrete component of the model takes place on two subsets of Ω that may
vary from one time step to the next. We call these subdomains the hypoxic cell
subdomain Ωhyc and the tip endothelial cell subdomain Ωtec .
The hypoxic cell subdomain
This subdomain is associated to hypoxic cell locations, where the TAFs are released.
At the initial time stage, t0, we define this set as Ωhyc(t0) =
⋃Nhyc
i=1 Ω
i
hyc(t0),
where Nhyc is the initial number of hypoxic cells and each of the Ωihyc(t0) is
a circular-shaped (spherical-shaped if d = 3) subset of Ω with radius Rhyc and
center xihyc . This can be considered as an initial condition, which determines
the location of the hypoxic cells that release TAF, triggering the growth of new
capillaries. This set may vary from one time step to the next, because some TAF
sources may become inactive and stop releasing TAF. In particular, at each time
step, the set Ωhyc(tn+1) is obtained from Ωhyc(tn) using biologically motivated
deterministic conditions to be defined in subsection 2.2.4. If at the time stage tn,
a particular subdomain indexed by j meets those conditions, then Ωjhyc(tn+1) =
Ωjhyc(tn). If those conditions fail to be satisfied, then Ω
j
hyc(tn+1) = ∅.
The tip endothelial cell subdomain
This subdomain is associated to TECs, which are mobile discrete agents in the
model. At the initial time stage t0, there are no active TECs, and, thus, Ωtec(t0) =
∅. As time evolves, some TECs will get activated, leading at the stage tn, to a set
Ωtec(tn) =
⋃Ntec(tn)
i=1 Ω
i
tec(tn), where each of the Ωitec(tn) is a circular-shaped
(spherical-shaped if d = 3) subset of Ω with radius Rtec and center xitec . Note
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Figure 2.2. Two-dimensional representation of the different spatial domains in-
volved in the model. The boundary Γ of the domain Ω has natural boundary conditions. The
unit normal outward to the boundary is denoted by n. In addition, there are two types of circular
subdomains in Ω, namely, Ωitec (red) that move with a velocity vitec , where i = 1, 2, and Ω
j
hyc ,
j = 1, . . . , 8, (green) with fixed positions. Ω simulates a tissue, Ωtec the tip endothelial cells,
and Ωhyc the hypoxic cells.
that the number of subdomains Ntec(t) composing Ωtec may vary from one time
step to the next, because new subdomains are created when new TECs become
active. The biological conditions under which a new subdomain is created will
be defined in subsection 2.2.4. Once a TEC subdomain is created, it needs to
satisfy some conditions (also to be defined in subsection 2.2.4) to remain active.
If an existing subdomain fails to satisfy those conditions at the time stage tn,
it will become the empty set at stage tn+1. Each of the existing subdomains
that still satisfy the conditions at the stage tn gives rise to a new, but different,
subdomain at the time stage tn+1. Let us assume that Ωktec(tn) is one of these
subdomains. Its corresponding subdomain at time tn+1 is obtained by applying
an affine transformation to Ωktec(tn). The affine transformation, namely, ϕkn, is
defined by
ϕkn(x) = x+ ∆tnv
k
tec , (2.1)
and the new subdomain is defined as Ωktec(tn+1) = ϕkn(Ωktec(tn)). In equa-
tion (2.1), vktec represents the velocity of the TEC and is defined by
vktec = χ∇f(xktec)L
(‖∇f(xktec)‖) , (2.2)
where χ is a chemotactic constant, L is a limiting function to be defined in
subsection 2.2.4, and the operator ‖·‖ denotes the Euclidean norm of a vector. Note
that equations (2.1) and (2.2) treat the TECs as discrete mobile agents, assigning
them an individual velocity that depends on the gradient of TAF (chemotactic
velocity).
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2.2.3 The coupled discrete/continuous model
Here we present the algorithmic rules to advance the fields of interest from one
time step, say tn, to the next. Given c(·, tn), f(·, tn),
{
Ωihyc(tn)
}
i=1,Nhyc
, and{
Ωitec(tn)
}
i=1,Ntec(tn)
, proceed as follows:
1. Find
{
Ωihyc(tn+1)
}
i=1,Nhyc
and
{
Ωitec(tn+1)
}
i=1,Ntec(tn+1)
following the
steps indicated in subsections 2.2.2 and 2.2.2, and the conditions defined in
subsection 2.2.4.
2. Set f = fhyc in Ωhyc(tn+1), overwriting the values of f(·, tn) in Ωhyc(tn+1).
Call the resulting field f˜(·, tn).
3. Set
c = citec =
Bp
(
f
(
xitec
))
piRtec
2‖vitec‖
(2.3)
in Ωitec(tn+1) for all i = 1, . . . , Ntec(tn+1), overwriting the values of c(·, tn)
in Ωtec(tn+1). Call the resulting field c˜(·, tn).
4. Solve the boundary value problem
∂f
∂t
= ∇ · (D∇f)−BufcH (c) in Ω× (tn, tn+1) (2.4)
∂c
∂t
= ∇ · (M∇ (µc − λ2∆c))+ Bp (f) cH (c) in Ω× (tn, tn+1) (2.5)
D∇f · n = 0 on Γ× (tn, tn+1) (2.6)
M∇ (µc − λ2∆c) · n = 0 on Γ× (tn, tn+1) (2.7)
Mλ2∆c = 0 on Γ× (tn, tn+1) (2.8)
f(x, tn) = f˜(x, tn) in Ω (2.9)
c(x, tn) = c˜(x, tn) in Ω. (2.10)
The notation in the boundary value problem is as follows: D is the diffusion
constant; Bu is the uptake rate constant; H(·) is the Heaviside function; M
is the constant mobility; µc is the chemical potential; λ is a positive constant
proportional to the width of the capillaries wall; and Bp(·) is the proliferative rate
function. In what follows, we describe in detail all the functions and algorithmic
rules involved in the theory.
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2.2.4 The discrete component
The discrete, agent-based component of the model includes the production of
angiogenic factor by the hypoxic cells, the deactivation of the hypoxic cells, and
the activation, migration, and deactivation of the tip endothelial cells.
Hypoxic cells
The tumor angiogenic factor is produced by randomly-distributed hypoxic cells
with fixed positions denoted by xihyc . It is assumed that the hypoxic cells create a
subdomain Ωihyc around them in which the value of f remains constant and equal
to fhyc while the hypoxic cell is active. The hypoxic cells are only deactivated,
ceasing their production, when a capillary, considered here as all those points
in which c ≥ cact, is closer than a distance δnox. This distance represents the
diffusion length of the nutrients and oxygen from the blood vessels.
Tip endothelial cells
Activation of tip endothelial cells When the tumor angiogenic factor reaches
a capillary, a new tip endothelial cell is activated if the following conditions are
met in a point x∗ ∈ Ω:
1. c ≥ cact,
2. f ≥ fact,
3. G ≥ Gact, and
4. ‖x∗ − xjtec‖ ≥ δ4, ∀j = 1, . . . , Ntec(tn).
Condition 1 restricts the candidate points to tip endothelial cells to those satisfying
c ≥ cact, i.e., those inside a capillary. The following two are lower limit conditions:
the value of the factor f and the modulus of its gradient G = ‖∇f‖ must be
greater than certain thresholds defined by f ≥ fact and G ≥ Gact, respectively.
Finally, condition 4 accounts for lateral inhibition, that is, the above-described
differentiation phenomena driven by the Dll-4 ligand and the Notch receptor. In
the model, no point can be activated as the position of the new tip endothelial
cell if there is another closer than a certain distance δ4. This distance represents
the range of action of the ligand Dll-4.
If the four conditions are met in x∗, then a new subdomain is created. Let us assign
the index l to the new subdomain Ωltec(tn+1), which is centered at x∗ = xltec
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Figure 2.3. Limiting function and velocity modulus. Limiting function L(·) for the
velocity of the tip endothelial cells plotted in red and velocity modulus ‖vjtec‖ plotted in green.
For this graph χ = 242.67 and GM = 0.03.
and defined as
Ωltec(tn+1) =
{
x ∈ Ω ∣∣‖x− xltec‖ ≤ Rtec} , (2.11)
If there are two or more points that satisfy the conditions, only one tip endothelial
cell is created per time step. Inside the subdomain Ωltec(tn+1), the value of the
concentration of endothelial cells is described by equation (2.3), merging thus the
discrete component with the continuous description. This value is the ratio of the
material produced in the subdomain by proliferation and the area swept in the
movement of the tip endothelial cell, assuming that the problem is posed on a
two-dimensional domain.
Migration of tip endothelial cells The subdomains {Ωjtec}j=1,...,Ntec(tn)
are updated using equation (2.1), which translates them into the direction of the
gradient of angiogenic factor with a modulus proportional to this gradient through
χ. In addition, the modulus of the velocity is affected by a function given by
L (‖∇f‖) = 1 +
(
GM
‖∇f‖ − 1
)
H (‖∇f‖ −GM ) (2.12)
where GM is a constant. This function maintains the modulus of the velocity
under a threshold, namely, vtec,max = χGM . Both the function and its effect on
the velocity are represented in figure 2.3.
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Deactivation of tip endothelial cells The deactivation of tip endothelial
cells is accomplished through two conditions. Whenever the value of the tumor
angiogenic factor or its gradient is less than their activation thresholds, fact and
Gact, respectively, the corresponding TEC is deactivated, vanishing its associated
subdomain.
2.2.5 The boundary value problem
The boundary value problem (2.4)–(2.10) determines the continuous part of the
model. The tumor angiogenic factor diffuses throughout the domain Ω according
to equation (2.4) and is consumed by the endothelial cells at a rate of Bu, as
modeled by the reactive term in the equation. Free flux conditions are imposed
on the boundary Γ through equation (2.6). The initial conditions for the tumor
angiogenic factor at each time stage are described by equation (2.9). The dynamics
of the endothelial cells are modeled by a phase-field equation (2.5), where c is
the order parameter of the concentration of endothelial cells. If we assume that
the reactive term Bp (f) cH (c) is small, the evolution of c is such that it tends to
adopt the configuration of minimum energy given by the energy functional:
E (c) =
∫
Ω
(Ψc + Ψs) dx, (2.13)
where Ψc is the chemical free energy and Ψs is the surface free energy. The
chemical free energy, given by
Ψc = −c
2
2
+
c4
4
, (2.14)
is a double-well, non-convex function with two local minima, each one representing
a phase, as shown on the left-hand side of figure 2.4. One of the minima is at
c = 1, where the concentration of endothelial cells is maximum, and the other is
at c = −1, where there are no endothelial cells, but only host tissue cells. The
local maximum in c = 0 corresponds to the capillary walls. The energy term
Ψc leads to the separation of the phases. The chemical potential µc is given by
µc = Ψ
′
c = −c+ c3, where Ψ′c is the derivative of the chemical free energy with
respect to c. The surface free energy is defined as
Ψs =
1
2
λ2‖∇c‖2, (2.15)
where λ is a length scale of the model. The surface term endows the capillary
walls with an energy, penalizing the appearance of new sprouts. Equation (2.5)
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Figure 2.4. Energy functional and proliferation function. Plot of the energy functional
(left) that leads to phase separation and plot of the proliferation function (right) that controls
the proliferation of the endothelial cells.
also involves a reactive term that makes the theory non-conservative (Emmerich,
2008). This term is introduced to model the proliferation of endothelial cells in
the presence of angiogenic factor (SECs). The proliferative rate function Bp(f),
present in the reactive term, and given by
Bp(f) =
{
Bpf if f < fp
Bpfp if f ≥ fp
, (2.16)
increases with the value of TAF until a threshold fp. Above fp the proliferation
remains constant. The function is plotted on the right-hand side of figure 2.4.
For the phase field equation, we also apply free flux boundary conditions on Γ,
described by equations (2.7) and (2.8). At each time step, the initial condition
for the phase field is defined by equation (2.10).
2.2.6 Parameters
Many of the parameters that characterize the equations of the model were ob-
tained by Travasso et al. from observed values in vivo (see references in Travasso
et al., 2011b). On the contrary, those related with the tumor angiogenic factor
quantity and the condition of the order parameter for TEC activation (cact) are es-
timated for the simulation (we note that, in this context, the validation/calibration
methodology for parameters presented in Hawkins-Daarud et al., 2012 may be
relevant). As the equations are written in dimensionless form, it is necessary to
obtain the corresponding dimensionless parameters (referred to as the in silico
value of the parameters) for those that come from in vivo observation. The length
and time scales L0 = 1.25 µm and T0 = 1560 s allow retrieving physical values
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from the simulation results. Table 2.1 presents all the parameters of the model,
including the in vivo and in silico values.
2.3 Numerical method
In this section we propose a numerical method for solving the equations of the
mathematical model. We consider separately the discrete component and the
boundary value problem (2.4)–(2.10). We explain first the numerical method for
the discrete component in subsection 2.3.1, where we describe how the discrete
rules are considered and how the discrete component is merged with the continu-
ous equations. Subsection 2.3.2 describes the algorithms utilized to discretize the
continuous problem. Finally, we detail the implementation of the code in subsec-
tion 2.3.3. For the reader’s convenience, we present a flowchart of the numerical
method and the code in figure 2.6.
2.3.1 The discrete component
The numerical method for the discrete module of the theory is composed of two
parts, namely, the update of the spatial domains Ωhyc and Ωtec and the algorithm
to overwrite the values of the fields f and c on Ωhyc and Ωtec , respectively.
Update of the spatial domains of the discrete component
We define a sufficiently fine uniform grid of sample points (typically, twice as
fine as that used for the continuous boundary value problem), where we calculate
the values of the tumor angiogenic factor, its gradient, and the order parameter.
With these evaluations we are able to determine whether the discrete rules for the
activation and deactivation of the tip endothelial cells are satisfied. In addition,
we calculate the value of the order parameter in those points which are closer than
a distance δnox from the center of the subdomains {Ωihyc}i=1,...,Nhyc that permit
us to deactivate the HYC according to the discrete rules. Finally, we evaluate
the tumor angiogenic factor, its gradient, and the order parameter in the center
of the subdomains {Ωitec}i=1,...,Ntec(tn) to calculate the corresponding imposed
order parameter cjtec and velocity v
j
tec necessary to move the subdomains using
equation (2.1).
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Table 2.1. In vivo and in silico values of the parameters of the model. The in vivo parameters
were obtained from experiments detailed in the references of Travasso et al. (2011b).
Parameter Symbol In vivo value In silico value
TEC radius Rtec 5 µm 4
HYC radius Rhyc 5 µm 4
Nutrient and oxygen diffusion
length
δnox 25 µm 20
Dll-4 range of action δ4 20 µm 16
Interface width λ 1.25 µm 1
Diffusion constant D 10−13 m2 s−1 100
Constant mobility M 10−15 m2 s−1 1
Uptake rate constant Bu 0.004 s−1 6.25
Proliferative rate Bp 1.401
Chemotactic constant χ 242.67
TAF production fhyc 1
TAF condition for highest prolif-
eration
fp 0.3
Order parameter condition for ac-
tivation/deactivation
cact 0.9
TAF condition for activa-
tion/deactivation
fact 0.055
TAF gradient condition for acti-
vation/deactivation
Gact 0.01
TAF gradient for highest velocity GM 0.03
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Impose the constraints on the fields ch(x, tn) and fh(x, tn)
Since we will use isogeometric analysis to solve the boundary value problem
(2.4)–(2.10), the phase field and the TAF field will be elements of a finite dimen-
sional space. This is why we use the notation ch(x, tn) and fh(x, tn) with the
superscript h. We have to impose fhyc in {Ωihyc}i=1,...,Nhyc and cjtec in Ωjtec ,
∀j = 1, . . . Ntec(tn), according to equation (2.3). Let us illustrate how we over-
write the value of ch(x, tn) on a given subdomain Ω
j
tec(tn), where j is a fixed
index that takes one of its admissible values, namely, 1, . . . , Ntec(tn). Let us
define the template function gjc : Ω 7→ [−1, 1] as
gjc(x) =
(
cjtec − 1
2
)
−
(
cjtec + 1
2
)
tanh
(
‖x− xjtec‖ −Rtec
2
)
(2.17)
where  = 0.1. Note that gjc is a multidimensional generalization of an exact one-
dimensional solution to the Cahn-Hilliard equation on an infinite domain. Thus,
we overwrite the value of ch(x, tn), using a template function as close as possible
to the fundamental solution of the partial differential equation (2.5). Figure 2.5
presents a one-dimensional illustration of gjc in which Ω
j
tec(tn) = (30, 40). Taking
into account all of this, our goal is to find
c˜j(x, tn) =
{
gjc (x) if x ∈ Ωjtec ,
c (x, tn) otherwise.
(2.18)
To undertake the coupling between the discrete and continuous parts of the
algorithm, we need to find an approximation of c˜j(x, tn) that lives in the finite
dimensional space. Let us call Π the L2 projection operator associated to the
discrete space. We define c˜j,h(x, tn) = Π
(
c˜j(x, tn)
)
. This process can be repeated
for all relevant j to obtain the overwritten field c˜h(x, tn).
We proceed analogously to impose the constraints on the field fh(x, tn). This
case is somewhat simpler because the imposed value fhyc will always be greater
than the value of the field fh(x, tn) due to the maximum principle satisfied
by equation (2.4). Let us illustrate the process by imposing the restriction on
Ωihyc(tn). We define the template function gif : Ω 7→ [0, fhyc ] as
gif (x) =
1
2
− 1
2
tanh
(‖x− xihyc‖ −Rhyc
2
)
. (2.19)
Figure 2.5 shows a one-dimensional illustration of the template function. Since
gif will be greater than f
h(x, tn) in Ωihyc(tn), we can define f˜ i(x, tn) as
f˜ i(x, tn) = max
(
fh(x, tn), g
i
f (x)
)
. (2.20)
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Figure 2.5. Template functions. One-dimensional examples of the template functions used
to merge the discrete component with the continuous variables. In green is plotted gif (x) and in
red gjc(x), where Ωihyc(tn) = (10, 20), Ω
j
tec(tn) = (30, 40), and c
j
tec = 1.
The process is finalized projecting f˜ i onto the discrete space as f˜ i,h(x, tn) =
Π
(
f˜ i(x, tn)
)
, and repeating for all relevant i.
Remark:
1. Only when the value of cjtec is greater than c(x
j
tec , tn), equation (2.18)
reduces to
c˜j(x, tn) = max
(
ch(x, tn), g
j
c(x)
)
. (2.21)
However, in the opposite case, cjtec ≤ c(xjtec , tn), we also use the latter
equation. We have verified that using this simplification rather than equa-
tion (2.18) does not lead to significant changes in the solutions.
2.3.2 The continuous equations
We begin by considering a weak form of equations (2.4) and (2.5). Let V denote the
trial and weighting function spaces, which are assumed to be identical. The space
V is a subset of H2, the Sobolev space of square integrable functions with square
integrable first and second derivatives. The weak form of the problem is obtained
by multiplying equations (2.4) and (2.5) with smooth functions, integrating over
the domain, and applying integration by parts repeatedly under the assumption
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of free flux boundary conditions. The problem may be stated as follows: find
f, c ∈ V such that ∀w, q ∈ V:(
w,
∂f
∂t
)
Ω
+ (∇w,D∇f)Ω + (w,BufcH (c))Ω = 0(
q,
∂c
∂t
)
Ω
+ (∇q,M∇µc)Ω
+
(
∆q,Mλ2∆c
)
Ω
− (q,Bp (f) cH (c))Ω = 0

, (2.22)
where (·, ·)Ω is the L2 inner product with respect to the domain Ω. We make
use of the Galerkin method to obtain the spatial discretization of the previous
weak formulation. We approximate equation (2.22) by the following variational
problem over the finite dimensional spaces: find fh, ch ∈ Vh ⊂ V such that
∀wh, qh ∈ Vh ⊂ V:(
wh,
∂fh
∂t
)
Ω
+
(∇wh, D∇fh)
Ω
+
(
wh, Buf
hchH (ch))
Ω
= 0(
qh,
∂ch
∂t
)
Ω
+
(∇qh,M∇µ (ch))
Ω
+
(
∆qh,Mλ2∆ch
)
Ω
− (qh,Bp (fh) chH (ch))Ω = 0

. (2.23)
Here fh is defined as
fh (x, t) =
nb∑
A=1
fA (t)NA (x) , (2.24)
where nb is the dimension of the discrete space Vh and fA are the so-called control
variables, which act as coefficients of the basis functions NA. The functions ch,
wh, and qh, which also live in the space Vh, are defined analogously. Since we
will use a conforming discretization, the relation Vh ⊂ V holds and the discrete
functions are required to be in H2. This condition is satisfied by the globally C1-
continuous basis functions that we consider in this thesis, by means of isogeometric
analysis, as explained in subsection 1.2.3. In particular, as we will only deal with
two-dimensional squared geometries in this chapter, we use B-splines of order
p = 2.
We integrate in time using the generalized-α method (Chung and Hulbert, 1993;
Jansen et al., 2000). The generalized-α method is a second-order accurate, un-
conditionally A-stable method with controllable high-frequency dissipation that
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can be easily implemented within an adaptive time step framework. All these
features make it a good choice for highly nonlinear problems (Bazilevs et al.,
2006, 2010; Gomez et al., 2013) such as that addressed in this thesis (for time
integrators specifically designed for phase-field models, the reader is referred to
Gomez and Hughes, 2011; Liu et al., 2013). In addition, we use a time-step size
selection algorithm that considerably reduces the computational time. This algo-
rithm was first proposed for reaction-diffusion equations and was then utilized for
other mathematical models, such as in Gomez et al. (2008). After space and time
discretization, we obtain a non-linear system which is solved using a predictor
multi-corrector algorithm based on the Newton-Raphson method.
We use the notation f˙hn , fhn , c˙hn, chn for the fully discrete solutions of the tumor
angiogenic factor time derivative, the tumor angiogenic factor, the phase-field
time derivative, and the phase-field, respectively. The problem can be stated as:
given f˙hn , fhn , c˙hn, chn, and ∆tn = tn+1 − tn, find f˙hn+1, fhn+1, c˙hn+1, chn+1 such that:(
wh, f˙hn+αm
)
Ω
+
(
∇wh, D∇fhn+αf
)
Ω
+
(
wh, Buf
h
n+αf
chn+αfH
(
chn+αf
))
Ω
= 0(
qh, c˙hn+αm
)
Ω
+
(
∇qh,M∇µ
(
chn+αf
))
Ω
+
(
∆qh,Mλ2∆chn+αf
)
Ω
−
(
qh,Bp
(
fhn+αf
)
chn+αfH
(
chn+αf
))
Ω
= 0

, (2.25)
where
f˙hn+αm = f˙
h
n + αm
(
f˙hn+1 − f˙hn
)
, (2.26)
fhn+αf = f
h
n + αf
(
fhn+1 − fhn
)
, (2.27)
fhn+1 = f
h
n + ∆tnf˙
h
n + γ∆tn
(
f˙hn+1 − f˙hn
)
, (2.28)
c˙hn+αm = c˙
h
n + αm
(
c˙hn+1 − c˙hn
)
, (2.29)
chn+αf = c
h
n + αf
(
chn+1 − chn
)
, (2.30)
chn+1 = c
h
n + ∆tnc˙
h
n + γ∆tn
(
c˙hn+1 − c˙hn
)
, (2.31)
γ =
1
2
+ αm − αf , (2.32)
αm =
1
2
(
3− ρ∞
1 + ρ∞
)
, (2.33)
αf =
1
1 + ρ∞
, (2.34)
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and ρ∞ is the spectral radius of the amplification of the matrix as ∆t→∞. We
obtain second-order accuracy if γ = 12 + αm − αf is satisfied and unconditional
stability (for a linear problem) provided that αm ≥ αf ≥ 12 .
Now, let F˙n, Fn, C˙n, and Cn be the vector of degrees of freedom of f˙hn , fhn , c˙hn,
and chn, respectively, and Sn = {Fn,Cn}T be a vector of all the degrees of freedom.
The time stepping scheme may be implemented as follows: given S˙n, Sn, and ∆tn,
find S˙n+1 and Sn+1 such that R = 0 where
R =
R
f
A
RcA
 , (2.35)
RfA =
(
NA, f˙
h
n+αm
)
Ω
+
(
∇NA, D∇fhn+αf
)
Ω
+
(
NA, Buf
h
n+αf
chn+αfH
(
chn+αf
))
Ω
RcA =
(
NA, c˙
h
n+αm
)
Ω
+
(
∇NA,M∇µ
(
chn+αf
))
Ω
+
(
∆NA,Mλ
2∆chn+αf
)
Ω
−
(
NA,Bp
(
fhn+αf
)
chn+αfH
(
chn+αf
))
Ω

. (2.36)
Equating the residual to zero, we define a non-linear system of algebraic equations.
We use the Newton-Raphson method to solve the system, which leads to a two-
stage predictor-corrector algorithm:
1. Predictor stage: Set
S˙n+1,(0) =
γ − 1
γ
S˙n, (2.37)
Sn+1,(0) = Sn. (2.38)
2. Multi-corrector stage: Repeat the following steps for i = 1, 2, . . . , imax or un-
til ‖Rn+1,(i)f ‖/‖Rn+1,(0)f ‖ ≤ ΥN-R and ‖Rn+1,(i)c ‖/‖Rn+1,(0)c ‖ ≤ ΥN-R ,
where ΥN-R is a given tolerance.
(a) Evaluate the iterates at the α-levels:
S˙n+αm,(i) = S˙n + αm
(
S˙n+1,(i−1) − S˙n
)
, (2.39)
Sn+αf ,(i) = Sn + αf
(
Sn+1,(i−1) − Sn
)
. (2.40)
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(b) Assemble the residual vector and tangent matrix:
Rn+1,(i); Kn+1,(i) = ∇S˙n+1,(i)Rn+1,(i), (2.41)
where
∇S˙n+1,(i)(·) =

∂(·)
∂F˙n+1,(i)
∂(·)
∂C˙n+1,(i)
 . (2.42)
(c) Solve the following linear system using the GMRES algorithm:
Kn+1,(i)∆S˙
n+1,(i)
= −Rn+1,(i). (2.43)
(d) Use ∆S˙n+1,i to update the iterates:
S˙n+1,(i) = S˙n+1,(i−1) + ∆S˙n+1,(i), (2.44)
Sn+1,(i) = Sn+1,(i−1) + γ∆tn∆S˙n+1,(i). (2.45)
The implementation of an adaptive time step reduces the computation time
of the numerical simulations more than an order of magnitude compared with
maintaining a constant time step. Further, it permits us to analyze the accuracy
of the method, regarding the time integration. To define an adaptive time step, we
make use of the fact that the generalized-α method transforms into the backward
Euler method by setting γ = αm = αf = 1. Comparing the results from both
methods we are able to evaluate an error estimate e and to update the time-step
size using the formula
F (e,∆t) = ρ
(
Υ∆t
e
) 1
2
∆t, (2.46)
where, according to the values suggested in Lang (1995), the safety coefficient ρ is
set to 0.9 and the tolerance of the method Υ∆t is set to 10−3. Thus, for a certain
time-step n, we can implement a time-step size adaptive algorithm as follows:
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Algorithm 1 Adaptive time-step size
Given: S˙n, Sn, and ∆tn,
1: Compute Sn+1be using backward Euler and ∆tn
2: Compute Sn+1α using generalized-α and ∆tn
3: Calculate en+1 =
‖Sn+1be −Sn+1α ‖
‖Sn+1α ‖
4: if en+1 > Υ∆t then
5: Recalculate time-step size ∆tn ← F (en−1,∆tn)
6: goto 1
7: else
8: Update time-step size ∆tn+1 = F (en+1,∆tn)
9: continue
10: end if
2.3.3 Code development and implementation
Open or free source isogeometric codes such as PetIGA, igatools, or GeoPDEs
focus on the resolution of partial differential equations. As we want to solve
a hybrid model that involves discrete agent-based elements besides the partial
differential equations, we have developed a home-made code based on the above-
explained numerical method1. The most prominent features of this code are: (1)
It is capable of handling both discrete agents and partial differential equations; (2)
it runs efficiently sequentially and in parallel (the code has been tested with up to
512 processors); (3) it can perform simulations both in two- and three-dimensions
with any NURBS geometry of arbitrary degree; (4) it uses the generalized-α
method and an adaptive time-step for the time iterations, the Newton-Raphson
method for nonlinear system, and GMRES as linear parallel solver; (5) it finds
efficiently parametric coordinates of a physical point in parallel.
The flow of the code is as follows (see figure 2.6). The code starts by initializing
all the appropriate variables and by reading the input files. The most important of
these input files is the one that contains the mesh, which was previously generated
with our own meshing algorithm. If the mesh contains several patches (as it is
the case for parallel simulations), this file is accompanied by connectivity files
that particularize the connections and continuity restrictions among contiguous
patches. Then, the code enters a time loop with a preset time step (typically 10−4).
Note that this time step will automatically adapt to the requirements of the model,
so the initial value is just a first approximation. Each time iteration the code
goes through three subroutines or modules. The first one is the HYC module that
1In addition, by the time this thesis started, these codes were just not available.
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handles the HYC discrete agents. It loops through all HYC deactivating those
which are located closer than a distance δnox to a capillary and updates the TAF
field f using equation (2.20). The second module, namely the TEC module, deals
with tip endothelial cells. It checks whether any point in the sample point grid
fulfills the activation conditions specified in subsection 2.2.4 and activates a new
TEC if appropriate. Then, it loops through all TECs, deactivating those that fail to
meet the deactivation conditions detailed in subsection 2.2.4 and moving those that
remain active following equation (2.2). Finally, using equation (2.21), the phase-
field c is updated. Following these two modules for the discrete components of the
model comes the cnt module that solves the updated continuous fields c and f .
This module encodes the first three steps of algorithm 1: It computes the solution
of the continuous model using both backward Euler and generalized-α methods
and then calculates the relative error en+1 with respect to the generalized-α
solution of the time step. For computing the solution of the continuous model, the
code uses the two-stage, predictor-corrector algorithm described in the previous
subsection 2.3.2, as shown in figure 2.6. After the modules, the flow of the code
returns to the main thread, where the relative error is compared with a given
tolerance Υ∆t, as in algorithm 1. If the error is greater than the tolerance, the
time-step size is recomputed using equation (2.46). Note that the code does not
return to the beginning of the time step, but to the TEC loop instead, because
the previous calculations remain equal. Contrarily, if the relative error is below
the tolerance, the time-step size is updated (also with equation (2.46)) and time
iteration ends. The simulation continues until there are no HYCs, neither TECs,
and all TAF is consumed. Finally, prior to termination, the code outputs the
necessary information to post-process the results (post-processing is also done
with a home-made code and visualization with Paraview Ahrens et al., 2005).
As mentioned above, this code can run in parallel using message passing interface
(MPI) protocol. Note that in figure 2.6 at certain points of the flowchart appears
a bubble symbol. It is only at those points that the processors share information
with each other. Great care has been taken to reduce these communications to
a minimum in order to improve the efficiency of the code. The paralelization of
the code is done by dividing the mesh into rectangular (in the parametric space)
patches, so that each processor takes care of one patch. In order to generate these
patches, our mesh generator code first generates a single-patch geometry and then
divides it in multiple patches by inserting knots at those knot lines selected as
processor division lines until the local continuity of the mesh reduces to C02. This
strategy provides each processor with its own mesh (one patch) so that it can
perform calculations independently from other processors during a great part of
2Knot insertion does not change the NURBS mesh geometrically or parametrically, thus the
patches match.
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the simulations. However, the original continuity (C1 for our fourth order problem)
must be enforced at certain stages of the code, namely, in the linear solver and
in the c and f updates in the discrete modules (as shown in figure 2.6 by the
above-mentioned symbols). To do it, the code uses the continuity constraints
created by the mesh generator which are added to the global linear system. In
our particular case, C1 is maintained across processors by enforcing the two last
control points of one processor to be aligned with the two first control points of
the next processor in one direction.
One of the major challenges in the implementation of this hybrid mathematical
model is to evaluate efficiently the continuous fields at physical points to assess the
discrete rules. The challenge stems from two facts. First, the discrete agents may
be located at any point in the physical domain: HYCs are initialized at random
positions and TECs, although they get activated at known points (the sample grid),
they can move to any point within the physical domain. Therefore, to compute
the continuous fields at the evaluation points we first have to invert the mapping
to retrieve the parametric coordinates each time step and for each evaluation
point3. This would not suppose a major computational cost if it were not for
the second fact: the code must be able to deal with complex, three-dimensional
geometries and with multiple patches that live in different processors. Hence,
for each evaluation point and each time step, the code must solve a nonlinear
system (because the mapping is nonlinear for complex geometries) for each patch
or processor. Furthermore, to assess a discrete rule of a discrete agent located
in one processor, we need to evaluate the continuous fields at points that may
or may not lie in the same processors. This increases the communication among
processors, which, if not addressed in an efficient way, results in unmanageable
computational times.
2.4 Results and discussion
In this section we present some numerical results of our numerical method for the
tumor angiogenesis model. We begin with the description of the development of
a vascular network through a numerical example. We also show the effect of the
time-step size adaptivity. Next, we present the influence of relevant parameters of
the model in a parametric study. Finally, we conclude the section with an analysis
of different examples with variations in the initial conditions.
3If, on the contrary, the evaluation points were restricted to a set of a priori fixed points, we
could invert the mapping just once at the initialization of the code.
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2.4.1 Numerical example
We perform this numerical example on a square domain Ω = [0, 300]2 which
represents a tissue of 375 µm× 375 µm. We define a mesh composed by 2562
quadratic elements that spans all the domain. The simulation implements the
numerical method described in section 2.3, including the adaptive time stepping
scheme presented in algorithm 1.
We establish the following initial conditions for this numerical example: The value
of the order parameter is set to minus one, c = −1, in all the domain, except
for a stripe of constant width at the bottom of the domain, where we set c = 1.
This stripe represents a pre-existent 37.5 µm wide blood vessel (note that at the
scale considered in this example, the average capillary width varies from 5 µm
to 10 µm Shiu et al., 2005). At the beginning of the simulation Ωtec(t0) = ∅
and Ωhyc(t0) =
⋃200
j=1 Ω
j
hyc(t0), where the x
j
hyc , j = 1, . . . , 200, are randomly
distributed in Ω. We employ periodic boundary conditions in the horizontal
direction and free flux conditions in the vertical direction. The above-described
initial configuration, shown in figure 2.7, simulates an avascular tumor and its
environment in a tissue. The tissue is square, although the implementation of the
periodic boundary conditions allows the vasculature and the tumor angiogenic
factor to spread horizontally without reaching the end of the domain in this
direction. The tumor is modeled as 200 hypoxic cells, Ωhyc , and the environment
y
Initial conditions Profiles
Order 
parameter
Tumor 
angiogenic
factor 
y-y'c
, 
f
1.0
0
-1.0
y
'
0.5
-0.5
Figure 2.7. Initial conditions. Initial conditions of the numerical examples of figures 2.8
and 2.10. On the left-hand side is plotted a square domain (Ω = [0, 300]2) that represents a
tissue with an initial capillary at the bottom (red) and 200 randomly-distributed hypoxic cells
(green). The profiles of the order parameter and the tumor angiogenic factor along y − y′ are
plotted on the right-hand side.
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is composed by host cells, c = −1, and endothelial cells forming a capillary, c = 1.
Figure 2.8 shows snapshots of the numerical example at different times (the in-
terested can find the full simulation in video S2.1 in the supporting information).
The tumor angiogenic factor produced by the hypoxic cells diffuses from them
throughout the domain, filling it. As the diffusible factor reaches the endothelial
cells, they consume it. For a time lapse there is a pseudo-equilibrium situation,
in which all the domain is filled with tumor angiogenic factor and the TAF pro-
duced is consumed by the endothelial cells. This situation is maintained, until
the factor pervades the capillary in a point with enough quantity to activate a
tip endothelial cell. Figure 2.8b presents a snapshot several time steps after the
pseudo-equilibrium is broken. The incipient capillary starts to take shape starting
by a single cell followed by proliferative cells in the stalk of the sprout. The prolif-
eration entails a consumption of the tumor angiogenic factor that becomes more
evident in figure 2.8c. The capillary continues growing and new sprouts appear
forming branches (figures 2.8d and 2.8e). During the simulation the tip endothe-
lial cells find other endothelial cells in their growing direction. In these cases (see
details in figures 2.8f and 2.8g) they merge one with another originating anas-
tomoses. The growth and branching proceeds (figure 2.8h) until all the hypoxic
cells become normoxic. This process creates a vascular pattern characteristic of
tumor angiogenesis, shown in figure 2.8i.
Figure 2.9 shows the evolution of the time step size, ∆t, with respect to time,
t. At the beginning of the simulation, the ∆t is set to 10−4. Then it follows
an increasing trajectory, along which the time step becomes larger. During this
period, the dominating phenomenon is the diffusion of the tumor angiogenic factor.
Also several new capillaries appear at the end of ascending slope, characterized
by little descends in the time-step size. The time step size acquires its maximum
value in the vicinity of t = 19. From this point, the time-step curve presents a
global descending trend with several fluctuations. This implies a deceleration of
the numerical method related with the increment in complexity of the vascular
network. The local minima of the fluctuations correspond to the creation of new
sprouts.
2.4.2 Parametric study of the model
Here we present a study of two of the most biologically relevant parameters of
the model: Bp, that controls the proliferation, and χ, that alters the chemotactic
velocity. The characteristics of the domain size, mesh, and initial and boundary
conditions are the same as those used for the numerical example in subsection 2.4.1.
All the parameters of the model, except those object of the study, maintain the
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(a) t = 0 (b) t = 4.58 (c) t = 15.69
(d) t = 22.83 (e) t = 28.91 (f) t = 35.75
(g) t = 44.71 (h) t = 50.49 (i) t = 74.7
Figure 2.8. Snapshots of the formation of a vascular pattern at different times. The
parameters used for this numerical example are those presented in table 2.1 and the domain is
Ω = [0, 300]2. The tumor angiogenic factor (green) is produced by randomly-distributed hypoxic
cells and promotes the growth of new capillaries (red) from the initial one situated at the bottom
of the domain. In their growth, the capillaries fuse one with another (anastomosis) as shown in
the highlighted areas. The final pattern shows the disorganized sprouting and tortuous capillaries
characteristic of tumor angiogenesis.
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Figure 2.9. Time-step size. Evolution of the time-step size (∆t) with respect to time (t) of
the numerical example of figure 2.8 using the adaptive time-step algorithm 1. The snapshots
show captures of the evolution of the capillary growth at different instants. The time-step size
increases at the beginning when there are few new capillaries until a maximum around t = 19.
From this point the evolution of the time step is characterized by a decrease in its size due to
an increment in the complexity in the capillaries pattern.
values given in table 2.1.
We used our numerical method to perform nine simulations (figure 2.10) in which
the parameters take the following values: 50, 100, and 130 % of Bp (as given in
table 2.1) and 16, 100, and 200 % of χ (as given in table 2.1). The disposition
of the simulations is such that the one with lower proliferation and chemotactic
velocity is in the bottom-left corner and the one with the highest parameter values
is in the opposite corner. In the center of the grid is shown the final pattern of
the numerical example of subsection 2.4.1, which we take as reference point for
comparison purposes.
The resulting vascular networks present different characteristic patterns. If we
compare the simulations within the same row, we observe a decrease in the
capillary width as the chemotactic velocity increases. This behavior is produced
by the fact that the stalk endothelial cells are provided with less time to proliferate.
An analysis of the second column, shows a variation in the capillary width driven
by the proliferative parameter. As Bp increases, so does the width of the capillaries.
Furthermore, these simulations show sparser patterns when the proliferation is
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Figure 2.10. Parametric study of the model. Comparison of nine stationary patterns
resulting from different parameter combinations. The value of the parameters is shown in the
axis as a percentage of the proliferation (Bu) and chemotaxis (χ) from table 2.1. The nine
patterns evolved from the same initial conditions defined in figure 2.7.
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low. It is remarkable the difference in the patterns of the first column and the
rest. The low value of the chemotactic velocity, 16 % of χ, gives rise to very wide
capillaries. In addition, within this column we can easily appreciate the influence
of the proliferation rate. When it is low, the capillaries are over-dimensioned, but
with well-defined boundaries. Conversely, they become a mass of endothelial cells
that spans almost all the domain when the proliferation is high as shown in the
snapshot in the top-left corner.
2.4.3 Influence of the hypoxic cell distribution and initial
capillaries
We study the influence of HYCs distribution and initial capillaries by perform-
ing several simulations on the domain Ω = [0, 700]2, which represents a tissue
of 875 µm× 875 µm. Note that the surface of the domain is approximately 5.4
times larger than that of the previous examples. However, we use the same mesh
composed by 2562 quadratic elements. We implement our numerical method and
the adaptive time step scheme given in algorithm 1. As initial conditions, we set
diverse capillary configurations, maintaining the width of the vessels to 37.5 µm.
The location of the initial hypoxic cells is random and different between the nu-
merical examples. The tumor angiogenic factor is initially zero in Ω\Ωhyc(t0), and
there are no TECs at the beginning of the simulations, therefore, Ωtec(t0) = ∅.
We present in figure 2.11 the results of four different numerical examples with an
initial capillary at the bottom of each domain. We also present the full evolution
of the top-left simulation in video S2.2 in the supporting information. Each
simulation has a different random distribution of 200 hypoxic cells according
to a uniform density function. The objective of these simulations is double. On
the one hand, these simulations serve as proof for the accuracy of the method.
Although we use here the same mesh as in subsection 2.4.1 for a domain with
a surface approximately 5.4 times larger, the numerical method is still able to
capture the more complex vascular pattern with accuracy. On the other hand,
these simulations allow us to perform an analysis of the different patterns formed
under the influence of diverse initial hypoxic cells. From figure 2.11 we may
conclude that the final patterns hold similar characteristics, regarding the width
of capillaries, the number of branches, and the density of the pattern. Note that,
because the model does not include haptotaxis, the number of anastomosis events
in all simulations is low and most of them are mainly located at the position
of hypoxic cells. In addition, as highlighted in the left-hand side plots of the
figure, TECs get deactivated even in the proximity of other capillaries. This
phenomenon is an artifact result of the mathematical model because TECs are
only guided by chemotaxis. In this particular case, TECs should have anastomosed
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Figure 2.11. Numerical examples of the model with different randomly distributed
hypoxic cells on the domain Ω = [0, 700]2. The patterns present similar characteristics
in all four simulations regarding the width and number of capillaries and the density of the
network.
and formed vessel loops with nearby capillaries following mechanotactic cues. If
haptotaxis and mechanotaxis were included in the model, anastomosis events
would be more frequent and not determined by HYC locations. We also observe
differences in the distance between the sprouts that grow from the main initial
capillary. Usually, the growth from the initial capillary occurs when the pseudo-
equilibrium situation mentioned in subsection 2.4.1 is broken. Thereafter, the
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few capillaries that originate from the initial one get soon deactivated due to the
scarcity of TAF in the region. One remarkable difference in the patterns is the
wide capillary highlighted in the bottom-right plot. This situation is caused by
the initial conditions of that particular simulation: Several initial HYCs gathered
in a small region and surrounded by an empty zone produce great amounts of
TAF promoting high SEC proliferation. Finally, as the model does not include
the characteristic capillary regression observed in tumor-induced angiogenesis, the
final pattern is full of short, useless vessels that do not allow blood flow.
Finally, figure 2.12 shows three numerical examples (see also videos S2.3 to S2.5 in
the supporting information). We performed each of the simulations with different
initial conditions for the hypoxic cell distribution and the initial capillaries. We
show these initial configurations on the left-hand side snapshots of figure 2.12,
while the correspondent final results are shown on the right-hand side snapshots.
For the simulation in the first row, we choose a circular initial capillary surround-
ing two hundred hypoxic cells randomly distributed in the domain according to
a uniform density function. This configuration could be interpreted as a two-
dimensional approach of an in vivo assay of angiogenesis in a cornea (Kenyon
et al., 1996; Muthukkaruppan et al., 1982), at a different scale. The circular cap-
illary would be equivalent to the corneal limbus and the space inside with the
hypoxic cells would be the avascular cornea with cancerous cells. Additionally,
the configuration could also be compared to the vascular growth of a tumor im-
planted in the dorsal skin of a mouse and observed trough intravital microscopy
(Jain et al., 2002) with no previous capillaries in the observed domain. The final
network of this configuration is formed by three main capillaries grown from the
circular one that branch as they get closer to the hypoxic cells. In the second row
of figure 2.12 we present a simulation in which the two hundred hypoxic cells are
the same as in the previous row, but the initial capillaries are different. Instead of
geometric shapes, we create a more likely approach to an initial vascular network
in a real tissue. The resulting pattern covers the positions of the hypoxic cells.
Finally, we present in the last row of figure 2.12 a configuration with four initial
capillaries, each of them in one boundary of the domain. In addition, we choose
a distribution of hypoxic cells based on four normal density functions. Thus, the
initial conditions of this simulation mimic a multifocal tumor in a tissue. This
result shows how the model is able to create vascular patterns for each of the foci.
2.5 Conclusions
The dynamics of tumor angiogenesis and its impact on cancer growth remain
as fundamental open problems in cancer biology. In this chapter, we derive an
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Figure 2.12. Numerical simulations with different initial conditions. Initial conditions
(left) and final patterns (right) of three simulations. The first row presents a circular initial
capillary, the second represents a more real configuration of several capillaries in a tissue, and
the third shows a multifocal distribution of hypoxic cells. The three simulations were performed
on the domain Ω = [0, 700]2.
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algorithmic framework for a hybrid model that couples cellular-scale kinetics
and an averaged phase field description at the macroscale. We formulate the
discrete cellular kinetics into a functional framework that seamlessly integrates
with the continuous description and permits an efficient numerical treatment of the
coupled problem. We perform several numerical simulations using our algorithms.
The examples show the accuracy and efficiency of the method in a number of
physically relevant situations. Our simulations provide insight into the dynamics
of the governing equations and the underlying biological process behind them.
They also highlight the lack of some key mechanisms of angiogenesis in the model,
like haptotaxis, mechanotaxis, or vessel regression.
Both the developed mathematical framework and the multidimensional parallel
code serve as a starting point for the remaining mathematical models of this
thesis. In addition, by using IGA we paved the way for numerical simulations in
three-dimensional, complex geometries.
2.6 Supporting information
Supporting information includes the following four videos that can be found online
at http://caminos.udc.es/gmni/gente/gvilanovac/thesis/:
Video S2.1. Formation of the capillary network of figure 2.8. Two hundred
randomly distributed hypoxic cells on a domain Ω = [0, 300]2 promote the growth
of the vasculature by means of the TAF.
Video S2.2. Formation of a capillary network whose final pattern is presented
in the top-left plot of figure 2.11. The domain of this simulation is Ω = [0, 700]2,
approximately 5.4 times the size of the domain in figure 2.8.
Video S2.3. Formation of the capillary network from an initial circular capillary
on a [0, 700]2 domain. This video corresponds to the simulation shown in the first
row of figure 2.12.
Video S2.4. Formation of the capillary network of the simulation presented in
the second row of figure 2.12. The initial setup of the parent capillaries try to
replicate a realistic configuration.
Video S2.5. Formation of the capillary network of the simulation presented in
the third row of figure 2.12. Angiogenesis is triggered by four groups of hypoxic
cells as in a multifocal tumor.
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Chapter3
Tip endothelial cells guided by
chemotatic and haptotactic cues
In this chapter, we couple the previous hybrid deterministic model with a circular
random walk model biased in the direction of chemotactic migration. We believe
that the stochastic component may represent a simple mathematical conceptu-
alization of haptotaxis, a biological phenomenon whose underlying physics takes
place at a significantly smaller spatial scale. We use our model and simulations
to investigate the role of haptotaxis and chemotaxis in the mobility of tip en-
dothelial cells and its influence in the final vascular patterns. Furthermore, we
developed an automated numerical method that allow us to study the patterns
using quantitative indicators, complementing the usual qualitative observations.
3.1 Haptotaxis
As explained in subsection 1.2.1 the migration of tip endothelial cells is thought
to be driven by several coordinated mechanisms. One of them is chemotaxis, de-
fined as the movement following a gradient of concentration of a certain soluble
chemical, in this case the soluble fraction of angiogenic factor. This mechanism
was implemented in the model of the previous chapter. A second one is hapto-
taxis, which is the motion driven by gradients of non-soluble chemoattractants
bounded to the substrate of the extracellular matrix (in angiogenesis the fraction
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of angiogenic factor bounded to the extracellular matrix) or driven by gradients of
focal adhesion sites (see figure figure 3.1). Both the non-soluble chemoattractants
and the focal adhesion sites depend on the spatial distribution of the fibers of the
extracellular matrix. As the characteristic length scale of the fiber distribution
is significantly smaller than that of the global motion of the tip endothelial cells,
haptotaxis may be understood as variations in the direction of cells movement.
In this chapter, we extend the model to account for haptotaxis cues during the
migration of the tip endothelial cells. The original model treats this type of
cells as discrete agents and assumes their movement to be deterministic and
driven by chemotaxis. Thus, the velocity of tip endothelial cells is proportional
to the gradient of the tumor angiogenic factor. We introduce a new definition
for the velocity based on the random walk framework, specifically on the work
in Plank and Sleeman (2004). The new model considers the migration of the
tip endothelial cells as an stochastic process and defines it as a biased circular
random walk. The biasing direction of the random walk represents chemotaxis,
whereas the directional randomness is understood as haptotaxis, which acts at
a smaller spatial scale. In addition, we detail the formulation of the model for
three-dimensional settings, so that, after its analysis in the current chapter, we
can use it to perform subject-specific, three-dimensional simulations in chapter 4.
Remark:
1. Tip endothelial cells also migrate by mechanotaxis, that is, the movement
stimulated by mechanical forces. It is not implemented in the model, al-
Chemotaxis Haptotaxis
Focal adhesion site
Haptotactic direction
Chemotactic direction
Soluble chemoattractant
Extracellular matrix
Bounded chemoattractant
Figure 3.1. Chemotaxis and haptotaxis. Chemotaxis is the movement following gradients
of soluble chemoattractants, while haptotaxis is the motility up a gradient of matrix-bounded
chemoattractants or focal adhesion sites. (Adapted from Friedl and Weigelin, 2008)
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though we plan to include it in the future (see chapter 7).
3.2 The mathematical model
In the following, we summarize the new model, detailing the definition of the
velocity of the tip endothelial cells. First, we describe the continuous equations
for the tumor angiogenic factor and the quiescent and stalk endothelial cells.
Afterwards, we explain the discrete agents, both for the hypoxic cells and for
the tip endothelial cells. At this point, we introduce the biased circular random
walk for the tip cells. Then, we proceed describing how the discrete agents at the
cellular level are coupled with the macro-scale, continuous equations.
3.2.1 The continuous problem
The model considers two continuous variables defined in the spatial domain Ω ⊂
Rd, where d = 2, 3. The first one, f , represents a balance of tumor angiogenic
factors released by hypoxic cells that promote the activation of tip endothelial
cells and the proliferation of the stalk cells. The second continuous variable, c, is a
phase field defining the location of the capillaries in the extracellular matrix. The
equation that governs the dynamics of c favors two homogeneous states (c = 1 and
c = −1) that can co-exist stably. The region where c ≥ 0 represents the capillaries,
while c < 0 defines the area of the extracellular matrix without capillaries.
The dynamics of the tumor angiogenic factor concentration is governed by the
following reaction-diffusion equation
∂f
∂t
= ∇ · (D∇f)−BufcH (c) , (3.1)
where D is the diffusion constant, Bu is the uptake rate constant, and H(·) is
the Heaviside function. The first term on the right-hand side of the equation
models the diffusion of the tumor angiogenic factor from the hypoxic cells to
the remaining part of the extracellular matrix. The second term accounts for the
consumption of the factor by the endothelial cells.
The dynamics of the quiescent and stalk endothelial cells is described by the
phase-field equation
∂c
∂t
= ∇ · (M∇ (µc − λ2∆c))+ Bp (f) cH (c) , (3.2)
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where M is the constant mobility, µc(c) = −c+ c3 is the chemical potential, and
λ is a positive constant proportional to the width of the capillary wall. Bp(·) is
the proliferative rate function, given by
Bp(f) =
{
Bpf if f < fp
Bpfp if f ≥ fp
, (3.3)
where Bp is the proliferative rate constant and fp is the tumor angiogenic factor
condition for highest proliferation.
The dynamics of equation (3.2) may be understood in the context of phase-field
methods. The chemical potential µc is the derivative of a double-well potential
that energetically favors two homogeneous states separated by a smooth interface.
The separation force can be interpreted from a biological standpoint as the driving
force that maintains endothelial cells together exerted by the cells themselves. In
addition, the second term on the right-hand side accounts for the proliferation of
stalk cells in presence of tumor angiogenic factor.
Remarks:
1. In equation (3.2) the value of λ defines the length scale of the problem. As
λ→ 0 the model tends to a sharp interface model (Kobayashi, 1994). The
lower this value, the more accurate is the description of the capillary walls,
at the expense of a higher computational cost.
2. The proliferative rate is defined as a piecewise linear function with a plateau
that imposes a maximum threshold for proliferation. Hence, this function
accounts for the saturation of the tumor angiogenic factor receptors of the
surface of the endothelial cells.
3.2.2 The discrete agents
The model accounts for two types of discrete agents, which represent, respectively,
hypoxic and tip endothelial cells. These cells are supposed to be spherical with
radii Rhyc and Rtec , respectively.
Hypoxic cells
A hypoxic cell is assumed to be a static agent centered at a fixed point that we call
generically xhyc . The agents associated to hypoxic cells have two states: active
and inactive. Initially, all the hypoxic cells are distributed in the hypoxic regions
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of the tissue and are active. While they are active, they produce a fixed amount of
angiogenic factor fhyc . Whenever a hypoxic cell becomes normoxic, its associated
agent becomes inactive. The model assumes that this situation happens when
a capillary is closer than a certain distance, δnox, which represents the oxygen
characteristic diffusion length. An inactive agent does not produce angiogenic
factor.
Tip endothelial cells
These agents may be created at any point of the domain or removed according
to several criteria. A new agent is created at a point, provided that the following
conditions are met: (1) the point is inside a capillary (c ≥ cact); (2) the tumor
angiogenic factor concentration is high enough to stimulate the differentiation of an
endothelial cell (f ≥ fact); (3) the chemotactic signal is strong (G = ‖∇f‖ ≥ Gact);
and (4) there is no other tip endothelial cell nearby releasing Dll-4 to prevent
its differentiation. The characteristic range of action of the Dll-4 is denoted here
by δ4. If at some point a tip endothelial cell fails to meet these conditions, its
associated agent is removed, assuming that the cell changed its phenotype to a
non-migratory one.
In contrast to hypoxic cells, tip endothelial cells are mobile. We define the move-
ment of a tip endothelial cell as a biased circular random walk. Let us discretize
the time interval of interest, namely (0, T ), into N sub-intervals In = (tn−1, tn);
n = 1, . . . , N , where 0 = t0 < t1 < · · · < tN = T . We call ∆tn = tn − tn−1. Given
a tip endothelial cell defined by its center, xntec = (xntec , yntec , zntec), at time tn,
we define its trajectory by the set of equations
xntec = x
n−1
tec + ρ cos(θn) sin(ϕn)∆tn
yntec = y
n−1
tec + ρ sin(θn) sin(ϕn)∆tn
zntec = z
n−1
tec + ρ cos(ϕn)∆tn
 , (3.4)
where ρ, the velocity magnitude, is a deterministic function of the model parame-
ters and the magnitude of the gradient of tumor angiogenic factor concentration.
θn and ϕn are realizations of the discrete stochastic variables Θn and Φn which
denote, respectively, the azimuthal and the polar (zenith) angles of the spherical
system of coordinates. We will assume that Θn and Φn are independent for all
n > 0. The range of Θn, namely RΘn , is defined as
RΘn = {θn−1 + δ, θn−1, θn−1 − δ} , (3.5)
while the range of Φn is
RΦn = {ϕn−1 + δ, ϕn−1, ϕn−1 − δ} . (3.6)
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Equations (3.5) and (3.6) can be straightforwardly applied to the case n > 1.
When n = 1, θ0 and ϕ0 should be understood as deterministic values given by
the gradient of the angiogenic factor at the initial time. We denote the azimuthal
component of the gradient by θch0 and the polar component by ϕch0 , where the
superscript indicates that this is the direction of chemotactic migration. Note that
{Θn}n>0 and {Φn}n>0 define two Markov chains, as follows from equations (3.5)
and (3.6), and the independence of Θn and Φn for all n > 0. Equations (3.5)
and (3.6) show that, from one time step to the next and for each angular direction,
the tip endothelial cell may turn clockwise or anticlockwise an angle δ or remain
advancing in the same direction. The probabilities of these events are given by
the probability functions of Θn and Φn defined as
P [Θn = θn−1 + δ] = τˆ+θchn ∆tn , (3.7)
P [Θn = θn−1 − δ] = τˆ−θchn ∆tn , (3.8)
P [Θn = θn−1] =
(
1− τˆ+
θchn
∆tn − τˆ−θchn ∆tn
)
, (3.9)
P [Φn = ϕn−1 + δ] = τˆ+ϕchn ∆tn , (3.10)
P [Φn = ϕn−1 − δ] = τˆ−ϕchn ∆tn , (3.11)
P [Φn = ϕn−1] =
(
1− τˆ+
ϕchn
∆tn − τˆ−ϕchn ∆tn
)
, (3.12)
where τˆ+
θchn
, τˆ−
θchn
, τˆ+
ϕchn
, and τˆ−
ϕchn
are the so-called transition rates and θchn and ϕchn
are the azimuthal and polar directions given by the positive gradient of the tumor
angiogenic factor at time tn. The transition rates are given by
τˆ±
θchn
= 2ν
τ
θchn
((
n± 12
)
δ
)
τ
θchn
((
n+ 12
)
δ
)
+ τ
θchn
((
n− 12
)
δ
) , (3.13)
τˆ±
ϕchn
= 2ν
τ
ϕchn
((
n± 12
)
δ
)
τ
ϕchn
((
n+ 12
)
δ
)
+ τ
ϕchn
((
n− 12
)
δ
) , (3.14)
where ν = Drδ2 and Dr is the so-called rotational diffusivity. The derivation of
the transition rates can be found at Othmer and Stevens (1997). The transition
probabilities τθchn and τϕchn used in equations (3.13) and (3.14) are von Mises
probability density functions given by
τθchn (α) =
1
2piI0(
dv
Dr
)
exp
(
dv
Dr
cos(α− θchn )
)
, (3.15)
τϕchn (α) =
1
2piI0(
dv
Dr
)
exp
(
dv
Dr
cos(α−ϕchn )
)
, (3.16)
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where I0(·) is the modified Bessel function of the first kind and zeroth order and
dv is the turning coefficient. Figure 3.2 shows the evolution of the probability
function of turning clockwise for 200 time steps and for various values of the
turning coefficient.
Following Travasso et al. (2011b), the velocity magnitude of the tip endothelial cell
is a function of the norm of the gradient of the tumor angiogenic factor evaluated
at the center of the tip endothelial cell, such that
ρ = χ ‖∇f (xtec)‖L (‖∇f(xtec)‖) , (3.17)
where χ is a chemotactic constant, the operator ‖ · ‖ denotes the Euclidean norm
0
0
n
P
[Θ
n
=
θ n
−
1
+
δ
]
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0
0
n
P
[Θ
n
=
θ n
−
1
+
δ
]
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0.1
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Figure 3.2. Turning probability function. Probability function of turning clockwise through
an angle δ = pi
50
for 200 time steps. We plot three probability functions, each for a different
value of the turning rate dv. The rotational diffusivity is Dr = 1, the biased direction is θ0 = 0,
and the time step size is ∆tn = 0.001.
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of a vector, and L is a limiting function defined as
L (‖∇f‖) = 1 +
(
GM
‖∇f‖ − 1
)
H (‖∇f‖ −GM ) , (3.18)
where GM is a constant.
3.2.3 The continuum/discrete coupling
Both the discrete hypoxic cells and tip endothelial cells must be coupled with
the continuous equations of the model. First, as said above, hypoxic cells are
responsible for the introduction of the tumor angiogenic factor in the system.
Hence, these discrete components are coupled with equation (3.1). In the regions
occupied by active hypoxic cells the value of the tumor angiogenic factor is constant
and equal to fhyc . Second, as discrete tip endothelial cells move, they produce, by
proliferation, an excess in the concentration of endothelial cells. Consequently, they
are coupled with equation (3.2). The ratio of the material produced in the tip cell
to the volume swept as the cell migrates, gives us the value of the order parameter
inside the tip endothelial cell. Thus, in the region of the domain occupied by a
tip endothelial cell, the order parameter is given by
ctec =
4Bp (f (xtec))Rtec
3ρ
. (3.19)
3.2.4 Parameters
As the equations of the mathematical model are written in dimensionless form,
we detail the value of all the corresponding dimensionless parameters. The model
presented here shares some parameters with the one presented in the previous
chapter. These parameters are kept equal, as many of them were matched to or
obtained from experiments in vivo (see Travasso et al., 2011b and the references
therein). For the convenience of the reader we repeat their value here. The physical
values of these parameters may be retrieved using the length and time scales
L0 = 1.25 µm and T0 = 1560 s.
In table 3.1 we show the dimensionless parameters of the continuous equations (3.1)
and (3.2) in the same order as in the text. The remaining parameters come from
the discrete agent description. The radii of the discrete agents, namely Rhyc
and Rtec are assumed to be equal. Travasso et al. (2011b), in agreement with
Gebb and Stevens (2004), fixed the radius of the tip endothelial cells in 5 µm,
which is 4 in the dimensionless formulation of the model. The mean nutrient and
86
3.3 · Numerical method
Table 3.1. Dimensionless parameters of the continuous equations (3.1) and (3.2).
Parameter Value
Diffusion constant D = 100
Uptake rate constant Bu = 6.25
Constant mobility M = 1
Interface width λ = 1
Proliferative rate Bp = 1.401
TAF condition for highest proliferation fp = 0.3
oxygen diffusion length, δnox, is 25 µm (20 in dimensionless quantities) as in Grote
(1989). The production of tumor angiogenic factor per time step is fhyc = 1. The
parameters that determine the activation or deactivation of tip endothelial cells
are:
1. Order parameter condition for activation or deactivation cact = 0.9.
2. Tumor angiogenic factor condition for activation or deactivation fact =
0.055.
3. Tumor angiogenic factor gradient condition for activation or deactivation
Gact = 0.01.
4. Dll-4 range of action δ4 = 16. The value of this parameter in vivo is 20 µm.
Finally, in table 3.2 we show the dimensionless parameters related to the movement
of tip endothelial cells. The value of the rotational diffusivity and the turning
coefficient were obtained through a parametric study of the model. The value of
the turning angle δ was maintained equal to that proposed in Plank and Sleeman
(2004).
3.3 Numerical method
In this section we present a numerical method to solve the mathematical model. As
in the model, we naturally divide the algorithm in three blocks: the method for the
discrete agents, the method for coupling the discrete and the continuous variables,
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Table 3.2. Parameters related to the movement of the tip endothelial cells.
Parameter Value
Chemotactic constant χ = 242.67
TAF gradient for highest velocity GM = 0.03
Rotational diffusivity Dr = 0.05
Turning coefficient dv = 25
Turning angle δ = pi50
and the algorithm for solving the continuous equations. In the method for the
discrete agents, we first evaluate the discrete rules that determine the activation
and deactivation of the agents. This process is simple, so we omit the details of
the related algorithms. Therefore, we start this section explaining the method to
compute the displacement of the tip endothelial cells following the biased circular
random walk. Then, we outline how we solve the coupling between the discrete
components and the continuous equations. We close the section explaining the
method for solving the continuous equations, which is essentially the one used in
the previous chapter.
3.3.1 The tip endothelial cell motion
After activation/deactivation of the discrete agents in time step tn, we move each
active tip endothelial cell according to equation (3.4). The velocity magnitude
ρ is a deterministic function given by equation (3.17) which we evaluate at the
center of the tip endothelial cells. The angles that determine the direction, on the
contrary, are given by the realizations θn and ϕn of the random variables Θn and
Φn, respectively.
We follow the technique used in Plank and Sleeman (2004); Sleeman and Wallis
(2002) to obtain the value of the realizations. For the direction Θ we generate a
random number r with uniform distribution over the interval [0,1] and divide the
unit interval in three sub-intervals. If the random number falls into the first sub-
interval, [0, τˆ+n ∆tn), then θn = θn−1+δ and the tip endothelial cell turns clockwise
through an angle δ; if it falls into the second sub-interval, [τˆ+n ∆tn, 2ν∆tn), then
θn = θn−1 − δ and the cell turns anticlockwise through an angle δ; and if the
random number falls into the last sub-interval, (2ν∆tn, 1], then θn = θn−1 and
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the tip endothelial cell continues in its current direction. The realization ϕn is
obtained analogously.
Remark:
1. Note that equations (3.7) to (3.12) impose an upper bound on the time step
∆tn, because all probabilities should remain below one. We think of this
restriction as an stability condition for the time-stepping scheme.
3.3.2 The coupling methodology
We start by giving some definitions for the domains of the discrete agents, following
the ideas of the mathematical framework of this model developed in the previous
section. Recalling that for any time step, each hypoxic cell is characterized by its
center and its constant radius, Rhyc , we can define Ωihyc as the domain occupied
by the i-th hypoxic cell, which in three dimensions is a sphere centered at xihyc .
Furthermore, we can define the domain of all the active hypoxic cells for a given
time step, say tn, as
Ωhyc(tn) =
⋃
k∈Ahyc(tn)
Ωkhyc (3.20)
where Ahyc(tn) is the set of indices of the active hypoxic cells at time tn.
Similarly, for the same time step we define the domain Ωjtec(tn) as the spherical
domain occupied by the j-th tip endothelial cell, with radius Rtec and center x
j
tec .
Notice the time dependency of the domain of each tip cell due to its movement,
opposed to the hypoxic-cell domains which are time-independent and only the set
of indices depends on time, indicating which agents are active. The domain of tip
endothelial cells is given by
Ωtec(tn) =
⋃
l∈Atec(tn)
Ωltec(tn) (3.21)
where Atec(tn) is the set of indices of tip endothelial cells at time tn. All of the
above-defined domains are subsets of Ω.
These definitions facilitate the coupling between the discrete components and
the continuum variables. Therefore, we can now overwrite the value of the tumor
angiogenic factor, f(tn−1), and the value of the order parameter, c(tn−1), in the
subdomains Ωhyc(tn) and Ωtec(tn), with fhyc and ctec , respectively. Conse-
quently, we would introduce discontinuities in the fields f and c. However, we try
to avoid the artificial inclusion of sharp transitions in the continuous variables,
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for it goes against the philosophy of the phase-field equation. For this purpose we
define template functions for fhyc and ctec that are multidimensional general-
izations of the analytical solution to the one-dimensional Cahn-Hilliard equation,
a simplified version of equation (3.2). The template functions are continuous and
introduce smooth transitions between the fields and the imposed values inside the
subdomains of the discrete agents. As shown below, the discrete counterparts of
the continuous variables f and c live in the finite dimensional space Vh. For this
reason, the template functions must be projected onto the same finite dimensional
space Vh before overwriting the discretized fields.
3.3.3 The continuous equations
We begin by considering a weak form of equations (3.1) and (3.2). Let V denote the
trial solution and the weighting function spaces, which are assumed to be the same.
At this point we assume free-flux boundary conditions. Equations (3.1) and (3.2)
may be recast in variational form by multiplying them with smooth functions,
integrating over the domain, and applying integration by parts repeatedly. The
problem may be stated as follows: find f, c ∈ V such that ∀w, q ∈ V:∫
Ω
w
∂f
∂t
dΩ +
∫
Ω
∇wD∇fdΩ +
∫
Ω
wBufcH (c) dΩ
+
∫
Ω
q
∂c
∂t
dΩ +
∫
Ω
∇qM∇µc dΩ +
∫
Ω
∆qMλ2∆c dΩ
−
∫
Ω
qBp (f) cH (c) dΩ = 0 (3.22)
The space V is a subset ofH2, the Sobolev space of square integrable functions with
square integrable first and second derivatives. To perform the spatial discretization
of the previous weak formulation we make use of the Galerkin method. Let us
define the discrete space Vh, which is a subset of V. We approximate equation (3.22)
by the following variational problem over the finite dimensional space: find fh, ch ∈
Vh ⊂ V such that ∀wh, qh ∈ Vh ⊂ V:∫
Ω
wh
∂fh
∂t
dΩ +
∫
Ω
∇whD∇fhdΩ
+
∫
Ω
whBuf
hchH (ch) dΩ + ∫
Ω
qh
∂ch
∂t
dΩ
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+
∫
Ω
∇qhM∇µ(ch)dΩ +
∫
Ω
∆qhMλ2∆chdΩ
−
∫
Ω
qhBp
(
fh
)
chH (ch) dΩ = 0 (3.23)
Here fh is defined as
fh (x, t) =
nb∑
A=1
fA (t)NA (x) (3.24)
where nb is the dimension of the discrete space Vh and NA are the basis functions.
The rest of the variables of equation (3.23), namely ch, wh, and qh, are defined
analogously to fh. Since we will use a conforming discretization, the relation
Vh ⊂ V holds and the discrete functions are required to be in H2. This condition
is satisfied by the globally C1-continuous basis functions that we consider in this
thesis, by means of isogeometric analysis.
As in chapter 2, we integrate in time using the generalized-α method (Chung and
Hulbert, 1993; Jansen et al., 2000). In addition, we use a time-step size selection
algorithm that considerably reduces the computational time. After space and time
discretization, we obtain a non-linear system which is solved using a predictor
multi-corrector algorithm based on the Newton-Raphson method.
3.4 Results and discussion
In this section we analyze the proposed tumor angiogenesis model. Although the
theory is prepared for three-dimensional simulations, this analysis is performed in
two dimensions, as the visualization of the patterns created during angiogenesis is
easier in this simplified setting. Then, in the next chapter, we will use the results of
this study to perform three-dimensional simulations. Here, we show in figure 3.3
various snapshots that capture the time evolution of the vascular network. In
this simulation we analyze the directionality of the tip endothelial cells, from the
initiation of angiogenesis until the complete oxygenation of the tissue. Then, we
compare the final patterns of the vasculature of this simulation with an identical
one that does not include haptotaxis. The comparison is done qualitatively, but
also quantitatively by transforming the vasculatures into distance-weighted graphs
through skeletonization (see figure 3.4). Lastly, we present the final patterns of four
two-dimensional simulations in figures 3.5a and 3.5b. One of the two parameters
that determine the biased circular random walk, namely the rotational diffusivity
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(Dr) and the turning coefficient (dv), is changed for each pair of simulations. This
enables us to study how the frequency and the amplitude of the turnings influence
the development of the network.
The simulations that we present are performed on the square domain Ω = [0, 300]2.
This domain represents a tissue of 375 µm× 375 µm, although the periodic condi-
tion imposed in the horizontal direction, allows the vasculature to spread further
than in a tissue of the mentioned size. We have used a regular mesh defined by
1282 knot spans and quadratic basis functions with C1-continuity across element
boundaries. In order to facilitate the comparison among the two-dimensional sim-
ulations, all the initial conditions are the same: a blood vessel at the bottom of
the domain and 200 hypoxic cells randomly scattered on the extracellular matrix
according to a uniform distribution. Note that this distribution is the same one as
that used in the first simulation of chapter 2 (figure 2.8) to facilitate comparison.
The radius of the initial vessel is set to 37.5 µm. The first snapshot of figure 3.3
shows these initial conditions, where we maintained the color code of the previ-
ous chapter (and will be maintained throughout the figures and videos of this
document): red color for capillaries and green color for tumor angiogenic factor.
Figure 3.3 and video S3.1 shows the initiation and evolution of a new vascular
network promoted by an avascular tumor, represented here by its hypoxic region.
The simulation uses the parameters of the model presented in subsection 3.2.4.
At the beginning of the simulation, the 200 hypoxic cells start to release tumor
angiogenic factor, which diffuses throughout the domain. The angiogenesis process
is initiated when the factor reaches the initial vessel at the bottom of the domain,
with enough quantity to activate a tip endothelial cell. Thus, in the second snapshot
of figure 3.3 we observe that one tip endothelial cell has become active and has
started its migration. At this moment, there is only one of these cells, because
the cell itself prevents the differentiation of the surrounding cells into the tip
endothelial cell phenotype by means of the lateral inhibition mechanisms. The
other cells stimulated by the tumor angiogenic factor, instead, attain a proliferative
phenotype, generating the capillary behind the tip endothelial cell. However, as
the leading cell moves away, new tip endothelial cells get activated, for the delta-
like ligand 4 released by the first tip endothelial cell does not affect them anymore.
Hence, more sprouts are created and the vascular network spreads. As the network
grows, it consumes tumor angiogenic factor and returns the hypoxic cells into
their normoxic condition, as shown in the remaining snapshots.
In this simulation we can study the movement of tip endothelial cells. Although
the global migration of the leading cells is governed by the gradient of the tumor
angiogenic factor, we observe how tip endothelial cells turn and reorient towards
this gradient. This phenomenon, introduced by the biased circular random walk
in the mathematical model, represents our conceptualization of haptotaxis. The
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Figure 3.3. Formation of a vascular network driven by tumor induced angiogenesis.
200 hypoxic cells produce tumor angiogenic factor (green) that promotes the initiation and
growth of new sprouts (red). The simulation is performed on the domain Ω = [0, 300]2 using
the parameters presented in subsection 3.2.4.
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variation of gradients of non-soluble molecules bounded to the extracellular ma-
trix hinders the movement towards hypoxic cells. Tip endothelial cells find their
chemotaxis-driven migration obstructed by a scarcity of non-soluble molecules, so
they eventually alter their direction of migration. Additionally, the turns allow
the cells to better detect the changes in their micro-environment, as they explore
a broader area when they turn. In figure 3.3, several of these turning events are
highlighted. For example, in the fifth snapshot (third row, first column) we distin-
guish a zigzag movement of various tip endothelial cells. This kind of short-angled,
high-frequent turns only affect the direction of the capillary growth and do not
create zigzag final patterns, for the undulating morphology is afterwards elimi-
nated by the local remodeling of the phase-field equation. When the direction is
maintained for a large time because the gradient of non-soluble molecules of the
extracellular matrix favors one direction, tip cells do not reorient and the capillar-
ies deviate from their supposed objective (the hypoxic cells). In these cases, the
final pattern of the vasculature is significantly altered, as in the sixth snapshot
where the highlighted tip endothelial cell turns leftward although a hypoxic cell is
just above it. The previous set of examples shows, as observed in experiments, the
relevant role of haptotaxis in the patterns of the vasculature after an angiogenesis
event.
The influence of haptotaxis is more apparent in figure 3.4, where we compare the
final pattern of this simulation (in red) with exactly the same simulation (identical
initial conditions, boundary conditions, and parameters) without haptotaxis (in
gray). The reader is also referred to the interactive figure S3.2 in the supporting
information to compare both final patterns. Note that the simulation without
haptotaxis is the final pattern of the numerical example in subsection 2.4.1. When
the two final patterns defined by the phase-field are qualitatively compared, as
in figure 3.4a, it is clear that, although both vasculatures span the domain and
oxygenate the tissue, they are different. The superimposed images on the right-
hand side of this figure show that the only characteristic shared by the patterns
is that both were initiated from the same point in the parent vessel. This was
predictable, as the criteria for the activation are equal. Besides this point (and
the beginning of the branch that starts there), both vasculatures differ; there is
not a single branch that follows the same path in both simulations.
In order to make a quantitative comparison we developed a numerical method to
extract the graphs of both vascular networks. This numerical method is divided
into two parts. The first one is to transform a discretized binary image of the
phase-field that represents the capillaries into an skeleton, that is, a one-point-
wide, body-centered curve topologically equivalent to the vascular network (see
figure 3.4b). To obtain the skeleton, we use a two-fold-iteration parallel thinning
algorithm based on Zhang and Suen (1984). As this algorithm does not ensure the
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(a) Comparison of the phase fields. The superimposed image on the right-hand side shows that
haptotaxis completely alters the vascular patterns.
(b) Skeletonization of the phase fields. The increased anastomosis in the simulation with haptotaxis
changes the skeleton to lattice-like structure.
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(c) Skeletons are transformed into distance-weighted graphs to quantify the vascular networks.
Note the increased connectivity and efficiency when haptotaxis is present.
Figure 3.4. Comparison of two simulations without and with haptotaxis. The simu-
lation without haptotaxis (in gray) is that of figure 2.8i and the simulation with haptotaxis (in
red) is final pattern of the previous example in figure 3.3. The parameters, initial conditions,
and boundary conditions were kept equal in both simulations.
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skeleton to be one-point wide, we designed a sequential thinning algorithm that
we apply to the previous skeleton to guarantee this property. The second part of
the method is to define a distance-weighted simple graph from the skeleton. This
is done by means of an algorithm that identifies the vertices and edges in the
skeleton and assigns a distance to the edges (used as weights). From the resulting
weighted graph (figure 3.4c) we can define and study quantities of interest to
compare the vasculatures generated by both models.
The first remarkable observation is the representation of the skeletons in figure 3.4b
already reveals distinguishing characteristics of the networks that were not clear
in the phase-field representation. The skeleton of the simulation that includes
haptotaxis shoes a lattice-like structure compared to the tree-like structure of the
purely chemotatic simulation. This fact is even more apparent when we prune the
branches of the skeleton that do not form loops (represented in light gray and red).
These branches are those capillaries that do not allow blood flow because they do
not form loops, so they barely contribute to tissue oxygenation. In addition, we
observe that the reason for the lattice-like structure is that the branches of the
skeleton do not run parallel to each other due to the haptotaxis conceptualization
incorporated in this model. The quantitative measurements of the extracted
graphs shown in figure 3.4c backup all these observations and add useful indices
to compare the vasculatures. The graph of the model with haptotaxis presents a
higher number of vertices and edges, that, is the model promotes more branching
and anastomosis events. Furthermore, the average edge length is lower (10.31
versus 16.19 for the purely chemotactic) and the algebraic connectivity (Fiedler,
1973) is higher, distinctive of a more lattice-like network. And, as such, the graph
of the haptotactic model has more than twice number of loops than the other
(41 versus 20). We also analyzed the distance-weighted efficiency of the network,
defined as
E =
1
n (n− 1)
∑
i,j∈[1,n],i6=j
1
d (i, j)
, (3.25)
where n is the number of vertices and d (i, j) is the distance of the shortest
path between vertices i and j. The efficiency measures the traffic capacity of the
network and reflects its parallel transfer ability (Criado et al., 2006). In our case,
it represents the ability of the network to transport oxygen and nutrients to the
tissue. It is the graph from the haptotactic model the one with higher efficiency.
In this mathematical model, anastomosis events can occur for two reasons. The
first one, also considered in the model without the biased circular random walk,
is the distribution of hypoxic cells. In this case, tip cells migrate towards the
gradient of angiogenic factor and they mainly anastomose at the location of the
hypoxic cells. The second cause of anastomosis is the new physics that we added
to the model: haptotactic migration. Anastomosis events occur more frequently
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in our model because tip endothelial cells alter their direction of migration and
come across another endothelial cell. One example is in the highlighted area of the
seventh snapshot where two capillaries turn towards the initial vessel producing
anastomosis, although the hypoxic cell is in the other direction. We can see there
that anastomosis events are not only determined by the location of hypoxic cells,
but also depend on haptotaxis. In addition, as shown in figure 3.4c, there are more
anastomoses than in the identical simulation of the model without haptotaxis.
Figures 3.5a and 3.5b allow us to further investigate how endothelial cells migrate
under different values of two of the parameters that define the biased random walk,
namely the rotational diffusivity Dr and the turning coefficient dv. We maintain
the remaining parameters and initial conditions equal to those in the simulation
of figure 3.3, for the sake of an easier comparison. Thus, for the two simulations in
figure 3.5a we alter the value of the rotational diffusivity. In the simulation on the
left-hand side the value of the parameter is 1000 % of Dr and in that of the right-
hand side, it is 10 % of Dr. The final patterns of both simulations are drastically
different. In the first one, since the rotational diffusivity is increased, the frequency
at which the turns occur is too high for tip endothelial cells to lead the capillaries
towards the hypoxic cells following a smooth curve. This may be interpreted
as a vascular network developing within an extracellular matrix with very low
concentration of non-soluble molecules or focal adhesion sites. The tip endothelial
cells in this situation wander in small regions, trying to find a migration path. In
contrast, in the second simulation, the low value of the rotational diffusivity almost
impedes the tip endothelial cells to deviate from its original trajectory. In this
case, the distribution of the non-soluble chemoattractants or of the focal adhesion
sites may be thought of as strongly biased in some preferential directions. The
resulting capillaries are highly tortuous in the first simulation and too straight in
the second.
In figure 3.5b, in the simulation on the left-hand side, the value of the turning
coefficient is 200 % of dv and in that of the right-hand side, it is 10 % of dv.
When the value of the turning coefficient is high, the ability of tip endothelial
cells to reorient towards the preferred direction at each turn is increased, while
when it is low, for the same value of the rotational diffusivity, the reorientation is
hindered. We observe in the figure that the tip endothelial cells on the left-hand-
side simulation tend to go rapidly towards the hypoxic cells, compared to the
simulation on the right-hand side. The reason is that the bias of the random walk
is increased on the left-hand-side simulation, so the chemotatic direction is highly
favored. In addition, the higher the value of the turning coefficient the lower the
number of anastomoses that are not promoted by the distribution of the hypoxic
cells.
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(a) Comparison of the final patterns of two simulations for different values of the rotational
diffusivity: 1000 % (left) and 10 % (right) of Dr. The remaining parameters and conditions of
the simulations are the same as those in figure 3.3. Tip endothelial cells constantly change their
direction for high values of the rotational diffusivity and do not change it for low values.
(b) Comparison of the final patterns of two simulations for different values of the turning co-
efficient: 200 % (left) and 10 % (right) of dv. The remaining parameters and conditions of the
simulations are the same as those in figure 3.3. The higher the values of dv the better tip endothe-
lial cells reorient towards hypoxic cells.
Figure 3.5. Study of rotational diffusivity and turning coefficient values.
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3.5 Conclusions
Tumor-induced angiogenesis is a complex biological phenomenon and our under-
standing of it is still limited. However, it is widely accepted that the migration
of tip endothelial cells during the growth of new capillaries is driven by three
migration mechanisms: chemotaxis, haptotaxis, and mechanotaxis. In this chapter,
we coupled an existing continuum theory with a random walk model, to develop
a generalized mathematical model that accounts for chemotaxis and a simple
modelization of haptotaxis. We also proposed accurate and efficient algorithms
to approximate the solution to the model.
Our model and algorithms provide a framework to study the role of haptotaxis
and its interaction with chemotaxis in angiogenesis. Our results indicate that
haptotaxis may have a significant impact in the final pattern achieved by capillary
networks. We also prepared the formulation of the model and the numerical
method to perform in silico three-dimensional assays, which are presented in the
next chapter.
We believe that the quantitative method we employed to compare the vascula-
tures may serve as a basis for a future development of a robust and automated
quantitative method which is needed both for the analysis of mathematical models
of angiogenesis and for model validation. We also plan to extend the model to
include mechanotaxis.
3.6 Supporting information
Supporting information includes the following video and interactive image that can
be found online at http://caminos.udc.es/gmni/gente/gvilanovac/thesis/:
Video S3.1. Evolution of the vascular network of figure 3.3.
Figure S3.2. Comparison of two simulations without and with haptotaxis. This
interactive figure shows both the phase-field and the skeleton of the vascular
networks presented in figure 3.4.
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Chapter4
Mouse corneal micropocket
angiogenesis assay
Among the variety of in vivo assays developed to study angiogenesis, the mouse
corneal micropocket assay is one of the most widely used. As explained below, the
main reasons for its success are the simplicity in the observation and quantification
of the new vessels and the immunologically privileged conditions of the cornea.
However, the assay is technically demanding, traumatic, and ethically question-
able. Motivated by these reasons, in this chapter we develop three-dimensional
numerical simulations of tumor-induced angiogenesis in setups that resemble that
of the mouse corneal micropocket angiogenesis assay. This in silico assay may be
regarded as a way to palliate the disadvantages of the experiment. In order to
achieve this objective, first we study the experiment in section 4.1, perform three-
dimensional simulations in a simple geometry (a cube) in section 4.2, and develop
a computational mesh for a subject-specific (c57BL/6 mouse strain) cornea in
section 4.3. With all these ingredients we are able to perform the in silico mouse
corneal micropocket angiogenesis assay (section 4.4). Furthermore, we compare
the neovasculature of the simulations with the in vivo experiment.
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4.1 The assay
There is a wide variety of angiogenesis assays, both in vitro and in vivo, as shown
in appendix D. While the former are undoubtedly useful and have produced
essential breakthroughs in the field, they lack the completeness of the latter. In
vivo angiogenesis assays are generally more informative as they show the overall
effects of the experiment in the whole organism (Norrby, 2006). Among all of
them, the corneal micropocket assay is considered one of the best in vivo assays
(Figg and Folkman, 2011b). It was first developed for rabbits, but nowadays is
mostly used in mice, as they are more economical, there are more reagents and
tumor lines for mice, and there is a wider variety of transgenic or knockout mouse
models than other animals.
The reason for the widespread use of the mouse corneal angiogenesis assay derives
from the own characteristics of the cornea, which is a multilayer tissue that covers
the anterior chamber, the iris, and the lens (see figure 4.1). It has five layers:
epithelium, Bowman’s layer, stroma, Descement’s membrane, and endothelium,
being the stroma approximately 90 percent of the corneal thickness (Staton et al.,
2007a). The function of the cornea is to provide fixed focus power to the eye by
refracting the light that comes from the exterior. The light can only go through
the cornea because it is a transparent tissue. In order to maintain transparency,
the layers of the cornea are organized so that the light con transverse them.
Furthermore, a whole machinery of biological mechanisms provides the cornea
with what is called the angiogenic privilege (Ellenberg et al., 2010), that is, they
maintain the cornea as an avascular tissue1. Corneal cells get nutrients and oxygen
from the anterior chamber and from the vasculature that surrounds the cornea,
located at the limbus (see figure 4.1). Hence, the avascularity and transparency
of the cornea makes it a privileged site for an angiogenesis assay, as there is no
previous vasculature, new capillaries can only start from a known location (the
limbus), and their growth can be easily monitored during the whole assay without
interfering in their evolution.
There are several ways to perform the corneal assay and all of them share the same
idea: To promote angiogenesis by releasing tumor pro-angiogenic factors to disturb
the angiogenic privilege of the cornea. The assays differ, however, in the means
of producing tumor angiogenic factor. Some examples are (Staton et al., 2007a):
Chemical cauterization or thermal injury, intrastromal injection, intrastromal
tumor implantation, mechanical debridement or denudation, intracorneal suture,
1Some pathological situations cause the loss of this transparency through corneal neovascu-
larization, such as viral or bacterial infections, parasite infestation, immune mediated keratitis,
and chemical or mechanical injuries. These pathologies up-regulate pro-angiogenic factors or
down-regulate anti-angiogenic factors, promoting the growth of capillaries from the limbal region.
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Figure 4.1. Characterization of the cornea. The cornea is a multilayer, transparent tissue
of the eye that covers the anterior chamber, the iris, and the lens. Its function is to refract light,
providing focus power to the eye. In order to be transparent, the cornea needs to be avascular,
being vessels located only at the limbus. (Histopathological corneal slice adapted from UCDavis,
2016)
surgical grafts, and implantation of a slow-release polymer pellet in a micropocket.
The last one is the most frequent because pellets permit a fair enough control over
the released factors, which is not possible by other means. Thus, in this chapter
we focus on the mouse corneal assay using this method (i.e. the mouse corneal
micropocket angiogenesis assay) which we briefly describe in the following.
The first step in the elaboration of the mouse corneal micropocket angiogenesis
assay is to produce the pellets. They are composed by four substances, namely
a carrier-free agent, a slow-release polymer, sucralfate, and absolute ethanol (see
figure 4.2). The carrier-free agent is a tumor angiogenic factor which can be used
in different concentrations, for instance, 160 ng of VEGF per pellet (Rogers et al.,
2007), 180ng of VEGF per pellet (Kenyon et al., 1996), or 80 ng of bFGF per pellet
(Rogers et al., 2007). Two polymers are commonly used: Elvax (poly ethylene-
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Figure 4.2. Pellet preparation. The components of the pellet, that is the tumor angiogenic
factor, the sucralfate, and the slow-release polymer, are mixed in with absolute ethanol. The
product is spread on a nylon mesh. Once dried, even pellets are cut from the mesh and folded
to the desired size. (Adapted from Cao et al., 2011)
vinylacetate) and Hydron (polyhydroxyethylmethacrylate). The combination of
the polymer and the sucralfate provide stability to the pellet and sustained slow-
rate release of the carrier-free agent. In the preparation of the pellet, the carrier-
free, the polymer, and the sucralfate are mixed together with the absolute ethanol
and spread into a nylon mesh. After drying, the mesh is cut apart into pellets
that are suitable for the assay using a rat model. For mice, the pellet is folded to
obtain a smaller one.
Once the pellets are ready, the mouse corneal micropocket assay proceeds as
follows (see the graphical description in figure 4.3). First, mice are anesthetized
and one eye2 is treated with a topical anesthetic. Then, a small incision is made
approximately one millimeter away from the limbus (figures 4.3a and 4.3b). This
distance may vary depending on the carrier-free agent of the pellet (the weaker the
agent angiogenic stimulation, the closer to the limbus). The incision is enlarged
with a special tool (Graef knife) towards the limbus to create a micropocket under
the epithelial layer and parallel to the layers (figure 4.3c), where the pellet is
carefully introduced (figures 4.3d and 4.3e). Finally, the eye is treated with a
topical ophtalmologic antibiotic ointment to prevent non-wanted inflammation
responses. New vessels appear approximately one day after the implantation and
they peak seven days after (figure 4.3f). Figure 4.4 shows several examples of
2The other eye is usually used as control.
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(a) (b) (c)
(d) (e) (f)
Figure 4.3. Protocol of the mouse corneal micropocket angiogenesis assay. Using
surgical procedures (a) a micropocket is done in the cornea (b). The pocket is enlarged (c) so
that a pellet, P, can be inserted into it (d, e). The angiogenic factors released by the pellet
promote angiogenesis (f). (Adapted from Rogers et al., 2007)
the resulting neovascularization promoted by a variety of tumor angiogenic factor
concentrations. For a detailed description of the protocol of the mouse corneal
micropocket angiogenesis assay the reader is referred to Rogers et al. (2007); Tang
et al. (2011) and the references therein.
As said above, the evolution of the vasculature can be easily monitored during the
assay using, for example, slit lamp microscopy as shown in Birsner et al. (2014).
This method is very fast and does not require killing the animal. Another way
to monitor the assay is through optical-resolution photoacustic microscopy (Liu
et al., 2014). Besides, at the end of the experiment, the corneas can be dissected
and mounted, allowing thus further studies of the neovasculature using fluorescein
angiography or a colloidal carbon-perfusion (Anijeet et al., 2012). Through all
these imaging techniques, the results of the experiment can be characterized using
different approaches. It can be done qualitatively by assigning positive or negative
results based on certain criteria (Polverini et al., 1991). Some authors also use
semi-quantitative scorings; for example, in Conrad et al. (1994) the authors use a
scale from 0 to 6+ according to the distances from the limbus to the end points
of new vessels. Notably, the corneal micropocket angiongenesis assay can be also
characterized quantitatively (Kirwan et al., 2012; Staton et al., 2007b; ?). Different
measures are used, like the vascularized area (expressed either as square mm or
as percentage over the whole cornea surface), the limbus circumference length
from which new vessels originate (usually in clock hours), various vessel lengths
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Figure 4.4. Examples of the mouse corneal micropocket angiogenesis assay. The re-
sulting vascular pattern varies with the distance of the pellet to the limbus and the concentration
of tumor angiogenic factor. (Adapted from Birsner et al., 2014)
(total, maximum, minimum, average), vascular density, and even detailed vascular
measures, such as capillary diameter or number of vessel sprouts.
4.2 Three-dimensional angiogenesis
In this section we perform large-scale simulations that show three-dimensional
angiogenesis at a significant level of detail, using the mathematical model and the
numerical algorithms developed in chapter 3 (recall that, although we only showed
two-dimensional simulations, everything was prepared for three-dimensional ones).
The objective of these simulations is to study the model in three dimensions in a
simple geometry, prior to its application to the real and bigger geometry required
to replicate the mouse corneal angiogenesis assay. By using a simple geometry,
we are able to study the mathematical model in three dimensions without the
inherent constraints and difficulties of a complex mesh. Hence, every simulation
in this section is performed on the computational domain Ω = [0, 300]3, which
represents a cube with side length 375 µm. We use quadratic basis functions
and a uniform mesh defined by the tensor product of open knot vectors, each
composed by 72 knots. The boundary conditions are no-flux conditions in all
directions, except in the direction parallel to the axis of the initial capillaries,
where the domain is periodic. Therefore, as in the two-dimensional simulations of
the previous chapters, we allow the capillaries to spread in the mentioned direction
forming more connected patterns.
4.2.1 Angiogenesis triggered by a cluster of hypoxic cells
Here, we analyze two simulations (figures 4.5 and 4.6 and videos S4.1 and S4.2),
showing four snapshots of the dynamic evolution of the vasculature. The first
snapshot of each simulation represents the initial conditions, while the rest are
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snapshots of relevant situations during the development of the vasculature. The
simulations differ from each other in the initial conditions, while all the parameters
are kept constant and equal to those described in chapters 2 and 3. For both
simulations, we set two initial capillaries, rectilinear and parallel, which traverse
the domain from one face of the cube to the opposite, being the axis of the
capillaries perpendicular to both faces. This configuration allows angiogenesis to
be initiated in both capillaries and increases the number of anastomoses. The
initial diameter of the capillaries is constant and equal to 12.5 µm, in accordance
with the data from the literature (Shiu et al., 2005). The difference in the initial
conditions comes from the distribution and number of hypoxic cells. In the first
simulation (figure 4.5), we set 200 hypoxic cells with locations that follow a normal
distribution and mimic a tumor centered in the domain. In the second example
(figure 4.6), we set 300 hypoxic cells that aim to represent a three-focus tumor.
In figures 4.5 and 4.6, we observe the initiation and development of two vascular
networks driven by the presence of hypoxic cells disposed in tumor-like structures.
In both simulations, the tumor angiogenic factor, represented by green isosurfaces,
diffuses from hypoxic cells until it reaches the initial capillaries. At that moment,
new capillaries are initiated in the regions where hypoxic cells are closer to the
initial capillaries. In the first simulation (figure 4.5), new sprouts appear first in
the upper capillary and they grow forming a network while they consume the
tumor angiogenic factor. Meanwhile, the factor reaches the other capillary and
several tip endothelial cells become active and start its migration. Both networks
continue growing, turning hypoxic cells into normoxic on their way. Towards the
end of the simulation, both networks get connected through various anastomoses,
allowing the blood to flow between the two main capillaries. The virtual tumor
at the center of the domain is now completely pervaded by tortuous capillaries
that may trigger the uncontrolled growth of the tumor.
In the second simulation (figure 4.6), the tumor angiogenic factor activates tip
endothelial cells in three regions of the initial capillaries in a short time span, as
shown in the second snapshot of the simulation. Thus, the three groups of new
sprouts grow at a similar rate and almost at the same time. The third snapshot of
the simulation shows a plain example of the effect of the biased circular random
walk. In the set of sprouts that grow from the upper initial capillary, there are
three of them which are led by tip endothelial cells that instead of migrating
towards the hypoxic tumor regions grow towards the observer. As shown in
chapter 3, in two-dimensional settings this migration driven by haptotaxis usually
leads to anastomosis events. However, in three dimensions the probability of a
tip endothelial cell coming across a capillary is significantly smaller. As shown in
the last snapshot, in this specific case, the three sprouts just stop their growth
when there is no more angiogenic factor before anastomosing. Furthermore, for
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Figure 4.5. Three-dimensional angiogenesis from two parent capillaries. A new vas-
cular network develops from two parent capillaries. The new sprouts are initiated by the tumor
angiogenic factor (green isosurfaces) released from hypoxic cells disposed forming a tumor-like
structure. The tip endothelial cells that lead the growth of the sprouts migrate by chemotaxis
and haptotaxis. At the end of the simulations the vasculature pervades the tumor, leaving no
cells under hypoxic conditions. Many anastomosis events create loops in the new vasculature
and connect the parent capillaries. The simulation is performed on the domain Ω = [0, 300]3
using the parameters presented in chapters 2 and 3.
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Figure 4.6. Evolution of a vascular network promoted by hypoxic cells mimicking
a multifocal tumor. Three sets of sprouts grow from the initial capillaries until there are not
hypoxic cells. The simulation is performed on the domain Ω = [0, 300]3 using the parameters
presented in chapters 2 and 3.
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the same reason the two parent capillaries, unlike the previous simulation, do not
get connected by the neovasculature.
In all the examples the simulation ends when there is no more tumor angiogenic
factor, i.e. no more hypoxic regions are present in the domain. This model does
not account either for the vascular shutdown produced by the high interstitial
pressure inside the tumor, or for the characteristic capillary regression and re-
growth (vascular remodeling) after the shutdown events. We think that this is
the reason why when both simulations are compared to in vivo tumor images
one may observe differences in the patterns (see figure 1 in Kaanders et al., 2004
where some tumors present hypoxic regions).
4.2.2 Angiogenesis triggered by randomly distributed hy-
poxic cells
In figures 4.7a and 4.7b and videos S4.3 and S4.4, we present two simulations
whereby we can analyze the influence of the number of hypoxic cells when they are
randomly distributed in the cubic domain. The location of the initial capillaries
is identical to that of the previous examples. On the snapshots of the initial
conditions (left-hand side of figures 4.7a and 4.7b) the position and number of
hypoxic cells is revealed by the isosurfaces of the tumor angiogenic factor: 200 for
the first simulation (figure 4.7a) and 100 for the second (figure 4.7b). As shown on
the remaining snapshots, the difference in the number of hypoxic cells promotes the
creation of vascular patterns with distinguishing characteristics. There are three
main differences, noticeable by simple observation: the thickness, local density, and
number of capillaries. The three differences are intimately related. For example,
in the first simulation, more hypoxic cells initiate more capillaries which, because
they are densely packed, consume the tumor angiogenic factor in a high-rate
manner. They leave less tumor angiogenic factor per branch for the proliferation
of the stalk endothelial cells, and, consequently, the capillaries are thinner. On the
contrary, in the second simulation, as fewer and more separated sprouts appear,
each branch has more angiogenic factor and more stalk cells proliferate, enlarging
the capillaries. Another difference is in the time of initiation of new branches,
being shorter for the first simulation. In the second, the branching is delayed due
to a lower number of hypoxic cells, which in turn, leads to a lower concentration
of angiogenic factor, and delays the initiation of new sprouts at the beginning. As
the network evolves, initiation events occur more and more frequently because the
tumor angiogenic factor has enough time to diffuse throughout the extracellular
matrix.
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(a) Vascular network promoted by 200 hypoxic cells.
(b) Vascular network promoted by 100 hypoxic cells.
Figure 4.7. Three-dimensional angiogenesis promoted by different number of hy-
poxic cells. A higher number of hypoxic cells promote the growth of more but thinner capillaries.
4.2.3 Importance of haptotaxis
In figure 4.8 we present four pairs of numerical simulations at an advanced time
stage of the network development, each pair corresponding to one of the rows of
the figure. In the snapshots on the left-hand side we present the same numerical
simulations we described in this section (figures 4.5, 4.6, 4.7a, and 4.7b) and in
the same order. Each of these simulations has an associated simulation presented
on the right-hand side of the figure, which represents exactly the same setting
and conditions that its left-hand-side counterpart, but considering no haptotac-
tic migration, that is, as the model in chapter 2. In the figure, we omitted the
representation of the tumor angiogenic factor, in order to focus on the different
vascular morphologies generated by both models.
We observe that the growth patterns are dissimilar in various aspects. The most
prominent difference is the tortuosity of the sprouts. Thus, in the simulations of the
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Figure 4.8. Influence of haptotaxis in angiogenesis. Left column: Final pattern of four
simulations (corresponding to figures 4.5, 4.6, 4.7a, and 4.7b). Right column: The same four
simulations (identical parameters and initial conditions), but assuming no haptotactic migration.
The patterns of the vasculature differ in tortuosity, number of anastomosis events (connectivity),
and length of the capillaries.
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extended model, tip endothelial cells randomly deviate from the path marked by
the gradient of angiogenic factor and create more tortuous capillaries. In contrast,
in the simulations on the right-hand side, the tip endothelial cells go directly
towards the hypoxic cells resulting in straighter capillaries. The second observable
difference is that the number of anastomoses is higher in our model, leading to
more connected vasculatures. This leads to a third fundamental difference between
the morphology of the networks of both models: the capillaries are shorter in the
proposed model because their growth is stopped by anastomosis. Note that these
dissimilarities between the models are clearer in the three-dimensional settings
than in the two-dimensional ones of chapter 3.
4.2.4 Discussion
The three-dimensional computations presented in this section serve us to investi-
gate the mathematical model in simple, three-dimensional setups. By altering the
initial conditions, we simulated several possible capillary and tumor arrangements
and obtained, as a result, a variety of final vascular patterns richer than those
presented in previous sections. The simulations suggest that, for mathematical
models to achieve the topological complexity observed in in vivo angiogenesis
experiments, two-dimensional simulations may not be enough. We also believe
that the accurate modeling of anastomosis, a crucial process in tumor angiogen-
esis, may require full-scale three-dimensional simulation. The computations are
also useful to test the numerical algorithms in three dimensions using a linear
parametric-to-physical mapping, before using them with non-linear mappings (as
required in the following sections for complex geometries).
4.3 Subject-specific computational mesh
In this section we describe the generation of a computational mesh for a mouse
cornea. Its geometry is taken from data from the literature and we build the
subject-specific mesh taking special care to construct analysis-suitable NURBS.
4.3.1 The geometry
There are many types of available laboratory mice that are commonly used for
the corneal micropocket angiogenesis assay. Among them we found that the most
widely used strain is the c57BL/6, hence we decided to use the same strain for
our in silico experiments.
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As said in the introduction, the main function of the cornea is to provide (fixed)
optical power to the eye. To do it the cornea has an specific geometry which is
defined by two spherical caps with different curvature. In particular, the radius
of curvature of the posterior cornea surface (the interior) is greater than that
of the anterior in mice3. In order to construct this geometry we take data from
in vivo measures available in the literature (Henriksson et al., 2009; Schmucker
and Schaeffel, 2004). Figure 4.9 shows this geometry, where the red-highlighted
measures are the in vivo data, while the rest are derived from them.
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Figure 4.9. Geometry of the cornea of a c57BL/6 mouse. Data drawn in red are taken
from in vivo measures and data drawn in black are derived from the former. Measures are given
in µm.
4.3.2 The mesh
Our strategy to design the computational mesh for the specific geometry of fig-
ure 4.9 is as follows (see figure 4.10 and video S4.5). The first step is to define a
disk of radius r = 1.3 mm, using an appropriate NURBS parametrization. The
3On the contrary, in humans, the radius of curvature of the posterior cornea surface is smaller
than that of the anterior.
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complication here is that every parametrization of the disk is singular, that is, it
involves at least one basis function that does not fulfill the required regularity
properties for integration. In our case, for the second order equations we require
all basis functions to live in the Sobolev space of square integrable functions with
square integrable first and second derivatives H2. Our approach to this problem is
to study the existent parametrizations and choose the one in which the problem-
atic basis function(s) are located at the boundary, so that we can remove them
from the discrete space imposing Diriclet boundary conditions.
We present in figure 4.10a three possible parametrizations of the unit disk. There,
we show both a coarse mesh in the top row and a refined mesh in the bottom row
for each parametrization. The coarse meshes highlight control points, emphasizing
those that share a common location, and control nets, that show how control points
are connected. On the other hand, the refined meshes show knot span lines, patch
lines, and only those control points associated to basis functions that are not in
H2. We start the study with one of the most used parametrizations of the disk,
which is built as a revolution surface rotating a segment 360 degrees around one
of its ends (figure 4.10a, left). As a result, there is a singularity at the center of the
disk due to the nine collapsing control points. The basis functions associated to
these control points are not in H1. As suggested in Takacs and Jüttler (2011), one
can replace these nine basis functions with a linear combination of them, so that
the new one is in H1. The new basis functions and those associated to the control
points adjacent to the central one are still in H2. The same authors, however,
proposed in Takacs and Jüttler (2012) yet another linear combination to replace
this functions with new ones that satisfies our regularity conditions. The counter
part of these solutions is the increased code complexity and a reduced number of
degrees of freedom in a region where we need full resolution, as the pellet is located
nearby. In order to move the singular point away from the center of the domain,
a second option is to build the disk using five patches (figure 4.10a, center): a
square one centered in the domain and surrounded by 4 identical patches. This
parametrization has 4 extraordinary points, one in each corner of the square patch,
and C−1-continuity lines at the interface between patches. Although there are
some ways to enforce the appropriate regularity in the related basis functions,
we still loose degrees of freedom inside our computational domain. Furthermore,
Collin and coworkers have recently shown in Collin et al. (2015) that this particular
parametrization for p = 2 present convergence problems (what they call C1 locking)
for the desired regularity. Yet, another option is to parametrize the domain as
in the right-hand side of figure 4.10a. We will refer to this parametrization as
inflated, because it can be generated by deforming a regular parametrization of a
square inscribed in a disk until all the disk is filled, as if the square was a balloon
that we had inflated inside a circle (see video S4.5 in the supporting information).
The inflated parametrization has four (symmetric) groups of 5 control points, each
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In atedRadial 5 patches
(a) Common NURBS parametrizations of the disk. Top row: Coarsest parametrizations. Bottom
row: Refined parametrizations. Black lines represent the control net (solid and dashed represent
directions), gray lines the knot span lines, green disks control points, and red disks control points
whose associated basis function is not in H2. Repeated control points are marked with a circle.
(b) Posterior corneal surface built with the
inflated parametrization of the disk.
(c) Posterior and anterior corneal surfaces
in their final location.
(d) The volumetric mesh is built joining the
posterior and anterior corneal surfaces.
(e) Example of an h-refined computational
mesh of the geometry of a c57BL/6 mouse.
Figure 4.10. Construction of the subject-specific computational mesh.
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located at the boundary of the domain, whose associated control points are not in
H2. Once again, Takacs and Jüttler (2012) have proposed a modification to the
basis functions to recover the required regularity at the expense of loosing two
degrees of freedom per quintuple. Alternatively, we avoid the integration in those
elements spanned by the non sufficiently regular basis functions associated with
this singular points by imposing Dirichlet boundary conditions for the phase-field
equation in them.
Once we have chosen and appropriate parametrization of the disk we continue
constructing the geometry. We transform this disk into a spherical cap with radius
Rp to build the posterior cornea surface (see figure 4.10b). As in Piegl (1986),
starting with the coarsest inflated parametrization of the disk (see figure 1.18c),
we change the weight and the z coordinate of the control point at the center of
the disk to z = d and w = 1− c, respectively, where
c =
(
2 +
√
2
)
g2
r2 + g2
, d =
√√√√cr2 (2− c (2−√2))(
2−√2) (1− c)2 , g = Rp − bp.
Then, we proceed similarly with the anterior cornea surface, but using g = Ra −
ba + t`, and vertically translate the latter until its boundary circle is at a distance
of t` with respect to the boundary circle of the first surface (see figure 4.10c).
The next step is to create a volume by joining the two spherical caps using linear
elements and order-elevate to also achieve C1-continuity in the vertical direction
(figure 4.10d). Finally, we can h-refine the mesh as desired. In particular, our
computational mesh is composed of 14489496 knot spans. Figure 4.10e shows
an example of a refined mesh, although, for the sake of plot clarity, this mesh
is coarser than the one we used. Note that the obtained computational mesh is
geometrically exact and not an approximation to that in figure 4.9.
4.4 Angiogenesis in the mouse cornea
As mentioned in the review of the literature (page 36), there are few models that
replicate the corneal micropocket angiogenesis assay, namely, Harrington et al.
(2007); Jackson and Zheng (2010); Tong and Yuan (2001, 2008b), and all of them
are two-dimensional. We showed in section 4.2 that three-dimensional simulations
show a topological complexity more in agreement with in vivo vascular patterns
which is not captured in two dimensions. Hence, in this section we reproduce for the
first time the mouse corneal micropocket angiogenesis assay in three dimensions
and in a real geometry with the aim of predicting the complex three-dimensional
vascular patterns observed in the experiment.
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The simulations shown here use the same mathematical model and numerical
algorithms developed in chapter 2, which have proven to be robust and efficient in
three dimensions and simple geometries in the previous chapter. Note, however,
that in order to reproduce the mouse corneal micropocket angiogenesis assay our
computational domain needs to be almost seven times greater than any one used
until now in this thesis: while the side of the cube was 375 µm, the diameter of the
cornea is 2600µm. As the mathematical model was not conceived for such large-
scale simulations, some parameters of the model which were not obtained from in
vivo or in vitro data4 need to be re-calibrated. Thus, we start this section with an
study of appropriate parameters in subsection 4.4.1 through numerical tests and
then proceed to simulate the assay and discuss the results in subsection 4.4.2.
4.4.1 Numerical tests
We perform the numerical tests in three different computational meshes, being
each one reduced-size versions of the geometry of the cornea of figure 4.9. Our
approach here is to study the behavior of the model in domains of increasing size.
In particular, we start with numerical tests (figure 4.11) in a geometry whose size
is one third of the real one, that is, in a fictitious cornea with radius r = 433.37 µm.
Note that, although smaller than a real cornea, this geometry is still more than
twice the size of the geometry of the simulations in a cube. The first numerical
test (figure 4.12a(i)) is performed using a relatively coarse computational mesh
composed by 128×128×16 knot spans and using the parameters of section 4.2. As
shown on the left-hand side of that figure, the entire cornea is initially avascular
except for its edge, where we locate a parent capillary that mimics the capillaries
of the limbal region. We also include a pellet using the concept of fixed hypoxic
cells developed in the mathematical model: It is modeled as one hypoxic cell
with Rhyc = 50 µm and located 240 µm away from the edge of the cornea in the
horizontal plane. The right-hand side snapshot of figure 4.12a(i) shows the vascular
pattern at the end of the simulation. This simulation reveals that the developed
numerical algorithm also works in a complex geometry with non-linear mappings.
However, is also evinces two problems. The first one is that the mesh is too coarse
to simulate such thin capillaries. Note that their surface is not smooth and that at
the end of the capillaries the elements can be visually appreciated5. The second
problem is that the final pattern is too dense compared to those generated in in
vivo assays. Our conjecture is that the model misses some important biological
mechanisms such as filopodia environment survey, migration by mechanotaxis,
4These parameters were estimated in the original model.
5Due to the phase-field dynamics, the base or beginning of the capillaries has already been
smoothed out and the elements are no longer discernible.
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(i) (ii)
(i) (iii)(ii)
(a) Initial conditions and final patterns of two numerical tests before (i) and after (ii) the first
parameter re-calibration.
(b) Evolution of the vascular pattern in a numerical test in which the pellet is farther from the
limbus. The value of fact needs to be reduced to get TEC activation.
Figure 4.11. Numerical tests using a thrice smaller cornea geometry.
and regression and regrowth of capillaries, which have to be incorporated in it.
With these new insights of the model we perform a second simulation on the same
geometry and maintaining the initial conditions, whose final pattern is shown in
figure 4.12a(ii). We h-refine the computational mesh in the horizontal directions
(the vertical was already fine enough) to get a mesh composed by 256×256×16 knot
spans. Furthermore, in an attempt to include the missing biological mechanisms
we increase the range of action of the Delta-Notch mechanisms fourfold and we
(temporarily) remove haptotaxis to easily observe its effect. As a result, we obtain
smoother capillaries that form a sparser final vascular pattern comparable with in
vivo assays and, hence, we maintain the new parameter value for the Delta-Notch.
One of the major differences in the setup of the mouse corneal angiogenesis assay
with respect to previous simulations is the distance between the hypoxic cells and
the initial capillary. In the assay, the pellet can be located up to 1mm away from
the limbus, while in previous simulations, the minimum distance from the hypoxic
cells to the initial capillaries was 40 µm. Hence, the next numerical tests in this
reduced geometry investigate changes in the initial conditions, in particular, we
study the behavior of the mathematical model as we move the pellet away from the
parent capillary. We perform several numerical tests (results not shown) starting
119
4 · Mouse corneal micropocket angiogenesis assay
with the same pellet location as in figure 4.11a and gradually moving the pellet
towards the center of the cornea. When the pellet is located 300 µm away from the
edge of the cornea in the horizontal plane (as in the left-hand side of figure 4.11b)
the mathematical model reaches a stationary state in which no TEC gets activated
(results not shown). This is a consequence of the parameter calibration of the TAF
diffusion equation which was originally estimated for smaller domains. In order
to get TEC activation, we opt to change their sensitivity to TAF. In particular,
by setting fact = 0.001 and Gact = 0, we recover TEC activation that creates
the vascular pattern shown in figure 4.11b. Note how, even at this reduced-size
geometry and without the haptotactic conceptualization, the capillaries cross one
over another (without touching) forming a three-dimensional pattern.
Our next step in this numerical study is to increase the size of the geometry to
two thirds of the real one. We also increase the number of knot spans of the
computational mesh to 512 × 512 × 32, accordingly. The initial conditions are
similar to the previous numerical tests, as shown on the left-hand side of figure 4.13.
However, as this geometry is larger, the pellet is located further away from the
limbus, at 600 µm from it. As before, we need to increase the sensitivity of TECs,
so that they detect the few amounts of TAF that reaches them. The result of
this test is the final pattern shown on the right-hand side of figure 4.13 using a
tenfold smaller value of fact. Although we achieved TEC activation, we detect a
problem which we show in the inset of the figure: capillaries break at their base by
the time the neovasculature reaches the pellet. Our hypothesis is that the lower
Figure 4.13. Numerical test using the cornea geometry reduced by a factor of 2/3.
The phase-field dynamics brake several capillaries at their base due to the reduced stalk cell
proliferation at low TAF levels.
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Table 4.1. Parameter re-calibration based on numerical tests to adapt the mathematical model
to the bigger geometry of the mouse corneal micropocket angiogenesis assay.
Parameter Value in small-domainsimulations
Value in the mouse corneal
micropocket angiogenesis assay
δ4 20 µm 80 µm
fact 0.055 0.0001
Gact 0.01 0.0
Rtec 5 µm 6.25 µm
δ 0.063 0.314
amounts of TAF towards limbal region favors the long-term phase-field dynamics
that tend to nucleate the capillary field. This effect could not be appreciated in
smaller-domain simulations as it was balanced by the proliferation of capillaries
that tend to enlarge them in the presence of higher amounts TAF. One way to
fix this problem is to increase the proliferative rate of stalk cell, that is, the value
of Bp. Yet, a simpler way is to increase the radius of TECs within its biological
range to Rtec = 6.25 µm. We opt for the latter, as it is easier to calibrate.
Finally, we perform a numerical test in the actual geometry of the cornea (results
not shown). As in the previous tests the sensitivity of TECs needs to be increased
so that they get activated by TAF released from a further away pellet. Table 4.1
summarizes the final values of the re-calibrated parameters that adapt the math-
ematical model developed for relatively small scales to the big scales spanned in
the mouse corneal micropocket angiogenesis assay.
4.4.2 Numerical simulations of the mouse corneal microp-
ocket angiogenesis assay
Here we present and discuss simulations of the mouse corneal micropocket an-
giogenesis assay using the mathematical model presented in chapter 3 with the
parameter re-calibration for large scales shown in table 4.1. The simulations are
performed in a computational mesh composed by 777×777×24 knot spans which
is an exact parametrization of the geometry of a c57BL/6 mouse defined in fig-
ure 4.9. Note that the mesh is more than three times finer than those used in
numerical tests on three times smaller corneas (figure 4.11), so that the resolution
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(a) (b)
D
p
Figure 4.14. Initial conditions of the mouse corneal micropocket angiogenesis assay.
(a) Plan and elevations of the initial conditions. (b) Perspective view showing the initial capillary,
the pellet, and half of the computational domain. The distance Dp varies among simulations.
of the mesh is enough to capture the phase-field interfaces.
Figure 4.14 shows the initial conditions of the simulations. The initial capillary
is a polished version of the one used for the numerical tests. Now, it is a thinner
capillary with an approximate radius of 7 µm with a toroidal shape located all
along the limbal region. The pellet is modeled as a spherical hypoxic cell of radius
62.5µm whose center is placed at a distance Dp from the edge of the cornea. As
explained in the introduction, this distance varies from experiment to experiment,
although the protocol recommends to perform the initial incision to place the
pellet at 1mm from the limbus. Hence, Dp will be different among simulations to
mimic different experimental setups.
In figure 4.15 and video S4.6 we show the time evolution of an in silico mouse
corneal micropocket angiogenesis assay. In this particular simulation the pellet is
located at Dp = 1.06mm, following the protocol recommendation. Figure 4.15a
shows a snapshot some time after the TAF has reached the initial capillary ac-
tivating several TECs that start their migration following TAF gradients. This
image evidences the important role of the lateral inhibition mechanism, whereby
the nascent spouts are initially separated forming a salt-and-pepper pattern. As
the capillaries grow towards the pellet (figure 4.15b), this regular pattern is lost,
partially due to the alteration of the TAF regular front by capillary consumption
and partially due to the activation of new TECs from the growing capillaries. Note
that as they approach the pellet, the pattern starts to present the characteristic
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(a)
(b)
(c)
Figure 4.15. Simulation of the mouse corneal micropocket angiogenesis assay in the
absence of haptotaxis. The vascular network shows the brush-border effect as it approaches
the pellet, located at Dp = 1.06mm.
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brush-border effect shown in the experiments (figure 4.16). In figure 4.15c we show
the vascular pattern just before the capillaries reach the pellet. At that moment
the brush-border effect has developed further and the leading capillaries get pro-
gressively closer one to each other driven by TAF gradients. Several new TECs
(23 specifically) were activated in the parent capillary since the beginning of the
simulation; however, comparison between figures 4.15a and 4.15c reveals that this
activation reduces with time, as little TAF reaches the parent capillary along the
simulation. Furthermore, the distance between TECs activated from the initial
capillary increases, meaning that the limiting mechanism for TEC activation is
no longer lateral inhibition, but the amount of available TAF.
We compare in vivo assays from Cao et al. (2003) with our simulations in fig-
ure 4.16. The in vivo assays differ one from the other both in the carrier-free agent
and in the location of the pellet. While in figure 4.16a the pellet is composed by
PDGF and located close to the limbus, in figure 4.16b it is composed by VEGF
and located almost at the center of the cornea. We replicate these experiments by
altering Dp in our simulations, setting Dp = 1.06mm in the first one (figure 4.16c)
and Dp = 1.21mm in the second one (figure 4.16d). Although we are not able to
change the carrier-free agent of the virtual pellet, we still obtain patterns that
resemble those presented in the experiments. Thus, when the pellet is closer to the
limbus the number of capillaries that start from the parent capillary is less than
when it is further from the limbus as in figures 4.16a and 4.16b. As a consequence,
the volume spanned by the neovasculature in the former is smaller than that in
the latter. Finally, we want to emphasize here that the results of our simulations
are three-dimensional vascular patterns that, as shown in the figure, resemble
more closely the experiments than previous two-dimensional simulations.
The comparison in figure 4.16 reveals that although the main distribution of
the neovasculature within in the cornea is captured in the simulations, the path
followed by the capillaries in silico is not as tortuous as that in vivo. Recall,
however, that we removed the conceptualization of haptotaxis to re-calibrate the
model and to better study the results at full scale, as in figure 4.15. We recover
now this conceptualization to show in figure 4.17 and video S4.7 the results of
the same simulation of figure 4.15, but with haptotaxis. As occurred before, the
parameters of the circular biased random walk presented in chapter 3 were not
prepared for such big domain and, consequently, the turning angle δ has been
increased five fold (see table 4.1).
From the very first moment, as shown in figure 4.17a, haptotaxis has a severe
effect in the tortuosity of the capillaries. TECs that before leaded the capillaries
straight towards the pellet (figures 4.16c and 4.16d), now wander around the
domain influenced by the ECM through haptotaxis. The first consequence of this
wandering is that capillaries no longer grow parallel to each other; instead, they
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(a) A pellet with a PDGF carrier-free agent
is located closer to the limbus.
(b) VEGF used as carrier-free agent is lo-
cated almost at the center of the cornea.
(c) When Dp = 1.06mm the neo-vasculature
grows from a short delimited section of the
limbus.
(d) Moving the pellet to Dp = 1.21mm in-
creases the limbus section from which new
capillaries grow.
Figure 4.16. In vivo and in silico mouse corneal micropocket angiogenesis assays.
These assays show the influence of pellet location (yellow arrows in vivo, green spheres in silico)
on the pattern of the neovasculature. ( In vivo assays reproduced from Cao et al., 2003)
have a more realistic, curved shape. What is more, TECs’ trajectory does not so
frequently lie on the middle plane of the cornea as before, so that as they move,
they generate a more three-dimensional vascular pattern (figures 4.17b to 4.17d).
In addition, this movement increases the likelihood of anastomosis events, even
in the absence of an explicit model of TEC filopodia which are believed to be
ultimately responsible for anastomosis. Thus, the neovasculature connectivity is
highly increased compared to the previous simulation from the very beginning
(figure 4.17b) and results in a more looped pattern (figure 4.17e). Another conse-
quence of haptotaxis is that the role of the lateral inhibition mechanism, although
still relevant, is not so marked in this simulation. As shown in figure 4.15c the
125
4 · Mouse corneal micropocket angiogenesis assay
(a)
(b)
(c)
Figure 4.17. Time evolution of a simulation of the mouse corneal micropocket
angiogenesis assay. Haptotaxis augments the connectivity of the network by increasing the
number of anastomosis. The pellet is located at Dp = 1.06mm.
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(d)
(e)
(f)
Figure 4.17. Time evolution of a simulation of the mouse corneal micropocket
angiogenesis assay. Continued.
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(g)
Figure 4.17. Time evolution of a simulation of the mouse corneal micropocket
angiogenesis assay. Continued.
salt-and-pepper pattern of capillaries starting from the initial capillary is now
lost.
Perhaps the most surprising consequence of haptotaxis in this simulation is the
emergence regression, a new phenomenon not observed until now in any previ-
ous simulation and not explicitly built in the model. We show in the insets of
figure 4.17c one of these events as an example. There, a capillary grows following
TAF gradients, but its TEC eventually gets deactivated long before reaching the
pellet due to the end of the stimuli (f < fact). This situation by itself was rarely
observable in previous simulations where most TECs either remained active until
the end of the simulation when all TAF was consumed or (less frequently with-
out haptotaxis) anastomosed. Here, however, several circumstances coalesce: The
amount of TAF is lower, there are more capillaries that consume TAF, haptotaxis
can drive TECs towards low-TAF regions, and the chances of anastomosis events,
although higher than without haptotaxis, are lower than in two-dimensional sim-
ulations. After the deactivation, it is only the phase-field dynamics that govern
the behavior of the capillary and, in particular, because there is no proliferation,
only the first term on the right hand side of equation (3.2). This dynamics tend
to minimize the area of the capillary which is particularly high due to its slender
shape. Consequently, most of the capillary slowly regresses towards its parent cap-
illary. Perhaps because it is a slow process, in the few TEC deactivation events in
previous simulations, because the domain was smaller and the capillaries rapidly
spanned the domain, there was no observable regression. Finally there are two
aspects of this regression that we think must be highlighted. The first one is that,
as shown in figure 4.17c, not the entire capillary regresses into its parent capillary,
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but part of it is transformed into a spherical-like mass (phase-field nucleation)
which eventually disappears. The second one, connected to the first, is that in the
absence of proliferation the phase-field equation conserves mass, which translated
to biological terms means that the endothelial cells in our simulation are not killed
by apoptosis (contrary to reality); instead they join the surrounding vessels.
4.5 Conclusions
In this chapter we have simulated one of the most common angiogenesis assays
in three dimensions using a subject-specific geometry and extracted the following
conclusions:
• The mouse corneal micropocket angiogenesis assay is a widely used assay
which provides a means to study angiogenesis in vivo in an avascular tissue,
to control the location of the pellet, to know the release rate of the desired
tumor angiogenic factor, and, what is more, to observe the whole angiogenic
process from beginning to end in a non-invasive way. These characteristics
fit with our model, as we have an avascular tissue and one tumor angio-
genic factor released from a known location and at a desired rate and our
simulations can be compared with the assay.
• The model and algorithms developed in chapters 2 and 3 provide a frame-
work to perform the in silico version of this assay in three-dimensional
simulations in complex geometries, which has not been previously done.
• The three-dimensional computations in simple geometries presented in this
chapter suggest that, for mathematical models to achieve the topological
complexity observed in in vivo angiogenesis experiments, two-dimensional
simulations may not be enough. In particular, we found denser patterns
with a higher number of anastomoses.
• Our results also indicate that haptotaxis may have a significant impact in the
final pattern achieved by capillary networks in three-dimensions. In contrast
with simulations of the model without haptotaxis, our results reveal increased
vascular pattern complexity, more tortuous TEC trajectories, higher number
of anastomosis events, and shorter capillaries.
• Our computational domain is the exact geometry of the cornea of a c57BL/6-
strain mouse as defined in the literature. The analysis of several parametriza-
tions of the disk using NURBS suggested the inflated parametrization as
the more appropriate for this geometry.
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• Numerical tests in scaled versions of the final geometry gave us insights
of the behavior of the model in big scales. These tests reveal the need to
re-calibrate five parameters for the model to produce results comparable
with the assay. These re-calibrations stems from the fact that the model was
calibrated for tumor angiogenesis occurring at small scales. The numerical
tests were also used to assess the number of knot spans needed to accurately
solve the problem, leading to a mesh composed by 14489496 knot spans.
• We performed several in silico mouse corneal micropocket angiogenesis
assay, which to the best knowledge of the author, were done for the first
time. They revealed that three-dimensional simulations are necessary to
capture angiogenesis, as this phenomenon is essentially three dimensional.
• These simulations, even in the absence of the haptotaxis conceptualization,
showed the well-known brush-border effect in three dimensions.
• Changes in the location of the pellet lead to different vascular patterns. In
particular, the shorter the distance between the pellet and the limbus, the
less number of capillaries that grow from the initial vessel and the less area
filled by the neovasculature. These patterns are in agreement with in vivo
assays through qualitative comparison.
• The simulations on the cornea uncovered a new phenomenon not explicitly
built into the model. The dimensions of the cornea lead to longer capillaries,
which required more time to develop. Under this longer time scales, the phase-
field dynamics came to the forefront where the levels of tumor angiogenic
factors were low. As result, the capillaries slip back into their parent vessels,
as their slender shape is not energetically stable in terms of the phase-field
dynamics. These behavior can be interpreted as capillary regression, which
is investigated in the following chapter.
4.6 Supporting information
Supporting information includes the following videos that can be found online at
http://caminos.udc.es/gmni/gente/gvilanovac/thesis/:
Video S4.1. Three-dimensional angiogenesis from two parent capillaries. This
video is related to figure 4.5.
Video S4.2. Evolution of a vascular network promoted by hypoxic cells mimick-
ing a multifocal tumor. Related to figure 4.6.
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Video S4.3. Three-dimensional angiogenesis promoted by 200 hypoxic cells. Re-
lated to figure 4.7a.
Video S4.4. Three-dimensional angiogenesis promoted by 100 hypoxic cells. Re-
lated to figure 4.7b.
Video S4.5. Construction of the subject-specific computational mesh using the
inflated parametrization presented in figure 4.10.
Video S4.6. Time evolution of a simulation of the mouse corneal micropocket
angiogenesis assay using the model without haptotaxis, as shown in figure 4.15.
Video S4.7. Time evolution of a simulation of the mouse corneal micropocket
angiogenesis assay, as shown in figure 4.17.
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Chapter5
Growth, regression, and regrowth
One of the most salient features of tumor-induced vascular networks is their
instability: they are stimulus-dependent and may undergo alternating stages of
growth, regression, and regrowth. Thus, tumor angiogenesis is a highly dynamic
phenomenon in which the new vasculature is a sequence of patterns that are
continuously shaping to tumor angiogenic factor distribution to better nourish and
oxygenate the cells. Previous efforts to model tumor angiogenesis, including those
presented in this thesis thus far, have chiefly focused on the initial growth of blood
vessels, often using models which are fundamentally unable to predict the natural
regression and regrowth observed in experiments. In this chapter, following a phase-
field methodology, we propose a new model of tumor angiogenesis that reproduces
the aforementioned features and highlights the importance of vascular regression
and regrowth. The model also includes a conceptualization of tip endothelial cell
filopodia (the cellular protrusions that aid TECs in their migration) that plays
a key role in regrowth and loop formation. The predictions of our model are in
quantitative agreement with in vivo experiments and may prove useful for the
design of antiangiogenic therapies.
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5.1 Stimuli dependency of tumor-induced vascula-
ture
Tumors give rise to dense, tortuous, and defective capillary networks (see fig-
ures 1.13 and 5.1a), which are significantly different from those formed in physio-
logical conditions (Carmeliet and Jain, 2000). Arguably, the most characteristic
feature of tumor-induced capillaries is that they are TAF-dependent, as sug-
gested by the experiments in Baffert et al. (2006); Falcon et al. (2011); Inai et al.
(2004); Mancuso et al. (2006). Specifically, in Mancuso et al. (2006), the authors
performed in vivo experiments where newly-formed capillaries regressed after
chemically inhibiting VEFG receptor signaling of endothelial cells for a time span
of 7 days (figure 5.1b). Perhaps more importantly, the experiment showed that
tumor-induced capillaries regrew when VEGF receptors were made functional
again (figures 5.1c and 5.1d). Due to this evidence, it is currently believed that
vascular regression can also happen locally and spontaneously in areas which are
temporarily well oxygenated. After local regression, nearby tumor cells become
hypoxic again, activating back the angiogenesis cascade.
Mancuso et al. also observed in their work that regressing capillaries leave (tem-
porarily) behind the vascular membrane that enveloped them. When new capillar-
ies regrew afterwards, these vascular membranes were used by TECs as an scaffold
that facilitated their migration (figure in supp material): By going through these
empty sleeves of basement membrane TECs avoid or at least minimize the effort
of degrading the ECM. As a consequence, the authors also observed that the
regrowth was faster than the normal growth. Notably, the role of detecting the
basement membranes relies on filopodia. As explained in the introduction of this
thesis, filopodia are receptor-rich, slender cytoplasmatic protrusions that TECs
extend to enhance their sensitivity (see figure 5.2). They can be thought as highly-
dynamic probes sent forward by TECs to investigate their microenvironment and
respond to it. In particular, as shown in figure 7c of Mancuso et al. (2006), when
the filopodia sense the remnants of basement membrane, TEC alter their direction
towards them to use them as the path of minimum resistance in their migration.
There is an emerging view that regression and regrowth may play a significant
role in the long-term dynamics of tumor angiogenesis and cancer development
(Goel et al., 2011; Potente et al., 2011). Numerous investigations have shed light
on the intricate growth of capillaries through mathematical models as shown in
subsection 1.2.2, but the dynamics of regression and regrowth has received little
attention (Logsdon et al., 2014). In this chapter, we present a model for tumor
angiogenesis that includes not only growth of new capillaries, but their natural
regression and regrowth. Due to the key role of filopodia in regrowth, we also
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(a) Growth of capillaries promoted by an un-
treated Rip-Tag2 tumor.
(b) Regressed capillaries after a 7-day inhi-
bition of VEGF receptors.
(c) Rapid regrowth of first sprouts (arrows)
2 days after inhibition removal.
(d) Regrown capillaries 7 days after inhibi-
tion removal showing pathological structure.
Figure 5.1. Growth, regression, and regrowth in vivo. Confocal micrographs of the
tumor-induced vasculature in a RIP-Tag2–transgenic mice before, during, and after a treatment
that inhibits VEGF receptors. Scale bar (applies to all images): 115 µm. (Adapted from Mancuso
et al., 2006).
incorporate a conceptualization of filopodia in our theory. Our results achieve
good agreement with in vivo experiments and suggest that our model could be
a useful tool for the design of antiangiogenic therapies, which are emerging as a
promising treatment for cancer (Maxwell and Ashcroft, 2009).
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(a) Scanning electron microscope image of an
endothelial cell extending filopodia (white ar-
rows). Scale bar: 2 µm. Reproduced from Figg
and Folkman, 2011a.
(b) Electron microscope snapshot of embry-
onic tip endothelial cell showing filopodia
extensions. Reproduced from Marin-Padilla,
1985.
Figure 5.2. Filopodia. Tip endothelial cells are characterized by the forward extension of
filopodia that aid them to guide the growth of new sprouts during angiogenesis.
5.2 The mathematical model
Our formulation accounts for three essential ingredients of angiogenesis, namely,
TAF, capillaries, and TECs, as shown in figure 5.3. In our theory, TAF is inter-
preted as one general and potent angiogenic factor, for instance VEGF (as shown
in appendix C the incomplete knowledge and wide variety of functions of TAFs
makes it effectively impossible to account for everyone). We model TAF as a
normalized continuous variable f ∈ [0, 1] representing the concentration of the
factor. Capillaries are modeled using an order parameter c ∈ [−1, 1], such that the
areas where c ≥ 0 are identified with the endothelial cells that form capillaries and
those where c < 0 represent the extravascular tissue. Furthermore, as capillaries
are enveloped by a basement membrane and occasionally by a thin cell coverage
(pericytes and smooth muscle cells), we extend the definition of c to include them:
The extravascular tissue (c < 0) is compartmentalized into the capillary coverage,
−0.9 < c < 0, and the extracellular matrix, c < −0.9. Finally, TECs are modeled
as discrete agents which follow chemical cues and sense trhough filopodia nearby
capillaries or empty basement membranes left by regressed capillaries.
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Tumor angiogenic factor TAF is produced by tumor cells when they enter
a hypoxic state. Tumor cells are located at fixed points and are assumed to be
hypoxic when they do not have a capillary closer than the nutrient and oxygen
diffusion length, δnox, as shown in figure 5.3. TAF diffuses from the hypoxic cells
and throughout the tissue, decays naturally, is consumed by endothelial cells, and
eventually triggers angiogenesis. Its dynamics is supposed to be governed by the
reaction-diffusion equation
∂f
∂t
= ∇ · (D∇f) + P (d) (fhyc − f)− U (c) f, (5.1)
where D is the diffusion constant and fhyc is the maximum TAF produced in a
HYC. P and U are, respectively, production and uptake functions defined as
P(d) =
{
P if d < Rhyc
0 if d ≥ Rhyc
, U(c) =
{
Buc if c ≥ 0
−Bdc if c < 0
. (5.2)
Here, P is the production rate, d is the distance to the closest hypoxic tumor cell,
Rhyc is an average cell radius, Bu is the endothelial cell uptake rate, and Bd is
the TAF natural decay rate and the uptake rate by other cells.
Capillaries Endothelial cells receptors stimulated by TAF activate molecular
pathways that change the cell phenotype either to a migratory (TECs, modeled
separately) or to a proliferative one. In the absence of stimuli, endothelial cells
lining immature, tumor-induced capillaries become apoptotic, which eventually
leads to vascular regression (Potente et al., 2011). The key idea to successfully
model this phenotype switch is to make use of non-conserved phase-field dynamics
rather than previously used conserved models (chapters 2 to 4). Thus, our phase-
field equation is
∂c
∂t
= M
(
λ2∆c− µ (c, f)) . (5.3)
Here, M > 0 is a parameter, λ is a constant proportional to the width of the
capillary wall, and
µ (c, f) =
1
4
(
c2 − 1) (c− 3αγ (f)) (5.4)
is the derivative with respect to c of the double-well potential (see figure 5.4)
Ψ (c, f) =
1
16
(c+ 1)
2
(c− 1)2 − 1
4
αγ (f) (c+ 1)
2
(c− 2) . (5.5)
In equations (5.4) and (5.5), α is a parameter and the function
γ (f) = exp [− exp(β(f − fact))]− exp(−1), (5.6)
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where β is a constant, tilts the double well in such a way that capillary growth
(proliferative phenotypes) is favored when f > fact, as shown by the triangle-
labeled curve in figure 5.4, and capillary regression (apoptotic phenotypes) is
promoted otherwise, as shown by the square-labeled curve in figure 5.4.
Remarks:
1. The parameter α guaranties that the energy potential Ψ has two minimums
provided that −0.52733 < α < 0.52733.
2. The reader is referred to Karma and Rappel (1998); Kim et al. (1999);
Kobayashi (1993); Provatas et al. (1998) for detailed descriptions of this
kind of phase-field models often used in dendritic solidification, but also in
biological problems (Ziebert et al., 2012).
Tip endothelial cells When capillaries receive TAF signals, some privileged
endothelial cells (TECs) acquire a migratory phenotype and lead the growth of new
sprouts (De Smet et al., 2009). This phenotype was not included in equations (5.3)
to (5.6). When an endothelial cell becomes a TEC, it expresses Delta-like ligand
4 (Dll-4). Dll-4 binds to Notch receptors of nearby endothelial cells preventing
them from becoming also TECs (Hellström et al., 2007; Thurston and Kitajewski,
2008). TECs migrate following cues that guide the new capillaries towards nutrient-
demanding cells. These cues may be, for example, chemical or mechanical. TECs
are especially sensitive to such cues because they extend highly-dynamic, receptor-
rich protrusions called filopodia (Gerhardt et al., 2003) towards the angiogenic
stimuli, as shown in figure 5.2 and in the top panel of figure 5.3. As filopodia
probe the cell’s microenvironment, they may detect nearby endothelial cells. In
this event, the TEC anastomoses with the identified endothelial cell forming a loop
between the growing sprout and the detected capillary. Note that this mechanism
increases the vascular network connectivity. Perhaps more surprisingly, filopodia
may even sense basement membranes left behind by regressed capillaries and use
them to improve their migratory capacity (see Murakami et al. (2006) and the
supporting information therein for examples of in vitro experiments).
As said above, the continuous field c represents the ECM, the basement membrane
(and the thin cell coverage), and the endothelial cells. However, the phase-field
equation that governs the dynamics of c was missing the migratory endothelial
cell phenotype, that is, TECs. The reason is that as no other cell will become
migratory in the vicinity of a TEC, they are ideally suited for a discrete description.
Thus, TECs are discrete agents in our formulation (see bottom panel of figure 5.3),
which are coupled with the continuous field c to close the model. They are modeled
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using ideas from the literature (Travasso et al., 2011b), but further extended to
include filopodia, to detect nearby capillaries, and to migrate not only following
chemotactic cues (figure 5.3, green arrows), but also using the empty sleeves of
basement membrane left in the extracellular matrix (figure 5.3, black arrow) by
regressed capillaries.
The discrete agents are characterized by their center and their radius Rtec . TEC
c>0
Hyp
oxic
 tum
or c
ells
-0.9<c<0
Figure 5.3. Conceptualization of tip endothelial cells. (Top) Tumor angiogenic factor
activates tip endothelial cells that extend filopodia to survey their environment. (Bottom) In the
model, discrete circular agents are activated and migrate following TAF gradients (chemotaxis).
Each agent evaluates conditions at filopodia check points. A positive check (c > −0.9) alters
the (otherwise chemotactic) migration direction.
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activation, that is, the phenotype switch from quiescent or proliferative to migra-
tory, is performed according to the following deterministic rules: A point of the
domain is the center of a new TEC if
1. it is deep inside a capillary (c > cact), to guarantee that it is an endothelial
cell;
2. the tumor angiogenic factor is greater than a threshold (f > fact), to assure
that the stimuli is potent; and
3. there is no other TEC is in the vicinity (distance to every TEC greater than
δ4), to account for the lateral inhibition.
Activated cells, unless they detect a nearby basement membrane or a capillary, mi-
grate following chemotactic cues with a velocity proportional to the TAF gradient,
given by
vtec = χ
∇f
|∇f | , (5.7)
where χ is the chemotactic constant and | · |, as in previous chapters, denotes the
Euclidean norm. They also develop filopodia, which we model as a set of check
points that mimic their high concentration of receptors (figure 5.3, gray crosses).
Because tumor angiogenic factors polarize TECs such that they spread filopodia
towards their front (De Smet et al., 2009), we evenly place the check points into
an annulus sector of angle 2pi/3 centered around the chemotactic direction, as
shown in the bottom panel of figure 5.3. The internal and external radius of the
annulus sector are set to 2Rtec and 4Rtec , respectively. Filopodia do not develop
immediately after TEC activation, thus, in the model, the check points are not
tested until the sprout has been initiated, that is, until the TEC has migrated a
diameter from its activation point and it is outside its parent vessel. A positive
check (figure 5.3, black cross), defined as c > −0.9, means that the TEC has
detected a basement membrane or a capillary through the filopodia. Under this
circumstance, the direction of migration is altered towards the check point and
the velocity module is doubled. In the event of several positive checks, the check
point where the value of c is higher is selected.
There are two ways by which a TEC can be deactivated, that is, the endothelial
cell looses its migratory phenotype. The first one occurs when the TEC anasto-
moses with another TEC or capillary. Anastomosis is modeled in a similar way
to filopodia: TECs test the value of c in an 2pi/3-radians arc with radius Rtec
centered around the direction of migration. If any of these values is greater that
0.9, that is, the TEC is already touching the capillary, then there is an anastomo-
sis event and the TEC gets deactivated. The second deactivating circumstance
happens when the stimuli ceases (failure to meet condition 2). In both cases the
discrete agent is removed.
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Figure 5.4. Chemical energy and tilting function. The chemical free energy (in red), is
a double-well potential tilted by the tumor angiogenic factor value through the function γ(f)
(in green). Low values of tumor angiogenic factor bias the evolution of c towards regression
(top-left graph), while high values of tumor angiogenic factor promote the growth of the phase
c = 1.
Finally, to close the model, TECs need to be included in the phase-field description
of endothelial cells, as they are also endothelial cells. This coupling between the
discrete agents and the continuous variable is performed by updating c to c = 1
in those regions of the computational domain occupied by TECs.
5.3 Numerical methods
Our theory is composed by two continuum variables and a set of discrete agents.
Thus, we need numerical methods for the partial differential equations, for the
discrete agents, and for coupling both of them. As these methods were already de-
veloped in previous chapters, here we just give a brief description of them. First,
we derive the weak form of the continuous partial differential equations (5.1)
and (5.3) and we discretize them in space and time using the Galerkin method
and the generalized-α method (Chung and Hulbert, 1993), respectively. Isogeomet-
ric Analysis (Cottrell et al., 2009; Hughes et al., 2005) permitted us to use globally
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Table 5.1. Parameters of the model in dimensionless units.
Description Symbol Value
Equation (5.1) – Diffusion D 100.0
Equation (5.1) – Maximum TAF production fhyc 1.0
Equation (5.2) – Production P 100.0
Equation (5.2) – Natural decay Bd 0.1
Equation (5.2) – Endothelial cell uptake Bu 6.25
Equation (5.3) – Mobility M 0.025
Equation (5.3) – Interface width λ 1.0
Equation (5.4) – Phenotype switch α 0.525
Equation (5.6) – Phenotype switch β 104
Equation (5.7) – Chemotatic constant χ 7.28
Condition 1 for TEC activation cact 0.9
Condition 2 for TEC activation fact 0.001
Condition 3 Dll-4 radius of action δ4 32.0
Nutrient and oxygen diffusion length δnox 20.0
TEC radius Rtec 4.0
HYC radius Rhyc 4.0
smooth functions on the domain and a means of accurately solve the equations.
Additionally we implemented a time-step correction algorithm similar to those in
(Gomez et al., 2008, 2013; Gomez and Hughes, 2011). Then, we develop an algo-
rithm that handles TEC activation, migration, filopodia probing, and deactivation.
Note that the migration of TECs is meshless meaning that it is independent of the
spatial discretization of the continuum variables. This fact hindered the coupling
between the discrete agents and the continuum variables, which we performed by
updating the value of the order parameter c at the locations of tip endothelial
cells every time step using the templates defined in chapter 2.
The parameter values used in the computations are summarized in table 5.1.
Some of them are taken from in vivo observations, while others have been used
in previous models of tumor angiogenesis (Travasso et al., 2011b). The physical
quantities of these parameters may be retrieved by using the length and time
scales L0 = 1.25 µm and T0 = 5460 s, respectively
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5.4 Results and discussion
We open this section with a simple simulation whose aim is to give insight and
study the proposed mathematical model. Then, we show how the theory is able
to capture the growth patterns of the previously shown models, in particular
in a two-dimensional simulation of the mouse corneal micropocket angiogenesis
assay. Finally, we present the full potential of this new theory in a simulation that
replicates the experiment shown in figure 5.1.
5.4.1 Intuition of the model
In order to give an intuition and to study how the model works, we perform
a quite simple simulation on a square domain (figure 5.5 and video S5.1). The
simulation has the same size and uses the same mesh as those of figures 2.8 and 3.3
of previous chapters, that is, a 375 µm× 375 µm domain and a mesh composed by
2562 quadratic elements; a configuration that has already proven to be enough
to capture the phase-field interface (see figure 5.5a). Figures 5.5c to 5.5k show
the time evolution of this simple simulation by means of zoomed snapshots. We
say it is simple because, contrary to the next simulation in this chapter, it only
has an initial straight capillary and one HYC located close to it – approximately
60 µm away (see figure 5.5b). Furthermore, for the sake of simplicity, we have set
fhyc to 0.1 so as to reduce the potential number of new capillaries.
The simulation starts with the TAF being produced at the HYC which diffuses
throughout the domain. The first activation of a TEC (red circumferences in
figure 5.5) occurs when enough TAF infiltrates the initial capillary, that is, when
the amount of TAF is greater than fact (green lines in figure 5.5) inside the
capillary. Several time steps afterwards, two other TECs get activated on both
sides of the first one. Note that all TECs are separated from each other as dictated
by the lateral inhibition mechanism. As shown in figure 5.5c, the three TECs
initially migrate following the chemotactic direction, marked with green arrows.
Figure 5.5d reveals, however, that the chemotactic direction may be altered. There,
the filopodia of the rightmost TEC detect the presence of a capillary located on
its left-hand side. Consequently, the chemotactic direction is overridden and, even
though the green arrow points to the top-right corner, the TEC moves towards
the detected capillary, anastomoses with it, and gets immediately deactivated.
Meanwhile, the two other TECs, that have already promoted the deactivation of
the HYC, continue their migration trough the ECM still following the chemotactic
cues and the proliferating cells keep widening the capillaries. And, as shown in
figure 5.5e, the growth process evolves unaltered until all TAF gets consumed.
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At this point, in the absence of TAF, the endothelial cells of the tumor-induced
vasculature, which are highly TAF-dependent, change their phenotype to an apop-
totic one and regression starts. Figures 5.5f to 5.5h show how this process, al-
though slower than the initial growth (note the time steps of the captions and
its duration in the video), promotes the gradual disappearance of the capillaries.
The vascular basement membrane that was enveloping the capillaries, however,
remains after the capillaries have regressed forming the already mentioned empty
sleeves, through which future TECs can migrate easily1. And, indeed, after the
HYC gets activated again the new TECs that orchestrate the regrowth, aided by
their filopodia, use these remnants of basement membrane to direct the formation
of new capillaries (figures 5.5i to 5.5k). As shown in figure 5.5k, the regrowth and
the growth pattern are not equal, even in this simple setup. The source of this
difference is that TECs migrate faster through the empty sleeves than through
the ECM, thus, their velocity is faster with respect to TAF consumption. In par-
ticular, in the regrowth process shown in that figure a new TEC gets activated
soon after the anastomosis event between the rightmost TEC and the middle
capillary, creating a new capillary that grows towards the top-right corner.
5.4.2 Vascular growth
As a first illustration of the capabilities of our model in an experimental-like
setup, we show in figure 5.6 and video S5.2 computations in a configuration
that resembles the mouse cornea micropocket angiogenesis assay (Rogers et al.,
2007, chapter 4). The cornea is an avascular tissue surrounded by a region called
limbus formed by capillaries. Tumor cells in the cornea may promote the creation
of new capillaries from the limbus. Thus, in our simulation, all the system is
initially avascular (figure 5.6a), except for a circular capillary (red) that mimics
the limbal vessels. We include a cluster of hypoxic tumor cells that release a
generic tumor angiogenic factor (green) that triggers angiogenesis. Figure 5.6b
shows a snapshot of the growing capillaries that are pervading the cornea and
forming a new vessel network. As this network grows, endothelial cells consume
angiogenic factor and tumor cells that are close to capillaries become normoxic
and stop releasing TAF. Capillaries grow led by tip endothelial cells. TECs follow
gradients of tumor angiogenic factor (triangle-labeled discrete agent of the inset),
unless they sense nearby capillaries through filopodia (star-labeled agent of the
same inset), until they reach the surrounding vasculature, producing anastomoses.
The pattern obtained in this numerical simulation immediately after capillary
growth has ceased (figure 5.6c) is similar to those observed in vivo (Kenyon
et al., 1996; Rogers et al., 2007; Tong and Yuan, 2008a) and in silico (Harrington
1Given enough time without TAF, the basement membranes would eventually regress.
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(d) Growth (t = 4.76).
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(k) Regrowth (t = 26.23, 26.85,
27.48, 28.36).
Figure 5.5. Intuition of the model. Simulation of the mathematical model in a simplistic
setup (a) that shows the process of growth (b-d), regression (e-f), and regrowth (g-i).
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et al., 2007; Tong and Yuan, 2001, 2008b). We performed a quantification of
the neovasculature over time (figure 5.6d). The vasculature starts as a tree-like
network (no loops) driven by an increasing number of TECs that create branches
or bifurcations. However, as their filopodia detect nearby capillaries, the number
of anastomosis events grows rapidly. Consequently, the tree-like network gradually
evolves to a mesh-like one with loops that facilitate blood flow. By the end of
the simulation approximately 30 anastomoses have shaped the vasculature into a
highly-interconnected network with more than 20 loops. The pace at which the
vasculature penetrates the cornea (measured as the distance from the limbus to
the innermost TEC using the shortest path) is linear, as reported in Kenyon et al.
(1996); Tong and Yuan (2008b). We also measured the maximum and average
capillary length (distance between bifurcations) and observed that anastomoses
reduce the maximum length compared to the penetration distance and, more
surprisingly, maintain the average length almost constant.
5.4.3 Regression and regrowth
The result in figure 5.6 illustrates the capabilities of the model to predict vascular
growth patterns, but a major goal of this work was to develop a model that natu-
rally leads to regression and regrowth. We study this phenomenon motivated by
the in vivo experiment shown in figure 5.1. To replicate the experiment, we need
first to simulate the growth process. To this end, we chose as our computational
domain the area enclosed by the dotted lines in figure 5.1. In the simulation, the
system is initially avascular, except for a capillary placed on the boundary which
serves as a precursor to the neo-vasculature (figure 5.7a). Randomly distributed
hypoxic cells (that resemble the Rip-Tag2 tumor in the experiment) release angio-
genic factor that activates tip endothelial cells. Initially, capillaries grow inwards,
forming new vasculature. Then, the vasculature regresses due to the absence of
TAF (figure 5.7c) and the system enters a transient behavior with local regressions
and regrowths (see video S5.3 in the supporting information) similar to those ob-
served in experiments. Figures 5.7d to 5.7h show snapshots of different patterns
that highlight the dynamism and adaptation of the vasculature when regression
and regrowth are considered. Note that in figure 5.7h the initial capillary has
completely regressed. We assume that this configuration (figure 5.7h) is analogous
to the starting point of the experiment (figure 5.1a).
The experimental procedure of Mancuso et al. is continued by chemically inhibiting
the VEGF receptors of endothelial cells, so that capillaries are unable to detect
the presence of TAF and eventually regress (figure 5.1b). The receptors are kept
blocked for 7 days and the capillaries regrow afterwards (figures 5.1c and 5.1d).
Our simulation proceeds along the same lines. We model the receptor inhibition
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of tumor cells that release tumor angiogenic factor (green). (b) Tip endothelial cells (TECs)
lead the growth of the new capillaries. (c) Vascular pattern after growth. (d) Neovasculature
quantification.
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by blocking the activation of new tip endothelial cells. Those that were active
will eventually get deactivated in the absence of tumor angiogenic factor. During
the inhibition, most capillaries regress, as shown in figures 5.7i to 5.7l. Note that
regressed capillaries leave behind a trail (grayish colors representing low values of c
in figure 5.7) which we identify with the basement membrane. If the treatment were
prolonged, all the capillaries and basement membranes will eventually disappear.
However, as in the experiment, we remove the inhibition after approximately 7
days (figure 5.7m) and the regrowth process starts (figures 5.7n to 5.7t). The high
availability of TAF due to the treatment promotes an almost instant activation
of TEC after its removal. New tip endothelial cells get rapidly activated. They
migrate attracted by TAF, but also extend filopodia that detects the old basement
membrane and guides capillaries to grow aided by the scaffold left behind after
regression. Eventually, the vascular density returns to a state similar to that before
the inhibition.
Visual inspection shows that the in vivo experiment and the numerical simula-
tion compare well. In both cases the network is composed of tortuous, highly
interconnected vessels that oxygenate the tissue unevenly. Also, as the new vas-
culature is particularly dependent on tumor angiogenic factor, the inhibition acts
successfully, leaving in both cases few, barely functional capillaries in the region.
The dependency on tumor angiogenic factor also implies that the vasculature
recovers rapidly after the treatment, a finding that may be useful in the design of
antiangiogenic therapies. Figure 5.8 shows a quantitative comparison between the
simulation and the experiment. Vascular density suffers a drastic drop due to the
inhibition. Then, the regrowth process starts and the vascular density eventually
recovers its original value. After the regrowth, our model predicts mild oscillations
of the vascular density due to spontaneous local regressions and regrowths. To
some extent, this can also be inferred in the experiment, but there is insufficient
data to be conclusive. Although precise agreement with in vivo experiments is a
daunting task, the simulation clearly captures the trend of the experiment.
5.5 Conclusions
In conclusion, our model reinforces the view that tumors need to be analyzed
as a complex system which interacts dynamically with its microenvironment. In
this context, our study highlights the importance of regression and regrowth of
tumor vasculature. The proposed model may be a useful tool not only to predict
capillary growth patterns, but also for the design of antiangiogenic therapies,
which are currently considered the fourth pillar of cancer treatment after surgery,
chemotherapy, and radiation.
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Figure 5.7. Tumor angiogenesis simulation: growth, regression, and regrowth. This
simulation replicates the experiment of figure 5.1 and both are compared in figure 5.8. The color
scales are equal to those in figure 5.6.
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5.6 Supporting information
Supporting information includes the following videos that can be found online at
http://caminos.udc.es/gmni/gente/gvilanovac/thesis/:
Video S5.1. Simulation of the mathematical model in a simplistic setup, as
shown in figure 5.5.
Video S5.2. Two-dimensional replication of the mouse corneal micropocket an-
giogenesis assay. This video is related to figure 5.6.
Video S5.3. Time evolution of a TAF-dependent vascular network featuring
capillary growth, regression, and regrowth. This simulation, shown in figure 5.7,
replicates the experiment of figure 5.1.
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Chapter6
Convection-driven vascular
patterns
In this chapter, we investigate the role of convection in tumor-induced angiogene-
sis. The blood that circulates in the capillaries leaks through the vascular wall and
reaches the cells, generating in the process an extravascular fluid flow. This flow
not only transports oxygen and nutrients towards the cells, but also the wastes
and signaling factors released by cells. In particular, in tumor angiogenesis, the
extravascular fluid flow convects tumor angiogenic factors (altering the otherwise
purely diffusive distribution), which, ultimately affects the creation of new vas-
culature. Here, we develop a continuum theory for intravascular, transvascular,
and extravascular fluid flow based on a non-homogeneous Darcy’s law. We couple
the velocity of the fluid with the tumor-induced angiogenesis model through a
convective term in the tumor angiogenic factor equation. We also develop efficient
numerical methods which permit us to study the influence of fluid flow on vascular
patterning under different hypothesis and configurations and to investigate the
effect of high intratumoral pressure in angiogenesis.
6.1 Blood flow in the micro-circulatory system
Cells obtain the building blocks that sustain their activities from blood, which is
transported by arteries, distributed within the micro-circulatory system (arteri-
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oles, capillaries, and venules), and returned through veins. The heart pumps the
blood through the circulatory system exerting a non-constant pressure gradient,
which generates an intravascular flow. This gradient, however, is progressively
damped as it travels from large-caliber arteries to the thinner micro-circulatory
vessels, where it is usually assumed to be constant. Once in the micro-circulatory
system, the blood exchanges material with the surrounding cells through the
vascular wall. Most of this material (oxygen, nutrients, wastes from the cellular
activity, or signaling factors) is dissolved in the fluid (water) and, consequently,
extravassates with it through the thin openings between the endothelial cells1.
The transvascular fluid flow is driven by the different pressures inside and outside
the capillaries (figure 6.1). In particular, the intravascular hydrostatic pressure in
the arterial side of the micro-circulatory system is approximately 32mmHg higher
than the extravascular hydrostatic pressure in the interstitium. In the venous side,
due to the wider caliber of the vessels and the frictional effects the difference in
the hydrostatic pressures drops to approximately 15mmHg. If this were the only
mechanism that orchestrated the transvascular transport, the water and those
substances dissolved in it would exclusively extravassate the capillaries. There is,
however, another mechanism involved, which is driven by the colloidal osmotic
pressure. The blood transports large proteins which, due to their size, are not able
go through the vascular wall, being their concentration higher in the intravascular
than in the extravascular region. This creates an osmotic pressure difference be-
tween the blood and the interstitial fluid of about −22mmHg which conveys the
fluid into the vasculature. Summing up both mechanisms, the fluid is driven out
of the capillaries in the arterial side by a net pressure of 10mmHg and into the
capillaries in the venous side by a net pressure of −7mmHg. In the extravascular
region, the substances reach the cells not only by diffusion, but the interstitial fluid
flow convects them from the vessels to the cells. Likewise, the waste products from
the cell cycle and other soluble substances (as signaling factors) reach the capillar-
ies which collect them using both diffusion and convection mechanisms. Arguably,
fluid flow has an influence in vascular patterning through convection, as soluble
substances like tumor angiogenic factors or systemically-delivered antiangiogenic
drugs are affected by convection.
As detailed in the review of the literature of this thesis (subsection 1.2.2) several
authors have developed mathematical models for tumor angiogenesis that include
fluid flow. All the works cited there that explicitly considered the vasculature base
their modeling for fluid flow on a similar approach, which is to divide flow into
different models: one for intravascular flow and one for extravascular flow, both
coupled with a model for transvascular flow. The intravascular flow is modeled by
1The greater and more frequent openings in tumor-induced capillaries facilitates the extravas-
sation of these substances and often creates high intratumoral pressures.
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Arterial side Venous side
Figure 6.1. Transvascular fluid flow. In the micro-circulatory system, fluid flows through
thin gaps in the capillary walls driven by the differences in hydrostatic and osmotic pressures.
a one-dimensional discrete method using Pries et al. (1990) or further augmented
versions like Pries et al. (2001, 1998). For the extravascular flow, on the contrary,
they use Darcy’s law which is a continuous theory. Finally, the transvascular flow
is modeled by Starling’s law (Starling, 1896) and couples the two previous ones.
Independently of the methods, the main goals of the referred works related to this
topic are to measure interstitial fluid flow and pressure inside the tumor and to
study drug delivery considering fluid convection, while tumor angiogenic factor
convection was not considered.
In this chapter we present a hybrid mathematical model for tumor angiogenesis
to study the influence of fluid flow in neovascular patterning through tumor
angiogenic factor convection. The novelty of this theory is that we model intra-,
trans-, and extra-vascular fluid flow at once using a continuous pressure variable,
rather than using three different models. Our theory is deeply grounded in the
smooth interfaces generated by the phase-field approach and on Darcy’s law with
highly non-linear hydraulic conductivity.
6.2 The mathematical model
Our model can be divided into a model for fluid flow and a model for angiogenesis.
Under the assumptions explained below, the former is a continuous model for
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fluid flow through porous media that uses Darcy’s law for its formulation. The
main variables of this model are the fluid velocity u and the pressure p. The latter
model, as in previous chapters, is a hybrid theory with two continuous partial
differential equations (a convection-diffusion equation for the tumor angiogenic
factor f and a phase-field equation for the endothelial cell density c) and a set
of discrete agents tecs for the tip endothelial cells. Both the fluid flow and the
angiogenesis model are fully coupled: the fluid convects tumor angiogenic factor,
which modifies the endothelial cell density field (both through endothelial cell
proliferation and through the creation of tecs), which, in turn, affects the flow
of the fluid through the variation of the hydraulic conductivity. In the rest of the
section we detail the models separately.
6.2.1 The fluid flow model
The tumor stroma is formed by several types of cells, such as cancerous and
host cells, and leaky tumor-induced capillaries, all embedded in the extracellular
matrix. From a macroscopic point of view, the stroma may be understood as a
continuous porous medium with a non-constant porous size through which blood
and interstitial fluid flow. Thus, considering that blood plasma and the interstitial
fluid have the same properties, we can model the fluid within the stroma using
Darcy’s law. Furthermore, under the assumptions of an incompressible, stationary,
creeping flow, the mass balance and the Navier-Stokes equations for the fluid flow
reduce, respectively, to
∇ · u = 0, (6.1)
u = −K∇p, (6.2)
where K is the conductivity function. As the porous size of the medium is different
throughout the tumor stroma, this function varies accordingly. Arguably, the major
differences in the porous size are those between the intravascular, the transvascular,
and the extravascular regions (see the remarks at the end of the section). Making
use of the smooth interfaces between the intravascular and extravascular regions
resulting from the phase field c, we define the following non-linear hydraulic
conductivity function
K (c, ‖∇c‖) = κeϑ (c) T (‖∇c‖) , (6.3)
where κe is the extravascular conductivity. Figure 6.2 illustrates the non-linearity
of K based on the one-dimensional solution of the phase-field equation in an
infinite domain. In equation (6.3), ϑ is a function of the phase field while T
depends on the gradient of the phase field. The former accounts for the different
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conductivities between the intra- and the extravascular region and is given by
ϑ (c) = 1 +
κ¯i − 1
2
(tanh (3c) + 1) , (6.4)
where κ¯i = κi/κe is the normalized intravascular conductivity and κi is the in-
travascular conductivity. The second factor of equation (6.3), T , can be understood
as a weighting function that modifies ϑ in the transvascular region and is defined
as
T (‖∇c‖) = 1 + κ¯
t
2
− 1− κ¯
t
2
tanh
(
10λ
(
‖∇c‖ − 1
2
√
2λ
))
, (6.5)
where κ¯t = κt/κe is the normalized transvascular conductivity and κt is the
transvascular conductivity. T depends on the gradient of the phase-field in such a
way that only affects K in the transvascular region, that is, when the gradient is
high. The term 1/(2
√
2λ) and the factor 10λ control the width and slope of this
region.

1.5
-0.5
-1.0
-6.0 -2.0 2.0 6.0-4.0 4.0
0.5
 (,||||)

 (||||)
 ()
Intravascular Transvascular Extravascular

	


1.0
Figure 6.2. Hydraulic conductivity. This figure plots the hydraulic conductivity K (and
their factors ϑ and T ) as a function c = tanh(−x/(√2λ)), that is, the 1D solution to the phase-
field equation in an infinite domain. The phase-field creates smooth interfaces that permit
the differentiation of intravascular, transvascular, and extravascular regions. Accordingly, the
hydraulic conductivity displays three plateaus, one per region, connected by smooth transitions.
In this plot κe = 1, κ¯i = 1.5, κ¯t = 0.01, and λ = 1.
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As a result of the product of the smoothed, step-like functions ϑ and T , the
hydraulic conductivity K is a three-plateau function connected by smooth transi-
tions. Each plateau has a value that correlates with the conductivity of a region
of interest in such a way that the fluid flows easier inside the capillaries than
outside them and extravassates with difficulty.
Remarks:
1. Tumor cells are densely packed compared to host cells, and consequently
the hydraulic conductivity is lower in the intratumoral region. This fact
is not explicitly considered in equation (6.3) as the tumor cell density is
not considered in this model. We know, however, the location of the tumor
through the hypoxic region and we use it in the examples to (weakly) impose
higher pressure inside the tumor.
2. Several tumor angiogenic factors are known to increase the patency of cap-
illaries (see appendix C). This mechanism may be built into the model by
transforming the parameter κt into a function that depends on the concen-
tration of that particular tumor angiogenic factor.
3. Several other choices are possible for the hydraulic conductivity K, such as
Heaviside functions; we opted, however, for a smooth continuous function,
which benefits the numerical resolution of the equations. Note also that our
definition of K preserves its properties through changes on the thickness of
the phase-field interface.
6.2.2 The angiogenesis model
In this chapter we use a model for tumor angiogenesis similar to those used in
other sections. For this reason, we describe it briefly, giving all its details, but
focusing only on the new tumor angiogenic factor convection term.
The continuous variables (f and c) The tumor angiogenic factor f and the
concentration of endothelial cells (or capillaries) c, that configure the continuous
part of the model, are governed, respectively, by equations
∂f
∂t
= ∇ · (D∇f)−∇ · (uf) + P (d) (fhyc − f)− U (c) f, (6.6)
∂c
∂t
= ∇ · (M∇ (µ (c)− λ2∆c))+ Bp (f) cH (c) , (6.7)
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where D is the diffusion constant, fhyc is the maximum TAF produced in a
hypoxic region, M is the mobility, λ is a positive constant proportional to the
width of the interface, andH is the Heaviside function. The remaining functions P,
U , µ, and Bp are, respectively, the TAF production, the TAF uptake by capillaries,
the chemical potential, and the endothelial cell proliferation, which are defined as
P(d) =
{
P if d < Rhyc
0 if d ≥ Rhyc
, U(c) =
{
Buc if c ≥ 0
−Bdc if c < 0
, (6.8)
µ (c) = −c+ c3, Bp(f) =
{
Bpf if f < fp
Bpfp if f ≥ fp
. (6.9)
Here, P is the production rate, d is the distance to the closest hypoxic region,Rhyc
is an average cell radius, Bu is the endothelial cell uptake rate, Bd is the TAF
natural decay rate and the uptake rate by other cells, Bp is the proliferative rate
constant, and fp is the tumor angiogenic factor condition for highest proliferation.
In addition, we take P = 0 if the concentration of endothelial cells is high in the
vicinity of a hypoxic region, that is, if c > 0.9 within a radius δnox (nutrients and
oxygen diffusion length) from the edge of the hypoxic cell.
Equation (6.6) is a convection-diffusion equation for the tumor angiogenic factor
with two reaction terms, a source and a sink. As in previous models presented in
this thesis, f is produced in hypoxic region (third term on the right-hand side),
diffuses throughout the extracellular matrix (first term on the right-hand side),
and is consumed by endothelial cells (last term). Now, additionally, the tumor
angiogenic factor is convected by the fluid, as modeled by the second term on the
right-hand side. Equation (6.7) is a phase-field equation whose first term drives
c either to c = 1 or to c = −1, generating smooth but thin transitions between
them,which we interpret here as the intravascular, extravascular, and transvascular
regions, respectively (see figure 6.2). Moreover, equation (6.7) includes a source
term that accounts for endothelial cell proliferation.
The discrete agents (TECs) and their coupling Tip endothelial cells are
modeled as circular discrete agents with radius Rtec , that can get activated at any
point in the domain if the following conditions are meet: 1) c > cact, 2) f > fact,
and 3) the distance to every other TEC is greater than δ4. An active TEC initially
moves with a constant velocity vtec = χ ∇f|∇f | , where χ is the chemotactic constant.
Once the TEC is outside the parent capillary, it develops filopodia, which we model
as a set of check points distributed in an annulus sector, centered in the direction
of the TAF gradient, with angle 2pi/3, and with internal and external radius 2Rtec
and 4Rtec , respectively (see figure 5.3). A positive check in one of these points
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(c > −0.9) implies that filopodia have detected a nearby endothelial cell and
the TEC alters its velocity direction towards it. Finally, TECs get deactivated if
they fail to meet any of the above-mentioned conditions for activation or if they
encounter another TEC or capillary in their migration path (anastomosis).
The discrete agents are fully coupled with the continuous variables. On the one
hand, their activation, movement, and deactivation depend on point-wise evalu-
ations of these continuous variables and their gradients. On the other hand, the
value of the phase-field c is overwritten at the region occupied by each TEC (a
circle with radius Rtec). In particular, c takes the value one within this region
and TECs form automatically part of the intravascular region defined in this
theory.
6.2.3 Parameters
Table 6.1 details the dimensionless values of the parameter of the model2. There,
following the order of the above explanation, we categorize the parameters ac-
cording to the different sub-models.
The fluid flow problem is completely defined by three parameters, namely, κe,
κi, and κt. As shown in the table, the extravascular hydraulic conductivity is
5.008× 10−10 cm2/s/mmHg, which is within the range of data from the literature
(Cattaneo and Zunino, 2014; Welter and Rieger, 2013). Note that in the definition
of the conductivity, we normalized the transvascular and intravascular hydraulic
conductivity with respect to the extravascular conductivity. We followed this strat-
egy motivated by the absence of available data for them, so that we can estimate
their values now. On the one hand, in the intravascular region the fluid flows more
easily than through the interstitium suggesting that κi  κe. However, inside
the capillaries the fluid is blood which due to its composition suffers resistance
when it flows through the micro-circulatory system (Pries et al., 1994). Thus, we
estimate a ten-fold ratio between the intravascular and the extravascular conduc-
tivity. On the other hand, fluid flow through the vascular wall is more difficult
than in the interstitium pointing to κt  κe. In our case, as we are dealing with
tumor-induced capillaries characterized by their high permeability, we estimate
that the transvascular conductivity is one order of magnitude lower than the
extravascular.
The remaining parameters shown in table 6.1 belong to the continuous and discrete
angiogenesis model, whose values were already established in previous chapters.
2Recall that the length and time scales to retrieve the physical values of these parameters
are L0 = 1.25 µm and T0 = 1560 s, respectively.
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Table 6.1. Values of the parameters grouped by the different sub-models given in dimensionless
units.
Sub-model Parameter Symbol Value
Fluid flow Extravascular hydraulic conductivity κe 50.0
(p and u) Normalized intravascular hydraulic
conductivity κ¯
i 10.0
Normalized transvascular hydraulic
conductivity κ¯
t 0.1
Angiogenesis Diffusion D 100.0
(c and f) Maximum TAF production fhyc 1.0
Mobility M 0.025
Interface width λ 1.0
Production P 100.0
Endothelial cell uptake Bu 6.25
Natural decay Bd 0.1
Proliferative rate Bp 1.401
TAF condition for highest
proliferation fp 0.3
Angiogenesis Chemotatic constant χ 7.28
(TECs) Nutrient and oxygen diffusion length δnox 20.0
Conditions for TEC activation cact 0.9
fact 0.001
δ4 64.0
TEC radius Rtec 4.0
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6.3 Numerical method
Our mathematical model is composed by a continuous and a discrete part. Fur-
thermore, the former involves both steady state and transient partial differential
equations. This results in several difficulties for the numerical method. In this
section we present how we deal with them and how we couple the different parts
of the model.
6.3.1 The continuous equations
Equations (6.1), (6.2), (6.6), and (6.7) form the continuous formulation of our
problem. Let Ω ⊂ Rd be an open set, where d = 2 or 3, and let ∂Ω = Γ = Γs∪Γg be
the Lipschitz boundary of this domain, where Γs ∩ Γg = ∅. Let also n be the well-
defined unit outward normal of Ω. Introducing equation (6.2) into equations (6.1)
and (6.6) yields the following strong form of this problem: find p, f, c such that
0 = ∇ · (−K∇p) (6.10)
∂f
∂t
= ∇ · (D∇f)−∇ · (−K∇pf) + P (x) (fhyc − f)−BufcH (c) (6.11)
∂c
∂t
= ∇ · (M∇ (µ (c)− λ2∆c))+ Bp (f) cH (c) (6.12)
in Ω× (0, T ) and satisfying the following boundary conditions
K∇p · n = 0 on Γs × (0, T ) (6.13)
p = pg (x) on Γg × (0, T ) (6.14)
∇f · n = 0 on Γ× (0, T ) (6.15)
M∇ (µ (c)− λ2∆c) · n = 0 on Γ× (0, T ) (6.16)
Mλ2∆c = 0 on Γ× (0, T ), (6.17)
where pg is a given function. In order to solve the above problem we first derive
an equivalent varational formulation and then an approximate the problem with
a space and time discretization.
Variational formulation Let V denote the trial and weighting function spaces,
which are assumed to be equal. After multiplying by test functions and integrating
by parts, we obtain the following weak form: find p, f, c ∈ V such that ∀r, w, q ∈ V:
0 =
(
∇r,K (c, ‖∇c‖)∇p
)
Ω
(6.18)
160
6.3 · Numerical method
0 =
(
w,
∂f
∂t
)
Ω
+
(
∇w,D∇f
)
Ω
+
(
∇w,K (c, ‖∇c‖)∇pf
)
Ω
−
(
w,P (x) (fhyc − f)
)
Ω
+
(
w,BufcH (c)
)
Ω
(6.19)
0 =
(
q,
∂c
∂t
)
Ω
+
(
∇q,M∇µ (c)
)
Ω
+
(
∆q,Mλ2∆c
)
Ω
−
(
q,Bp (f) cH (c)
)
Ω
, (6.20)
where (·, ·)Ω denotes the L2 inner product in Ω. The weak form is equivalent to
the strong formulation of the problem under the assumption that functions living
in the space V are sufficiently smooth. In particular, because of the second order
derivatives present in the weak form, V is a subset of H2, the Sobolev space of
square integrable functions with square integrable first and second derivatives.
Spatial discretization We obtain the spatial discretization of the weak form
making use of the Galerkin method. The above system of equations can thus be
approximated by the following variational problem: find ph, fh, ch ∈ Vh ⊂ V such
that ∀rh, wh, qh ∈ Vh ⊂ V:
0 =
(
∇rh,K (ch, ‖∇ch‖)∇ph)
Ω
(6.21)
0 =
(
wh,
∂fh
∂t
)
Ω
+
(
∇wh, D∇fh
)
Ω
+
(
∇wh,K (ch, ‖∇ch‖)∇phfh)
Ω
−
(
wh,P (x) (fhyc − fh))
Ω
+
(
wh, Buf
hchH (ch))
Ω
(6.22)
0 =
(
qh,
∂ch
∂t
)
Ω
+
(
∇qh,M∇µ (ch))
Ω
+
(
∆qh,Mλ2∆ch
)
Ω
−
(
qh,Bp
(
fh
)
chH (ch))
Ω
. (6.23)
Here, everything is defined except for the particular finite element space Vh =
span{NA}, A = 1, . . . , nb, being NA the basis functions and nb the number of
basis functions. Note that because we are using a conforming discretization this
subspace needs to fulfill the same smoothness properties as V. The discrete space
needs also to capture the smooth but steep phase-field interfaces as in previous
chapters. What is more, as suggested by figure 6.2, the pressure will have even
steeper transitions at the transvascular region than the phase-field, which also need
to be reproduced. Thus, in this model the pressure field is the major restriction
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for the numerical method. For these reasons we make use again of isogeometric
analysis, specially due to its high smoothness, variation diminishing property,
and proven accuracy. In particular we choose second-order B-splines as our basis
functions NA and we define ph, fh, and ch as
ph (x, t) =
nb∑
A=1
pA (t)NA (x) , (6.24)
fh (x, t) =
nb∑
A=1
fA (t)NA (x) , (6.25)
ch (x, t) =
nb∑
A=1
cA (t)NA (x) , (6.26)
where pA, fA, and cA are the control points.
Temporal discretization We use the notation phn, f˙hn , fhn , c˙hn, chn for the space
and time discrete solutions of the variables of the problem and their corresponding
time derivatives. Here we perform a finite-difference-type temporal discretization
of the spatially discretized problem. This problem derives, however, from a steady
state equation for the fluid flow and two transient equations for the continuous
angiogenesis model. We detail them separately and show afterwards how we
incorporate them in our numerical scheme.
The problem for the fluid flow is defined as: given fhn+βf , c
h
n+βf
, and the temporal
discretization ∆tn = tn+1 − tn, find phn+1 such that:
0 =
(
∇rh,K
(
chn+βf , ‖∇chn+βf ‖
)
∇phn+1
)
Ω
, (6.27)
where βf can be either one or zero and, as shown below, defines two different
staggering numerical schemes.
As in previous chapters, we integrate the continuous angiogenesis model in time
using the generalized-α method. The discrete angiogenesis problem can thus
be stated as: given phn+βf , f˙
h
n , f
h
n , c˙
h
n, c
h
n, and the temporal discretization ∆tn =
tn+1 − tn, find f˙hn+1, fhn+1, c˙hn+1, chn+1 such that:
0 =
(
wh, f˙hn+αm
)
Ω
+
(
∇wh, D∇fhn+αf
)
Ω
+
(
∇wh,K
(
chn+αf , ‖∇chn+αf ‖
)
∇phn+βf fhn+αf
)
Ω
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−
(
wh,P (x)
(
fhyc − fhn+αf
))
Ω
+
(
wh, Buf
h
n+αf
chn+αfH
(
chn+αf
))
Ω
, (6.28)
0 =
(
qh, c˙hn+αm
)
Ω
+
(
∇qh,M∇µ
(
chn+αf
))
Ω
+
(
∆qh,Mλ2∆chn+αf
)
Ω
−
(
qh,Bp
(
fhn+αf
)
chn+αfH
(
chn+αf
))
Ω
, (6.29)
where
f˙hn+αm = f˙
h
n + αm
(
f˙hn+1 − f˙hn
)
, (6.30)
fhn+αf = f
h
n + αf
(
fhn+1 − fhn
)
, (6.31)
fhn+1 = f
h
n + ∆tnf˙
h
n + γ∆tn
(
f˙hn+1 − f˙hn
)
, (6.32)
c˙hn+αm = c˙
h
n + αm
(
c˙hn+1 − c˙hn
)
, (6.33)
chn+αf = c
h
n + αf
(
chn+1 − chn
)
, (6.34)
chn+1 = c
h
n + ∆tnc˙
h
n + γ∆tn
(
c˙hn+1 − c˙hn
)
, (6.35)
γ =
1
2
+ αm − αf , (6.36)
αm =
1
2
(
3− ρ∞
1 + ρ∞
)
, (6.37)
αf =
1
1 + ρ∞
, (6.38)
and ρ∞ is the spectral radius of the amplification of the matrix as ∆t→∞.
Equation (6.11) is a convection-diffusion equation and, as such, the numerical
method may introduce instabilities in the form of spurious oscillations under
certain conditions. These conditions are well represented by the element Peclet
number, Pe, defined as
Pe =
‖u‖h
2D
, (6.39)
where h is the element side. This dimensionless number is a measure of convective
over the diffusion effects. When Pe > 1 the problem is said to be convection-
dominated and may produce boundary layers that the numerical method may be
unable to capture. Otherwise the problem is said to be diffusion-dominated.
A high element Peclet number indicates that an instability may arise during a sim-
ulation. However, other factors such as reaction terms or boundary conditions also
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influence whether the instability appears or not, even for a convection-dominated
problem. Consequently, we have to study our specific problem through simulations
and, in the eventuality of spurious oscillations in the solution, address the issue.
There are several alternatives to correctly solve boundary layers. The first and
more direct is to reduce the element size enough to be able to capture smaller
scales. This method is effective, but implies a higher computational cost. An-
other alternative is to implement one of the existent stabilization techniques,
such as, streamline upwind/Petrov–Galerkin (SUPG, Brooks and Hughes, 1982)
or variational multiscale (VMS, Hughes et al., 1998). Both of them involve the
incorporation of an extra term in equation (6.28). We advance here that we tested
our model under several h-refined meshes and with and without SUPG and found
no need to implement stabilization techniques in our problem.
6.3.2 The discrete component and the discrete–continuum
coupling
The algorithms of the discrete components for the activation, movement, deactiva-
tion, and filopodia probing, as well as the coupling with the continuous variables
are already explained in previous chapters of this thesis (see for example subsec-
tion 2.3.1 and section 5.3). For the sake of brevity, we avoid its repetition here.
We want to highlight, however, the role of the seamless coupling between TECs
and the continuous variables in this theory. The definition of the hydraulic con-
ductivity relies heavily on the smoothness of the vascular wall, which is a priori
guaranteed by the phase-field equation. However, in the coupling process, TECs
modify the phase field by overwriting c with a constant value. If not properly
handled, this could create sharp interfaces in the phase field in the transvascular
region surrounding TECs. This would result in high gradients, which, in turn,
would produce a non-smooth hydraulic conductivity. Our implementation of the
coupling with template functions circumvents this potential problem, as they are
based on the multidimensional generalization of an exact one-dimensional solution
to the Cahn-Hilliard equation. The templates guarantee the required smoothness
in the TECs transvascular region and, thus, a smooth hydraulic conductivity
function.
6.3.3 Numerical scheme
In previous chapters we developed a numerical scheme (see figure 6.3a) which we
restructure now to incorporate the equations for fluid flow (figures 6.3b and 6.3c).
The first thing to note is that we removed from our formulation the discrete agents
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Figure 6.3. Staggering numerical schemes. We modified the numerical scheme used in
other section (a) to incorporate the fluid flow sub-model (P module in the figure). The proposed
staggering numerical schemes (b) and (c) differ in the location of the P module.
for HYCs, as they are now incorporated as a source term in equation (6.11). TEC
and CNT modules for the discrete TEC agents and continuous angiogenesis sub-
model continue unaltered in the numerical scheme. The only exception is their
position within the scheme.
We have chosen to implement a staggering numerical scheme, rather than a mono-
lithic one, to reduce the computational cost. We present in figures 6.3b and 6.3c
two possibilities for these schemes, which we call scheme (b) and scheme (c), re-
spectively. Each scheme is related with one value of βf , so that βf = 1 yields the
former, and βf = 0 the latter. In scheme (b), for each time step we solve first the
same problem as in the scheme of figure 6.3a and then, with the updated values
of the TAF and the phase-field fhn+1, chn+1, we solve equation (6.27) (P module).
In scheme (c), on the contrary, equation (6.27) is solved before CNT module, but
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after TEC module, using the previous variable updates fhn , chn.
We analyzed both schemes and draw the following conclusions. Scheme (b) is faster
than scheme (c), as P module is outside of the time-step correction algorithm.
It is however more inaccurate for this reason. In addition, scheme (b) presents
problems because the pressure field used to update the convection term, phn, is
the solution from a previous time step, while the phase field chn may have changed
due to the discrete–continuum coupling. Finally, we decided to use scheme (c) in
our computations.
6.4 Results
In this section we present several simulations of the mathematical model. First, we
analyze the influence of tumor angiogenic factor convection in vascular patterning
by means of a comparison with a model that lacks this phenomenon. Then, we
study whether convection enhances tumor-induced angiogenesis in certain config-
urations, such as, different parent capillaries or hypoxic tumor sizes. Finally, we
address the role of intratumoral pressure in tumor vascularization and malignancy.
6.4.1 Vascular patterning with TAF convection
In this first example we study angiogenesis with and without tumor angiogenic
factor convection. As shown in figure 6.4 and video S6.1, we simulate our model in a
squared domain which represents a 375 µm× 375 µm piece of tissue. We place two
6.25 µm-thick capillaries along the left and right sides of the square and a hypoxic
region at its center, mimicking a 62.5µm-radius, fully-hypoxic tumor. Furthermore,
we arbitrarily define the left-hand side capillary to be the arterial side of the
vascular bed and the right-hand side capillary to be the venous side. We impose
accordingly, and as other models in the literature (Baxter and Jain, 1989; Cai et al.,
2011; Welter and Rieger, 2013), p = 10mmHg and p = 0mmHg, respectively, for
the pressure boundary conditions inside the capillaries. The remaining boundary
conditions are free-flux conditions. We choose this configuration, because it is
simple enough to study the model and the numerical method without added
complexities, but also reproduces a common setting: A small growing tumor
placed far enough from the capillaries to be hypoxic that triggers angiogenesis.
The first thing to asses in this model with respect to the numerical method is
whether we need to implement a stabilization technique or not. As said above
this decision is mainly based on the element Peclet number, defined here as Pe =
K‖∇p‖h
2D . Because of the highly nonlinear definition of the hydraulic conductivity, its
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(e). The numerical method captures the fluid velocity (f,g).
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value is difficult to estimate. In the intravascular region, we can assume that there
will be not enough TAF to form boundary layers because of the tumor angiogenic
consumption by endothelial cells. In the extravascular region we can approximate
K by κe and further assume a constant pressure drop, which using a 512 × 512
mesh, yields an estimated Pe = 1.42× 10−2, suggesting no spurious oscillations in
that region. We conclude then that the potential location of instabilities is within
the transvascular region, which we studied through computations. We simulated
the model with and without the SUPG stabilization technique (results not shown)
for the above mentioned initial and boundary conditions with a 512× 512 mesh
and found that there is no need to use SUPG3.
Figure 6.4 shows two numerical simulations: One in which we removed tumor
angiogenic factor convection (figure 6.4a) and one with the full model (figures 6.4b
to 6.4d). There, one can observe snapshots of the evolution of the four variables
of the model at t = 2.43, 10.22, 18.16, 39.67. Initially, there is a constant pressure
drop from the higher pressures on the left-hand side capillary to the lower one
in the right-hand side capillary (figure 6.4c1). The fluid flows accordingly from
left to right following straight trajectories as shown by the streamlines (black
lines) in figure 6.4d1. As it flows, the fluid convects tumor angiogenic factor to
the right (figure 6.4b1) altering its otherwise symmetric distribution when only
diffusive mechanisms are in action (figure 6.4a1). The difference in TAF distribu-
tions increases with time, and, by t = 10.22, it already promotes dissimilar TEC
activation: While convection promotes the early activation of three TECs from
the right-hand side parent capillary, the pure diffusive TAF distributions activates
two TECs from each capillary. This incipient vascular network has already altered
the pressure and velocity fields (figures 6.4c2 and 6.4d2) highlighting how deeply
the variables of the model are coupled. At t = 18.16 the capillaries are inside the
tumor and the TAF production has stopped. Figure 6.4a3 shows at the center of
the domain the first of many anastomosis events that will occur in these simula-
tions. In particular, this anastomosis event is the result of a TEC-TEC detection
by the filopodia of both cells which adjust their migration towards each other. In
the simulation of the full model, the connection between parent capillaries occurs
later because convection delays the activation of TECs from the right-hand side
capillary.
The last snapshots of figures 6.4a to 6.4d, taken at t = 39.67, show the final results
of these simulations. At this point, the vascular networks are fully developed
and they completely pervade the tumor and its surroundings. Their shape is,
however, completely different. We show in figure 6.4e and in figure S6.2 in the
supporting information the superimposed skeletons of these networks which are
3We also checked the appearance of spurious oscillations in all simulations performed in this
chapter and found none.
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obtained using the same method as in chapter 3. Through the figure, one can
easily appreciate that both networks differ in almost every feature. The only neo-
vessels that match in both simulations are those created by the first activated
TECs from the right-hand side, when the TAF distributions were more similar.
After that moment, convection altered the distributions leading to non-matching
patterns. The network generated only by TAF diffusion is more symmetric than
its counterpart generated also by convection: While the former is connected with
both parent capillaries by four vessels each, the latter has four connections to the
left-hand side capillary, but only one to the right-hand side capillary. As shown
in figure 6.4d4, the asymmetry leads to high velocities (dark colors) in the only
vessel that grew from the arterial side of the capillary bed. The majority of the
fluid that flows through the new vascular network goes through this vessel, whose
reduced caliber increases the velocity.
In figure 6.4f we show the velocity magnitude and phase-field profiles in a cut
marked with a black line in figure 6.4d4. The cut is perpendicular to the main
capillary that connects the parent vessels and includes part of the extravascular
region. The high continuity of the profiles shows that the numerical methods
are able to capture not only the phase-field interface as in previous chapter, but
also the steep interfaces of the velocity field. In the intra- and extravascular
regions, the velocity curve forms plateaus, being the former almost seven-fold
higher than the latter. The plateaus are connected with the lower velocity value
in transvascular region through smooth transitions. The hydraulic conductivity
in the transvascular region hinders the extravassation of the fluid. We show an
example of this phenomenon in figure 6.4g, were we draw fluid streamlines that
cross the black line at the center of the figure. The streamlines color and radius
are plotted according to the velocity of the fluid: The darker and greater the
radius, the higher velocity, and vice versa. Note that all stream lines but one
remain within the intravascular region. The only one that transverses the vascular
wall is thin, picturing a small velocity. Furthermore, note that, even under the
assumptions explained above, the model captures how the velocity is reduced and
how the streamlines separate from each at the center of the figure as they go
through a capillary intersection.
6.4.2 Study on capillary types and tumor sizes
In the previous example we analyzed the influence of tumor angiogenic factor
convection under the most basic configuration. Now we address how different
configurations may alter the effect of convection in vascular patterning and whether
it can favor the malignancy of a tumor.
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Our first approach is to change the behavior of the parent capillaries, that is, their
artery/venous conditions, by modifying the boundary conditions for the pressure
field in the initial capillaries. We present in figure 6.5 four numerical simulations.
Each one has different initial and boundary conditions, as shown in figure 6.5a. We
use again the same mesh (512× 512 knot spans), as it has proved to capture the
steep variable transitions without showing spurious oscillations. For simulation
(I) we choose the same configuration of the previous example, to allow an easy
comparison. For the other three we choose the following configurations:
(II) Two symmetric parent vessels that connect the arterial side (top) with the
venous side (bottom). The pressure varies linearly top to bottom from p = 10
to p = 0mmHg.
(III) Two antisymmetric parent vessels that connect the arterial side with the
venous side. The arterial side is located at the top for the left-hand side
capillary and at the bottom for the right-hand side counterpart. The pressure
varies linearly from p = 10 to p = 0mmHg top to bottom for the right
capillary, and vice versa.
(IV) Two parent vessels, one representing the arterial side of the capillary bed and
one representing the venous side (left and right, respectively) with pressure
drops along their longitudinal direction. The pressure also varies linearly,
but from p = 10 to p = 6.6mmHg in the left-hand side capillary and from
p = 0 to p = 3.3mmHg in the right-hand side one (top to bottom).
Among these configurations, (IV) may be considered as the more general and
realistic one. We show in figure 6.5b an intermediate time step (t =≈ 15) of the
simulations. There we represent the capillaries, streamlines in black lines, and TAF
equidistant contour lines. In addition, to measure the influence of convection we
plot vector glyphs whose length, color, and direction show the convective term uf .
Figure 6.5c presents the final (skeletonized) vascular patterns after the simulation
has finished.
In simulation (I) the fluid flows from the left parent capillary to the right one. The
streamlines are the straighter and shorter among the four simulations. During
a long time span of the simulation, the fluid is forced to travel through the
extravascular region to reach the venous side. As a result, TAF is convected
rightwards for a prolonged time and promotes the most asymmetric final vascular
pattern. As shown by the glyphs, the convection term reaches the highest values
in (I). In simulation (II), on the contrary, the fluid goes from the top corners of
the domain to the bottom ones. However, most part of it flows through the parent
capillaries. The vascular network initiates towards the bottom half of the domain.
In simulation (III), the right-hand side parent vessel is flipped with respect to
simulation (II). Consequently, the location of the first TECs that get activated in
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the left-hand side matches. Those that get activated from the right-hand side, on
the contrary, differ and tend to be at the upper half of the domain. This simulation
presents the lowest value of the convective term. Finally, the boundary conditions
of simulation (IV) may be viewed as a refined version of those in simulation (III),
and, as such, the network is initiated in almost matching locations from both
parent capillaries. Simulation (IV), however, presents a quite different velocity
profile, as shown by the streamlines and the values of the convection term.
In summary, different configurations of the parent capillaries alter the vascular
patterns, although in every one the tumor and its surroundings get pervaded by
capillaries. The main difference is that the location of connections of the networks
to the vascular patterns tends to be at the venous side of the capillary bed.
The second approach to study the effect of TAF convection is to alter the size of
the tumor that is producing TAF. The proposed configurations may be thought
of as increasingly small tumors that have the potential to induce angiogenesis, in
which we study whether TAF convection enhances their ability to actually trigger
angiogenesis. We show this study in figure 6.6, where we set the tumor radius in
each simulation to R = 50.00, 31.25, and 18.75 µm, from left to right. The top
and middle row of this figure correspond to intermediate time steps of simulations
without TAF convection and with the full model, respectively, and the bottom
row to the final vascular patterns. For these simulations we have used the same
setup and mesh as simulation (I) in the previous example.
The patterns generated under these configurations differ from one another. For all
the simulations with TAF convection, the vascular network only develops from the
right-hand side capillary, while in the absence of convection, when angiogenesis
occurs, new vessels grow from both parent capillaries. The model also predicts
a slower development of the vascular networks for the TAF convection model. A
comparison between the simulations with different tumor sizes reveals that the
smaller the tumor, the sparser the vascular network. This is a consequence of
the lower TAF concentration in the domain. Finally, the main conclusion from
these simulations is that TAF convection plays a relevant role in enhancing the
malignancy of small tumors. As shown in the simulations at the right-most column
of the figure, small tumors, may not be able to trigger angiogenesis in the absence
of convection. On the contrary, the model with convection predicts that the same
tumor gets fully vascularized and becomes malignant.
6.4.3 Intratumoral pressure
In the above examples we have assumed the fluid pressure inside the tumor to be
equal to that in the host tissue. This is, however, not necessarily true. Cancerous
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Figure 6.6. Convection-increased angiogenesis. TAF reaches both or one of the initial
capillaries at different times when the pellet radius is varied (40, 25, and 15 – left to right
in dimensionless units). In the absence of convection the smaller tumor is not able to trigger
angiogenesis.
cells replicate rapidly and group forming densely packed tumors. The higher
the density inside the tumor, the lower the interstitial space and, consequently,
the pressure of the fluid flowing among cancerous cells increases. Furthermore,
this high fluid pressure is not alleviated due to the absence of functional vessels,
either lymph or blood vessels. In this example we study if a fluid intratumoral
pressure higher than that of its micro-environment affects angiogenesis through
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TAF convection and if the model predicts an increased tumor malignancy.
The proposed mathematical model does not explicitly consider a variable that
represents cancerous cells; instead, the tumor is implicitly defined by one circular
hypoxic region as big as the tumor. We make use of this definition to incorporate
the intratumoral pressure in model. In particular, we impose p = pt in the
hypoxic region by means of the penalty method. Figure 6.7 and video S6.3 show
the result of a simulation in which pt = 7.4mmHg. This simulation has the
same setup as simulation (I) in the previous section: two initial capillaries at
the left and right edges of a 375 µm× 375 µm square tissue and one 62.6 µm-
radius hypoxic region at its center. The left capillary is considered to be on the
arterial side of the micro-circulatory system and consequently we impose there
a Dirichlet boundary condition for the pressure p = 10mmHg. The homologous
initial capillary represents the venous side and its associated boundary condition
for the pressure is p = 0mmHg.
Figure 6.7 presents three snapshots of the simulation, each at a different time
step and each highlighting different events and variables. Figure 6.7a displays the
simulation just after the first TEC reaches the tumor, at t = 13.09. There, we
plot contour lines of pressure (orange) and TAF (green), a black circle rendering
the contour of the tumor, glyphs representing the convection term uf , and the
distribution of TAF and capillaries. The pressure contour lines are mostly parallel
to the initial capillaries as in other simulations (see, e.g., figure 6.4c1), showing
the pressure drop between them. The imposed intratumoral pressure, however,
disrupts the parallelism in the central region and reveals the presence of the tumor,
even in the absence of the black circle. In particular, the contour line p = 7 bends
towards the right surrounding the tumor and exposing its location. The tumor
produces all the TAF in the domain that reaches the capillaries through diffusion
and convection. Convection is, however, virtually nonexistent inside the tumor as
shown by the absence of glyphs inside the tumor in the figure. After being pro-
duced, TAF escapes the tumor only by diffusion. Once in the extracellular matrix,
convection starts to play a role in TAF distribution. This is specially noticeable
at the right-hand side of the tumor, as shown by the color arrows representing the
convection term. There, the higher difference between the intratumoral pressure
and the extravascular pressure generates a high pressure gradient. In turn, convec-
tion is increased and drives TAF away from the tumor creating a region with low
values of TAF. As a result and contrary to other simulations, the figure shows how
the longest capillary turns upwards avoiding the tumor rather than going through
it. This trend continues as the simulation evolves. By time t = 20.07 (figure 6.7b)
two capillaries have almost fully encircled the tumor, one at the top and one at
the bottom. Only when TAF has been consumed in the vicinity of the tumor,
new capillaries penetrate this region. Figure 6.7b also displays the extravascular
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Figure 6.7. Influence of intratumoral pressure. Intratumoral pressure alters the distribu-
tion of TAF which, in turn, drives capillaries around the tumor. The fluid velocity inside the
tumor is low, even within the capillaries that transverse the tumor.
fluid velocity by means of streamlines. Each streamline starts at the left-hand side
capillary and its radius varies according to the magnitude of the fluid velocity.
Interestingly, few streamlines transverse the tumor and those that do it present the
smallest radius, that is the minimum velocities. In particular, ‖u‖ < 1 along these
lines inside the tumor. The higher fluid velocity in the extravascular region occurs
between the capillaries that encircle the tumor and those adjacent to them. The
vascular network continues evolving until, by time t = 32.07, all the TAF in the
domain has been consumed. We present a snapshot of this last step in figure 6.7c,
where we show the final vascular network represented by its skeleton (red lines),
streamlines of the velocity field (black lines), and the continuous velocity field
(shades of purple). As in previous simulations with a similar setup, the final vascu-
lar network is asymmetric, being denser towards the venous side due to the effect
of convection. The difference here is that the intratumoral pressure has forced
capillaries to envelop the tumor. The velocity field highlights, first, that the fluid
flows more rapidly within the capillaries and, second, that the velocity inside the
tumor is very low. In fact, the only capillary that transverses the tumor presents
velocities close to zero. The intratumoral pressure has rendered this capillary not
functional. Finally, as in figure 6.7b, the streamlines barely penetrate the tumor.
The simulation predicts that even though the tumor is vascularized, nutrients,
oxygen, or systemically administered drugs cannot easily reach the tumor, resulting
in an increased tumor malignancy. The fluid flow both within the capillaries and
in the extravascular region does not favor their penetration into the tumor.
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6.5 Conclusions
In this chapter we investigated the role of TAF convection in angiogenesis which
has been overlooked in mathematical models. We proposed a model for fluid flow
based on Darcy’s law which we coupled with a model for angiogenesis. The model
required the development of an appropriate staggering time integration scheme
to undertake the coupling. In addition, we studied the need to implement a sta-
bilization technique to address the possible appearance of numerical instabilities
due to the presence of a convection-diffusion equation.
We have shown through several simulations that TAF convection has a deep
effect on the formation of vascular networks in tumor-induced angiogenesis. Fluid
flow convects TAF from the arterial side of the micro-circulatory system to the
venous side. As a result, TECs activate sooner in the latter side and generate
an asymmetric final capillary network, which is denser towards the venous side.
The fewer capillaries branching from the arterial parent vessel promote higher
intravascular velocities at this side. The model predicts that TAF convection also
plays a role in enhancing the malignancy of small tumors. Finally, by artificially
including an intratumoral fluid pressure, the model predicts delayed capillary
penetration and low fluid velocity within the tumor, hindering the delivery of
treatments.
This model may be enhanced by the inclusion of convection-diffusion equations
for nutrients, oxygen, or systemically-delivered drugs. A proposed line of further
research is to change the definition of the hydraulic conductivity to capture the
intratumoral pressure.
6.6 Supporting information
Supporting information includes the following videos and images that can be
found online at http://caminos.udc.es/gmni/gente/gvilanovac/thesis/:
Video S6.1. Time evolution of vascular patterns without TAF convection and
with TAF convection, as shown in figure 6.4.
Figure S6.2. Comparison of the final vascular networks of the simulations of
figure 6.4.
Video S6.3. Development of a new vasculature influenced by intratumoral pres-
sure. Related to figure 6.7.
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Chapter7
Summary, conclusions, and further
work
This chapter presents a summary, the general conclusions, and a selection of lines
for further research that continue the work developed in this thesis.
7.1 Summary
In chapter 1 the main objective of this thesis was divided into three goals, namely,
modeling, simulation, and computational. Here we summarize the presented work
from the point of view of these goals.
Modeling
The dynamics of tumor angiogenesis and its impact on cancer growth remain
as fundamental open problems in cancer biology. Predictive medicine, and in
particular mathematical oncology, are growing fields whose aim is to predict and
give insight into these problems. To this end, in this thesis we have proposed
three new mathematical models for tumor angiogenesis based on the phase-field
method. The first one was developed in chapters 2 to 4. There, starting with
a previous model that featured chemotaxis, we added a conceptual model for
haptotaxis, which is one of the main mechanisms that governs tip endothelial
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cell migration. The second one, presented in chapter 5, focuses on the long-term
dynamics of tumor-induced angiogenesis, that is, on the regression and regrowth
events occurring after the first growth of capillaries. The formulation of the model
also incorporates filopodia as the tip endothelial cell apparatus to inspect their
environment and basement membranes as the shortcut scaffold for vessel regrowth.
Finally, in chapter 6, we developed a fully continuum theory for fluid flow at the
tissue scale, which we coupled with our model for tumor angiogenesis. As a result,
the model features how fluid flow alters tumor-induced vascular patterns.
Simulation
Throughout this thesis we have simulated the models under different settings
that try to replicate relevant in vitro or in vivo experiments. In particular, the
first model (chapters 2 to 4) was first studied under two-dimensional simplistic
configurations to gain insight into the governing equations with the final objec-
tive of replicating an experiment in three-dimensions and using a real geometry.
To this end, we evolved the settings first in two dimensions and then in three
dimensions to represent larger domains, different and more realistic capillary con-
figurations, and a variety of tumor arrangements. These simulations culminated
in the development of a tumor-induced angiogenesis simulation of one of the most
widely used in vivo assays, the mouse corneal micropocket angiogenesis assay,
using a three-dimensional, subject-specific geometry with more than 28.9 million
degrees of freedom. To the best knowledge of the author, this simulation allows
for the first time the comparison between a computation and an experiment in
a three-dimensional real geometry. Then, in chapter 5, the model for growth, re-
gression, and regrowth was simulated both in a two-dimensional replication of the
mouse corneal micropocket assay and in reproduction of an in vivo experimental
setup. Finally, the simulations of the model for tumor angiogenic factor convection
presented in chapter 6 were only done under theoretical setups.
Computational
The previous modeling and simulation goals could not have been achieved without
the appropriate development of algorithms. Every model is hybrid and involves
coupling cellular-scale discrete agents with averaged continuous theories. In ad-
dition, the models are grounded on the phase-field method which, in opposition
to the classical description of sharp interfaces, describes the interface between
phases as diffuse. This permits avoiding the resolution of moving boundary prob-
lems, but requires solving a higher-order partial differential equation with diffuse
interfaces evolving dynamically over the computational domain. The simulations
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in three-dimensional subject-specific geometries include a further hindrance, as
they require three-dimensional, non-linear mappings and high precision to capture
cellular-scale dynamics in tissue-scale domains.
Most numerical methods used in this thesis were introduced in chapters 2 and 3.
There, our first step was to describe the original model in a coherent mathematical
framework, so that we could afterwards define a seamless coupling between the
discrete elements and the continuous variables to permit an efficient numerical
treatment of the coupled problem. In addition, we devised a method to find
the parametric coordinates of the known physical coordinates of the discrete
agents in three-dimensional, non-linear mappings, which also works in parallel
computations. For the resolution of the high-order partial differential equations
involved in the formulation we used isogeometric analysis, which not only provides
accuracy and robustness but also the geometric flexibility that we required to
perform simulations in real geometries. We also used the generalized-α method
and an adaptive time-stepping scheme that increased our solving efficiency. Finally,
all these methods were adapted to run in parallel using a multi-patch technique.
7.2 General conclusions
The following conclusions are extracted from the work presented in this thesis:
• The model by Travasso et al. (2011b) presented in chapter 2 has shown
significant potential predicting tumor-induced capillary growth in small-
scale simulations. Using this model we have predicted different vascular
patterns as a function of the proliferation and chemotactic rates.
• We developed a set of numerical methods and algorithms that have proven to
be efficient, accurate, and robust. They allowed us to investigate the models
presented in this thesis in a number of physically relevant simulations. In
particular, for the above mentioned model, these methods provided us a
way to study angiogenesis in medium-size domains (approximately 5 times
larger than those used heretofore) under different hypoxic cell distributions
and initial capillaries. We concluded that the predicted vascular patterns
maintain their main characteristics at these scales.
• The model, which only featured chemotaxis, was extended with a conceptual-
ization of haptotaxis. The results of the new model indicate that haptotaxis
may have a significant impact in the final pattern achieved by capillary
networks. In contrast with simulations of the model without haptotaxis,
our results revealed increased vascular pattern complexity and connectivity,
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more tortuous TEC trajectories, higher number of anastomosis events, and
shorter capillaries.
• The mouse corneal micropocket angiogenesis assay is a widely used assay
whose characteristics provide an outstanding arrangement to calibrate, quan-
tify, and asses the predictability of tumor-induced angiogenesis mathematical
models. It poses, however, a variety of numerical and computational hur-
dles to overcome and to date has only been reproduced in two-dimensional
settings.
• The numerical methods and algorithms developed in this thesis provide a
framework to perform simulations in three-dimensional, complex geometries
as required for the mouse corneal micropocket angiogenesis assay. In partic-
ular, isogeometric analysis permitted to simulate the model in a computa-
tional domain which is the exact geometry of the cornea of a c57BL/6-strain
mouse as defined in the literature.
• The three-dimensional in silico mouse corneal micropocket angiogenesis
assay suggests that, for mathematical models to achieve the topological
complexity observed in in vivo angiogenesis experiments, two-dimensional
simulations may not be enough.
• The simulations on the cornea, even in the absence of the haptotaxis concep-
tualization, showed the well-known brush-border effect in three dimensions.
In addition, they revealed that changes in the location of the pellet lead
to different vascular patterns. These simulations also uncovered a new phe-
nomenon not explicitly built into the model, which can be interpreted as
capillary regression.
• The model for tumor-induced angiogenesis growth, regression, and regrowth
predicts the plasticity and dynamic evolution of capillaries at long time
spans. In particular, the simulations are in quantitative agreement with in
vivo experiments and capture capillary regression induced by TAF inhibition
and their subsequent regrowth after inhibition removal.
• Our conceptualization of filopodia has proven to increase the number of
anastomosis events and number of loops, increasing thus the connectivity of
the capillary network and favoring blood flow. Furthermore, our simulations
revealed that filopodia play a major role in vessel regrowth in the model,
as they enhance TEC exploration of the least resistant path for migration,
which is formed by the left-behind basement membranes.
• Tumor angiogenic factor convection has been overlooked in mathematical
modeling. We have shown, however, that it has a significant impact on
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vascular patterning and that it should be incorporated in the models to
enhance their predictive capabilities.
• Our numerical simulations predicted an increased malignancy of small solid
tumors, as convection increased their ability to induce angiogenesis. They
also showed that the combined effect of TAF convection and high intratu-
moral pressure hinders vascular spread through the tumor.
Finally, we conclude that mathematical modeling and numerical simulation of
tumor-induced angiogenesis provide insights into the biological mechanisms that
govern this complex phenomenon and may be used as a predictive tool.
7.3 Ongoing and further work
This thesis has opened new lines of research, some of them are the objective of
our current research. We detail below a number of them which are in our opinion
the most promising.
Mechanotaxis: Interaction among tip endothelial cells Tip endothelial
cells migrate using three different mechanisms, namely, chemotaxis, haptotaxis,
and mechanotaxis. In the first chapters of this thesis we augmented a model that
already featured the first mechanism (see figures 2.1 and 3.1) by adding a concep-
tualization of haptotaxis. Mechanotaxis, the remaining mechanism, is defined as
the migration of tip endothelial cells following cues delivered by mechanical forces.
Tip endothelial cells detect an interact with one another through this mechanism
as shown in figure 7.1. Thus, the next logical step is to incorporate mechanotaxis
into the model.
New sprouts
Traction
forces
Directed TEC migration Lumen formation
Figure 7.1. Mechanotaxis. Tip endothelial cells exert traction forces that can be detected by
other cells. (Based on Shiu et al., 2005)
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Quantitative analysis During the development of this work, one of the major
difficulties was to quantitatively compare the mathematical simulations with the
real experiments. We could only achieve quantitative comparisons in a reduced
number of two-dimensional cases. We have detected a lack of a well-founded
quantitative method from which one can extract the main features of the vascular
networks, specially in three dimensions. One of our ongoing lines of research tries
to alleviate this deficiency by using skeletonization techniques and graph theory
to characterize the new vasculature, as shown in figure 7.2. The major difficulty
thus far has been to process the images from the experiments.
Experiment or simulation Skeletonization Quanti cation
Figure 7.2. Quantification of a tumor induced vasculature. Skeletonization and graph
theory can be used as quantitative tool to characterize angiogenesis.
Flow-based regression and remodeling In chapter 5 we proposed a model
that incorporated TAF-dependent regression. There is also another kind of regres-
sion, more related to vascular remodeling, which depends on the functionality of a
capillary. Briefly, this regression works as follows: if there is blood flowing through
a capillary, the vessel is functional, recruits supporting cells, and maturates, while
in the absence of blood flow, the vessel is non-functional and regresses. Thus,
blood flow (and the forces that it exerts on the endothelial cells) mediates this
kind of regression. And, although with other objective in mind, we have already
posed in chapter 6 a model for fluid flow. We are currently working on a model
that incorporates this type of regression by coupling the theories presented in
chapters 5 and 6. With this model we expect to reproduce TAF and flow based
vascular regression and remodeling.
Coupling angiogenesis and tumor growth models Throughout this thesis
we have assumed the existence of a static, non-growing tumor whose only role was
to release tumor angiogenic factor. This assumption permitted us to exclusively
focus on the study of angiogenesis. However, for the model to be predictive, we
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need to account also for the tumor growth dynamics and the nutrient release. We
have been lately working on a two-dimensional theory that couples angiogenesis
and tumor growth (figure 7.3) and we are now generalizing to three-dimensional,
real geometries.
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Without angiogenesis
Tumor shrink
With angiogenesis
Tumor growth
Figure 7.3. Coupling angiogenesis and tumor growth. The mathematical model predicts
how a tumor able to trigger angiogenesis becomes malignant.
Other lines of research There are other research directions to advance the
field of mathematical oncology based on this work. One of them is to study nutrient,
oxygen, and drug delivery to tumors using the proposed continuous model for fluid
flow. This same theory can also be enhanced by using a more complex model to
incorporate other properties of blood. In addition, the numerical methods we used
pave the way to study tumor-induced angiogenesis in patient-specific geometries,
such as retinas or prostates.
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List of publications
The elaboration of this doctoral thesis has resulted in peer-reviewed publications in
international journals and contributions in national and international conferences
which we detail in the following.
Articles in peer-reviewed international journals
The following journal articles, which are directly related to this thesis, are currently
published:
• Vilanova, G., Colominas, I., and Gomez, H. 2001. A numerical study based
on the finite element method of a multiscale continuum model of tumor
angiogenesis, Journal of Biomechanics, vol. 45(S466), pp. S466. Associated
with chapter 2.
• Vilanova, G., Colominas, I., and Gomez, H. 2013. Capillary networks in
tumor angiogenesis: From discrete endothelial cells to averaged phase-field
descriptions via isogeometric analysis, International Journal for Numerical
Methods in Biomedical Engineering, vol. 29(10), pp. 1015–1037. Associated
with chapter 2.
• Vilanova, G., Colominas, I., and Gomez, H. 2014. Coupling of discrete ran-
dom walks and continuous modeling for three-dimensional tumor-induced
angiogenesis, Computational Mechanics, vol. 53(3), pp. 449–464. Associated
with chapters 3 and 4.
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Three further works have been submitted for publication or are already in prepa-
ration:
• Vilanova, G., Colominas, I., and Gomez, H., Three-dimensional simulation
of the mouse corneal micropocket angiogenesis assay, in preparation. Asso-
ciated with chapter 4.
• Vilanova, G., Colominas, I., and Gomez, H., A mathematical model of tumor
angiogenesis: Growth, regression, and regrowth, Journal of the Royal Society
Interface, submitted. Associated with chapter 5.
• Vilanova, G., Colominas, I., and Gomez, H., Convection of tumor angiogenic
factor modifies angiogenic vascular patterns, Computer Methods in Applied
Mechanics and Engineering, in preparation. Associated with chapter 6.
Finally, the following articles have been co-authored by the author, being the first
two closely related to this thesis:
• Xu, J., Vilanova, G., and Gomez, H. 2016. A mathematical model coupling
tumor growth and angiogenesis, PLoS ONE, vol. 11(2), pp. e0149422.
• Xu, J., Vilanova, G., and Gomez, H., Three-dimensional vascular tumor
growth in patient specific geometries, Computer Methods in Applied Me-
chanics and Engineering, in preparation.
• Lorenzo, G., Scott, M.A., Tew, K.B., Hughes, T.J.R., Zhang, J., Liu, L., Vi-
lanova, G., and Gomez, H., Tissue-scale, patient-specific modeling of prostate
cancer growth: a new perspective, Proceedings of the National Academy of
Sciences, under review.
Selected contributions in international conferences
The work of this thesis was presented in several national or international confer-
ences. A selection of these conferences includes:
• Kick-offMeeting – Mechanobiology Spanish Network of Excellence, Barcelona
(Spain), February 24-25, 2015.
• 11th World Congress on Computational Mechanics (WCCM XI), Barcelona
(Spain), July 20-25, 2015.
• Isogeometric Analysis: Integrating Design and Analysis (IGA 2014), Austin,
Texas (USA) January 8-10, 2014. The contribution to this conference won
the poster competition.
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• Third International, African Conference on Computational Mechanics (AfriCOMP),
Livingston (Zambia), July 30 to August 2, 2013.
• Congreso de Métodos Numéricos en Ingeniería, Bilbao (Spain), June 25-28,
2013.
• Mathways into Cancer II, Carmona (Spain), May 27-30, 2013.
• Advances in Computational Mechanics (ACM 2013) – A Conference Cele-
brating the 70th Birthday of Thomas J.R. Hughes, San Diego, California
(USA), February 24-27, 2013.
• ESB2012 – the 18th Congress of the European Society of Biomechanics,
Lisbon (Portugal), July 1-4, 2012.
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The Hallmarks of Cancer
Normal cells may become malignant and enable tumor growth, but only by acquir-
ing certain capabilities through mutations and/or changes in the transcriptional
control. Although some of these capabilities may be different among cancer types,
the basic ones are shared by the vast majority of them. In the last decades, they
have been independently studied by many researches, but it was in Hanahan and
Weinberg (2000, 2011) where Hanahan and Weinberg gathered them together
and developed them further. Under the name of Hallmarks of Cancer they elabo-
rated the following list (see Figure B.1): Sustaining proliferative signaling, evading
growth suppressors, resisting cell death, enabling replicative immortality, induc-
ing angiogenesis, activating invasion and metastasis, reprogramming of energy
metabolism, and evading immune destruction. Furthermore, they included two
enabling characteristics (tumor-promoting inflammation and genome instability
and mutation) and the aid from the recruited cells of the tumor micro-environment,
that favor the acquisition of the hallmarks.
All these hallmarks and enabling characteristics are not acquired at once, but
as a progressive multi-step evolution. However, it is also known that a single
mutation in a gene may influence one or more traits as, for example, the gene
TP53 which plays a role in programmed cell dead (apoptosis), genomic stability,
and angiogenesis inhibition. Even more, the order and moment in which tumor
suppressor genes and oncogenes are mutated is not the same among different types
of cancer, not even among same-type tumors. This appendix is a brief description
of the hallmarks of cancer and enabling characteristics.
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Sustaining proliferative signaling
In adult tissue normal cells are in an homeostatic1 state preserved by a complex
signaling network. The only way a cell is able to escape homeostasis and to
proliferate at a high rate, and thus acquire this hallmark, is to be self-sufficient
in this signaling. Albeit the signaling network is barely understood in normal
cells, it is considerably known how cancer cells achieve the necessary autonomy.
One method is by autocrine stimulation, that is, cells produce growth factors
(signals), release them to the exterior, and subsequently capture them by their own
membrane receptors, thus controlling the signaling by themselves. Another way is
to coerce non-cancerous and stromal cells to secrete growth factors. Proliferation
can also be triggered by deregulating cell membrane receptors or altering signaling
transduction, i.e., the modification of the pathway that follows a signal from the
surface receptor to the nucleus, leading to changes in gene transcription.
Evading growth suppressors
During the cell cycle there are several mechanisms that prevent cell proliferation
when the conditions of the environment are not suitable. Growth suppressors are
an essential piece of these mechanisms that act at certain moments of the cell cycle,
the so called checkpoints (Murray, 1994), and help to maintain tissue homeostasis.
Growth suppressors rely on antigrowth signals that depend, for example, on the
micro-environment level of glucose or oxygen. Hence, when these levels are low,
proliferating cells are conducted out of the cell cycle to a quiescent state at the
checkpoints. Through this hallmark, cells acquire the ability to downregulate the
growth suppressors function, making themselves insensitive to antigrowth signals,
and favoring uncontrolled proliferation.
Resisting cell death
Apoptosis is a complex process carried out in a multicellular organism by cells
when they are not viable or not useful. Cells that enter the apoptotic program
are divided in fragments which are suitable to be phagocytosed, thus preventing
intracellular material to be released to the extracellular matrix with its consequent
noxious effect. Apoptosis is tightly controlled by a wide variety of pro- and anti-
apoptotic signals, many of which are still under investigation. Apoptosis is a
1Homeostasis: The ability or tendency of a living organism, cell or group to keep the conditions
inside it the same, despite any changes in the conditions around it (from Cambridge dictionary).
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Figure B.1. The hallmarks of cancer and the enabling characteristics. A normal cell
must acquire all of them through mutations to become malignant. (Reproduced from Hanahan
and Weinberg, 2011).
natural barrier to tumor formation, as the body delivers pro-apoptotic signals to
cancerous cells hindering the creation of unwanted, high-proliferative solid masses.
However, cancer cells are able to circumvent the apoptotic program following
different strategies, such as:
• Loosing TP53 (DNA-damage suppressor gene) function.
• Increasing anti-apoptotic signaling.
• Downregulating pro-apoptotic factors.
• Short-circuiting the death pathway.
Enabling replicative immortality
Most cells are only able to replicate a limited number of times. This limit is
imposed by a region of non-coding, repetitive DNA at the end of the chromosomes
called telomere, whose role is to maintain the integrity of the chromosomes. Each
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time a cell undergoes a replication, the telomere is shortened. Hence, after a
certain number of replications, the telomere fails to perform its function, leading
to end-to-end chromosome fusion. Before this critical point, cells have two options:
either enter a rest state called senescence, in which the cell continues viable, but is
no more replicative, or continue dividing until the telomere is completely lost, thus
entering crisis, a state which leads to cell death due to chromosomic instability.
However, not all cells are restricted by this mechanism. Some cells, like stem
cells2, are able to divide as many times as required. They do not avoid telomere
shortening, but reconstruct it to its previous length using an ad hoc enzyme called
telomerase. For a cell to form a tumor, it must have the capacity to be immortal
in the previous sense. In most tumors, cancerous cells upregulate the expression of
telomerase, and less frequently use another methods to maintain telomere length.
Inducing angiogenesis
All cells in the body need sustenance, i.e. nutrients or oxygen, and a means of
waste removal. During embryogenesis an intricate blood vessel network is created
to perform these functions and, once the adult body is formed, only minimal vessel
growth takes place, because different signaling types restrict cell proliferation to
locations with appropriate sustenance, that is close enough to vessels. The episodes
of vessel creation that occur during adulthood are transient and tightly controlled
and only under certain circumstances such as wound healing.
However, cancer cells are aberrant and proliferate even without enough access
to nutrients. Thus they usually create local hypoxic regions within the tumor
where cells starve because nutrients and oxygen cannot arrive through diffusion
mechanisms. If they are deprived of nourishment for a long time span they may
become necrotic and die, creating a necrotic core of dead cells and debris inside the
tumor. The access to nutrients becomes more difficult as the tumor grows, causing
more and more cells to die from starvation. There is a point where the death and
proliferation rate get balanced causing the halt on the global tumor growth. For
tumors to grow beyond this threshold, cancerous cells must acquire the capability
of inducing angiogenesis, that permits them to create their own vasculature from
the preexisting one. This switch in tumor fate, usually called angiogenesis switch, is
performed through different mechanisms (as upsetting directly the signal balance
or indirectly by inflammatory cells) and in different gradations.
2Stem cells are biological cells found in all multicellular organisms, that can divide (through
mitosis) and differentiate into diverse specialized cell types and can self-renew to produce more
stem cells.
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Activating invasion and metastasis
Cancer cells may acquire the capability to spread to other tissues or organs. When
the colonized tissue is adjacent to the tissue where the tumor was originated, the
process is called invasion, while when the tissue is not connected to it, it is
called metastasis. Invasion is done at least in three different ways: mesenchymal,
collective invasion, and ameboid. The first one corresponds with the so-called
epithelial-to-mesenchymal transition (EMT). There are several genes thought to
be involved in EMT and through it cells may be able to invade, resist apoptosis,
and disseminate. In the second way of invasion, cancer cells advance en masse
into the adjacent tissues. In the last way, a single cell with a plastic morphology
that lacks its cell-cell and ECM-cell adhesions slips through the ECM interstices
(Friedl and Wolf, 2008, 2010) and migrates to a neighbor organ.
Metastasis is a more complex process, although it shares some underlying mecha-
nisms with invasion, such as EMT. Metastasis is usually divided into two major
phases: the dissemination of cancer cells and the colonization of the new em-
placement. The first one is thought to be achieved mainly through EMT. In it,
cancerous cells have to migrate through the local tissue, intravasate into the blood
or lymphatic vessels, survive in the cardiovascular or lymphatic system, extravasate
from the vessels, and establish in the new tissue forming micro-metastasis. Once
cells have arrived to their new emplacement they are no longer surrounded by
the malignant micro-environment they had created in the primary location, but
by a normal one which is not under their dominion. Thus, they need to colonize
the tissue to form macro-metastasis, which usually passes through the reversion
of their current migratory phenotype acquired via the EMT, undergoing the op-
posite process called mesenchymal-to-epithelial transition (MET). With the new
phenotype they may have the chance to activate the stroma, grow, and form a
new tumor (Hugo et al., 2007).
Reprogramming of energy metabolism
Normal non-proliferative cells in a tissue obtain the energy from of adenosine 5-
triphosphate or ATP 3 by transforming the received nutriment (glucose) through
two different processes, depending on the external conditions:
3Adenosine 5’-triphosphate or ATP transports chemical energy within cells for metabolism.
It is produced in cellular respiration and it is used as a source of energy in many vital processes
during cell lifespan. Once an ATP molecule is used, it converts into adenosine diphosphate
(ADP) or adenosine monophosphate (AMP) and can be phosphorylated again and reconverted
into ATP.
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• Oxidative phosphorylation: In presence of oxygen, glucose is first trans-
formed into pyruvate acid via a metabolic pathway called glycolysis. Then,
the major part of pyruvate is processed with the oxygen in the mitochon-
dria, obtaining 36 mol ATP per mol of glucose. The rest of pyruvate is
transformed into lactate.
• Anaerobic glycolysis: When there is not enough oxygen, all the pyruvate
obtained by glucose glycolysis is transformed into lactate, therefore obtaining
only 2 mol of ATP per mol of glucose.
The former produces a greater amount of ATP which may be thought as a greater
amount of available energy. Surprisingly, proliferative cells do not metabolize
the glucose via oxidative phosphorylation, even in presence of enough oxygen.
This fact was first observed by Otto Warburg in cancer cells and this aerobic
glycolysis is also called Warburg effect after him. Cancer cells, when proliferating,
change their metabolism and produce essentially lactate (Vander Heiden et al.,
2009). Besides, in the last years, a deeper investigation in this subject brought
to light that in the same tumor not all cells present the Warburg effect, but only
subgroups. Consequently, a symbiosis is made between subgroups, since the one
with altered metabolism produces lactate and the other uses it as the main source
of energy (Feron, 2009; Kennedy and Dewhirst, 2010; Semenza, 2008). Through
this emerging hallmark cancer cells change the energy metabolism and boost the
uncontrolled proliferation.
Evade immune destruction
The role of the immune system is to detect external agents and defective cells and
eliminate them to protect the organism. Consequently, it operates as a natural
barrier to cancer –since it recognizes potential cancerous cells as faulty–, reducing
tumor expansion in the vast majority of cancers, especially those which are virus-
induced. To avoid their destruction, cancerous cells must gain the ability to
eliminate the components dispatched by the immune system. What is more,
cancerous cells may even include immune cells into their malignant stroma. One
example is when the inflammatory cells are attracted with pro-inflammatory
signals to remove the necrotic debris (Galluzzi and Kroemer, 2008; Grivennikov
et al., 2010; White et al., 2010).
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Enabling characteristics
Two characteristics also shared by almost every cancer could be added to these
hallmarks. Both of them enable normal cells to acquire a malignant genotype.
These characteristics are:
• Genome instability and mutation: Instability of genome is inherent to
most cancer types (Loeb et al., 2003), because it is a requirement to acquire
the traits explained above. Every cell has a machinery whose mission is
to prevent mutations, usually surveying the genome during cell division.
Consequently, cancer cells need to breakdown and/or bypass one or several
components of this machinery. Once a cell has acquired a viable mutation
it proliferates and provides its offspring with the same genomic alteration.
Thereafter, one of the descendants may suffer another mutation, generating
thus clonal expansions (Loeb et al., 2003), each one with increased number
of acquired hallmarks.
• Tumor-promoting inflammation: For years, it has been known the pres-
ence of immune system cells in tumors and it has been thought that it was
an attempt by the immune system to eradicate malignant cells from the
tissues. Although this theory has been confirmed, another role has recently
been associated to immune cells, but this time as tumor-promoting ones.
Particularly, inflammatory cells contribute to the acquisition of many hall-
marks of cancer and to furnish potentially cancer cells with different aids.
Some examples extracted from DeNardo et al. (2010); Grivennikov et al.
(2010); Karnoub and Weinberg (2006-2007); Qian and Pollard (2010) are:
– Growth factors that sustain proliferative signals.
– Survival factors that limit cell death.
– Pro-angiogenic factors.
– ECM-modifying enzymes that facilitate angiogenesis, invasion and
metastasis.
– Inductive signals that lead to activation of the EMT.
– Other hallmarks-facilitating programs.
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AppendixC
Molecular mechanisms of
angiogenesis
Angiogenesis is a complex phenomenon governed by several molecular mechanism.
Our understanding of these mechanisms is limited, but has exponentially increased
over the last years. More knowledge on this topic has led to the improvement
of antiangiogenic therapies, and not only in cancer, but also in other diseases.
Nowadays, thousands of patients benefit from antiangiogenic therapies.The effect
of these treatments is, however, limited: some patients are refractory to them, and
many others develop resistance. Research continues in this field and strategies
based on recently discovered molecular pathways have shown promising results.
In this appendix we show a compilation of the most known molecular mechanisms
and a list of direct pharmacological inhibitors of angiogenesis, many of them
approved for their use as antiangiogenic drugs.
Tumor angiogenic factors
Tumor-induced angiogenesis is known to be orchestrated by more than a dozen
tumor angiogenic factors. This factors, their isoforms, and their receptors are
produced by tumor cells and their malignant stroma, have a wide variety of
functions, and can act in combination. Table C.1 summarizes the most well-known
of this factors and roles in angiogenesis.
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Other tumor angiogenic factors with relevant roles in tumor angiogenesis include:
• The Notch and WNT signalling pathways.
• Junctional molecules.
• Chemokines and G-protein-coupled receptors.
• Roundabouts (ROBO) are guidance receptors.
• UNC5B is a receptor for Netrins whose expression is enriched in tip cells.
• Semaphorins are secreted or membrane-bound guidance cues, although most
of them suppress angiogenesis.
• EPH receptors and their ephrin ligands are regulators of cell-contact-dependent
signaling.
The reader is referred to Carmeliet and Jain (2011); Figg and Folkman (2011a);
Potente et al. (2011); Tahtis and Bicknell (2005); Thurston and Kitajewski (2008);
Weis and Cheresh (2011) for more information on this subject.
Direct pharmacological inhibitors of angiogenesis
The objective of antiangiogenic therapies is to block the molecular mechanisms
that govern angiogenesis. They can be focused at different points of their molecular
pathways, such as, the diffusion of tumor angiogenic factors or the dimerization
of their receptors, and in many occasions they disrupt the pathways at several
points. We show below a list of direct inhibitors of angiogenesis for VEGF, were
we highlight those that have been approved for use in the clinic. Note that the
majority of them are approved only in combination with chemotherapy. More
angiogenic inhibitors that are at the present in clinical trials can be found at
Cancer Research UK (2015).
• Anti-VEGF agents
– Anti-human agents A4.6.1.
– Bevacizumav (Avastin): Approved for metastatic colorectal cancer,
metastatic non-squamous non-small-cell lung cancer (with chemother-
apy),metastatic breast cancer (with chemotherapy, and only in Europe),
recurrent glioblastoma multiforme (with interferon), and metastatic re-
nal cell carcinoma.
– Anti-murine VEGF-A antibodies.
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– Aflibercept (Zaltrap): Approved for metastatic colorectal cancer.
– Ramucirumab (Cyramza): Approved for advanced gastric or gastro-
esophageal junction adenocarcinoma and metastatic non-small-cell lung
carcinoma (in combination with chemotherapy).
• Anti-VEGFR agents
– DC101
– Rat anti-mouse VEGFR2 monoclonal antibody
– Antibody blocking dimerization of VEGFR2 and VEGFR3
– VEGF receptor tyrosine kinase inhibitors (TKIs)
∗ Sunitinib (Sutent): Approved for metastatic renal cell carci-
noma, imatinib-resistant gastrointestinal stromal tumor, and some
pancreatic cancers.
∗ Sorafenib (Nexavar): Approved for metastatic renal cell car-
cinoma, unresectable hepatocellular carcinoma, and radioactive
iodine resistant advanced thyroid carcinoma.
∗ Pazopanib (Votrient): Approved for metastatic renal cell carci-
noma, soft tissue sarcomas, and gastrointestinal stromal tumors.
∗ Vandetanib (Caprelsa): Approved for late-stage (metastatic)
medullary thyroid cancer.
∗ Nintedanib (Vergatef): Approved for non-small-cell lung cancer
(in combination with chemotherapy).
∗ Axitinib (Inlyta): Approved for kidney cancer.
∗ Cediranib
∗ Semaxanib
∗ TSU68
∗ Cabozantinib (Cometriq): Approved for thyroid cancer.
∗ Regorafenib (Stivarga): Colorectal cancer and gastrointestinal
stromal tumors.
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AppendixD
Angiogenesis assays
Angiogenesis assays are used to asses the validity and efficacy of antiangiogenic
therapies and to identify potential targets for new drugs. In this appendix we
detail the most used assays. They can be either in vitro or in vivo and most
studies use both of them, usually in that order. In vitro angiogenesis assays are
easier to perform than in vivo assays. In addition, they are usually faster, cheaper,
and their results are far more easy to quantitate. However, these results must
be interpreted with caution, as they may lack complex molecular mechanisms
involved in angiogenesis. They are usually complemented with in vivo assays
which, on the contrary, are more informative. The main disadvantage of the latter
is they are time consuming and difficult to quantitate.
In vitro assays Some of the more common in vitro assays include:
• Proliferation assays. They consist on monitoring endothelial cell proliferation
and counting.
• Cell migration assays: Either for chemokinesis (random) and chemotaxis
(directional).
• Tube formation in vitro.
• Coculture protocols: Their main components are endothelial cells, feeder
layers and tumor fragments.
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• Organ culture assays: They can more closely approximate in vivo assays.
The most widely used organ culture system is the aortic ring assay.
In vivo assays We detail in table D.1 the advantages and disadvantages of the
major in vivo assays. Among them, the most frequently used in current practice
are the CAM, the Matrigel plug, and the corneal micropocket assay (Figg and
Folkman, 2011a; Norrby, 2006).
Table D.1. Advantages and disadvantages of in vivo angiogenesis assays (Norrby, 2006)
Assay Advantages Disadvantages
C
or
n
ea
l
m
ic
ro
p
oc
ke
t
New vessels are easily identified.
Used in rabbits, rats, and mice.
Permits non-invasive observation and
long-term monitoring.
Quantitative.
Mammalian.
Immunologically privileged site before
vascularization.
Angiogenesis by sprouting.
Atypical angiogenesis, as the normal
cornea is avascular.
Technically demanding, especially in
mouse eye.
Traumatic technique.
Ethically questionable.
The cornea is not a highly relevant site
for tumor growth.
Exposure to oxygen via surface can af-
fect angiogenesis.
Non-specific inflammatory response
with some compounds.
Expensive.
C
A
M
Technically simple.
Inexpensive.
Suitable for large-scale screening.
Permits non-invasive observation.
Suitable for mammalian xenografts.
Very sensitive to increase in oxygen
tension.
Visualization of new vessels can be dif-
ficult.
Non-mammalian.
Embryonic.
Angiogenesis by sprouting and intus-
susceptive growth.
Accelerates or suppresses organogenic
angiogenesis (up to days 10-11).
Non-specific inflammatory reactions
common.
Drugs that require metabolic activa-
tion cannot be assessed.
D
is
c
as
sa
y
Technically simple.
Assesses wound healing and angiogen-
esis.
Quantitative analysis.
Encapsulated by granulation tissue.
The subcutaneous tissue is not highly
relevant for tumor growth.
Continued on next page
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Assay Advantages Disadvantages
M
es
en
te
ry
The adult tissue is vascularized and
lacks significant.
physiologic angiogenesis.
Truly quantitative, allowing dose-
response studies 3 in terms of
microvessel spatial extension, density
and number and length of microvessel
segments and sprouts (in rat).
Minimal trauma, if any, is inflicted in
the test tissue.
The test tissue is visceral; visceral
organs are frequent sites of metastasis.
Suitable for measurement of growth
factor-induced signaling in intact
microvessels.
Suitable for intravital microscopy.
Suitable for molecular-activity studies.
Angiogenesis by sprouting.
Time consuming.
Technically somewhat demanding.
Mice are less suitable for quantitative
angiogenesis analysis than rats.
Rats demand approximately 10 times
greater quantity of test agents than
mice.
Does not allow real-time observations.
S
p
on
ge
/m
at
ri
x
im
p
la
nt
Technically simple.
Inexpensive.
Well tolerated.
Time course of response can be
recorded.
Suitable for study of tumor angiogene-
sis.
Time consuming.
Encapsulated by granulation tissue.
Sponge composition varies, making
inter-experimental comparisons diffi-
cult.
Variable retention of test compound
within implant.
The subcutaneous tissue is not a highly
relevant site for tumor growth.
Animals have to be kept singly.
M
at
ri
ge
l
p
lu
g
Technically simple.
Suitable for large-scale screening.
Rapid quantitative analysis in cham-
bers.
The Matrigel is not chemically defined.
Difficult to make plugs uniform in 3-
dimensional shape (except in cham-
bers).
Analysis in plugs time consuming.
The subcutaneous tissue is not highly
relevant for tumor growth.
Expensive.
Not responsive to VEGF (in cham-
bers).
Z
eb
ra
fi
sh
Intact whole animal.
Technically simple.
Allows gene analysis of vessel develop-
ment.
Truly quantitative.
Large numbers of animals available for
statistical analysis.
Relatively fast assay.
Suitable for large-scale screening.
Non-mammalian.
Embryonic.
Expensive to maintain in breeding con-
dition.
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Other assays usually performed in mice or rabbits include:
• The matrigel plug assay.
• The directed in vivo angiogenesis assay (DIVAA).
• Anterior-eye chamber and eat chamber in the rabbit.
• The mouse cranial window.
• The dorsal skinfold and other skin chambers in mice.
• The dorsal air-sack.
• The hollow-fiber solid tumor model.
• Intravital microscopy.
• The Angiomouse R© system.
Research is also performed on other animals like hamsters, amphibians (as Rana
and Xenopus), Xenupus laevis tadpole or monkeys. In humans, the prime methods
employed in patients include the using imaging methods, such as, magnetic res-
onance imaging, positron emission tomography, or Doppler analysis. They allow
to determine mean vessel density, assessing vascular patterns, or visualize blood
flow.
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Extended summary in Spanish
Introducción
En la actualidad, el cáncer es la segunda mayor causa de las muertes que ocurren en
el mundo. El cáncer empieza con una única célula que ha acumulado una serie de
mutaciones normalmente tras un largo período de tiempo. Una de las principales
características de esta célula es su habilidad para crear copias de si misma sin
límites, produciendo, en la mayoría de los casos, una densa masa de células hijas
que forman un tumor sólido. La proliferación de las células cancerígenas y, por
lo tanto, el crecimiento del tumor, depende de los nutrientes y el oxígeno que les
suministran los capilares que existían previamente en el tejido. Este suministro no
es suficiente para mantener la alta tasa de crecimiento potencial de un tumor, que,
como consecuencia, mantiene un tamaño pequeño y entra en un estado de letargo;
es decir, es un tumor benigno. En algunas ocasiones, sin embargo, las células
cancerígenas adquieren la habilidad de estimular el crecimiento de nuevos vasos
capilares hacia ellas. Este proceso se llama angiogénesis tumoral y a través de él
los tumores adquieren un suministro constante de nutrientes y oxígeno. Por lo
tanto, aquellos tumores capaces de estimular la angiogénesis se vuelven malignos
al ser capaces de crecer sin límites. Los nuevos capilares les proporcionan además
acceso a todo el cuerpo a través del sistema circulatorio, facilitando la formación
de metástasis. Los tumores malignos pueden crecer tanto como para afectar el
correcto funcionamiento del órgano en el que se encuentran y, finalmente, producir
la muerte del individuo.
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La angiogénesis tumoral es un fenómeno complejo que describimos a continuación
brevemente.
Las células cancerígenas que son capaces de inducir la angiogénesis liberan sus-
tancias químicas solubles conocidas genéricamente como factores angiogénicos
tumorales. Cuando llegan a las células endoteliales que forman los vasos capilares
algunas de ellas adquieren un fenotipo migratorio y empiezan a moverse hacia
la fuente de factor angiogénico. Estas células se denominan células endoteliales
estrelladas debido a que desarrollan unas protuberancias (filopodios) que les dan
forma de estrella. Las células endoteliales adyacentes adquieren por el contrario
un fenotipo proliferativo y, a medida que se duplican, aumentan la longitud del
capilar. Las células endoteliales estrelladas migran utilizando tres mecanismos
diferentes: la quimiotaxis, la haptotaxis y la mecanotaxis. El primero está gob-
ernado por sustancias químicas solubles, el segundo por sustancias químicas no
solubles y por puntos de adhesión focal y el tercero por señales mecánicas. El
proceso de crecimiento de nuevos vasos capilares continúa hasta que las células
endoteliales estrelladas detectan otras células endoteliales próximas y se fusionan
con ellas en un proceso denominado anastomosis. Así se van generando nuevas
redes vasculares por los que puede circular la sangre y abastecer la demanda de
nutrientes y oxígeno. Debido a que la demanda de los tumores aumenta con su
tamaño y a que los nuevos capilares son defectuosos, la angiogénesis tumoral
continúa produciéndose a medida que el tumor crece.
Hace unas décadas, algunos científicos propusieron que boquear la angiogénesis
podría ser un tratamiento efectivo contra el cáncer. Esta terapia, denominada ter-
apia antiangiogénica, ha mostrado resultados prometedores en ensayos preclínicos,
pero no se han trasladado en los resultados esperados en la clínica. En la actuali-
dad, está emergiendo un nuevo paradigma en la Medicina, la Medicina Predictiva,
que se espera que cambie el campo de la Oncología y que puede proporcionar el
enfoque adecuado para entender el problema de las terapias antiangiogénicas. La
Medicina Predictiva está basada en modelos matemáticos y en la computación
y ha sido aplicada con éxito en varias áreas de la Medicina. En el campo de
la Oncología no ha hecho más que empezar, pero ya ha producido resultados
satisfactorios. Más concretamente, en la angiogénesis tumoral, numerosos inves-
tigadores han planteado modelos matemáticos para abordar el problema de las
terapias antiangiogénicas, aunque todavía son necesarias mejoras para lograr este
objetivo. La angiogénesis es un fenómeno complejo que involucra varias escalas y
mecanismos, muchos de los cuales todavía no están contemplados en estos mode-
los. Además, la mayoría de los modelos se simulan en geometrías bidimensionales
simples, mientras que la angiogénesis es un proceso tridimensional que ocurre en
tejidos u órganos con geometrías no triviales.
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Objetivos
En esta tesis desarrollamos modelos matemáticos de angiogénesis tumoral que
incluyen mecanismos biológicos fundamentales y simulamos estos modelos en con-
figuraciones experimentales relevantes y en geometrías tridimensionales específicas
de un sujeto. Esta tesis continúa la investigación desarrollada en el Grupo de
Métodos Numéricos en Ingeniería (GMNI) de la Universidade da Coruña en el
campo de la Mecánica Computacional y, en particular, es la primera en explorar
el subcampo de la Biomecánica Computacional. También es la primera tesis desar-
rollada dentro del proyecto Modeling and Simulation of Cancer Growth (MuSIC),
cuyo objetivo es desarrollar modelos predictivos para el crecimiento de cáncer con
el objetivo de cambiar el tradicional paradigma diagnóstico del tratamiento de
cáncer hacia uno predictivo y específico para cada paciente. El trabajo de esta
tesis también ha sido desarrollado en el Institute for Computational Engineering
and Sciences (ICES) de la University Of Texas At Austin durante una estancia
de investigación de cuatro meses de duración.
Los objetivos esta tesis se pueden dividir en las siguientes tres categorías:
• Modelización: La finalidad es desarrollar nuevos modelos matemáticos de
angiogénesis tumoral que incluyan mecanismos biológicos fundamentales,
en concreto, la migración de células endoteliales estrelladas por haptotaxis,
la capacidad de regresión y recrecimiento de los capilares en función de los
estímulos externos y la convección de los factores angiogénicos por el flujo
intersticial. Todos estos modelos incluyen variables continuas gobernadas
por ecuaciones diferenciales en derivadas parciales de alto orden, así como
elementos discretos.
• Simulación: La mayoría de los modelos matemáticos que se encuentran en
la literatura son simulados en geometrías bidimensionales simples. Estas con-
figuraciones facilitan el estudio de dichos modelos. En esta tesis realizaremos
simulaciones in silico de los modelos mencionados anteriormente utilizando
geometrías bidimensionales que tratan de replicar configuraciones relevantes
in vivo. Sin embargo, la angiogénesis es un proceso tridimensional que se
desarrolla en tejidos con geometrías complejas. Por lo tanto, el segundo obje-
tivo de esta tesis es ir paso más allá y realizar simulaciones tridimensionales
utilizando geometrías reales que permitan comparar los resultados con los
experimentales. En particular, nuestra meta es desarrollar simulaciones de
angiogénesis tumoral de uno de los experimentos in vivo más usados: el ex-
perimento denominado mouse corneal micropocket angiogenesis assay. Estas
simulaciones serán realizadas en tres dimensiones utilizando geometrías es-
pecíficas de sujetos y, hasta donde saben los autores, permitirán por primera
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vez la comparación entre una simulación y un experimento en geometrías
reales.
• Computacional: El tercer objetivo es desarrollar algoritmos numéricos
capaces de realizar de manera eficiente las simulaciones detalladas arriba.
En primer lugar, necesitamos desarrollar un marco matemático en el que
se puedan integrar perfectamente los elementos discretos y las variables
continúas del modelo. También necesitamos utilizar un tecnología reciente-
mente introducida, el análisis isogeométrico, capaz de manejar los términos
de alto orden de las ecuaciones en derivadas parciales, tanto en dos como
en tres dimensiones. Por último, los algoritmos tienen que ser robustos y
ser capaces de ejecutarse de manera eficiente en paralelo.
Metodología
La dinámica de la angiogénesis tumoral y su impacto en el crecimiento del cáncer
permanecen como problemas fundamentales abiertos en la biología del cáncer.
La Medicina Predictiva y, en particular la Oncología Matemática, son campos
que están en desarrollo y cuyo objetivo es predecir y proporcionar una mayor
comprensión de estos problemas. Con este fin, en este documento se han propuesto
tres nuevos modelos matemáticos para la angiogénesis tumoral que se han simulado
en dos y tres dimensiones, tanto en geometrías simples como complejas.
Los tres modelos propuestos comparten una serie de características comunes
desde el punto de vista numérico. Por lo tanto, para lograr nuestros objetivos de
modelado y simulación, hemos desarrollado en primer lugar algoritmos numéricos
adecuados. Los tres modelos son híbridos, es decir, involucran elementos discretos
gobernados por una serie de reglas discretas y variables continuas gobernadas
por ecuaciones en derivadas parciales. Ambos deben ser acoplados de manera
robusta y eficiente. Además, la evaluación de las reglas discretas implica evaluar
las variables continuas en determinados puntos. De estos puntos sólo se conocen
sus coordenadas físicas, mientras que las paramétricas, que son las necesarias para
evaluar las variables continuas, se desconocen. En geometrías simples con mapeos
lineales las coordenadas paramétricas se pueden obtener de manera directa. Sin
embargo, en geometrías complejas es necesario desarrollar un algoritmo adecuado
para obtenerlas. Por último, los tres modelos basan su definición de los capilares en
la teoría de campo de fase la cual involucra ecuaciones diferenciales en derivadas
parciales de alto orden. El método numérico tiene que ser capaz de lidiar con
estos términos para hallar una solución a las ecuaciones.
El primer paso para desarrollar el método numérico es describir los modelos en un
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marco matemático coherente. De esta manera podemos formular el acoplamiento
entre los elementos discretos y las variables continuas para permitir un tratamiento
numérico eficiente del problema junto. Esta formulación está basada en unas plan-
tillas predefinidas que utilizan la solución a la ecuación de campo de fase de
Cahn-Hilliard en una dimensión en un dominio infinito. Además, hemos desar-
rollado un método para encontrar las coordenadas paramétricas a partir de las
coordenadas físicas conocidas de los puntos en los que se evalúan las reglas discre-
tas. Este método funciona en geometrías tridimensionales complejas, que incluyen
mapeos no lineales. Está fundamentado en el método de Newton-Raphson y es
capaz de trabajar con cálculos paralelos. Para la resolución de las ecuaciones
en derivadas parciales de orden superior involucradas en la formulación de los
modelos se utilizó el análisis isogeométrico, que no sólo ofrece precisión y solidez
sino también la flexibilidad geométrica lo que necesitamos para llevar a cabo simu-
laciones en geometrías reales. También hemos utilizado el método α-generalizado
y un esquema de tiempo adaptativo que aumenta de la eficiencia de nuestros
cálculos. Por último, todos estos métodos han sido adaptados para funcionar en
paralelo usando una técnica multi-patch.
El primero modelo matemático que proponemos en esta tesis parte de uno previo
que consideraba la quimiotaxis como mecanismo de migración celular. A este mod-
elo le hemos añadido una conceptualización para la haptotaxis utilizando caminos
aleatorios circulares sesgados. Este modelo se estudió primero en configuraciones
bidimensionales con geometrías simples para adquirir una mayor comprensión
de las ecuaciones de gobierno y que nos permitieron evaluar el papel de hapto-
taxis en la angiogénesis tumoral. El objetivo final era sin embargo reproducir
un experimento en tres dimensiones usando de una geometría real. Con este fin,
hemos evolucionado la configuración inicial para representar primero geometrías
bidimensionales más grandes y después geometrías tridimensionales. En ellas re-
alizamos diferentes análisis variando la disposición de los capilares iniciales y de
los tumores, imitando configuraciones fisiológicas y experimentales. Estas simu-
laciones culminaron en el desarrollo de simulaciones de la angiogénesis tumoral
que reproducen el experimento in vivo conocido como mouse corneal micropocket
angiogenesis assay. En estas simulaciones utilizamos la geometría tridimensional,
específica de un sujeto (la córnea de un ratón c57BL/6) con más de 28, 9 millones
de grados de libertad. Hasta donde saben los autores, esta simulación permite
por primera vez la comparación entre un experimento in silico y uno in vivo en
una geometría tridimensional real.
El segundo modelo se centra en la dinámica a largo plazo de la angiogénesis
tumoral, es decir, sobre los fenómenos de regresión y recrecimiento que se pro-
ducen después del primer crecimiento de los vasos sanguíneos. La formulación de
este modelo incluye una ecuación no conservada de campo de fase (Allen-Cahn)
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cuya energía depende del factor angiogénico tumoral. Además, hemos incorpo-
rado una conceptualización de los filopodios que favorece la detección de células
endoteliales próximas y por lo tanto la anastomosis. El modelo se simuló tanto
en una réplica bidimensional del ensayo mouse corneal micropocket angiogenesis
assay como en una reproducción de un experimento in vivo con el que se comparó
cuantitativamente.
Por último, hemos desarrollado una teoría para el flujo sanguíneo e intersticial en
la escala de tejidos que acoplamos con el modelo para la angiogénesis tumoral. La
característica principal del modelo de flujo es que es una teoría completamente
continua que incluye el flujo en los capilares, a través de la pared vascular y en
el intersticio. El modelo de flujo está acoplado al de angiogénesis a través de
la convección de los factores angiogénicos. Los resultados de las simulaciones
muestran cómo el flujo altera los patrones vasculares inducidos por el tumor a
través de esta convección.
Conclusiones
Las siguientes conclusiones han sido extraídas del trabajo presentado en esta tesis:
• El modelo de Travasso et al. (2011b) presentado en el segundo capítulo
ha mostrado un potencial significativo en la predicción del crecimiento de
capilares inducidos por tumores en simulaciones a pequeña escala. Utilizando
este modelo hemos predecido la formación de diferentes patrones vasculares
en función de la proliferación y la quimiotaxis.
• Hemos desarrollado un conjunto de métodos numéricos y algoritmos que
han demostrado ser eficientes, precisos y robustos y que nos han permitido
investigar los modelos presentados en esta tesis en diferentes simulaciones
fisiológicamente relevantes. Respecto al modelo mencionado arriba en par-
ticular, estos métodos ha permitido estudiar la angiogénesis en dominios
de tamaño medio (aproximadamente cinco veces mayores que los utiliza-
dos hasta el momento) bajo diferentes distribuciones de células hipóxicas y
capilares iniciales. La conclusión de estas simulaciones es que los patrones
vasculares que predicen mantienen sus principales características a estas
escalas.
• El modelo, que originalmente solo incluía quimiotaxis, fue extendido con
una conceptualización de haptotaxis. Los resultados de este nuevo modelo
indican que la haptotaxis puede tener un papel relevante en los patrones
vasculares finales. A diferencia de las simulaciones que no incluyen hapto-
taxis, nuestros resultados revelan una complejidad y conectividad mayor
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de los patrones vasculares, unas trayectorias más tortuosas de las células
endoteliales estrelladas, un mayor número de eventos de anastomosis y unos
capilares más cortos.
• El experimento mouse corneal micropocket angiogenesis assay es amplia-
mente utilizado y sus características proporcionan un entorno excepcional
para calibrar, cuantificar y evaluar la capacidad de predicción de los mod-
elos matemáticos de angiogénesis. Este experimento plantea, sin embargo,
numerosos obstáculos numéricos y computacionales y, probablemente por
esta razón, sólo se ha reproducido en dos dimensiones hasta la fecha.
• Los métodos numéricos y algoritmos desarrollados en esta tesis proporcionan
un marco para llevar a cabo simulaciones en geometrías tridimensionales
complejas, tal y como se requiere para la reproducción del experimento
mouse corneal micropocket angiogenesis assay. En particular, el análisis
isogeométrico ha permitido simular el modelo en un dominio computacional
que es la geometría exacta de la córnea de un ratón c57BL/6 usando datos
de la literatura.
• Las simulaciones tridimensionales del experimento mouse corneal microp-
ocket angiogenesis assay sugieren que, para que los modelos matemáticos
puedan replicar la complejidad topológica observada in vivo, las simulaciones
bidimensionales pueden no ser suficientes.
• Las simulaciones en la córnea mostraron, incluso en ausencia de la concep-
tualización de la haptotaxis, el efecto conocido como brush-border effect en
tres dimensiones. Además, revelaron que los cambios en la ubicación de
la fuente de factor angiogénico conducen a diferentes patrones vasculares.
Estas simulaciones también dieron a conocer un nuevo fenómeno que no
estaba expresamente incorporado en el modelo, el cual se puede interpretar
como regresión capilar.
• El modelo de angiogénesis que incluye crecimiento, regresión, y recrecimiento
de capilares predice la plasticidad y la evolución dinámica de la angiogéne-
sis en períodos de tiempo largos. En concreto, las simulaciones muestran
similitudes cuantitativas con experimentos in vivo y capturan la regresión
de los capilares inducida por la inhibición de los factores angiogénicos y su
posterior recrecimiento tras la eliminación de la inhibición.
• La convección de los factores angiogénicos tumorales ha sido pasada por
alto en el modelado matemático. Hemos demostrado, sin embargo, que tiene
un impacto significativo en el desarrollo de patrones vasculares y que debe
ser incorporada en los modelos para mejorar sus capacidades predictivas.
• Nuestras simulaciones numéricas predicen un aumento de la malignidad de
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los tumores sólidos pequeños, ya que la convección aumenta su capacidad
de inducir la angiogénesis. También demuestran que el efecto combinado
de la convección de los factores angiogénicos y la alta presión intratumoral
dificulta la infiltración de la vasculatura en el tumor.
Por último, concluimos que los modelos matemáticos y la simulación numérica
de la angiogénesis inducida por tumores proporcionan una mayor comprensión
de los mecanismos biológicos que rigen este complejo fenómeno y que pueden ser
utilizados como una herramienta predictiva.
Futuras líneas de trabajo
Esta tesis ha abierto nuevas líneas de investigación, algunas de las cuales son el
objetivo de nuestra trabajo actual. A continuación detallamos algunas de las que,
en nuestra opinión, son más prometedoras.
Mecanotaxis: Interacción entre células endoteliales estrelladas En los
primeros capítulos aumentamos un modelo que ya contaba con quimiotaxis con
una conceptualización de la haptotaxis. El mecanismo restante, la mecanotaxis, se
define como la migración de las células endoteliales estrelladas siguiendo señales
inducidas por fuerzas mecánicas. Además, a través de la mecanotaxis las células
endoteliales estrelladas se detectan e interactúan unas con otras. Por lo tanto, el
siguiente paso lógico es incorporar la mecanotaxis en el modelo.
Análisis cuantitativo Durante el desarrollo de este trabajo, una de las mayores
dificultades fue comparar cuantitativamente las simulaciones matemáticas con
los experimentos reales. Sólo pudimos lograr comparaciones de este tipo en un
número reducido de casos bidimensionales. Hemos detectado la falta de un método
cuantitativo a partir del cual se puedan extraer las principales características de
las redes vasculares, especialmente en tres dimensiones. Una de nuestras líneas de
investigación en curso trata de paliar esta deficiencia mediante el uso de técnicas
de esqueletonización y la teoría de grafos para caracterizar la nueva vasculatura.
La mayor dificultad hasta ahora ha sido obtener y procesar las imágenes de los
experimentos.
Regresión y remodelación vascular basada en flujo En el penúltimo capí-
tulo de esta tesis hemos propuesto un modelo que incorpora regresión de vasos
sanguíneos en función de los factores angiogénicos. Existe también otro tipo
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de regresión, más relacionada con la remodelación vascular, que depende de la
funcionalidad de un capilar entendida como su capacidad de transportar sangre.
Actualmente estamos trabajando en un modelo que incorpora este tipo de re-
gresión mediante el acoplamiento de las teorías presentadas en el penúltimo y
en el último capítulo. Con este modelo se espera reproducir la regresión y la
remodelación vascular basada tanto en el factor angiogénico como en el flujo
sanguíneo.
Acoplamiento de la angiogénesis con un modelo de crecimiento tumoral
A lo largo de esta tesis se ha supuesto la existencia de un tumor estático que
no crece, cuya única función consiste en liberar factor angiogénico tumoral. Esta
suposición nos permitió centrarnos exclusivamente en el estudio de la angiogénesis.
Sin embargo, para mejorar las capacidades predictivas del modelo, tenemos que
tener en cuenta también la dinámica de crecimiento del tumor y la liberación de nu-
trientes por parte de los capilares. Hemos estado trabajando recientemente en una
teoría de dos dimensiones que acopla angiogénesis y crecimiento tumoral a través
de los nutrientes y ahora estamos generalizando a geometrías tridimensionales
reales.
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AppendixF
Extended summary in Galician
Introdución
Na actualidade, o cancro é a segunda maior causa das mortes que ocorren no
mundo. O cancro empeza cunha única célula que acumulou unha serie de mu-
tacións normalmente tras un longo período de tempo. Unha das principais carac-
terísticas desta célula é a súa habilidade para crear copias de si mesma sen límites,
producindo, na maioría dos casos, unha densa masa de células fillas que forman un
tumor sólido. A proliferación das células canceríxenas e, por tanto, o crecemento
do tumor, depende dos nutrientes e o osíxeno que lles fornecen os capilares que
existían previamente no tecido. Esta subministración non é suficiente para manter
a alta taxa de crecemento potencial dun tumor, que, como consecuencia, mantén
un tamaño pequeno e entra nun estado de letargo; é dicir, é un tumor benigno.
Nalgunhas ocasións, con todo, as células canceríxenas adquiren a habilidade de
estimular o crecemento de novos vasos capilares cara elas. Este proceso chámase
angiogénesis tumoral e a través del os tumores adquiren unha subministración
constante de nutrientes e osíxeno. Por tanto, aqueles tumores capaces de estimular
a angiogénesis vólvense malignos ao ser capaces de crecer sen límites. Os novos
capilares proporciónanlles ademais acceso a todo o corpo a través do sistema
circulatorio, facilitando a formación de metástases. Os tumores malignos poden
crecer tanto como para afectar o correcto funcionamento do órgano no que se
atopan e, finalmente, producir a morte do individuo.
A angiogénesis tumoral é un fenómeno complexo que describimos a continuación
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brevemente.
As células canceríxenas que son capaces de inducir a angiogénesis liberan sub-
stancias químicas solubles coñecidas xenericamente como factores angiogénicos
tumorales. Cando chegan ás células endoteliales que forman os vasos capilares
algunhas delas adquiren un fenotipo migratorio e empezan a moverse cara á fonte
de factor angiogénico. Estas células denomínanse células endoteliales estreladas
debido a que desenvolven unhas protuberancias (filopodios) que lles dan forma
de estrela. As células endoteliales adxacentes adquiren pola contra un fenotipo
proliferativo e, a medida que se duplican, aumentan a lonxitude do capilar. As
células endoteliales estreladas migran utilizando tres mecanismos diferentes: a
quimiotaxis, a haptotaxis e a mecanotaxis. O primeiro está gobernado por sub-
stancias químicas solubles, o segundo por substancias químicas non solubles e
puntos de adhesión focal e o terceiro por sinais mecánicos. O proceso de crece-
mento de novos vasos capilares continúa ata que as células endoteliales estreladas
detectan outras células endoteliales próximas e fusiónanse con elas nun proceso
denominado anastomose. Así se van xerando novas redes vasculares polos que
pode circular o sangue e abastecer a demanda de nutrientes e osíxeno. Debido a
que a demanda dos tumores aumenta co seu tamaño e a que os novos capilares
son defectuosos, a angiogénesis tumoral continúa producíndose a medida que o
tumor crece.
Hai unhas décadas, algúns científicos propuxeron que boquear a angiogénesis
podería ser un tratamento efectivo contra o cancro. Esta terapia, denominada
terapia antiangiogénica, mostrou resultados prometedores en ensaios preclínicos,
pero non se trasladaron nos resultados esperados na clínica. Na actualidade, está
a emerxer un novo paradigma na Medicina, o Medicina Preditiva, que se espera
que cambie o campo da Oncoloxía e que pode proporcionar o enfoque adecuado
para entender o problema das terapias antiangiogénicas. A Medicina Preditiva
está baseada en modelos matemáticos e na computación e foi aplicada con éxito
en varias áreas da Medicina. No campo da Oncoloxía non fixo máis que empezar,
pero xa produciu resultados satisfactorios. Máis concretamente, na angiogénesis
tumoral, numerosos investigadores expuxeron modelos matemáticos para abordar
o problema das terapias antiangiogénicas, aínda que son necesarias melloras para
lograr este obxectivo. A angiogénesis é un fenómeno complexo que involucra varias
escalas e mecanismos, moitos dos cales aínda non están contemplados nestes
modelos. Ademais, a maioría dos modelos simúlanse en xeometrías bidimensionais
simples, mentres que a angiogénesis é un proceso tridimensional que ocorre en
tecidos ou órganos con xeometrías non triviais.
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Obxectivos
Nesta tese desenvolvemos modelos matemáticos de angiogénesis tumoral que
inclúen mecanismos biolóxicos fundamentais e simulamos estes modelos en con-
figuracións experimentais relevantes e en xeometrías tridimensionais específicas
dun suxeito. Esta tese continúa a investigación desenvolvida no Grupo de Méto-
dos Numéricos en Enxeñería (GMNI) da Universidade dá Coruña no campo da
Mecánica Computacional e, en particular, é a primeira en explorar o subcampo
da Biomecánica Computacional. Tamén é a primeira tese desenvolvida dentro
do proxecto Modeling and Simulation of Cancer Growth (MuSIC), cuxo obxec-
tivo é desenvolver modelos preditivos para o crecemento de cancro co obxectivo
de cambiar a tradicional paradigma diagnóstico do tratamento de cancro cara
a un preditivo e específico para cada paciente. O traballo desta tese tamén foi
desenvolvido no Institute for Computational Engineering and Sciences (ICES) da
University Of Texas At Austin durante unha estancia de investigación de catro
meses de duración.
Os obxectivos desta tese pódense dividir nas seguintes tres categorías:
• Modelización: A finalidade é desenvolver novos modelos matemáticos de
angiogénesis tumoral que inclúan mecanismos biolóxicos fundamentais, en
concreto, a migración de células endoteliales estreladas por haptotaxis, a
capacidade de regresión e recrecemiento dos capilares en función dos estímu-
los externos e a convección dos factores angiogénicos polo fluxo intersticial.
Todos estes modelos inclúen variables continuas gobernadas por ecuacións
diferenciais en derivadas parciais de alta orde, así como elementos discretos.
• Simulación: A maioría dos modelos matemáticos que se atopan na liter-
atura son simulados en xeometrías bidimensionais simples. Estas configu-
racións facilitan o estudo dos devanditos modelos. Nesta tese realizaremos
simulacións in silico dos modelos mencionados anteriormente utilizando
xeometrías bidimensionais que tratan de replicar configuracións relevantes in
vivo. Con todo, a angiogénesis é un proceso tridimensional que se desenvolve
en tecidos con xeometrías complexas. Por tanto, o segundo obxectivo desta
tese é ir un paso máis aló e realizar simulacións tridimensionais utilizando
xeometrías reais que permitan comparar os resultados cos experimentais.
En particular, a nosa meta é desenvolver simulacións de angiogénesis tu-
moral dun dos experimentos in vivo máis usados: o experimento denominado
mouse corneal micropocket angiogenesis assay. Estas simulacións serán re-
alizadas en tres dimensións utilizando xeometrías específicas de suxeitos e,
ata onde saben os autores, permitirán por primeira vez a comparación entre
unha simulación e un experimento en xeometrías reais.
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• Computacional: O terceiro obxectivo é desenvolver algoritmos numéricos
capaces de realizar de maneira eficiente as simulacións detalladas arriba.
En primeiro lugar, necesitamos desenvolver un marco matemático no que
se poidan integrar perfectamente os elementos discretos e as variables con-
tinúas do modelo. Tamén necesitamos utilizar unha tecnoloxía recentemente
introducida, a análise isoxeométrica, capaz de manexar os termos de alta
orde das ecuacións en derivadas parciais, tanto en dúas como en tres di-
mensións. Por último, os algoritmos teñen que ser robustos e ser capaces de
executarse de maneira eficiente en paralelo.
Metodoloxía
A dinámica da angiogénesis tumoral e o seu impacto no crecemento do cancro
permanecen como problemas fundamentais abertos na bioloxía do cancro. A
Medicina Preditiva e, en particular a Oncoloxía Matemática, son campos que
están en desenvolvemento e cuxo obxectivo é predicir e proporcionar unha maior
comprensión destes problemas. Con este fin, neste documento propuxéronse tres
novos modelos matemáticos para a angiogénesis tumoral que se simularon en dúas
e tres dimensións, tanto en xeometrías simples como complexas.
Os tres modelos propostos comparten unha serie de características comúns desde
o punto de vista numérico. Por tanto, para lograr os nosos obxectivos de modelado
e simulación, desenvolvemos en primeiro lugar algoritmos numéricos adecuados.
Os tres modelos son híbridos, é dicir, involucran elementos discretos gobernados
por unha serie de regras discretas e variables continuas gobernadas por ecuacións
en derivadas parciais. Ambos deben ser acoplados de maneira robusta e eficiente.
Ademais, a avaliación das regras discretas implica avaliar as variables continuas
en determinados puntos. Destes puntos só se coñecen as súas coordenadas físicas,
mentres que as paramétricas, que son as necesarias para avaliar as variables con-
tinuas, descoñécense. En xeometrías simples con mapeos lineais as coordenadas
paramétricas pódense obter de maneira directa. Con todo, en xeometrías com-
plexas é necesario desenvolver un algoritmo adecuado para obtelas. Por último,
os tres modelos basean a súa definición dos capilares na teoría de campo de fase a
cal involucra ecuacións diferenciais en derivadas parciais de alta orde. O método
numérico ten que ser capaz de lidar con estes termos para achar unha solución ás
ecuacións.
O primeiro paso para desenvolver o método numérico é describir os modelos nun
marco matemático coherente. Desta maneira podemos formular o acoplamento
entre os elementos discretos e as variables continuas para permitir un tratamento
numérico eficiente do problema xunto. Esta formulación está baseada nuns padróns
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predefinidos que utilizan a solución á ecuación de campo de fase de Cahn-Hilliard
nunha dimensión nun dominio infinito. Ademais, desenvolvemos un método para
atopar as coordenadas paramétricas a partir das coordenadas físicas coñecidas dos
puntos nos que se avalían as regras discretas. Este método funciona en xeometrías
tridimensionais complexas, que inclúen mapeos non lineais. Está fundamentado
no método de Newton-Raphson e é capaz de traballar con cálculos paralelos. Para
a resolución das ecuacións en derivadas parciais de orde superior involucradas
na formulación dos modelos utilizouse a análise isoxeométrico, que non só ofrece
precisión e solidez senón tamén a flexibilidade xeométrica o que necesitamos
para levar a cabo simulacións en xeometrías reais. Tamén utilizamos o método
α-xeneralizado e un esquema de tempo adaptativo que aumenta da eficiencia dos
nosos cálculos. Por último, todos estes métodos foron adaptados para funcionar
en paralelo usando unha técnica multi-patch.
O primeiro modelo matemático que propoñemos nesta tese parte dun previo que
consideraba a quimiotaxis como mecanismo de migración celular. A este mod-
elo engadímoslle unha conceptualización para a haptotaxis utilizando camiños
aleatorios circulares nesgados. Este modelo estudouse primeiro en configuracións
bidimensionaies con xeometrías simples para adquirir unha maior comprensión
das ecuacións de goberno e que nos permitiron avaliar o papel da haptotaxis na
angiogénesis tumoral. O obxectivo final era con todo reproducir un experimento
en tres dimensións usando dunha xeometría real. Con este fin, evolucionamos a
configuración inicial para representar primeiro xeometrías bidimensionais máis
grandes e despois xeometrías tridimensionais. Nelas realizamos diferentes análises
variando a disposición dos capilares iniciais e dos tumores, imitando configuracións
fisiológicas e experimentais. Estas simulacións culminaron no desenvolvemento
de simulacións da angiogénesis tumoral que reproducen o experimento in vivo
coñecido como mouse corneal micropocket angiogenesis assay. Nestas simulacións
utilizamos a xeometría tridimensional, específica dun suxeito (a córnea dun rato
c57BL/6) con máis de 28, 9 millóns de graos de liberdade. Ata onde saben os
autores, esta simulación permite por primeira vez a comparación entre un experi-
mento in silico dun in vivo nunha xeometría tridimensional real.
O segundo modelo céntrase na dinámica a longo prazo da angiogénesis tumoral,
é dicir, sobre os fenómenos de regresión e recrecemiento que se producen despois
do primeiro crecemento dos vasos sanguíneos. A formulación deste modelo in-
clúe unha ecuación non conservada de campo de fase (Allen-Cahn) cuxa enerxía
depende do factor angiogénico tumoral. Ademais, incorporamos unha conceptual-
ización dos filopodios que favorece a detección de células endoteliales próximas e
por tanto a anastomose. O modelo simulouse tanto nunha réplica bidimensional
do ensaio mouse corneal micropocket angiogenesis assay como nunha reprodución
dun experimento in vivo co que se comparou cuantitativamente.
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Por último, desenvolvemos unha teoría para o fluxo sanguíneo e intersticial na
escala de tecidos que acoplamos co modelo para a angiogénesis tumoral. A carac-
terística principal do modelo de fluxo é que é unha teoría completamente continua
que inclúe o fluxo nos capilares, a través da parede vascular e no intersticio. O
modelo de fluxo está acoplado ao de angiogénesis a través da convección dos
factores angiogénicos. Os resultados das simulacións mostran como o fluxo altera
os patróns vasculares inducidos polo tumor a través desta convección.
Conclusións
As seguintes conclusións foron extraídas do traballo presentado nesta tese:
• O modelo de Travasso et al. (2011b) presentado no segundo capítulo mostrou
un potencial significativo na predición do crecemento de capilares inducidos
por tumores en simulacións a pequena escala. Utilizando este modelo predix-
emos a formación de diferentes patróns vasculares en función da proliferación
e a quimiotaxis.
• Desenvolvemos un conxunto de métodos numéricos e algoritmos que de-
mostraron ser eficientes, precisos e robustos e que nos permitiron investigar
os modelos presentados nesta tese en diferentes simulacións fisiológicamente
relevantes. Respecto ao modelo mencionado arriba en particular, estes méto-
dos permitiu estudar a angiogénesis en dominios de tamaño medio (aprox-
imadamente cinco veces maiores que os utilizados ata o momento) baixo
diferentes distribucións de células hipóxicas e capilares iniciais. A conclusión
destas simulacións é que os patróns vasculares que predín manteñen as súas
principais características a estas escalas.
• O modelo, que orixinalmente só incluía quimiotaxis, foi estendido cunha
conceptualización de haptotaxis. Os resultados deste novo modelo indican
que a haptotaxis pode ter un papel relevante nos patróns vasculares finais.
A diferenza das simulacións que non inclúen haptotaxis, os nosos resultados
revelan unha complexidade e conectividade maior dos patróns vasculares,
unhas traxectorias máis tortuosas das células endoteliales estreladas, un
maior número de eventos de anastomoses e uns capilares máis curtos.
• O experimento mouse corneal micropocket angiogenesis assay é amplamente
utilizado e as súas características proporcionan unha contorna excepcional
para calibrar, cuantificar e avaliar a capacidade de predición dos modelos
matemáticos de angiogénesis. Este experimento expón, con todo, numerosos
obstáculos numéricos e computacionales e, probablemente por esta razón,
só se reproduciu en dúas dimensións ata a data.
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• Os métodos numéricos e algoritmos desenvolvidos nesta tese proporcio-
nan un marco para levar a cabo simulacións en xeometrías tridimension-
ais complexas, tal e como se require para a reprodución do experimento
mouse corneal micropocket angiogenesis assay. En particular, a análise isox-
eométrico permitiu simular o modelo nun dominio computacional que é a
xeometría exacta da córnea dun rato c57BL/6 usando datos da literatura.
• As simulacións tridimensionais do experimento mouse corneal micropocket
angiogenesis assay suxiren que, para que os modelos matemáticos poidan
replicar a complexidade topolóxica observada in vivo, as simulacións bidi-
mensionais poden non ser suficientes.
• As simulacións na córnea mostraron, mesmo en ausencia da conceptual-
ización da haptotaxis, o efecto coñecido como brush-border effect en tres
dimensións. Ademais, revelaron que os cambios na localización da fonte
de factor angiogénico conducen a diferentes patróns vasculares. Estas sim-
ulacións tamén deron a coñecer un novo fenómeno que non estaba expre-
samente incorporado no modelo, o cal se pode interpretar como regresión
capilar.
• O modelo de angiogénesis que inclúe crecemento, regresión, e recrecemiento
de capilares predín a plasticidade e a evolución dinámica da angiogénesis
en períodos de tempo longos. En concreto, as simulacións mostran simil-
itudes cuantitativas con experimentos in vivo e capturan a regresión dos
capilares inducida pola inhibición dos factores angiogénicos e o seu posterior
recrecemiento tras a eliminación da inhibición.
• A convección dos factores angiogénicos tumorales foi pasada por alto no
modelado matemático. Demostramos, con todo, que ten un impacto significa-
tivo no desenvolvemento de patróns vasculares e que debe ser incorporada
nos modelos para mellorar as súas capacidades preditivas.
• Nosas simulacións numéricas predín un aumento da malignidade dos tumores
sólidos pequenos, xa que a convección aumenta a súa capacidade de inducir
a angiogénesis. Tamén demostran que o efecto combinado da convección dos
factores angiogénicos e a alta presión intratumoral dificulta a infiltración
da vasculatura no tumor.
Por último, concluímos que os modelos matemáticos e a simulación numérica
da angiogénesis inducida por tumores proporcionan unha maior comprensión
dos mecanismos biolóxicos que rexen este complexo fenómeno e que poden ser
utilizados como unha ferramenta preditiva.
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Futuras liñas de traballo
Esta tese abriu novas liñas de investigación, algunhas das cales son o obxectivo
de nosa traballo actual. A continuación detallamos algunhas das que, na nosa
opinión, son máis prometedoras.
Mecanotaxis: Interacción entre células endoteliales estreladas Nos primeiros
capítulos aumentamos un modelo que xa contaba con quimiotaxis cunha concep-
tualización da haptotaxis. O mecanismo restante, a mecanotaxis, defínese como a
migración das células endoteliales estreladas seguindo sinais inducidos por forzas
mecánicas. Ademais, a través da mecanotaxis as células endoteliales estreladas
detéctanse e interactúan unhas con outras. Por tanto, o seguinte paso lóxico é
incorporar a mecanotaxis no modelo.
Análise cuantitativa Durante o desenvolvemento deste traballo, unha das
maiores dificultades foi comparar cuantitativamente as simulacións matemáticas
cos experimentos reais. Só puidemos lograr comparacións deste tipo nun número
reducido de casos bidimensionais. Detectamos a falta dun método cuantitativo a
partir do cal se poidan extraer as principais características das redes vasculares,
especialmente en tres dimensións. Unha das nosas liñas de investigación en curso
trata de paliar esta deficiencia mediante o uso de técnicas de esqueletonización e
a teoría de grafos para caracterizar a nova vasculatura. A maior dificultade ata
agora foi obter e procesar as imaxes dos experimentos.
Regresión e remodelación vascular baseada en fluxo No penúltimo capí-
tulo desta tese propuxemos un modelo que incorpora regresión de vasos sanguíneos
en función dos factores angiogénicos. Existe tamén outro tipo de regresión, máis
relacionada coa remodelación vascular, que depende da funcionalidade dun capilar
entendida como a súa capacidade de transportar sangue. Actualmente estamos a
traballar nun modelo que incorpora este tipo de regresión mediante o acoplamento
das teorías presentadas no penúltimo e no último capítulo. Con este modelo es-
pérase reproducir a regresión e a remodelación vascular baseada tanto no factor
angiogénico como no fluxo sanguíneo.
Acoplamento da angiogénesis cun modelo de crecemento tumoral Ao
longo desta tese supúxose a existencia dun tumor estático que non crece, cuxa
única función consiste en liberar factor angiogénico tumoral. Esta suposición
permitiunos centrarnos exclusivamente no estudo da angiogénesis. Con todo, para
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mellorar as capacidades preditivas do modelo, temos que ter en conta tamén
a dinámica de crecemento do tumor e a liberación de nutrientes por parte dos
capilares. Traballamos recentemente nunha teoría de dúas dimensións que acopla
angiogénesis e crecemento tumoral a través dos nutrientes e agora estamos a
xeneralizar a xeometrías tridimensionais reais.
227
F · Extended summary in Galician
228
Bibliography
Adam, J.A. 1986. A simplified mathematical model of tumor growth. Mathematical
Biosciences, vol. 81(2), pp. 229–244. ↑30
Adam, J.A. 1987a. A mathematical model of tumor growth. II. Effects of geometry
and spatial uniformity on stability. Mathematical Biosciences, vol. 86(2), pp.
183–211. ↑30
Adam, J.A. 1987b. A mathematical model of tumor growth. III. Comparison with
experiment. Mathematical Biosciences, vol. 86(2), pp. 213–227. ↑30
Adam, J.A. and Maggelakis, S.A. 1989. Mathematical models of tumor growth.
IV. Effects of a necrotic core. Mathematical Biosciences, vol. 97(1), pp. 121–136.
↑30
Adam, J.A. and Maggelakis, S.A. 1990. Diffusion regulated characteristics of a
spherical prevascular carcinoma. Bulletin of Mathematical Biology, vol. 52(4),
pp. 549–582. ↑30
Addison-Smith, B., McElwain, D.L.S., and Maini, P.K. 2008. A simple mecha-
nistic model of sprout spacing in tumour-associated angiogenesis. Journal of
Theoretical Biology, vol. 250(1), pp. 1 – 15. ↑34
Ahrens, J., Geveci, B., and Law, C. 2005. Visualization Handbook, chapter Par-
aView: An End-User Tool for Large Data Visualization. Elsevier. ISBN 978-
0123875822. ↑67
Akkerman, I., Bazilevs, Y., Kees, C.E., and Farthing, M.W. 2011. Isogeometric
analysis of free-surface flow. Journal of Computational Physics, vol. 230(11),
pp. 4137–4152. ↑40
Alarcón, T., Byrne, H.M., and Maini, P.K. 2003. A cellular automaton model for
tumour growth in inhomogeneous environment. Journal of Theoretical Biology,
vol. 225(2), pp. 257–274. ↑38
Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P. 2007.
Molecular biology of the cell. Garland Science. ISBN 0-8153-3218-1. ↑10 , ↑13
, ↑17 , ↑20
American Asociation for Cancer Research 2015. AACR Cancer Progress Report
2015. Clinical Cancer Research, vol. 21(Supplement I), pp. SI–S128. ↑5
Ames, B.N., Gold, L.S., and Willettt, W.C. 1995. The causes and prevention
of cancer. Proceedings of the National Academy of Sciences, vol. 92(12), pp.
5258–5265. ↑5
229
Anderson, A.R.A. 2005. A hybrid mathematical model of solid tumour invasion:
the importance of cell adhesion. Mathematical Medicine and Biology, vol. 22(2),
pp. 163–186. ↑31 , ↑38
Anderson, A.R.A. and Chaplain, M.A.J. 1998a. Continuous and discrete mathe-
matical models of tumor-induced angiogenesis. Bulletin of Mathematical Biology,
vol. 60(5), pp. 857–899. ↑32 , ↑35 , ↑36 , ↑38
Anderson, A.R.A. and Chaplain, M.A.J. 1998b. A mathematical model for capil-
lary network formation in the absence of endothelial cell proliferation. Applied
Mathematics Letters, vol. 11(3), pp. 109–114. ↑32
Anderson, A.R.A., Chaplain, M.A.J., García-Reimbert, C., and Vargas, C.A. 2000.
A gradient-driven mathematical model of antiangiogenesis. Mathematical and
Computer Modelling, vol. 32(10), pp. 1141–1152. ↑32
Anijeet, D.R., Zheng, Y., Tey, A., Hodson, M., Sueke, H., and Kaye, S.B. 2012.
Imaging and evaluation of corneal vascularization using fluorescein and indo-
cyanine green angiography. Investigative Ophthalmology & Visual Science,
vol. 53(2), p. 650. ↑105
Araujo, R.P. and McElwain, D.L.S. 2004. A history of the study of solid tumour
growth: The contribution of mathematical modelling. Bulletin of Mathematical
Biology, vol. 66(5), pp. 1039–1091. ↑28
Arroyo, M. and Ortiz, M. 2006. Local maximum-entropy approximation schemes:
A seamless bridge between finite elements and meshfree methods. International
Journal for Numerical Methods in Engineering, vol. 65(13), pp. 2167–2202. ↑39
Auricchio, F., Beirão da Veiga, L., Buffa, A., Lovadina, C., Reali, A., and Sangalli,
G. 2007. A fully “locking-free” isogeometric approach for plane linear elastic-
ity problems: A stream function formulation. Computer Methods in Applied
Mechanics and Engineering, vol. 197(1-4), pp. 160–172. ↑44
Auricchio, F., Beirão da Veiga, L., Hughes, T.J.R., Reali, A., and Sangalli, G.
2010. Isogeometric collocation methods. Mathematical Models and Methods in
Applied Sciences, vol. 20(11), pp. 2075–2107. ↑40
Auricchio, F., Beirão da Veiga, L., Hughes, T.J.R., Reali, A., and Sangalli, G. 2012.
Isogeometric collocation for elastostatics and explicit dynamics. Computer
Methods in Applied Mechanics and Engineering, vol. 249-252, pp. 2–14. ↑40
Auricchio, F., Conti, M., Ferraro, M., Morganti, S., Reali, A., and Taylor, R.L.
2015. Innovative and efficient stent flexibility simulations based on isogeometric
analysis. Computer Methods in Applied Mechanics and Engineering, vol. 295,
pp. 347–361. ↑40
230
Baffert, F., Le, T., Sennino, B., Thurston, G., Kuo, C.J., Hu-Lowe, D., and Mc-
Donald, D.M. 2006. Cellular changes in normal blood capillaries undergoing
regression after inhibition of VEGF signaling. American Journal of Physiology
- Heart and Circulatory Physiology, vol. 290(2), pp. H547–H559. ↑134
Balding, D. and McElwain, D.L.S. 1985. A mathematical model of tumour-induced
capillary growth. Journal of Theoretical Biology, vol. 114(1), pp. 53–73. ↑31
Baluk, P., Hashizume, H., and McDonald, D.M. 2005. Cellular abnormalities of
blood vessels as targets in cancer. Current Opinion in Genetics & Development,
vol. 15(1), pp. 102–111. ↑25
Bartha, K. and Rieger, H. 2006. Vascular network remodeling via vessel cooption,
regression and growth in tumors. Journal of Theoretical Biology, vol. 241(4),
pp. 903–918. ↑38
Bauer, A.L., Jackson, T.L., and Jiang, Y. 2007. A cell-based model exhibiting
branching and anastomosis during tumor-induced angiogenesis. Biophysical
Journal, vol. 92(9), pp. 3105–3121. ↑36
Bauer, A.L., Jackson, T.L., and Jiang, Y. 2009. Topography of extracellular matrix
mediates vascular morphogenesis and migration speeds in angiogenesis. PLoS
Computational Biology, vol. 5(7), p. e1000445. ↑36
Baxter, L.T. and Jain, R.K. 1989. Transport of fluid and macromolecules in
tumors I. Role of interstitial pressure and convection. Microvascular Research,
vol. 37(1), pp. 77–104. ↑38 , ↑166
Baxter, L.T. and Jain, R.K. 1990. Transport of fluid and macromolecules in
tumors II. Role of heterogeneous perfusion and lymphatics. Microvascular
Research, vol. 4(2), pp. 246–263. ↑38
Baxter, L.T. and Jain, R.K. 1991a. Transport of fluid and macromolecules in
tumors III. Role of binding and metabolism. Microvascular Research, vol. 41(1),
pp. 5–23. ↑38
Baxter, L.T. and Jain, R.K. 1991b. Transport of fluid and macromolecules in
tumors IV. A microscopic model of the perivascular distribution. Microvascular
Research, vol. 41(2), pp. 252–272. ↑38
Bazilevs, Y., Calo, V.M., Cottrell, J.A., Hughes, T.J.R., Reali, A., and Scovazzi, G.
2007. Variational multiscale residual-based turbulence modeling for large eddy
simulation of incompressible flows. Computer Methods in Applied Mechanics
and Engineering, vol. 197(1-4), pp. 173–201. ↑40
Bazilevs, Y., Calo, V.M., Hughes, T.J.R., and Zhang, Y. 2008. Isogeometric fluid-
231
structure interaction: Theory, algorithms, and computations. Computational
Mechanics, vol. 43(1), pp. 3–37. ↑40
Bazilevs, Y., Calo, V.M., Zhang, Y., and Hughes, T.J.R. 2006. Isogeometric
fluid–structure interaction analysis with applications to arterial blood flow.
Computational Mechanics, vol. 38(4-5), pp. 310–322. ↑40 , ↑62
Bazilevs, Y., Michler, C., Calo, V.M., and Hughes, T.J.R. 2010. Isogeometric
variational multiscale modeling of wall-bounded turbulent flows with weakly
enforced boundary conditions on unstretched meshes. Computer Methods in
Applied Mechanics and Engineering, vol. 199(13-16), pp. 780–790. ↑39 , ↑62
Benson, D.J., Bazilevs, Y., Hsu, M.C., and Hughes, T.J.R. 2010. Isogeometric shell
analysis: The Reissner–Mindlin shell. Computer Methods in Applied Mechanics
and Engineering, vol. 199(5-8), pp. 276–289. ↑40
Bentley, K., Mariggi, G., Gerhardt, H., and Bates, P.A. 2009. Tipping the balance:
Robustness of tip cell selection, migration and fusion in angiogenesis. PLoS
Computational Biology, vol. 5(10), p. e1000549. ↑34 , ↑35
Bergers, G. and Benjamin, L.E. 2003. Tumorigenesis and the angiogenic switch.
Nature Reviews Cancer, vol. 3(6), pp. 401–410. ↑7 , ↑12
Birsner, A.E., Benny, O., and D’Amato, R.J. 2014. The corneal micropocket assay:
A model of angiogenesis in the mouse eye. Journal of Visualized Experiments:
JoVE, (90), pp. e51375–e51375. ↑105 , ↑106
Bock, K.D., Georgiadou, M., and Carmeliet, P. 2013. Role of endothelial cell
metabolism in vessel sprouting. Cell Metabolism, vol. 18(5), pp. 634 – 647. ↑27
Boon, R.A. and Dimmeler, S. 2015. MicroRNAs in myocardial infarction. Nature
Reviews Cardiology, vol. 12(3), pp. 135–142. ↑27
Boondirek, A., Triampo,W., and Nuttavut, N. 2010. A review of cellular automata
models of tumor growth. In International Mathematical Forum, vol. 5, pp. 3023–
3029. ↑31
Breward, C.J.W., Byrne, H.M., and Lewis, C.E. 2004. A multiphase model de-
scribing vascular tumour growth. Bulletin of Mathematical Biology, vol. 65(4),
pp. 609–640. ↑38
Brooks, A.N. and Hughes, T.J.R. 1982. Streamline upwind/Petrov-Galerkin
formulations for convection dominated flows with particular emphasis on the in-
compressible Navier-Stokes equations. Computer Methods in Applied Mechanics
and Engineering, vol. 32(1-3), pp. 199 – 259. ↑164
232
Bueno, J., Bona-Casas, C., Bazilevs, Y., and Gomez, H. 2015. Interaction of
complex fluids and solids: theory, algorithms and application to phase-change-
driven implosion. Computational Mechanics, vol. 55(6), pp. 1105–1118. ↑40
Bueno, J., Starodumov, I., Gomez, H., Galenko, P., and Alexandrov, D. 2016. Three
dimensional structures predicted by the modified phase field crystal equation.
Computational Materials Science, vol. 111, pp. 310 – 312. ↑40
Buffa, A., Sangalli, G., and Vázquez, R. 2010. Isogeometric analysis in electro-
magnetics: B-splines approximation. Computer Methods in Applied Mechanics
and Engineering, vol. 199(17-20), pp. 1143–1152. ↑40
Burri, P.H., Hlushchuk, R., and Djonov, V. 2004. Intussusceptive angiogenesis: its
emergence, its characteristics, and its significance. Developmental Dynamics,
vol. 231(3), pp. 474–488. ↑20
Burton, A.C. 1966. Rate of growth of solid tumours as a problem of diffusion.
Growth, vol. 30(2), pp. 157–176. ↑30
Byrne, H.M. 1999. A weakly nonlinear analysis of a model of avascular solid
tumour growth. Journal of Mathematical Biology, vol. 39(1), pp. 59–89. ↑30
Byrne, H.M. and Chaplain, M.A.J. 1995. Mathematical models for tumour an-
giogenesis: Numerical simulations and nonlinear wave solutions. Bulletin of
Mathematical Biology, vol. 57(3), pp. 461–486. ↑31 , ↑33
Byrne, H.M. and Chaplain, M.A.J. 1996. Explicit solutions of a simplified model
of capillary sprout growth during tumor angiogenesis. Applied Mathematics
Letters, vol. 9(1), pp. 69–74. ↑31
Byrne, H.M. and Chaplain, M.A.J. 1997. Free boundary value problems associated
with the growth and development of multicellular spheroids. European Journal
of Applied Mathematics, vol. 8(6), pp. 639–658. ↑30
Byrne, H.M., King, J.R., McElwain, D.L.S., and Preziosi, L. 2003. A two-phase
model of solid tumour growth. Applied Mathematics Letters, vol. 16(4), pp.
567–573. ↑31
Byrne, H.M. and Preziosi, L. 2003. Modelling solid tumour growth using the theory
of mixtures. Mathematical Medicine and Biology, vol. 20(4), pp. 341–366. ↑31
Cai, Y., Wu, J., Xu, S., Long, Q., and Yao, W. 2011. Numerical simulation of
inhibiting effects on solid tumour cells in anti-angiogenic therapy: application
of coupled mathematical model of angiogenesis with tumour growth. Applied
Mathematics and Mechanics - English Edition, vol. 32(10), pp. 1287–1296. ↑38
, ↑166
233
Camidge, D.R. and Jodrell, D.I. 2005. Introduction to the Cellular and Molecular
Biology of Cancer, chapter Chemotherapy, pp. 399–413. Oxford University Press
Inc. ISBN 019852563X. ↑16
Campelo, F. and Hernández-Machado, A. 2006. Dynamic model and stationary
shapes of fluid vesicles. European Physical Journal E, vol. 20(1), pp. 37–45.
↑49
Cancer Research UK 2015. URL http://www.cancerresearchuk.org/. ↑10 ,
↑203
Cao, R., Brakenhielm, E., Pawliuk, R., Wariaro, D., Post, M.J., Wahlberg, E.,
Leboulch, P., and Cao, Y. 2003. Angiogenic synergism, vascular stability and
improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2.
Nature Medicine, vol. 9(5), pp. 604–613. ↑124 , ↑125
Cao, R., Lim, S., Ji, H., Zhang, Y., Yang, Y., Honek, J., Hedlund, E.M., and Cao,
Y. 2011. Mouse corneal lymphangiogenesis model. Nature Protocols, vol. 6(6),
pp. 817–826. ↑104
Capasso, V. and Morale, D. 2009. Stochastic modelling of tumour-induced angio-
genesis. Journal of Mathematical Biology, vol. 58(1-2), pp. 219–233. ↑34
Carlier, A., Geris, L., Bentley, K., Carmeliet, G., Carmeliet, P., and Van Ooster-
wyck, H. 2012. MOSAIC: A multiscale model of osteogenesis and sprouting
angiogenesis with lateral inhibition of endothelial cells. PLoS Computational
Biology, vol. 8(10), p. e1002724. ↑37
Carmeliet, P. 2005. Angiogenesis in life, disease and medicine. Nature, vol.
438(7070), pp. 932–936. ↑19
Carmeliet, P. and Jain, R.K. 2000. Angiogenesis in cancer and other diseases.
Nature, vol. 407(6801), pp. 249–257. ↑19 , ↑134
Carmeliet, P. and Jain, R.K. 2011. Molecular mechanisms and clinical applications
of angiogenesis. Nature, vol. 473(7347), pp. 298–307. ↑21 , ↑22 , ↑203
Casquero, H., Bona-Casas, C., and Gomez, H. 2015a. A NURBS-based immersed
methodology for fluid-structure interaction. Computer Methods in Applied
Mechanics and Engineering, vol. 284, pp. 943–970. ↑40
Casquero, H., Lei, L., Bona-Casas, C., Zhang, J., and Gomez, H. 2015b. A hy-
brid variational-collocation immersed method for fluid-structure interaction
using unstructured T-splines. International Journal for Numerical Methods in
Engineering, vol. 105(11), pp. 855–880. ↑39
234
Casquero, H., Lei, L., Zhang, J., Reali, A., and Gomez, H. 2016. Isogeometric
collocation using analysis-suitable T-splines of arbitrary degree. Computer
Methods in Applied Mechanics and Engineering, vol. 301, pp. 164–186. ↑40
Cattaneo, L. and Zunino, P. 2014. Computational models for fluid exchange
between microcirculation and tissue interstitium. Networks and Heterogeneous
Media, vol. 9(1), pp. 135–159. ↑158
Chaplain, M.A.J. 1996. Avascular growth, angiogenesis and vascular growth in
solid tumours: The mathematical modelling of the stages of tumour development.
Mathematical and Computer Modelling, vol. 23(6), pp. 47–87. ↑28
Chaplain, M.A.J. 2000. Mathematical modelling of angiogenesis. Journal of
Neuro-Oncology, vol. 50(1-2), pp. 37–51. ↑36
Chaplain,M.A.J. and Anderson,A.R.A. 1996. Mathematical modelling, simulation
and prediction of tumour-induced angiogenesis. Invasion Metastasis, vol. 16(4-
5), pp. 222–234. ↑36
Chaplain, M.A.J. and Anderson, A.R.A. 1999. On Growth and Form: Spatio-
Temporal Pattern Formation in Biology, chapter Modeling the growth and form
of capillary networks., pp. 225–249. Wiley. ↑32
Chaplain, M.A.J. and Anderson, A.R.A. 2006. Mathematical modeling of tumor-
induced angiogenesis. Annual Review of Biomedical Engineering, vol. 8, pp.
233–257. ↑28
Chaplain, M.A.J. and Britton, N. 1993. On the concentration profile of a growth
inhibitory factor in multicell spheroids. Mathematical Biosciences, vol. 115(2),
pp. 233–243. ↑30
Chaplain, M.A.J., Giles, S.M., Sleeman, B.D., and Jarvis, R.J. 1995. A mathe-
matical analysis of a model for tumour angiogenesis. Journal of Mathematical
Biology, vol. 33(7), pp. 744–770. ↑32
Chaplain, M.A.J. and Orme, M.E. 1998. Vascular Morphogenesis: In vivo, in
vitro, in mente, chapter Mathematical modeling of tumor-induced angiogenesis,
pp. 205–240. Birkhauser Boston. ↑32
Chaplain, M.A.J. and Stuart, A.M. 1993. A model mechanism for the chemotactic
response of endothelial cells to tumour angiogenesis factor. IMA Journal of
Mathematics Applied in Medicine and Biology, vol. 10(3), pp. 149–168. ↑31
Chauviere, A.H., Hatzikirou, H., Lowengrub, J.S., Frieboes, H.B., Thompson, A.M.,
and Cristini, V. 2010. Mathematical oncology: How are the mathematical and
physical sciences contributing to the war on breast cancer? Current Breast
Cancer Reports, vol. 2(3), pp. 121–129. ↑7
235
Chen, L.Q. 2002. Phase-field models for microstructure evolution. Annual Review
of Materials Science, vol. 32, pp. 113–140. ↑49
Chung, J. and Hulbert, G.M. 1993. A time integration algorithm for structural dy-
namics with improved numerical dissipation: The generalized-α method. Jour-
nal of Applied Mechanics, vol. 60, pp. 371–375. ↑61 , ↑91 , ↑141
Codling, E.A., Plank, M.J., and Benhamou, S. 2008. Random walk models in
biology. Journal of The Royal Society Interface, vol. 5(25), pp. 813–834. ↑34
Collier, N., Dalcin, L., and Calo, V.M. 2013. PetIGA: High-performance isogeo-
metric analysis. URL https://bitbucket.org/dalcinl/petiga. ↑40
Collin, A., Sangalli, G., and Takacs, T. 2015. Approximation properties of multi-
patch C1 isogeometric spaces. ArXiv e-prints. ↑115
Conrad, T.J., Chandler, D.B., Corless, J.M., and Klintworth, G.K. 1994. In vivo
measurement of corneal angiogenesis with video data acquisition and comput-
erized image analysis. Laboratory investigation; a journal of technical methods
and pathology, vol. 70(3), pp. 426–434. ↑105
Cottrell, J.A., Hughes, T.J.R., and Bazilevs, Y. 2009. Isogeometric analysis:
Toward integration of CAD and FEA. Wiley. ISBN 9786612259470. ↑141
Cottrell, J.A., Reali, A., Bazilevs, Y., and Hughes, T.J.R. 2006. Isogeometric
analysis of structural vibrations. Computer Methods in Applied Mechanics and
Engineering, vol. 195(41-43), pp. 5257–5296. ↑40
Criado, R., del Amo, A.G., Hernández-Bermejo, B., and Romance, M. 2006. New
results on computable efficiency and its stability for complex networks. Journal
of Computational and Applied Mathematics, vol. 192(1), pp. 59 – 74. ↑96
Cristini, V., Li, X., Lowengrub, J.S., and Wise, S.M. 2009. Nonlinear simulations
of solid tumor growth using a mixture model: Invasion and branching. Journal
of Mathematical Biology, vol. 58(4-5), pp. 723–763. ↑31 , ↑49
Cristini, V., Lowengrub, J.S., and Nie, Q. 2003. Nonlinear simulation of tumor
growth. Journal of Mathematical Biology, vol. 46(3), pp. 191–224. ↑38
Cueto-Felgueroso, L. and Juanes, R. 2009. A phase field model of unsaturated
flow. Water Resources Research, vol. 45(10), p. W10409. ↑49
Cyron, C.J., Arroyo, M., and Ortiz, M. 2009. Smooth, second order, non-negative
meshfree approximants selected by maximum entropy. International Journal
for Numerical Methods in Engineering, vol. 79(13), pp. 1605–1632. ↑39
Das, A., Lauffenburger, D., Asada, H., and Kamm, R.D. 2010. A hybrid continuum-
discrete modelling approach to predict and control angiogenesis: Analysis of
236
combinatorial growth factor and matrix effects on vessel-sprouting morphology.
Philosophical Transactions of the Royal Society A: Mathematical, Physical and
Engineering Sciences, vol. 368(1921), pp. 2937–2960. ↑34
de Falco, C., Reali, A., and Vázquez, R. 2011. GeoPDEs: A research tool for
isogeometric analysis of PDEs. Advances in Engineering Software, vol. 42(12),
pp. 1020–1034. ↑40
De Lorenzis, L., Temizer, I., Wriggers, P., and Zavarise, G. 2011. A large deforma-
tion frictional contact formulation using NURBS-based isogeometric analysis.
International Journal for Numerical Methods in Engineering, vol. 87(13), pp.
1278–1300. ↑40
De Smet, F., Segura, I., De Bock, K., Hohensinner, P.J., and Carmeliet, P. 2009.
Mechanisms of vessel branching: Filopodia on endothelial tip cells lead the way.
Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29(5), pp. 639–649.
↑138 , ↑140
Deakin, A. 1976. Model for initial vascular patterns in melanoma transplants.
Growth, vol. 40(2), pp. 191–201. ↑31
DeNardo, D.G., Andreu, P., and Coussens, L.M. 2010. Interactions between lym-
phocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer
and Metastasis Reviews, vol. 29(2), pp. 309–316. ↑195
Dhote, R.P., Gomez, H., Melnik, R.N.V., and Zu, J. 2014. Isogeometric analysis
of a dynamic thermo-mechanical phase-field model applied to shape memory
alloys. Computational Mechanics, vol. 53(6), pp. 1235–1250. ↑40
Dhote, R.P., Gomez, H., Melnik, R.N.V., and Zu, J. 2015. 3D coupled thermo-
mechanical phase-field modeling of shape memory alloy dynamics via isogeo-
metric analysis. Computers & Structures, vol. 154, pp. 48 – 58. ↑40
Dias Soares Quinas Guerra, M.M. and Travasso, R.D.M. 2012. Novel approach to
vascular network modeling in 3D. In Bioengineering (ENBENG), 2012 IEEE
2nd Portuguese Meeting in, pp. 1–6. ↑37
Dimitri, R., De Lorenzis, L., Wriggers, P., and Zavarise, G. 2014a. NURBS- and T-
spline-based isogeometric cohesive zone modeling of interface debonding. Com-
putational Mechanics, vol. 54(2), pp. 369–388. ↑40
Dimitri, R., Lorenzis, L.D., Scott, M.A., Wriggers, P., Taylor, R.L., and Zavarise,
G. 2014b. Isogeometric large deformation frictionless contact using T-splines.
Computer Methods in Applied Mechanics and Engineering, vol. 269, pp. 394 –
414. ↑40
237
Ellenberg, D., Azar, D.T., Hallak, J.A., Tobaigy, F., Han, K.Y., Jain, S., Zhou, Z.,
and Chang, J.H. 2010. Novel aspects of corneal angiogenic and lymphangiogenic
privilege. Progress in Retinal and Eye Research, vol. 29(3), pp. 208 – 248. ↑102
Emmerich, H. 2003. The diffuse interface approach in materials science, vol. 73 of
Lecture Notes in Physics. Springer Berlin Heidelberg. ISBN 978-3-540-36409-2.
↑49
Emmerich, H. 2008. Advances of and by phase-field modelling in condensed-matter
physics. Advances in Physics, vol. 57(1), pp. 1–87. ↑56
Engel, G., Garikipati, K., Hughes, T.J.R., Larson, M.G., Mazzei, L., and Taylor,
R.L. 2002. Continuous/discontinuous finite element approximations of fourth-
order elliptic problems in structural and continuum mechanics with applications
to thin beams and plates, and strain gradient elasticity. Computer Methods in
Applied Mechanics and Engineering, vol. 191(34), pp. 3669–3750. ↑39
Evans, J.A. and Hughes, T.J.R. 2013. Isogeometric divergence-conforming B-
splines for the unsteady Navier–Stokes equations. Journal of Computational
Physics, vol. 241, pp. 141–167. ↑40
Falcon, B.L., Barr, S., Gokhale, P.C., Chou, J., Fogarty, J., Depeille, P., Miglarese,
M., Epstein, D.M., and McDonald, D.M. 2011. Reduced VEGF production,
angiogenesis, and vascular regrowth contribute to the antitumor properties of
dual mTORC1/mTORC2 inhibitors. Cancer Research, vol. 71(5), pp. 1573–
1583. ↑134
Fentiman, I.S. 2005. Introduction to the Cellular and Molecular Biology of Cancer,
chapter Local treatment of cancer, pp. 390–398. Oxford University Press Inc.
ISBN 019852563X. ↑16
Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo,
M., Parkin, D., Forman, D., and Bray, F. 2012. GLOBOCAN 2012 v1.0, Cancer
incidence and mortality worldwide: IARC CancerBase No. 11. URL http:
//globocan.iarc.fr. ↑1 , ↑2
Feron, O. 2009. Pyruvate into lactate and back: From the Warburg effect to
symbiotic energy fuel exchange in cancer cells. Radiotherapy and Oncology,
vol. 92(3), pp. 329–333. ↑194
Fidler, I.J. 2003. The pathogenesis of cancer metastasis: the “seed and soil”
hypothesis revisited. Nature Reviews Cancer, vol. 3(6), pp. 453–458. ↑13
Fiedler, M. 1973. Algebraic connectivity of graphs. Czechoslovak mathematical
journal, vol. 23(2), pp. 298–305. ↑96
238
Figg, W.D. and Folkman, J. 2011a. Angiogenesis: An integrative approach from
science to medicine. Springer. ISBN 978-0-387-71518-6. ↑22 , ↑136 , ↑203 ,
↑206
Figg, W.D. and Folkman, J. 2011b. Angiogenesis: An integrative approach from
science to medicine, chapter Models for Angiogenesis, pp. 299–312. Springer.
ISBN 978-0-387-71518-6. ↑102
Fischer, P., Klassen, M., Mergheim, J., Steinmann, P., and Müller, R. 2011. Isoge-
ometric analysis of 2D gradient elasticity. Computational Mechanics, vol. 47(3),
pp. 325–334. ↑44
Folkman, J. 1971. Tumor angiogenesis: Therapeutic implications. New England
Journal of Medicine, vol. 285(21), pp. 1182–1186. ↑6 , ↑12 , ↑30
Folkman, J. and Kalluri, R. 1984. Holland-Frei Cancer Medicine, chapter Tumor
angiogenesis, pp. 161–194. BC Decker Inc., 6 edition. ISBN 1-55009-213-8. ↑12
Frieboes, H.B., Jin, F., Chuang, Y.L., Wise, S.M., Lowengrub, J.S., and Cristini,
V. 2010. Three-dimensional multispecies nonlinear tumor growth-II: Tumor
invasion and angiogenesis. Journal of Theoretical Biology, vol. 264(4), pp. 1254–
1278. ↑38
Frieboes, H.B., Lowengrub, J.S., Wise, S.M., Zheng, X., Macklin, P., Bearer, E.L.,
and Cristini, V. 2007. Computer simulation of glioma growth and morphology.
NeuroImage, vol. 37(Suppl. 1), pp. S59–S70. ↑38 , ↑39
Friedl, P. and Weigelin, B. 2008. Interstitial leukocyte migration and immune
function. Nature Immunology, vol. 9(9), pp. 960–969. ↑80
Friedl, P. and Wolf, K. 2008. Tube travel: the role of proteases in individual and
collective cancer cell invasion. Cancer Research, vol. 68, pp. 7247–7249. ↑193
Friedl, P. and Wolf, K. 2010. Plasticity of cell migration: a multiscale tuning
model. Journal of Cell Biology, vol. 188, pp. 11–19. ↑193
Galluzzi, L. and Kroemer, G. 2008. Necroptosis: a specialized pathway of pro-
grammed necrosis. Cell, vol. 135(7), pp. 1161–1163. ↑194
Gatenby, R.A. and Maini, P.K. 2003. Mathematical oncology: Cancer summed
up. Nature, vol. 421(6921), pp. 321–321. ↑7
Gebb, S. and Stevens, T. 2004. On lung endothelial cell heterogeneity. Microvas-
cular Research, vol. 68(1), pp. 1 – 12. ↑86
Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abrams-
son, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D., and Betsholtz, C. 2003.
239
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. Jour-
nal of Cell Biology, vol. 161(6), pp. 1163–1177. ↑24 , ↑138
Gerlee, P. and Anderson, A.R.A. 2007. Stability analysis of a hybrid cellular
automaton model of cell colony growth. Physical Review E, vol. 75(5), p. 051911.
↑31
Gevertz, J.L. and Torquato, S. 2006. Modeling the effects of vasculature evolution
on early brain tumor growth. Journal of Theoretical Biology, vol. 243(4), pp.
517–531. ↑38
Gimbrone Jr, M.A., Cotran, R.S., Leapman, S.B., and Folkman, J. 1974. Tumor
growth and neovascularization: an experimental model using the rabbit cornea.
Journal of the National Cancer Institute, vol. 52(2), pp. 699–705. ↑36
Goel, S., Duda, D.G., Xu, L., Munn, L.L., Boucher, Y., Fukumura, D., and Jain,
R.K. 2011. Normalization of the vasculature for treatment of cancer and other
diseases. Physiological Reviews, vol. 91(3), pp. 1071–1121. ↑26 , ↑134
Gomez, H., Calo, V.M., Bazilevs, Y., and Hughes, T.J.R. 2008. Isogeometric
analysis of the Cahn-Hilliard phase-field model. Computer Methods in Applied
Mechanics and Engineering, vol. 197(49-50), pp. 4333–4352. ↑40 , ↑44 , ↑49 ,
↑62 , ↑142
Gomez, H., Cueto-Felgueroso, L., and Juanes, R. 2013. Three-dimensional sim-
ulation of unstable gravity-driven infiltration of water into a porous medium.
Journal of Computational Physics, vol. 238, pp. 217–239. ↑62 , ↑142
Gomez, H. and Hughes, T.J.R. 2011. Provably unconditionally stable, second-
order time-accurate, mixed variational methods for phase-field models. Journal
of Computational Physics, vol. 230(13), pp. 5310–5327. ↑49 , ↑62 , ↑142
Gomez, H., Hughes, T.J.R., Nogueira, X., and Calo, V.M. 2010. Isogeometric anal-
ysis of the isothermal Navier-Stokes-Korteweg equations. Computer Methods
in Applied Mechanics and Engineering, vol. 199(25-28), pp. 1828–1840. ↑44
Gomez, H. and Nogueira, X. 2012. An unconditionally energy-stable method for
the phase field crystal equation. Computer Methods in Applied Mechanics and
Engineering, vol. 249-252, pp. 52–61. ↑44
Gomez, H. and París, J. 2011. Numerical simulation of asymptotic states of the
damped Kuramoto-Sivashinsky equation. Physical Review E, vol. 83, p. 046702.
↑44
Graner, F. and Glazier, J.A. 1992. Simulation of biological cell sorting using a
two-dimensional extended Potts model. Physical Review Letters, vol. 69(13),
pp. 2013–2016. ↑36
240
Greenspan, H.P. 1972. Models for the growth of a solid tumor by diffusion. Studies
in Applied Mathematics, vol. 52(4), pp. 317–340. ↑30
Greenspan, H.P. 1974. On the self-inhibited growth of cell cultures. Growth,
vol. 38(1), pp. 81–95. ↑30
Grivennikov, S.I., Greten, F.R., and Karin, M. 2010. Immunity, inflammation and
cancer. Cell, vol. 140(6), pp. 883–899. ↑194 , ↑195
Grote, J. 1989. Tissue respiration, pp. 598–612. Springer Berlin Heidelberg. ISBN
978-3-642-73833-3. ↑87
Hanahan, D. and Weinberg, R.A. 2000. The hallmarks of cancer. Cell, vol. 100(1),
pp. 57–70. ↑10 , ↑189
Hanahan, D. and Weinberg, R.A. 2011. Hallmarks of cancer: The next generation.
Cell, vol. 144(5), pp. 646–674. ↑10 , ↑15 , ↑189 , ↑191
Harrington, H.A., Maier, M., Naidoo, L., Whitaker, N., and Kevrekidis, P.G. 2007.
A hybrid model for tumor-induced angiogenesis in the cornea in the presence of
inhibitors. Mathematical and Computer Modelling, vol. 46(3-4), pp. 513 – 524.
↑35 , ↑36 , ↑117 , ↑144
Hawkins-Daarud, A., Prudhomme, S., van der Zee, K.G., and Oden, J.T. 2013.
Bayesian calibration, validation, and uncertainty quantification of diffuse inter-
face models of tumor growth. Journal of Mathematical Biology, vol. 67(6-7),
pp. 1457–1485. ↑31
Hawkins-Daarud, A., van der Zee, K.G., and Oden, J.T. 2012. Numerical simula-
tion of a thermodynamically consistent four-species tumor growth model. Inter-
national Journal for Numerical Methods in Biomedical Engineering, vol. 28(1),
pp. 3–24. ↑31 , ↑39 , ↑56
Hellström, M., Phng, L.K., Hofmann, J.J., Wallgard, E., Coultas, L., Lindblom, P.,
Alva, J., Nilsson, A.K., Karlsson, L., Gaiano, N., Yoon, K., Rossant, J., Iruela-
Arispe, M.L., Kalén, M., Gerhardt, H., and Betsholtz, C. 2007. Dll4 signalling
through Notch1 regulates formation of tip cells during angiogenesis. Nature,
vol. 445(7129), pp. 776–780. ↑22 , ↑138
Henriksson, J.T., McDermott, A.M., and Bergmanson, J.P.G. 2009. Dimensions
and morphology of the cornea in three strains of mice. Investigative Ophthal-
mology & Visual Science, vol. 50(8), pp. 3648–3654. ↑114
Hill, N.A. and Häder, D.P. 1997. A biased random walk model for the trajectories
of swimming micro-organisms. Journal of Theoretical Biology, vol. 186(4), pp.
503 – 526. ↑34
241
Hinow, P., Gerlee, P., McCawley, L.J., Quaranta, V., Ciobanu, M., Wang, S., Gra-
ham, J.M., Ayati, B.P., Claridge, J., Swanson, K.R., et al. 2009. A spatial
model of tumor-host interaction: application of chemotherapy. Mathematical
Biosciences and Engineering: MBE, vol. 6(3), p. 521. ↑30
Hogea, C.S., Murray, B.T., and Sethian, J.A. 2006. Simulating complex tumor
dynamics from avascular to vascular growth using a general level-set method.
Journal of Mathematical Biology, vol. 53(1), pp. 86–134. ↑38
Holmes, M.J. and Sleeman, B.D. 2000. A mathematical model of tumour an-
giogenesis incorporating cellular traction and viscoelastic effects. Journal of
Theoretical Biology, vol. 202(2), pp. 95–112. ↑32
Hughes, T.J.R. 1987. The Finite Element Method: Linear Static and Dynamic
Finite Element Analysis. Dover Civil and Mechanical Engineering. Dover Pub-
lications. ISBN 0486411818. ↑39
Hughes, T.J.R., Cottrell, J.A., and Bazilevs, Y. 2005. Isogeometric analysis: CAD,
finite elements, NURBS, exact geometry and mesh refinement. Computer Meth-
ods in Applied Mechanics and Engineering, vol. 194(39-41), pp. 4135–4195. ↑39
, ↑141
Hughes, T.J.R., Feijóo, G.R., Mazzei, L., and Quincy, J.B. 1998. The variational
multiscale method–a paradigm for computational mechanics. Computer Meth-
ods in Applied Mechanics and Engineering, vol. 166(1-2), pp. 3 – 24. ↑164
Hughes, T.J.R., Reali, A., and Sangalli, G. 2008. Duality and unified analysis of
discrete approximations in structural dynamics and wave propagation: Compar-
ison of ρ-method finite elements with k -method NURBS. Computer Methods
in Applied Mechanics and Engineering, vol. 197(49-50), pp. 4104–4124. ↑40
Hughes, T.J.R., Reali, A., and Sangalli, G. 2010. Efficient quadrature for NURBS-
based isogeometric analysis. Computer Methods in Applied Mechanics and
Engineering, vol. 199(5-8), pp. 301–313. ↑40
Hugo, H., Ackland, M.L., Blick, T., Lawrence, M.G., Clements, J.A., Williams,
E.D., and Thompson, E.W. 2007. Epithelial–mesenchymal and mesenchymal–
epithelial transitions in carcinoma progression. Journal of Cellular Physiology,
vol. 213, pp. 374–383. ↑193
Hystad, M.E. and Rofstad, E.K. 1994. Oxygen consumption rate and mito-
chondrial density in human melanoma monolayer cultures and multicellular
spheroids. International Journal of Cancer, vol. 57(4), pp. 532–537. ↑30
Inai, T., Mancuso, M., Hashizume, H., Baffert, F., Haskell, A., Baluk, P., Hu-Lowe,
D.D., Shalinsky, D.R., Thurston, G., Yancopoulos, G.D., and McDonald, D.M.
242
2004. Inhibition of vascular endothelial growth factor (VEGF) signaling in
cancer causes loss of endothelial fenestrations, regression of tumor vessels, and
appearance of basement membrane ghosts. The American Journal of Pathology,
vol. 165(1), pp. 35 – 52. ↑134
Jackson, A.M. and Porte, J. 2005. Introduction to the Cellular and Molecular
Biology of Cancer, chapter Immunotherapy of cancer, pp. 443–457. Oxford
University Press Inc. ISBN 019852563X. ↑16
Jackson, T. and Zheng, X. 2010. A cell-based model of endothelial cell migra-
tion, proliferation and maturation during corneal angiogenesis. Bulletin of
Mathematical Biology, vol. 72(4), pp. 830–868. ↑35 , ↑36 , ↑117
Jain, R.K. 2001. Normalizing tumor vasculature with anti-angiogenic therapy: A
new paradigm for combination therapy. Nature Medicine, vol. 7(9), pp. 987–989.
↑26
Jain, R.K. 2005. Normalization of tumor vasculature: An emerging concept in
antiangiogenic therapy. Science, vol. 307(5706), pp. 58–62. ↑26 , ↑27
Jain, R.K., Munn, L.L., and Fukumura, D. 2002. Dissecting tumour pathophysiol-
ogy using intravital microscopy. Nature Reviews Cancer, vol. 2(4), pp. 266–276.
↑76
Jakobsson, L., Franco, C.A., Bentley, K., Collins, R.T., Ponsioen, B., Aspalter,
I.M., Rosewell, I., Busse, M., Thurston, G., Medvinsky, A., Schulte-Merker, S.,
and Gerhardt, H. 2010. Endothelial cells dynamically compete for the tip
cell position during angiogenic sprouting. Nature Cell Biology, vol. 12(10), pp.
943–953. ↑24
Jansen, K.E., Whiting, C.H., and Hulbert, G.M. 2000. A generalized-α method for
integrating the filtered Navier-Stokes equations with a stabilized finite element
method. Computer Methods in Applied Mechanics and Engineering, vol. 190(3-
4), pp. 305 – 319. ↑61 , ↑91
Kaanders, J.H.A.M., Bussink, J., and van der Kogel, A.J. 2004. Clinical studies
of hypoxia modification in radiotherapy. Seminars in Radiation Oncology,
vol. 14(3), pp. 233–240. ↑110
Kadapa, C., Dettmer, W.G., and Perić, D. 2015. NURBS based least-squares
finite element methods for fluid and solid mechanics. International Journal for
Numerical Methods in Engineering, vol. 101(7), pp. 521–539. ↑40
Karma, A. and Rappel, W.J. 1998. Quantitative phase-field modeling of dendritic
growth in two and three dimensions. Physical Review E, vol. 57, pp. 4323–4349.
↑138
243
Karnoub, A.E. and Weinberg, R.A. 2006-2007. Chemokine networks and breast
cancer metastasis. Breast Disease, vol. 26(1), pp. 75–85. ↑195
Kennedy, K.M. and Dewhirst, M.W. 2010. Tumor metabolism of lactate: the
influence and therapeutic potential for MCT and CD147 regulation. Future
Oncology, vol. 6(1), pp. 127–148. ↑194
Kenyon, B.M., Voest, E.E., Chen, C.C., Flynn, E., Folkman, J., and D’Amato, R.J.
1996. A model of angiogenesis in the mouse cornea. Investigative Ophthalmology
& Visual Science, vol. 37(8), pp. 1625–1632. ↑76 , ↑103 , ↑144 , ↑146
Kevrekidis, P.G. andWhitaker, N. 2005. Towards a reduced model for angiogenesis:
A hybrid approach. Mathematical and Computer Modelling, vol. 41(8-9), pp.
987–996. ↑36
Kevrekidis, P.G., Whitaker, N., Good, D.J., and Herring, G.J. 2006. Minimal
model for tumor angiogenesis. Physical Review E, vol. 73(6), p. 061926. ↑36
Kiendl, J., Bazilevs, Y., Hsu, M.C., Wüchner, R., and Bletzinger, K.U. 2010. The
bending strip method for isogeometric analysis of Kirchhoff–Love shell struc-
tures comprised of multiple patches. Computer Methods in Applied Mechanics
and Engineering, vol. 199(37-40), pp. 2403–2416. ↑40
Kilarski, W.W., Samolov, B., Petersson, L., Kvanta, A., and Gerwins, P. 2009.
Biomechanical regulation of blood vessel growth during tissue vascularization.
Nature Medicine, vol. 15(6), pp. 657–664. ↑19
Kiltie, A. 2005. Introduction to the Cellular and Molecular Biology of Cancer, chap-
ter Radiotherapy and molecular radiotherapy, pp. 414–427. Oxford University
Press Inc. ISBN 019852563X. ↑16
Kim, Y.T., Provatas, N., Goldenfeld, N., and Dantzig, J. 1999. Universal dynamics
of phase-field models for dendritic growth. Physical Review E, vol. 59, pp. R2546–
R2549. ↑138
Kirwan, R.P., Zheng, Y., Tey, A., Anijeet, D., Sueke, H., and Kaye, S.B. 2012.
Quantifying changes in corneal neovascularization using fluorescein and indo-
cyanine green angiography. American Journal of Ophthalmology, vol. 154(5),
pp. 850–858.e2. ↑105
Kobayashi, R. 1993. Modeling and numerical simulations of dendritic crystal
growth. Physica D: Nonlinear Phenomena, vol. 63(3-4), pp. 410–423. ↑138
Kobayashi, R. 1994. A numerical approach to three-dimensional dendritic solidi-
fication. Experimental Mathematics, vol. 3(1), pp. 59–81. ↑49 , ↑82
244
Kurz, H., Burri, P.H., and Djonov, V.G. 2003. Angiogenesis and vascular remodel-
ing by intussusception: From form to function. News in Physiological Sciences,
vol. 18(2), pp. 65–70. ↑19 , ↑20
Laird, A.K. 1964. Dynamics of tumour growth. British Journal of Cancer,
vol. 18(3), pp. 490–502. ↑30
Lang, J. 1995. Two-dimensional fully adaptive solutions of reaction-diffusion
equations. Applied Numerical Mathematics, vol. 18(1-3), pp. 223–240. ↑64
Lee, D.S., Rieger, H., and Bartha, K. 2006. Flow correlated percolation during
vascular remodeling in growing tumors. Physical Review Letters, vol. 96(5), p.
058104. ↑38
Leenders, W.P.J., Küsters, B., and de Waal, R.M.W. 2002. Vessel co-option:
How tumors obtain blood supply in the absence of sprouting angiogenesis.
Endothelium, vol. 9(2), pp. 83–87. ↑19
Levine, H.A., Pamuk, S., Sleeman, B.D., and Nilsen-Hamilton, M. 2001a. Mathe-
matical modeling of capillary formation and development in tumor angiogenesis:
Penetration into the stroma. Bulletin of Mathematical Biology, vol. 63(5), pp.
801–863. ↑32
Levine, H.A., Sleeman, B.D., and Nilsen-Hamilton, M. 2000. A mathematical
model for the roles of pericytes and macrophages in angiogenesis. I. The role of
protease inhibitors in preventing angiogenesis. Mathematical Biosciences, vol.
168(1), pp. 77–115. ↑32 , ↑34
Levine, H.A., Sleeman, B.D., and Nilsen-Hamilton, M. 2001b. Mathematical
modeling of the onset of capillary formation initiating angiogenesis. Journal of
Mathematical Biology, vol. 42(3), pp. 195–238. ↑32
Levine, H.A., Tucker, A.L., and Nilsen-Hamilton, M. 2002. A mathematical model
for the role of cell signal transduction in the initiation and inhibition of angio-
genesis. Growth Factors, vol. 20(4), pp. 155–175. ↑32
Lima, E.A., Oden, J.T., and Almeida, R.C. 2014. A hybrid ten-species phase-field
model of tumor growth. Mathematical Models and Methods in Applied Sciences,
vol. 24(13), pp. 2569–2599. ↑38
Lima, E.A.B.F., Almeida, R.C., and Oden, J.T. 2015. Analysis and numerical
solution of stochastic phase-field models of tumor growth. Numerical Methods
for Partial Differential Equations, vol. 31(2), pp. 552–574. ↑31
Liu,G., Qutub,A.A., Vempati, P.,Mac Gabhann, F., and Popel, A.S. 2011. Module-
based multiscale simulation of angiogenesis in skeletal muscle. Theoretical
Biology and Medical Modelling, vol. 8(6), pp. 1–26. ↑37
245
Liu, J., Gomez, H., Evans, J.A., Hughes, T.J.R., and Landis, C.M. 2013. Func-
tional entropy variables: A new methodology for deriving thermodynamically
consistent algorithms for complex fluids, with particular reference to the isother-
mal Navier-Stokes-Korteweg equations. Journal of Computational Physics, vol.
248, pp. 47–86. ↑40 , ↑62
Liu, J., Landis, C.M., Gomez, H., and Hughes, T.J.R. 2015. Liquid–vapor phase
transition: Thermomechanical theory, entropy stable numerical formulation, and
boiling simulations. Computer Methods in Applied Mechanics and Engineering,
vol. In press. ↑40
Liu, W., Schultz, K.M., Zhang, K., Sasman, A., Gao, F., Kume, T., and Zhang,
H.F. 2014. In vivo corneal neovascularization imaging by optical-resolution
photoacoustic microscopy. Photoacoustics, vol. 2(2), pp. 81 – 86. ↑105
Loeb, L.A., Loeb, K.R., and Anderson, J.P. 2003. Multiple mutations and cancer.
Proceedings of the National Academy of Sciences, vol. 100(3), pp. 776–781. ↑10
, ↑195
Logsdon, E.A., Finley, S.D., Popel, A.S., and Mac Gabhann, F. 2014. A systems
biology view of blood vessel growth and remodelling. Journal of Cellular and
Molecular Medicine, vol. 18(8), pp. 1491–1508. ↑28 , ↑134
Lowengrub, J.S., Frieboes, H.B., Jin, F., Chuang, Y.L., Li, X., Macklin, P., Wise,
S.M., and Cristini, V. 2010. Nonlinear modelling of cancer: Bridging the gap
between cells and tumours. Nonlinearity, vol. 23(1), pp. R1–R9. ↑28
Mahoney, A.W., Smith, B.G., Flann, N.S., and Podgorski, G.J. 2008. Discovering
novel cancer therapies: A computational modeling and search approach. In
Computational Intelligence in Bioinformatics and Computational Biology, 2008.
CIBCB ’08. IEEE Symposium on, pp. 233–240. ↑36
Mancuso, M.R., Davis, R., Norberg, S.M., O’Brien, S., Sennino, B., Nakahara, T.,
Yao, V.J., Inai, T., Brooks, P., Freimark, B., Shalinsky, D.R., Hu-Lowe, D.D.,
and McDonald, D.M. 2006. Rapid vascular regrowth in tumors after reversal of
VEGF inhibition. Journal of Clinical Investigation, vol. 116(10), pp. 2610–2621.
↑24 , ↑134 , ↑135
Mantzaris, N.V., Webb, S., and Othmer, H.G. 2004. Mathematical modeling of
tumor-induced angiogenesis. Journal of Mathematical Biology, vol. 49(2), pp.
111–187. ↑28
Marieb, E.N. 2003. Essentials of Human Anatomy & Physiology. Benjamin
Cummings. ISBN 0321695984. ↑18
Marin-Padilla, M. 1985. Early vascularization of the embryonic cerebral cortex:
246
Golgi and electron microscopic studies. The Journal of Comparative Neurology,
vol. 241(2), pp. 237–249. ↑136
Maxwell, P.H. and Ashcroft, M. 2009. Antiangiogenic cancer therapy. British
Journal of Cancer, vol. 100(9), p. 1515. ↑135
May, M. 2014. Statistics: Attacking an epidemic. Nature, vol. 509(7502), pp.
S50–S51. ↑3
Mayneord, W.V. 1932. On a law of growth of Jensen’s rat sarcoma. American
Journal of Cancer, vol. 16, pp. 841–846. ↑30
McDonald, D.M. and Choyke, P.L. 2003. Imaging of angiogenesis: from microscope
to clinic. Nature Medicine, vol. 9(6), pp. 713–725. ↑25
McDougall, S.R., Anderson, A.R.A., and Chaplain, M.A.J. 2006. Mathematical
modelling of dynamic adaptive tumour-induced angiogenesis: Clinical implica-
tions and therapeutic targeting strategies. Journal of Theoretical Biology, vol.
241(3), pp. 564–589. ↑36
McDougall, S.R., Anderson, A.R.A., Chaplain, M.A.J., and Sherrat, J.A. 2002.
Mathematical modelling of flow through vascular networks: Implications for
tumour-induced angiogenesis and chemotherapy strategies. Bulletin of Mathe-
matical Biology, vol. 64(4), pp. 673–702. ↑36
McDougall, S.R.,Watson,M.G., Devlin, A.H., Mitchell, C.A., and Chaplain, M.A.J.
2012. A hybrid discrete-continuum mathematical model of pattern prediction in
the developing retinal vasculature. Bulletin of Mathematical Biology, vol. 74(10),
pp. 2272–2314. ↑36
Milde, F., Bergdorf, M., and Koumoutsakos, P. 2008. A hybrid model for
three-dimensional simulations of sprouting angiogenesis. Biophysical Journal,
vol. 95(7), pp. 3146–3160. ↑34 , ↑35
Moreira, J. and Deutsch, A. 2002. Cellular automaton models of tumor develop-
ment: A critical review. Advances in Complex Systems, vol. 5(2-3), pp. 247–267.
↑28 , ↑31
Morganti, S., Auricchio, F., Benson, D.J., Gambarin, F.I., Hartmann, S., Hughes,
T.J.R., and Reali, A. 2015. Patient-specific isogeometric structural analysis of
aortic valve closure. Computer Methods in Applied Mechanics and Engineering,
vol. 284, pp. 508–520. ↑40
Murakami, T., Suzuma, K., Takagi, H., Kita, M., Ohashi, H., Watanabe, D., Ojima,
T., Kurimoto, M., Kimura, T., Sakamoto, A., Unoki, N., and Yoshimura, N. 2006.
Time-lapse imaging of vitreoretinal angiogenesis originating from both quiescent
247
and mature vessels in a novel ex vivo system. Investigative Ophthalmology &
Visual Science, vol. 47(12), pp. 5529–5536. ↑138
Murray, A. 1994. Cell cycle checkpoints. Current Opinion in Cell Biology, vol. 6(6),
pp. 872–876. ↑190
Muthukkaruppan, V.R., Kubai, L., and Auerbach, R. 1982. Tumor-induced neo-
vascularization in the mouse eye. Journal of the National Cancer Institute,
vol. 69(3), pp. 699–708. ↑36 , ↑76
Nagy, J. and Dvorak, H. 2012. Heterogeneity of the tumor vasculature: the
need for new tumor blood vessel type-specific targets. Clinical & Experimental
Metastasis, vol. 29(7), pp. 657–662. ↑26 , ↑27
Nguyen-Thanh, N., Nguyen-Xuan, H., Bordas, S.P.A., and Rabczuk, T. 2011. Iso-
geometric analysis using polynomial splines over hierarchical T-meshes for two-
dimensional elastic solids. Computer Methods in Applied Mechanics and Engi-
neering, vol. 200(21-22), pp. 1892–1908. ↑39
Nonomura, M. 2012. Study on multicellular systems using a phase field model.
PLoS ONE, vol. 7(4), p. e33501. ↑49
Norrby, K. 2006. In vivo models of angiogenesis. Journal of Cellular and Molecular
Medicine, vol. 10(3), pp. 588–612. ↑102 , ↑206
Oden, J.T., Hawkins-Daarud, A., and Prudhomme, S. 2010. General diffuse-
interface theories and an approach to predictive tumor growth modeling. Math-
ematical Models and Methods in Applied Sciences, vol. 20(3), pp. 477–517. ↑31
, ↑49
Oden, J.T., Lima, E.A.B.F., Almeida, R.C., Feng, Y., Rylander, M.N., Fuentes,
D., Faghihi, D., Rahman, M.M., DeWitt, M., Gadde, M., and Zhou, J.C. 2015.
Toward predictive multiscale modeling of vascular tumor growth. Archives of
Computational Methods in Engineering, pp. 1–45. ↑28
Oden, J.T., Prudencio, E.E., and Hawkins-Daarud, A. 2013. Selection and assess-
ment of phenomenological models of tumor growth. Mathematical Models and
Methods in Applied Sciences, vol. 23(7), pp. 1309–1338. ↑31
Olsen, L., Sherratt, J.A., Maini, P.K., and Arnold, F. 1997. A mathematical model
for the capillary endothelial cell-extracellular matrix interactions in wound-
healing angiogenesis. Mathematical Medicine and Biology, vol. 14(4), pp. 261–
281. ↑37
Olszewski, M.M. 2010. From macroscopic to microscopic: A brief history of the
origins and treatment of cancer in the western world. University of Toronto
Medical Journal, vol. 87(3), pp. 181–186. ↑4
248
Orme, M.E. and Chaplain, M.A.J. 1996a. A mathematical model of the first
steps of tumour-related angiogenesis: Capillary sprout formation and secondary
branching. IMA Journal of Mathematics Applied in Medicine and Biology,
vol. 13(2), pp. 73–98. ↑34
Orme, M.E. and Chaplain, M.A.J. 1996b. A mathematical model of vascular
tumour growth and invasion. Mathematical and Computer Modelling, vol. 23(10),
pp. 43 – 60. ↑38
Orme, M.E. and Chaplain, M.A.J. 1997. Two-dimensional models of tumour an-
giogenesis and anti-angiogenesis strategies. Mathematical Medicine and Biology,
vol. 14(3), pp. 189–205. ↑32 , ↑33
Othmer, H.G. and Stevens, A. 1997. Aggregation, blowup, and collapse: The
ABC’s of taxis in reinforced random walks. SIAM Journal on Applied Mathe-
matics, vol. 57(4), pp. 1044–1081. ↑84
Pauletti, M.S., Martinelli, M., Cavallini, N., and Antolin, P. 2015. Igatools: An
isogeometric analysis library. SIAM Journal on Scientific Computing, vol. 37(4),
pp. C465–C496. ↑40
Pérez-García, V.M., Calvo, G.F., Belmonte-Beitia, J., Diego, D., and Pérez-
Romasanta, L. 2011. Bright solitary waves in malignant gliomas. Physical
Review E, vol. 84(2), p. 021921. ↑31
Perfahl, H., Byrne, H.M., Chen, T., Estrella, V., Alarcón, T., Lapin, A., Gatenby,
R.A., Gillies, R.J., Lloyd, M.C., Maini, P.K., Reuss, M., and Owen, M.R. 2011.
Multiscale modelling of vascular tumour growth in 3D: The roles of domain
size and boundary conditions. PLoS ONE, vol. 6(4), p. e14790. ↑38
Peterson, J.W., Carey, G.F., Knezevic, D.J., and Murray, B.T. 2007. Adaptive
finite element methodology for tumour angiogenesis modelling. International
Journal for Numerical Methods in Engineering, vol. 69(6), pp. 1212–1238. ↑32
, ↑33
Phipps, C. and Kohandel, M. 2011. Mathematical model of the effect of interstitial
fluid pressure on angiogenic behavior in solid tumors. Computational and
Mathematical Methods in Medicine, vol. 2011(Article ID 843765), pp. 1–9. ↑38
Piegl, L. 1986. The sphere as a rational Bézier surface. Computer Aided Geometric
Design, vol. 3(1), pp. 45 – 52. ↑117
Piegl, L. and Tiller, W. 1997. The NURBS Book. Springer-Verlag Berlin Heidel-
berg. ISBN 978-3-642-97385-7. ↑39
Plank, M.J. and Sleeman, B.D. 2003. A reinforced random walk model of tumour
249
angiogenesis and anti-angiogenic strategies. Mathematical Medicine and Biology,
vol. 20(2), pp. 135–181. ↑34
Plank, M.J. and Sleeman, B.D. 2004. Lattice and non-lattice models of tumour
angiogenesis. Bulletin of Mathematical Biology, vol. 66(6), pp. 1785–1819. ↑34
, ↑80 , ↑87 , ↑88
Plank, M.J., Sleeman, B.D., and Jones, P.F. 2004. A mathematical model of
tumour angiogenesis, regulated by vascular endothelial growth factor and the
angiopoietins. Journal of Theoretical Biology, vol. 229(4), pp. 435 – 454. ↑32
Polverini, P.J., Bouck, N.P., and Rastinejad, F. 1991. Assay and purification of
naturally occurring inhibitor of angiogenesis. In Peptide Growth Factors Part
C, vol. 198 of Methods in Enzymology, pp. 440 – 450. Academic Press. ↑105
Potente, M., Gerhardt, H., and Carmeliet, P. 2011. Basic and therapeutic aspects
of angiogenesis. Cell, vol. 146(6), pp. 873–887. ↑22 , ↑134 , ↑137 , ↑203
Preziosi, L. and Tosin, A. 2009. Multiphase modelling of tumour growth and
extracellular matrix interaction: mathematical tools and applications. Journal
of Mathematical Biology, vol. 58(4-5), pp. 625–656. ↑31
Pries, A.R., Reglin, B., and Secomb, T.W. 2001. Structural adaptation of mi-
crovascular networks: functional roles of adaptive responses. American Journal
of Physiology - Heart and Circulatory Physiology, vol. 281(3), pp. H1015–H1025.
↑38 , ↑153
Pries, A.R., Secomb, T.W., and Gaehtgens, P. 1996. Biophysical aspects of blood
flow in the microvasculature. Cardiovascular Research, vol. 32(4), pp. 654–667.
↑38
Pries, A.R., Secomb, T.W., and Gaehtgens, P. 1998. Structural adaptation and
stability of microvascular networks: theory and simulations. American Journal
of Physiology - Heart and Circulatory Physiology, vol. 275(2), pp. H349–H360.
↑38 , ↑153
Pries, A.R., Secomb, T.W., Gaehtgens, P., and Gross, J.F. 1990. Blood flow in
microvascular networks: Experiments and simulation. Circulation Research,
vol. 67(4), pp. 826–834. ↑38 , ↑153
Pries, A.R., Secomb, T.W., Geβner, T., Sperandio, M.B., Gross, J.F., and Gae-
htgens, P. 1994. Resistance to blood and flow in microvessels and in vivo.
Circulation Research, vol. 75(5), pp. 904–915. ↑38 , ↑158
Provatas, N., Goldenfeld, N., and Dantzig, J. 1998. Efficient computation of
dendritic microstructures using adaptive mesh refinement. Physical Review
Letters, vol. 80, pp. 3308–3311. ↑138
250
Qian, B.Z. and Pollard, J.W. 2010. Macrophage diversity enhances tumor pro-
gression and metastasis. Cell, vol. 141(1), pp. 39–51. ↑195
Qutub, A.A., Mac Gabhann, F., Karagiannis, E.D., Vempati, P., and Popel, A.S.
2009. Multiscale models of angiogenesis. Engineering in Medicine and Biology
Magazine, IEEE, vol. 28(2), pp. 14 –31. ↑28
Reali, A. and Gomez, H. 2015. An isogeometric collocation approach for Bernoulli–
Euler beams and Kirchhoff plates. Computer Methods in Applied Mechanics
and Engineering, vol. 284, pp. 623 – 636. ↑40
Reali, A. and Hughes, T.J.R. 2015. An introduction to isogeometric collocation
methods. In G. Beer and S. Bordas, editors, Isogeometric Methods for Numerical
Simulation, vol. 561 of CISM International Centre for Mechanical Sciences, pp.
173–204. Springer Vienna. ISBN 978-3-7091-1842-9. ↑40
Reina-Romo, E., Valero, C., Borau, C., Rey, R., Javierre, E., Gómez-Benito, M.J.,
Domínguez, J., and García-Aznar, J.M. 2013. Mechanobiological modelling of
angiogenesis: Impact on tissue engineering and bone regeneration. In L. Geris,
editor, Computational Modeling in Tissue Engineering, vol. 10 of Studies in
Mechanobiology, Tissue Engineering and Biomaterials, pp. 379–404. Springer
Berlin Heidelberg. ISBN 978-3-642-32562-5. ↑37
Rogers, D.F. 2001. An Introduction to NURBS: With Historical Perspective.
Morgan Kaufmann Publishers Inc., San Francisco, CA, USA. ISBN 1-55860-
669-6. ↑39
Rogers, M.S., Birsner, A.E., and D’Amato, R.J. 2007. The mouse cornea microp-
ocket angiogenesis assay. Natature Protocols, vol. 2(10), pp. 2545–2550. ↑103 ,
↑105 , ↑144
Roose, T., Chapman, S.J., and Maini, P.K. 2007. Mathematical models of avascular
tumor growth. SIAM Reviews, vol. 49(2), pp. 179–208. ↑28
Rosolen, A. and Arroyo, M. 2013. Blending isogeometric analysis and local maxi-
mum entropy meshfree approximants. Computer Methods in Applied Mechanics
and Engineering, vol. 264, pp. 95–107. ↑40
Rosolen, A., Millán, D., and Arroyo, M. 2013. Second-order convex maximum
entropy approximants with applications to high-order PDE. International
Journal for Numerical Methods in Engineering, vol. 94(2), pp. 150–182. ↑39
Sanga, S., Frieboes, H.B., Zheng, X., Gatenby, R., Bearer, E.L., and Cristini, V.
2007. Predictive oncology: A review of multidisciplinary, multiscale in silico
modeling linking phenotype, morphology and growth. NeuroImage, vol. 37(Sup-
plement 1), pp. S120 – S134. ↑7
251
Sanga, S., Sinek, J.P., Frieboes, H.B., Ferrari, M., Fruehauf, J.P., and Cristini, V.
2006. Mathematical modeling of cancer progression and response to chemother-
apy. Expert Review of Anticancer Therapy, vol. 6(10), pp. 1361–1376. ↑28
Santos-Oliveira, P., Correia, A., Rodrigues, T., Ribeiro-Rodrigues, T.M.,Matafome,
P., Rodríguez-Manzaneque, J.C., Seiça, R., Girão, H., and Travasso, R.D.M.
2015. The force at the tip - Modelling tension and proliferation in sprouting
angiogenesis. PLoS Computational Biology, vol. 11(8), p. e1004436. ↑32
Schillinger, D., Dedé, L., Scott, M.A., Evans, J.A., Borden, M.J., Rank, E., and
Hughes, T.J.R. 2012. An isogeometric design-through-analysis methodology
based on adaptive hierarchical refinement of NURBS, immersed boundary meth-
ods, and T-spline CAD surfaces. Computer Methods in Applied Mechanics and
Engineering, vol. 249-252, pp. 116–150. ↑39
Schmidt, R., Wüchner, R., and Bletzinger, K.U. 2012. Isogeometric analysis of
trimmed NURBS geometries. Computer Methods in Applied Mechanics and
Engineering, vol. 241-244, pp. 93–111. ↑39
Schmucker, C. and Schaeffel, F. 2004. A paraxial schematic eye model for the
growing C57BL/6 mouse. Vision Research, vol. 44(16), pp. 1857–1867. ↑114
Scianna, M., Bell, C.G., and Preziosi, L. 2013. A review of mathematical models
for the formation of vascular networks. Journal of Theoretical Biology, vol. 333,
pp. 174–209. ↑28
Sciumè, G., Gray, W., Ferrari, M., Decuzzi, P., and Schrefler, B. 2013a. On com-
putational modeling in tumor growth. Archives of Computational Methods in
Engineering, vol. 20(4), pp. 327–352. ↑31
Sciumè, G., Gray, W., Hussain, F., Ferrari, M., Decuzzi, P., and Schrefler, B.
2014. Three phase flow dynamics in tumor growth. Computational Mechanics,
vol. 53(3), pp. 465–484. ↑31
Sciumè, G., Shelton, S., Gray, W.G., Miller, C.T., Hussain, F., Ferrari, M., Decuzzi,
P., and Schrefler, B.A. 2013b. A multiphase model for three-dimensional tumor
growth. New Journal of Physics, vol. 15(1), p. 015005. ↑31
Scott, M.A., Thomas, D.C., and Evans, E.J. 2014. Isogeometric spline forests.
Computer Methods in Applied Mechanics and Engineering, vol. 269, pp. 222–264.
↑39
Secomb, T.W., Alberding, J.P., Hsu, R., Dewhirst, M.W., and Pries, A.R. 2013.
Angiogenesis: An adaptive dynamic biological patterning problem. PLoS Com-
putational Biology, vol. 9(3), p. e1002983. ↑38
252
Secomb, T.W. and Pries, A.R. 2011. The microcirculation: physiology at the
mesoscale. The Journal of Physiology, vol. 589(5), pp. 1047–1052. ↑38
Semenza,G.L. 2008. Tumormetabolism: cancer cells give and take lactate. Journal
of Clinical Investigation, vol. 118(12), pp. 3835–3837. ↑194
Sherratt, J.A. and Chaplain, M.A.J. 2001. A new mathematical model for avas-
cular tumour growth. Journal of Mathematical Biology, vol. 43(4), pp. 291–312.
↑30
Shirinifard, A., Gens, J.S., Zaitlen, B.L., Popławski, N.J., Swat, M., and Glazier,
J.A. 2009. 3D multi-cell simulation of tumor growth and angiogenesis. PLoS
ONE, vol. 4(10), p. e7190. ↑38
Shiu, Y.T., Weiss, J.A., Hoying, J.B., Iwamoto, M.N., Joung, I.S., and Quam,
C.T. 2005. The role of mechanical stresses in angiogenesis. Critical Reviews in
Biomedical Engineering, vol. 33(5), pp. 431–510. ↑69 , ↑107 , ↑181
Sleeman, B. and Wallis, I.P. 2002. Tumour induced angiogenesis as a reinforced
random walk: Modelling capillary network formation without endothelial cell
proliferation. Mathematical and Computer Modelling, vol. 36(3), pp. 339–358.
↑34 , ↑88
Speleers, H., Manni, C., Pelosi, F., and Sampoli, M.L. 2012. Isogeometric analysis
with Powell–Sabin splines for advection–diffusion–reaction problems. Computer
Methods in Applied Mechanics and Engineering, vol. 221-222, pp. 132–148. ↑39
Stamper, I.J., Byrne, H.M., Owen, M.R., and Maini, P.K. 2007. Modelling the
role of angiogenesis and vasculogenesis in solid tumour growth. Bulletin of
Mathematical Biology, vol. 69(8), pp. 2737–2772. ↑32
Starling, E.H. 1896. On the absorption of fluids from the connective tissue spaces.
The Journal of Physiology, vol. 19(4), pp. 312–326. ↑153
Staton, C.A., Lewis, C., and Bicknell, R., editors 2007a. Angiogenesis Assays: A
critical appraisal of current techniques, chapter Corneal angiogenesis assay, p.
Siqing Shan and Mark W. Dewhirst. John Wiley & Sons. ISBN 978-0-470-
01600-8. ↑102
Staton, C.A., Lewis, C., and Bicknell, R., editors 2007b. Angiogenesis Assays: A
critical appraisal of current techniques. John Wiley & Sons. ISBN 978-0-470-
01600-8. ↑105
Stéphanou, A., McDougall, S.R., Anderson, A.R.A., and Chaplain, M.A.J. 2005.
Mathematical modelling of flow in 2D and 3D vascular networks: Applications
to anti-angiogenic and chemotherapeutic drug strategies. Mathematical and
Computer Modelling, vol. 41(10), pp. 1137–1156. ↑36
253
Stéphanou, A., McDougall, S.R., Anderson, A.R.A., and Chaplain., M.A.J. 2006.
Mathematical modelling of the influence of blood rheological properties upon
adaptative tumour-induced angiogenesis. Mathematical and Computer Mod-
elling, vol. 44(1-2), pp. 96–123. ↑36
Stogner, R.H. and Carey, G.F. 2007. c1 macroelements in adaptive finite ele-
ment methods. International Journal for Numerical Methods in Engineering,
vol. 70(9), pp. 1076–1095. ↑39
Stokes, C.L. and Lauffenburger, D.A. 1991. Analysis of the roles of microvessel
endothelial cell random motility and chemotaxis in angiogenesis. Journal of
Theoretical Biology, vol. 152(3), pp. 377–403. ↑34
Sudhakar, A. 2009. History of cancer, ancient and modern treatment methods.
Journal of cancer science & therapy, vol. 1(2), pp. 1–4. ↑4
Sun, S., Wheeler, M.F., Obeyesekere, M., and Patrick, C.W. 2005. A deterministic
model of growth factor-induced angiogenesis. Bulletin of Mathematical Biology,
vol. 67(2), pp. 313–337. ↑34
Szabó, A. and Czirók, A. 2010. The role of cell-cell adhesion in the formation of
multicellular sprouts. Mathematical Modelling of Natural Phenomena, vol. 5(1),
pp. 106–122. ↑36
Szabó, A., Mehes, E., Kosa, E., and Czirók, A. 2008. Multicellular sprouting in
vitro. Biophysical Journal, vol. 95(6), pp. 2702 – 2710. ↑36
Tahtis, K. and Bicknell, R. 2005. Introduction to the Cellular and Molecular
Biology of Cancer, chapter Tumour angiogenesis, pp. 289–304. Oxford University
Press Inc. ISBN 019852563X. ↑203
Takacs, T. and Jüttler, B. 2011. Existence of stiffness matrix integrals for singularly
parameterized domains in isogeometric analysis. Computer Methods in Applied
Mechanics and Engineering, vol. 200(49-52), pp. 3568 – 3582. ↑115
Takacs, T. and Jüttler, B. 2012. H2 regularity properties of singular parameter-
izations in isogeometric analysis. Graphical Models, vol. 74(6), pp. 361–372.
↑115 , ↑117
Talmadge, J.E. and Fidler, I.J. 2010. AACR centennial series: the biology of cancer
metastasis: historical perspective. Cancer Research, vol. 79, pp. 5649–5669. ↑13
Tang, Z., Zhang, F., Li, Y., Arjunan, P., Kumar, A., Lee, C., and Li, X. 2011. A
mouse model of the cornea pocket assay for angiogenesis study. Journal of
Visualized Experiments: JoVE, (54), p. e3077. ↑105
254
Taylor, C.A. and Figueroa, C.A. 2009. Patient-specific modeling of cardiovascular
mechanics. Annual Review of Biomedical Engineering, vol. 11(1), pp. 109–134.
↑7
Taylor, M. and Prendergast, P.J. 2015. Four decades of finite element analysis
of orthopaedic devices: Where are we now and what are the opportunities?
Journal of Biomechanics, vol. 48(5), pp. 767 – 778. ↑7
Thompson, K. and Byrne, H.M. 1999. Modelling the internalization of labelled
cells in tumour spheroids. Bulletin of Mathematical Biology, vol. 61(4), pp.
601–623. ↑31
Thurston, G. and Kitajewski, J. 2008. VEGF and Delta-Notch: interacting sig-
nalling pathways in tumour angiogenesis. British Journal of Cancer, vol. 99(8),
pp. 1204–1209. ↑138 , ↑203
Tong, S. and Yuan, F. 2001. Numerical simulations of angiogenesis in the cornea.
Microvascular Research, vol. 61(1), pp. 14–27. ↑35 , ↑36 , ↑38 , ↑117 , ↑146
Tong, S. and Yuan, F. 2008a. Dose response of angiogenesis to basic fibroblast
growth factor in rat corneal pocket assay: I. experimental characterizations.
Microvascular Research, vol. 75(1), pp. 10–15. ↑144
Tong, S. and Yuan, F. 2008b. Dose response of angiogenesis to basic fibroblast
growth factor in rat corneal pocket assay: II. numerical simulations. Microvas-
cular Research, vol. 75(1), pp. 16 – 24. ↑36 , ↑117 , ↑146
Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., and Jemal, A.
2015. Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians,
vol. 65(2), pp. 87–108. ↑5
Travasso, R.D.M., Castro, M., and Oliveira, J.C.R.E. 2011a. The phase-field model
in tumor growth. Philosophical Magazine, vol. 91(1), pp. 183–206. ↑28
Travasso, R.D.M., Corvera Poiré, E., Castro, M., Rodríguez-Manzaneque, J.C., and
Hernández-Machado, A. 2011b. Tumor angiogenesis and vascular patterning:
A mathematical model. PLoS ONE, vol. 6(5), p. e19989. ↑37 , ↑39 , ↑47 ,
↑48 , ↑56 , ↑58 , ↑85 , ↑86 , ↑139 , ↑142 , ↑179 , ↑214 , ↑224
UCDavis 2016. URL http://www.vetmed.ucdavis.edu/courses/vet_eyes/
eye_path/epath_overview_index.html. ↑103
Valenciano, J. and Chaplain, M.A.J. 2004. An explicit subparametric spectral
element method of lines applied to a tumour angiogenesis system of partial
differential equations. Mathematical Models and Methods in Applied Sciences,
vol. 14(2), pp. 165–187. ↑32
255
Valero, C., Javierre, E., García-Aznar, J.M., and Gómez-Benito, M.J. 2013. Numer-
ical modelling of the angiogenesis process in wound contraction. Biomechanics
and Modeling in Mechanobiology, vol. 12(2), pp. 349–360. ↑37
Valero, C., Javierre, E., García-Aznar, J.M., Gómez-Benito, M.J., and Menzel, A.
2015a. Modeling of anisotropic wound healing. Journal of the Mechanics and
Physics of Solids, vol. 79, pp. 80 – 91. ↑37
Valero, C., Javierre, E., García-Aznar, J.M., Menzel, A., and Gómez-Benito, M.J.
2015b. Challenges in the modeling of wound healing mechanisms in soft bio-
logical tissues. Annals of Biomedical Engineering, vol. 43(7), pp. 1654–1665.
↑37
Valizadeh, N., Bazilevs, Y., Chen, J.S., and Rabczuk, T. 2015. A coupled IGA–
Meshfree discretization of arbitrary order of accuracy and without global geome-
try parameterization. Computer Methods in Applied Mechanics and Engineering,
vol. 293, pp. 20–37. ↑40
Vander Heiden, M.G., Cantley, L.C., and Thompson, C.B. 2009. Understanding
the Warburg effect: the metabolic requirements of cell proliferation. Science,
vol. 324, pp. 1029–1033. ↑194
Vermolen, F.J. and Javierre, E. 2012. A finite-element model for healing of
cutaneous wounds combining contraction, angiogenesis and closure. Journal of
Mathematical Biology, vol. 65(5), pp. 967–996. ↑37
Wall, W.A., Frenzel, M.A., and Cyron, C. 2008. Isogeometric structural shape
optimization. Computer Methods in Applied Mechanics and Engineering, vol.
197(33-40), pp. 2976–2988. ↑40
Ward, J.P. and King, J.R. 1997. Mathematical modelling of avascular-tumour
growth. Mathematical Medicine and Biology, vol. 14(1), pp. 39–69. ↑31
Ward, J.P. and King, J.R. 1999. Mathematical modelling of avascular-tumour
growth II: modelling growth saturation. Mathematical Medicine and Biology,
vol. 16(2), pp. 171–211. ↑31
Weinberg, R. 1998. One renegade cell: How cancer begins. Basic Books. ISBN
0786724013. ↑4 , ↑11
Weis, S.M. and Cheresh, D.A. 2011. Tumor angiogenesis: molecular pathways
and therapeutic targets. Nature Medicine, vol. 17(11), pp. 1359–1370. ↑22 ,
↑203
Welter, M., Bartha, K., and Rieger, H. 2008. Emergent vascular network inho-
mogeneities and resulting blood flow patterns in a growing tumor. Journal of
Theoretical Biology, vol. 250(2), pp. 257–280. ↑38
256
Welter, M., Bartha, K., and Rieger, H. 2009. Vascular remodelling of an arterio-
venous blood vessel network during solid tumour growth. Journal of Theoretical
Biology, vol. 259(3), pp. 405–422. ↑38
Welter, M. and Rieger, H. 2010. Physical determinants of vascular network re-
modeling during tumor growth. The European Physical Journal E, vol. 33(2),
pp. 149–163. ↑38
Welter, M. and Rieger, H. 2013. Interstitial fluid flow and drug delivery in vascu-
larized tumors: A computational model. PLoS ONE, vol. 8(8), p. e70395. ↑38
, ↑158 , ↑166
White, E., Karp, C., Strohecker, A.M., Guo, Y., and Mathew, R. 2010. Role of
autophagy in suppression of inflammation and cancer. Current Opinion in Cell
Biology, vol. 22(2), pp. 212–217. ↑194
Wise, S.M., Lowengrub, J.S., Frieboes, H.B., and Cristini, V. 2008. Three-
dimensional multispecies nonlinear tumor growth-I: Model and numerical
method. Journal of Theoretical Biology, vol. 253(3), pp. 524–543. ↑31 , ↑39
World Bank 2014. World development indicators. URL http://dx.doi.org/10.
1596/978-1-4648-0163-1. ↑1
Wu, J., Long, Q., Xu, S., and Padhani, A.R. 2009. Study of tumor blood perfusion
and its variation due to vascular normalization by anti-angiogenic therapy based
on 3D angiogenic microvasculature. Journal of Biomechanics, vol. 42(6), pp.
712–721. ↑38
Wu, J., Xu, S., Long, Q., Collins, M.W., König, C.S., Zhao, G., Jiang, Y., and
Padhani, A.R. 2008. Coupled modeling of blood perfusion in intravascular, in-
terstitial spaces in tumor microvasculature. Journal of Biomechanics, vol. 41(5),
pp. 996–1004. ↑38
Wu,M., Frieboes, H.B.,McDougall, S.R., Chaplain,M.A.J., Cristini, V., and Lowen-
grub, J. 2013. The effect of interstitial pressure on tumor growth: Coupling
with the blood and lymphatic vascular systems. Journal of Theoretical Biology,
vol. 320, pp. 131–151. ↑38
Xia, S., Wang, X., and Qian, X. 2015. Continuity and convergence in rational
triangular Bézier spline based isogeometric analysis. Computer Methods in
Applied Mechanics and Engineering, vol. In press. ↑39
Xia, Y., Xu, Y., and Shu, C.W. 2007. Local discontinuous Galerkin methods
for the Cahn-Hilliard type equations. Journal of Computational Physics, vol.
227(1), pp. 472–491. ↑39
257
Ye, X. and Cheng, X. 2005. The Fourier spectral method for the Cahn-Hilliard
equation. Applied Mathematics and Computation, vol. 171(1), pp. 345–357.
↑39
Yu, P., Mustata, M., Peng, L., Turek, J.J., Melloch, M.R., French, P.M.W., and
Nolte, D.D. 2004. Holographic optical coherence imaging of rat osteogenic
sarcoma tumor spheroids. Applied Optics, vol. 43(25), pp. 4862–4873. ↑11
Zhang, T.Y. and Suen, C.Y. 1984. A fast parallel algorithm for thinning digital
patterns. Communications of the ACM, vol. 27(3), pp. 236–239. ↑94
Zheng, X., Wise, S.M., and Cristini, V. 2005. Nonlinear simulation of tumor necro-
sis, neo-vascularization and tissue invasion via an adaptive finite-element/level-
set method. Bulletin of Mathematical Biology, vol. 67(2), pp. 211–259. ↑38
Ziebert, F., Swaminathan, S., and Aranson, I.S. 2012. Model for self-polarization
and motility of keratocyte fragments. Journal of The Royal Society Interface,
vol. 9(70), pp. 1084–1092. ↑138
258
